<?xml version="1.0" encoding="UTF-8"?>
<java version="1.8.0_161" class="java.beans.XMLDecoder">
 <object class="Frame" id="Frame0">
  <void property="trialList">
   <void method="add">
    <object class="TrialObject" id="TrialObject0">
     <void property="attritionBiasJudgement">
      <string>It is reported that no one discontinued due to adverse effects, however it does not state if there were discontinuations due to any other reason.</string>
     </void>
     <void property="attritionBiasRisk">
      <string>Unclear Risk</string>
     </void>
     <void property="authorYearLetter">
      <string>Bailine1987</string>
     </void>
     <void property="countries">
      <string>USA</string>
     </void>
     <void property="detectionBiasJudgement">
      <string>BPRS was rater-blinded. However, it is not clear whether other outcomes were blinded.</string>
     </void>
     <void property="detectionBiasRisk">
      <string>Unclear Risk</string>
     </void>
     <void property="mainAuthor">
      <string>Bailine</string>
     </void>
     <void property="meerKatCountry">
      <string>USA</string>
     </void>
     <void property="otherBiasJudgement">
      <string>Small short study.</string>
     </void>
     <void property="otherBiasRisk">
      <string>High risk</string>
     </void>
     <void property="outcomeList">
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: b. CHLORPROMAZINE</string>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>20</int>
        </void>
        <void property="group2Name">
         <string>chlorpromazine</string>
        </void>
        <void property="group2Total">
         <int>14</int>
        </void>
        <void property="outcomeName">
         <string>Leaving the study early</string>
        </void>
        <void property="subgroupName">
         <string>any reason/general reasons</string>
        </void>
       </object>
      </void>
     </void>
     <void property="performanceBiasJudgement">
      <string>Not stated.</string>
     </void>
     <void property="performanceBiasRisk">
      <string>Unclear Risk</string>
     </void>
     <void property="references">
      <array class="java.lang.String" length="9">
       <void index="0">
        <string>JOURNAL_ARTICLE</string>
       </void>
       <void index="1">
        <string>NO</string>
       </void>
       <void index="2">
        <string>Bailine SH, Lesser MS, Krubit G, Ravasz TJ, Davis RA, Kane JM</string>
       </void>
       <void index="3">
        <string>Comparison of IM haloperidol and IM chlorpromazine in the treatment of acutely psychotic patients</string>
       </void>
       <void index="4">
        <string>Psychiatric Hospital</string>
       </void>
       <void index="5">
        <string>1987</string>
       </void>
       <void index="6">
        <string>18</string>
       </void>
       <void index="7">
        <string>3</string>
       </void>
       <void index="8">
        <string>127-9</string>
       </void>
      </array>
     </void>
     <void property="reportingBiasJudgement">
      <string>Only the significant findings/factors are reported for a number of outcomes.</string>
     </void>
     <void property="reportingBiasRisk">
      <string>High risk</string>
     </void>
     <void property="revManID">
      <string>STD-Bailine-1987</string>
     </void>
     <void property="selectionBiasAllocationConcealmentBiasRisk">
      <string>Unclear Risk</string>
     </void>
     <void property="selectionBiasAllocationConcealmentJudgement">
      <string>Not stated.</string>
     </void>
     <void property="selectionBiasRandomSequenceBiasRisk">
      <string>Low risk</string>
     </void>
     <void property="selectionBiasRandomSequenceJudgement">
      <string>&quot;random number sequence&quot;.</string>
     </void>
     <void property="year">
      <int>1987</int>
     </void>
    </object>
   </void>
   <void method="add">
    <object class="TrialObject" id="TrialObject1">
     <void property="attritionBiasJudgement">
      <string>No evidence of incomplete outcome data.</string>
     </void>
     <void property="attritionBiasRisk">
      <string>Low risk</string>
     </void>
     <void property="authorYearLetter">
      <string>Baldacara2011</string>
     </void>
     <void property="detectionBiasJudgement">
      <string>&quot;Patients were assessed by two psychiatrists. The psychiatrists were all masked with regard to the patient’s treatment assignment&quot; (p.31); no information whether the blindness was effective.</string>
     </void>
     <void property="detectionBiasRisk">
      <string>High risk</string>
     </void>
     <void property="mainAuthor">
      <string>Baldacara</string>
     </void>
     <void property="meerKatCountry">
      <string></string>
     </void>
     <void property="otherBiasJudgement">
      <string>None obvious.</string>
     </void>
     <void property="otherBiasRisk">
      <string>Low risk</string>
     </void>
     <void property="outcomeList">
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: e. OLANZAPINE</string>
        </void>
        <void property="group1Events">
         <int>4</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>30</int>
        </void>
        <void property="group2Events">
         <int>1</int>
        </void>
        <void property="group2Name">
         <string>olanzapine</string>
        </void>
        <void property="group2Total">
         <int>30</int>
        </void>
        <void property="outcomeName">
         <string>Repeated need for tranquillisation - needing additional injection</string>
        </void>
        <void property="subgroupName">
         <string>by 2 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: e. OLANZAPINE</string>
        </void>
        <void property="group1Events">
         <int>23</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>30</int>
        </void>
        <void property="group2Events">
         <int>7</int>
        </void>
        <void property="group2Name">
         <string>olanzapine</string>
        </void>
        <void property="group2Total">
         <int>30</int>
        </void>
        <void property="outcomeName">
         <string>Repeated need for tranquillisation - needing additional injection</string>
        </void>
        <void property="subgroupName">
         <string>by 12 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: e. OLANZAPINE</string>
        </void>
        <void property="group1Events">
         <int>6</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>30</int>
        </void>
        <void property="group2Events">
         <int>1</int>
        </void>
        <void property="group2Name">
         <string>olanzapine</string>
        </void>
        <void property="group2Total">
         <int>30</int>
        </void>
        <void property="outcomeName">
         <string>Global outcome: 1a. General - need for additional measures</string>
        </void>
        <void property="subgroupName">
         <string>additional restraint, seclusion or special observation</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: e. OLANZAPINE</string>
        </void>
        <void property="group1Events">
         <int>11</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>30</int>
        </void>
        <void property="group2Events">
         <int>5</int>
        </void>
        <void property="group2Name">
         <string>olanzapine</string>
        </void>
        <void property="group2Total">
         <int>30</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 1a. General</string>
        </void>
        <void property="subgroupName">
         <string>one or more drug related adverse events</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: e. OLANZAPINE</string>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>30</int>
        </void>
        <void property="group2Name">
         <string>olanzapine</string>
        </void>
        <void property="group2Total">
         <int>30</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 1b. General - serious</string>
        </void>
        <void property="subgroupName">
         <string>death</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: e. OLANZAPINE</string>
        </void>
        <void property="group1Events">
         <int>3</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>30</int>
        </void>
        <void property="group2Events">
         <int>1</int>
        </void>
        <void property="group2Name">
         <string>olanzapine</string>
        </void>
        <void property="group2Total">
         <int>30</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2b. Specific - arousal level - i. various</string>
        </void>
        <void property="subgroupName">
         <string>excessive sedation during 24 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: e. OLANZAPINE</string>
        </void>
        <void property="group1Name">
         <string>HALOPERIDOL </string>
        </void>
        <void property="group1NameProse">
         <string>HALOPERIDOL </string>
        </void>
        <void property="group1Total">
         <int>30</int>
        </void>
        <void property="group2Events">
         <int>1</int>
        </void>
        <void property="group2Name">
         <string>olanzapine</string>
        </void>
        <void property="group2NameProse">
         <string> other antipsychotic: e. olanzapine</string>
        </void>
        <void property="group2Total">
         <int>30</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2f. Specific - cardiovascular i. binary</string>
        </void>
        <void property="subgroupName">
         <string>hypotension during 24 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: e. OLANZAPINE</string>
        </void>
        <void property="group1Events">
         <int>5</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>30</int>
        </void>
        <void property="group2Name">
         <string>olanzapine</string>
        </void>
        <void property="group2Total">
         <int>30</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2i. Specific - movement disorder - i. various</string>
        </void>
        <void property="subgroupName">
         <string>EPS during 24 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: j. ZIPRASIDONE</string>
        </void>
        <void property="group1Events">
         <int>4</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>30</int>
        </void>
        <void property="group2Events">
         <int>11</int>
        </void>
        <void property="group2Name">
         <string>ziprasidone</string>
        </void>
        <void property="group2Total">
         <int>30</int>
        </void>
        <void property="outcomeName">
         <string>Repeated need for tranquillisation - need for additional drugs for tranquillisation</string>
        </void>
        <void property="subgroupName">
         <string>up to 2 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: j. ZIPRASIDONE</string>
        </void>
        <void property="group1Events">
         <int>23</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>30</int>
        </void>
        <void property="group2Events">
         <int>14</int>
        </void>
        <void property="group2Name">
         <string>ziprasidone</string>
        </void>
        <void property="group2Total">
         <int>30</int>
        </void>
        <void property="outcomeName">
         <string>Repeated need for tranquillisation - need for additional drugs for tranquillisation</string>
        </void>
        <void property="subgroupName">
         <string>up to 24 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: j. ZIPRASIDONE</string>
        </void>
        <void property="group1Events">
         <int>6</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>30</int>
        </void>
        <void property="group2Events">
         <int>10</int>
        </void>
        <void property="group2Name">
         <string>ziprasidone</string>
        </void>
        <void property="group2Total">
         <int>30</int>
        </void>
        <void property="outcomeName">
         <string>Global outcome: 1. General - need for additional measures</string>
        </void>
        <void property="subgroupName">
         <string>additional restraint, seclusion or special observation during 12 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: j. ZIPRASIDONE</string>
        </void>
        <void property="group1Events">
         <int>11</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>30</int>
        </void>
        <void property="group2Events">
         <int>8</int>
        </void>
        <void property="group2Name">
         <string>ziprasidone</string>
        </void>
        <void property="group2Total">
         <int>30</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 1a. General - i. up to 24 hours</string>
        </void>
        <void property="subgroupName">
         <string>one or more drug related adverse effects - by 12 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: j. ZIPRASIDONE</string>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>30</int>
        </void>
        <void property="group2Name">
         <string>ziprasidone</string>
        </void>
        <void property="group2Total">
         <int>30</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 1c. General - serious</string>
        </void>
        <void property="subgroupName">
         <string>death</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: j. ZIPRASIDONE</string>
        </void>
        <void property="group1Events">
         <int>3</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>30</int>
        </void>
        <void property="group2Events">
         <int>3</int>
        </void>
        <void property="group2Name">
         <string>ziprasidone</string>
        </void>
        <void property="group2Total">
         <int>30</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2b. Specific - arousal level - i. various</string>
        </void>
        <void property="subgroupName">
         <string>excessive sedation at 12 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: j. ZIPRASIDONE</string>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>30</int>
        </void>
        <void property="group2Events">
         <int>6</int>
        </void>
        <void property="group2Name">
         <string>ziprasidone</string>
        </void>
        <void property="group2Total">
         <int>30</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2f. Specific - cardiovascular</string>
        </void>
        <void property="subgroupName">
         <string>hypotension at 12 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: j. ZIPRASIDONE</string>
        </void>
        <void property="group1Events">
         <int>5</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>30</int>
        </void>
        <void property="group2Name">
         <string>ziprasidone</string>
        </void>
        <void property="group2Total">
         <int>30</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2i. Specific - movement disorders - i. binary measures</string>
        </void>
        <void property="subgroupName">
         <string>EPS - by 12 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs COMBINATIONS: c. HALOPERIDOL + MIDAZOLAM</string>
        </void>
        <void property="group1Events">
         <int>4</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>30</int>
        </void>
        <void property="group2Events">
         <int>15</int>
        </void>
        <void property="group2Name">
         <string>haloperidol//midazolam</string>
        </void>
        <void property="group2NameProse">
         <string> combinations: c. haloperidol + midazolam</string>
        </void>
        <void property="group2Total">
         <int>30</int>
        </void>
        <void property="outcomeName">
         <string>Repeated need for tranquillisation</string>
        </void>
        <void property="subgroupName">
         <string>need for additional drugs for tranquillisation up to 2 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs COMBINATIONS: c. HALOPERIDOL + MIDAZOLAM</string>
        </void>
        <void property="group1Events">
         <int>23</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>30</int>
        </void>
        <void property="group2Events">
         <int>26</int>
        </void>
        <void property="group2Name">
         <string>haloperidol//midazolam</string>
        </void>
        <void property="group2NameProse">
         <string> combinations: c. haloperidol + midazolam</string>
        </void>
        <void property="group2Total">
         <int>30</int>
        </void>
        <void property="outcomeName">
         <string>Repeated need for tranquillisation</string>
        </void>
        <void property="subgroupName">
         <string>need for additional drugs for tranquillisation by 12 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs COMBINATIONS: c. HALOPERIDOL + MIDAZOLAM</string>
        </void>
        <void property="group1Events">
         <int>6</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>30</int>
        </void>
        <void property="group2Events">
         <int>21</int>
        </void>
        <void property="group2Name">
         <string>haloperidol//midazolam</string>
        </void>
        <void property="group2NameProse">
         <string> combinations: c. haloperidol + midazolam</string>
        </void>
        <void property="group2Total">
         <int>30</int>
        </void>
        <void property="outcomeName">
         <string>Global outcomes: 1. General - need for additional measures</string>
        </void>
        <void property="subgroupName">
         <string>additional restraint, seclusion or special observation during 12 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs COMBINATIONS: c. HALOPERIDOL + MIDAZOLAM</string>
        </void>
        <void property="group1Events">
         <int>11</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>30</int>
        </void>
        <void property="group2Events">
         <int>15</int>
        </void>
        <void property="group2Name">
         <string>haloperidol//midazolam</string>
        </void>
        <void property="group2NameProse">
         <string> combinations: c. haloperidol + midazolam</string>
        </void>
        <void property="group2Total">
         <int>30</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 1b. General - one or more adverse events</string>
        </void>
        <void property="subgroupName">
         <string>during 12 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs COMBINATIONS: c. HALOPERIDOL + MIDAZOLAM</string>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>30</int>
        </void>
        <void property="group2Name">
         <string>haloperidol//midazolam</string>
        </void>
        <void property="group2NameProse">
         <string> combinations: c. haloperidol + midazolam</string>
        </void>
        <void property="group2Total">
         <int>30</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 1a. General - serious</string>
        </void>
        <void property="subgroupName">
         <string>death</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs COMBINATIONS: c. HALOPERIDOL + MIDAZOLAM</string>
        </void>
        <void property="group1Events">
         <int>3</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>30</int>
        </void>
        <void property="group2Events">
         <int>12</int>
        </void>
        <void property="group2Name">
         <string>haloperidol//midazolam</string>
        </void>
        <void property="group2NameProse">
         <string> combinations: c. haloperidol + midazolam</string>
        </void>
        <void property="group2Total">
         <int>30</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2a. Specific - arousal - i. various</string>
        </void>
        <void property="subgroupName">
         <string>excessive sedation by 12 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs COMBINATIONS: c. HALOPERIDOL + MIDAZOLAM</string>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>30</int>
        </void>
        <void property="group2Events">
         <int>5</int>
        </void>
        <void property="group2Name">
         <string>haloperidol//midazolam</string>
        </void>
        <void property="group2NameProse">
         <string> combinations: c. haloperidol + midazolam</string>
        </void>
        <void property="group2Total">
         <int>30</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2e. Specific - cardiovascular</string>
        </void>
        <void property="subgroupName">
         <string>hypotension by 12 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs COMBINATIONS: c. HALOPERIDOL + MIDAZOLAM</string>
        </void>
        <void property="group1Events">
         <int>5</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>30</int>
        </void>
        <void property="group2Events">
         <int>3</int>
        </void>
        <void property="group2Name">
         <string>haloperidol//midazolam</string>
        </void>
        <void property="group2NameProse">
         <string> combinations: c. haloperidol + midazolam</string>
        </void>
        <void property="group2Total">
         <int>30</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2f. Specific - movement disorders</string>
        </void>
        <void property="subgroupName">
         <string>EPS by 12 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs COMBINATIONS: d. HALOPERIDOL + PROMETHAZINE</string>
        </void>
        <void property="group1Events">
         <int>4</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>30</int>
        </void>
        <void property="group2Events">
         <int>14</int>
        </void>
        <void property="group2Name">
         <string>haloperidol//promethazine</string>
        </void>
        <void property="group2NameProse">
         <string> combinations: d. haloperidol + promethazine</string>
        </void>
        <void property="group2Total">
         <int>30</int>
        </void>
        <void property="outcomeName">
         <string>Repeated need for tranquillisation - need for additional drugs for tranquillisation</string>
        </void>
        <void property="subgroupName">
         <string>by 2 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs COMBINATIONS: d. HALOPERIDOL + PROMETHAZINE</string>
        </void>
        <void property="group1Events">
         <int>23</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>30</int>
        </void>
        <void property="group2Events">
         <int>21</int>
        </void>
        <void property="group2Name">
         <string>haloperidol//promethazine</string>
        </void>
        <void property="group2NameProse">
         <string> combinations: d. haloperidol + promethazine</string>
        </void>
        <void property="group2Total">
         <int>30</int>
        </void>
        <void property="outcomeName">
         <string>Repeated need for tranquillisation - need for additional drugs for tranquillisation</string>
        </void>
        <void property="subgroupName">
         <string>by 12 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs COMBINATIONS: d. HALOPERIDOL + PROMETHAZINE</string>
        </void>
        <void property="group1Events">
         <int>6</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>30</int>
        </void>
        <void property="group2Events">
         <int>5</int>
        </void>
        <void property="group2Name">
         <string>haloperidol//promethazine</string>
        </void>
        <void property="group2NameProse">
         <string> combinations: d. haloperidol + promethazine</string>
        </void>
        <void property="group2Total">
         <int>30</int>
        </void>
        <void property="outcomeName">
         <string>Global outcomes: 1. General - need for additional measures</string>
        </void>
        <void property="subgroupName">
         <string>additional restraint, seclusion or special observation during 12 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs COMBINATIONS: d. HALOPERIDOL + PROMETHAZINE</string>
        </void>
        <void property="group1Events">
         <int>11</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>30</int>
        </void>
        <void property="group2Events">
         <int>10</int>
        </void>
        <void property="group2Name">
         <string>haloperidol//promethazine</string>
        </void>
        <void property="group2NameProse">
         <string> combinations: d. haloperidol + promethazine</string>
        </void>
        <void property="group2Total">
         <int>30</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 1a. General</string>
        </void>
        <void property="subgroupName">
         <string>one or more adverse effects up to 24 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs COMBINATIONS: d. HALOPERIDOL + PROMETHAZINE</string>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>30</int>
        </void>
        <void property="group2Name">
         <string>haloperidol//promethazine</string>
        </void>
        <void property="group2NameProse">
         <string> combinations: d. haloperidol + promethazine</string>
        </void>
        <void property="group2Total">
         <int>30</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 1b. General - serious</string>
        </void>
        <void property="subgroupName">
         <string>death</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs COMBINATIONS: d. HALOPERIDOL + PROMETHAZINE</string>
        </void>
        <void property="group1Events">
         <int>3</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>30</int>
        </void>
        <void property="group2Events">
         <int>1</int>
        </void>
        <void property="group2Name">
         <string>haloperidol//promethazine</string>
        </void>
        <void property="group2NameProse">
         <string> combinations: d. haloperidol + promethazine</string>
        </void>
        <void property="group2Total">
         <int>30</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2a. Specific - arousal - i. various</string>
        </void>
        <void property="subgroupName">
         <string>excessive sedation by 12 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs COMBINATIONS: d. HALOPERIDOL + PROMETHAZINE</string>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>30</int>
        </void>
        <void property="group2Events">
         <int>3</int>
        </void>
        <void property="group2Name">
         <string>haloperidol//promethazine</string>
        </void>
        <void property="group2NameProse">
         <string> combinations: d. haloperidol + promethazine</string>
        </void>
        <void property="group2Total">
         <int>30</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2e. Specific - cardiovascular</string>
        </void>
        <void property="subgroupName">
         <string>hypotension by 12 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs COMBINATIONS: d. HALOPERIDOL + PROMETHAZINE</string>
        </void>
        <void property="group1Events">
         <int>5</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>30</int>
        </void>
        <void property="group2Events">
         <int>5</int>
        </void>
        <void property="group2Name">
         <string>haloperidol//promethazine</string>
        </void>
        <void property="group2NameProse">
         <string> combinations: d. haloperidol + promethazine</string>
        </void>
        <void property="group2Total">
         <int>30</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2f. Specific - movement disorders</string>
        </void>
        <void property="subgroupName">
         <string>EPS by 12 hours</string>
        </void>
       </object>
      </void>
     </void>
     <void property="performanceBiasJudgement">
      <string>&quot;study medications were packaged in identical color-coded boxes&quot; (p.31); stated as double blind, however &quot;patients were instructed not to reveal their current treatment to the investigators&quot; (p.31); no information whether the blindness was effective.</string>
     </void>
     <void property="performanceBiasRisk">
      <string>High risk</string>
     </void>
     <void property="references">
      <array class="java.lang.String" length="9">
       <void index="0">
        <string>OTHER</string>
       </void>
       <void index="1">
        <string>NO</string>
       </void>
       <void index="2">
        <string>Baldacara L, Sanches M, Cordeiro DC, Jackoswski AP</string>
       </void>
       <void index="3">
        <string>Rapid tranquilization for agitated patients in emergency psychiatric rooms: A randomized trial of olanzapine, ziprasidone, haloperidol plus promethazine, haloperidol plus midazolam and haloperidol alone</string>
       </void>
       <void index="4">
        <string>Revista Brasileira de Psiquiatria</string>
       </void>
       <void index="5">
        <string>2011</string>
       </void>
       <void index="6">
        <string>33</string>
       </void>
       <void index="7">
        <string>1</string>
       </void>
       <void index="8">
        <string>30-9</string>
       </void>
      </array>
     </void>
     <void property="reportingBiasJudgement">
      <string>Endpoint scores at 1 hour are discordant between text (p.32-33) and Table 2 (p.35).</string>
     </void>
     <void property="reportingBiasRisk">
      <string>High risk</string>
     </void>
     <void property="revManID">
      <string>STD-Baldacara-2011</string>
     </void>
     <void property="selectionBiasAllocationConcealmentBiasRisk">
      <string>Unclear Risk</string>
     </void>
     <void property="selectionBiasAllocationConcealmentJudgement">
      <string>Not stated.</string>
     </void>
     <void property="selectionBiasRandomSequenceBiasRisk">
      <string>Unclear Risk</string>
     </void>
     <void property="selectionBiasRandomSequenceJudgement">
      <string>&quot;randomization employed in this clinical trial was allocation by permuted blocks&quot; (p.31); no further informations on the randomisation process.</string>
     </void>
     <void property="year">
      <int>2011</int>
     </void>
    </object>
   </void>
   <void method="add">
    <object class="TrialObject" id="TrialObject2">
     <void property="attritionBiasJudgement">
      <string>&quot;two patients were excluded from the efficacy analysis. It was determined after enrolment that both received proscribed antipsychotic medication before entering the study.&quot;</string>
     </void>
     <void property="attritionBiasRisk">
      <string>High risk</string>
     </void>
     <void property="authorYearLetter">
      <string>Battaglia1997</string>
     </void>
     <void property="countries">
      <string>USA</string>
     </void>
     <void property="detectionBiasJudgement">
      <string>&quot;The ED [Emergency Department] psychiatrist who treated and rated the patient remained blinded to the identity of the patient&apos;s medication throughout treatment&quot; (p.336).[italic added by reviewers]. Not tested.</string>
     </void>
     <void property="detectionBiasRisk">
      <string>Low risk</string>
     </void>
     <void property="mainAuthor">
      <string>Battaglia</string>
     </void>
     <void property="meerKatCountry">
      <string>USA</string>
     </void>
     <void property="otherBiasJudgement">
      <string>Sponsored by drug company.</string>
     </void>
     <void property="otherBiasRisk">
      <string>High risk</string>
     </void>
     <void property="outcomeList">
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs BENZODIAZEPINE: b. LORAZEPAM</string>
        </void>
        <void property="group1Events">
         <int>24</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>35</int>
        </void>
        <void property="group2Events">
         <int>11</int>
        </void>
        <void property="group2Name">
         <string>lorazepam</string>
        </void>
        <void property="group2Total">
         <int>31</int>
        </void>
        <void property="outcomeName">
         <string>Tranquillisation or asleep - not asleep</string>
        </void>
        <void property="subgroupName">
         <string>by 3 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs BENZODIAZEPINE: b. LORAZEPAM</string>
        </void>
        <void property="group1Events">
         <int>31</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>35</int>
        </void>
        <void property="group2Events">
         <int>24</int>
        </void>
        <void property="group2Name">
         <string>lorazepam</string>
        </void>
        <void property="group2Total">
         <int>31</int>
        </void>
        <void property="outcomeName">
         <string>Repeated need for rapid tranquillisation</string>
        </void>
        <void property="subgroupName">
         <string>more than 1 injection</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs BENZODIAZEPINE: b. LORAZEPAM</string>
        </void>
        <void property="group1Events">
         <int>10</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>35</int>
        </void>
        <void property="group2Events">
         <int>8</int>
        </void>
        <void property="group2Name">
         <string>lorazepam</string>
        </void>
        <void property="group2Total">
         <int>31</int>
        </void>
        <void property="outcomeName">
         <string>Repeated need for rapid tranquillisation</string>
        </void>
        <void property="subgroupName">
         <string>more than 3 injections</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs BENZODIAZEPINE: b. LORAZEPAM</string>
        </void>
        <void property="group1Events">
         <int>14</int>
        </void>
        <void property="group1Name">
         <string>HALOPERIDOL </string>
        </void>
        <void property="group1NameProse">
         <string>HALOPERIDOL </string>
        </void>
        <void property="group1Total">
         <int>35</int>
        </void>
        <void property="group2Events">
         <int>11</int>
        </void>
        <void property="group2Name">
         <string>lorazepam</string>
        </void>
        <void property="group2Total">
         <int>31</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 1a. General</string>
        </void>
        <void property="subgroupName">
         <string>one or more drug-related adverse effect up to 24 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs BENZODIAZEPINE: b. LORAZEPAM</string>
        </void>
        <void property="group1Events">
         <int>3</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>35</int>
        </void>
        <void property="group2Events">
         <int>5</int>
        </void>
        <void property="group2Name">
         <string>lorazepam</string>
        </void>
        <void property="group2Total">
         <int>31</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2a. Specific - anticholinergic</string>
        </void>
        <void property="subgroupName">
         <string>dry mouth up to 24 hours (only reported if occurred ≥9%)</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs BENZODIAZEPINE: b. LORAZEPAM</string>
        </void>
        <void property="group1Events">
         <int>3</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>35</int>
        </void>
        <void property="group2Events">
         <int>3</int>
        </void>
        <void property="group2Name">
         <string>lorazepam</string>
        </void>
        <void property="group2Total">
         <int>31</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2c. Specific - cardiovascular</string>
        </void>
        <void property="subgroupName">
         <string>dizziness (only reported if occurred in ≧9%) - during 24 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs BENZODIAZEPINE: b. LORAZEPAM</string>
        </void>
        <void property="group1Events">
         <int>1</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>35</int>
        </void>
        <void property="group2Name">
         <string>lorazepam</string>
        </void>
        <void property="group2Total">
         <int>31</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2c. Specific - cardiovascular</string>
        </void>
        <void property="subgroupName">
         <string>hypertension - use of additional clonidine - during 24 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs BENZODIAZEPINE: b. LORAZEPAM</string>
        </void>
        <void property="group1Events">
         <int>1</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>35</int>
        </void>
        <void property="group2Events">
         <int>2</int>
        </void>
        <void property="group2Name">
         <string>lorazepam</string>
        </void>
        <void property="group2Total">
         <int>31</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2d. Specific - movement disorder</string>
        </void>
        <void property="subgroupName">
         <string>ataxia (only reported if occurred in ≧9%) - during 24 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs BENZODIAZEPINE: b. LORAZEPAM</string>
        </void>
        <void property="group1Events">
         <int>4</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>35</int>
        </void>
        <void property="group2Events">
         <int>1</int>
        </void>
        <void property="group2Name">
         <string>lorazepam</string>
        </void>
        <void property="group2Total">
         <int>31</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2d. Specific - movement disorder</string>
        </void>
        <void property="subgroupName">
         <string>dystonia (only reported if occurred in ≧9%) - during 24 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs BENZODIAZEPINE: b. LORAZEPAM</string>
        </void>
        <void property="group1Events">
         <int>3</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>35</int>
        </void>
        <void property="group2Name">
         <string>lorazepam</string>
        </void>
        <void property="group2Total">
         <int>31</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2d. Specific - movement disorder</string>
        </void>
        <void property="subgroupName">
         <string>hypertonia/rigidity (only reported if occurred in ≧9%) - during 24 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs BENZODIAZEPINE: b. LORAZEPAM</string>
        </void>
        <void property="group1Events">
         <int>4</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>35</int>
        </void>
        <void property="group2Events">
         <int>2</int>
        </void>
        <void property="group2Name">
         <string>lorazepam</string>
        </void>
        <void property="group2Total">
         <int>31</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2d. Specific - movement disorder</string>
        </void>
        <void property="subgroupName">
         <string>speech disorder (only reported if occurred in ≧9%) - during 24 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs BENZODIAZEPINE: b. LORAZEPAM</string>
        </void>
        <void property="group1Events">
         <int>2</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>35</int>
        </void>
        <void property="group2Events">
         <int>1</int>
        </void>
        <void property="group2Name">
         <string>lorazepam</string>
        </void>
        <void property="group2Total">
         <int>31</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2d. Specific - movement disorder</string>
        </void>
        <void property="subgroupName">
         <string>tremor (only reported if occurred in ≧9%) - during 24 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs BENZODIAZEPINE: b. LORAZEPAM</string>
        </void>
        <void property="group1Events">
         <int>9</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>35</int>
        </void>
        <void property="group2Events">
         <int>4</int>
        </void>
        <void property="group2Name">
         <string>lorazepam</string>
        </void>
        <void property="group2Total">
         <int>31</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2d. Specific - movement disorder</string>
        </void>
        <void property="subgroupName">
         <string>use of additional benztropine - during 24 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs COMBINATIONS: b. HALOPERIDOL + LORAZEPAM</string>
        </void>
        <void property="group1Events">
         <int>24</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>35</int>
        </void>
        <void property="group2Events">
         <int>12</int>
        </void>
        <void property="group2Name">
         <string>haloperidol//lorazepam</string>
        </void>
        <void property="group2NameProse">
         <string> combinations: b. haloperidol + lorazepam</string>
        </void>
        <void property="group2Total">
         <int>32</int>
        </void>
        <void property="outcomeName">
         <string>Tranquillisation or asleep - asleep</string>
        </void>
        <void property="subgroupName">
         <string>not asleep by 3 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs COMBINATIONS: b. HALOPERIDOL + LORAZEPAM</string>
        </void>
        <void property="group1Events">
         <int>31</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>35</int>
        </void>
        <void property="group2Events">
         <int>27</int>
        </void>
        <void property="group2Name">
         <string>haloperidol//lorazepam</string>
        </void>
        <void property="group2NameProse">
         <string> combinations: b. haloperidol + lorazepam</string>
        </void>
        <void property="group2Total">
         <int>32</int>
        </void>
        <void property="outcomeName">
         <string>Repeated need for rapid tranquillisation</string>
        </void>
        <void property="subgroupName">
         <string>needing additional injection during 24 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs COMBINATIONS: b. HALOPERIDOL + LORAZEPAM</string>
        </void>
        <void property="group1Events">
         <int>10</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>35</int>
        </void>
        <void property="group2Events">
         <int>3</int>
        </void>
        <void property="group2Name">
         <string>haloperidol//lorazepam</string>
        </void>
        <void property="group2NameProse">
         <string> combinations: b. haloperidol + lorazepam</string>
        </void>
        <void property="group2Total">
         <int>32</int>
        </void>
        <void property="outcomeName">
         <string>Repeated need for rapid tranquillisation</string>
        </void>
        <void property="subgroupName">
         <string>more than 3 injections during 24 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs COMBINATIONS: b. HALOPERIDOL + LORAZEPAM</string>
        </void>
        <void property="group1Events">
         <int>14</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>35</int>
        </void>
        <void property="group2Events">
         <int>11</int>
        </void>
        <void property="group2Name">
         <string>haloperidol//lorazepam</string>
        </void>
        <void property="group2NameProse">
         <string> combinations: b. haloperidol + lorazepam</string>
        </void>
        <void property="group2Total">
         <int>32</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 1. General</string>
        </void>
        <void property="subgroupName">
         <string>one or more drug-related adverse effect during 24 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs COMBINATIONS: b. HALOPERIDOL + LORAZEPAM</string>
        </void>
        <void property="group1Events">
         <int>3</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>35</int>
        </void>
        <void property="group2Events">
         <int>3</int>
        </void>
        <void property="group2Name">
         <string>haloperidol//lorazepam</string>
        </void>
        <void property="group2NameProse">
         <string> combinations: b. haloperidol + lorazepam</string>
        </void>
        <void property="group2Total">
         <int>32</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2a. Specific - anticholinergic</string>
        </void>
        <void property="subgroupName">
         <string>dry mouth (only reported if occurred in ≧9%) during 24 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs COMBINATIONS: b. HALOPERIDOL + LORAZEPAM</string>
        </void>
        <void property="group1Events">
         <int>3</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>35</int>
        </void>
        <void property="group2Events">
         <int>2</int>
        </void>
        <void property="group2Name">
         <string>haloperidol//lorazepam</string>
        </void>
        <void property="group2NameProse">
         <string> combinations: b. haloperidol + lorazepam</string>
        </void>
        <void property="group2Total">
         <int>32</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2b. Specific - cardiovascular</string>
        </void>
        <void property="subgroupName">
         <string>dizziness (only reported if occurred in ≧9%) during 24 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs COMBINATIONS: b. HALOPERIDOL + LORAZEPAM</string>
        </void>
        <void property="group1Events">
         <int>1</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>35</int>
        </void>
        <void property="group2Events">
         <int>1</int>
        </void>
        <void property="group2Name">
         <string>haloperidol//lorazepam</string>
        </void>
        <void property="group2NameProse">
         <string> combinations: b. haloperidol + lorazepam</string>
        </void>
        <void property="group2Total">
         <int>32</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2b. Specific - cardiovascular</string>
        </void>
        <void property="subgroupName">
         <string>hypertension - use of additional clonidine during 24 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs COMBINATIONS: b. HALOPERIDOL + LORAZEPAM</string>
        </void>
        <void property="group1Events">
         <int>1</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>35</int>
        </void>
        <void property="group2Events">
         <int>3</int>
        </void>
        <void property="group2Name">
         <string>haloperidol//lorazepam</string>
        </void>
        <void property="group2NameProse">
         <string> combinations: b. haloperidol + lorazepam</string>
        </void>
        <void property="group2Total">
         <int>32</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2c. Specific - movement disorders</string>
        </void>
        <void property="subgroupName">
         <string>ataxia (only reported if occurred in &gt;9%) during 24 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs COMBINATIONS: b. HALOPERIDOL + LORAZEPAM</string>
        </void>
        <void property="group1Events">
         <int>4</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>35</int>
        </void>
        <void property="group2Name">
         <string>haloperidol//lorazepam</string>
        </void>
        <void property="group2NameProse">
         <string> combinations: b. haloperidol + lorazepam</string>
        </void>
        <void property="group2Total">
         <int>32</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2c. Specific - movement disorders</string>
        </void>
        <void property="subgroupName">
         <string>dystonia (only reported if occurred in &gt;9%) during 24 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs COMBINATIONS: b. HALOPERIDOL + LORAZEPAM</string>
        </void>
        <void property="group1Events">
         <int>3</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>35</int>
        </void>
        <void property="group2Events">
         <int>1</int>
        </void>
        <void property="group2Name">
         <string>haloperidol//lorazepam</string>
        </void>
        <void property="group2NameProse">
         <string> combinations: b. haloperidol + lorazepam</string>
        </void>
        <void property="group2Total">
         <int>32</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2c. Specific - movement disorders</string>
        </void>
        <void property="subgroupName">
         <string>hypertonia/rigidity (only reported if occurred in &gt;9%) during 24 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs COMBINATIONS: b. HALOPERIDOL + LORAZEPAM</string>
        </void>
        <void property="group1Events">
         <int>2</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>35</int>
        </void>
        <void property="group2Events">
         <int>1</int>
        </void>
        <void property="group2Name">
         <string>haloperidol//lorazepam</string>
        </void>
        <void property="group2NameProse">
         <string> combinations: b. haloperidol + lorazepam</string>
        </void>
        <void property="group2Total">
         <int>32</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2c. Specific - movement disorders</string>
        </void>
        <void property="subgroupName">
         <string>tremor (only reported if occurred in &gt;9%) during 24 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs COMBINATIONS: b. HALOPERIDOL + LORAZEPAM</string>
        </void>
        <void property="group1Events">
         <int>4</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>35</int>
        </void>
        <void property="group2Events">
         <int>3</int>
        </void>
        <void property="group2Name">
         <string>haloperidol//lorazepam</string>
        </void>
        <void property="group2NameProse">
         <string> combinations: b. haloperidol + lorazepam</string>
        </void>
        <void property="group2Total">
         <int>32</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2c. Specific - movement disorders</string>
        </void>
        <void property="subgroupName">
         <string>speech disorder (only reported if occurred in &gt;9%) during 24 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs COMBINATIONS: b. HALOPERIDOL + LORAZEPAM</string>
        </void>
        <void property="group1Events">
         <int>9</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>35</int>
        </void>
        <void property="group2Events">
         <int>3</int>
        </void>
        <void property="group2Name">
         <string>haloperidol//lorazepam</string>
        </void>
        <void property="group2NameProse">
         <string> combinations: b. haloperidol + lorazepam</string>
        </void>
        <void property="group2Total">
         <int>32</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2c. Specific - movement disorders</string>
        </void>
        <void property="subgroupName">
         <string>use of additional benztropine during 24 hours</string>
        </void>
       </object>
      </void>
     </void>
     <void property="performanceBiasJudgement">
      <string>&quot;The ED [Emergency Department] psychiatrist who treated and rated the patient remained blinded to the identity of the patient&apos;s medication throughout treatment&quot; (p.336). [italic added by reviewers], &quot;Double blind&quot; - participant blinding not specifically mentioned.</string>
     </void>
     <void property="performanceBiasRisk">
      <string>Low risk</string>
     </void>
     <void property="references">
      <array class="java.lang.String" length="9">
       <void index="0">
        <string>JOURNAL_ARTICLE</string>
       </void>
       <void index="1">
        <string>NO</string>
       </void>
       <void index="2">
        <string>Battaglia J, Moss S, Rush J, Kang J, Mendoza R, Leedom L, et al</string>
       </void>
       <void index="3">
        <string>Haloperidol, lorazepam, or both for psychotic agitation? A multicenter, prospective, double-blind, emergency department study</string>
       </void>
       <void index="4">
        <string>American Journal of Emergency Medicine</string>
       </void>
       <void index="5">
        <string>1997</string>
       </void>
       <void index="6">
        <string>15</string>
       </void>
       <void index="7">
        <string>4</string>
       </void>
       <void index="8">
        <string>335-40</string>
       </void>
      </array>
     </void>
     <void property="reportingBiasJudgement">
      <string>More details on level of significance for outcomes with P &lt; 0.05. Adverse effects for central nervous system reported only if present in ≥ 9%.</string>
     </void>
     <void property="reportingBiasRisk">
      <string>High risk</string>
     </void>
     <void property="revManID">
      <string>STD-Battaglia-1997</string>
     </void>
     <void property="selectionBiasAllocationConcealmentBiasRisk">
      <string>Unclear Risk</string>
     </void>
     <void property="selectionBiasAllocationConcealmentJudgement">
      <string>Not stated.</string>
     </void>
     <void property="selectionBiasRandomSequenceBiasRisk">
      <string>Low risk</string>
     </void>
     <void property="selectionBiasRandomSequenceJudgement">
      <string>&quot;Computer-generated table of random numbers&quot;.</string>
     </void>
     <void property="year">
      <int>1997</int>
     </void>
    </object>
   </void>
   <void method="add">
    <object class="TrialObject" id="TrialObject3">
     <void property="attritionBiasJudgement">
      <string>The authors only account for 5 of the 26 people who did not complete the 24 hours study.</string>
     </void>
     <void property="attritionBiasRisk">
      <string>High risk</string>
     </void>
     <void property="authorYearLetter">
      <string>Battaglia2002</string>
     </void>
     <void property="countries">
      <string>Australia, Austria, Belgium, Canada, Czech Republic, France, Greece, Hungary, Israel, South Africa, Spain, UK, USA</string>
     </void>
     <void property="detectionBiasJudgement">
      <string>&quot;Both drugs and placebo were administered in identical, color-blinded, translucent standard syringes, and raters and study personnel were blind to treatment assignment&quot; (Wright 2001, p.1149). [italic added by reviewers].</string>
     </void>
     <void property="detectionBiasRisk">
      <string>Low risk</string>
     </void>
     <void property="mainAuthor">
      <string>Battaglia</string>
     </void>
     <void property="meerKatCountry">
      <string>Multi-Center//Australia//Austria//Belgium//Canada//Czech Republic//France//Greece//Hungary//Israel//South Africa//Spain//UK//USA</string>
     </void>
     <void property="otherBiasJudgement">
      <string>Sponsored by the manufacturers of olanzapine.</string>
     </void>
     <void property="otherBiasRisk">
      <string>High risk</string>
     </void>
     <void property="outcomeList">
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs PLACEBO/NIL</string>
        </void>
        <void property="group1Events">
         <int>106</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>126</int>
        </void>
        <void property="group2Events">
         <int>53</int>
        </void>
        <void property="group2Name">
         <string>placebo</string>
        </void>
        <void property="group2Total">
         <int>54</int>
        </void>
        <void property="outcomeName">
         <string>Tranquillisation or asleep - asleep</string>
        </void>
        <void property="subgroupName">
         <string>not asleep up to 2 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs PLACEBO/NIL</string>
        </void>
        <void property="group1Events">
         <int>36</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>126</int>
        </void>
        <void property="group2Events">
         <int>27</int>
        </void>
        <void property="group2Name">
         <string>placebo</string>
        </void>
        <void property="group2Total">
         <int>54</int>
        </void>
        <void property="outcomeName">
         <string>Repeated need for tranquillisation</string>
        </void>
        <void property="subgroupName">
         <string>needing additional injection during 24 hours (agitation only)</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs PLACEBO/NIL</string>
        </void>
        <void property="group1Events">
         <int>25</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>126</int>
        </void>
        <void property="group2Events">
         <int>21</int>
        </void>
        <void property="group2Name">
         <string>placebo</string>
        </void>
        <void property="group2Total">
         <int>54</int>
        </void>
        <void property="outcomeName">
         <string>Global outcome: 2. Need for benzodiazepine up to 24 hours</string>
        </void>
        <void property="subgroupName">
         <string>need for benzodiazepine up to 24 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs PLACEBO/NIL</string>
        </void>
        <void property="group1Events">
         <int>10</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>126</int>
        </void>
        <void property="group2Events">
         <int>2</int>
        </void>
        <void property="group2Name">
         <string>placebo</string>
        </void>
        <void property="group2Total">
         <int>54</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2a. Specific - arousal level</string>
        </void>
        <void property="subgroupName">
         <string>somnolence during 24 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs PLACEBO/NIL</string>
        </void>
        <void property="group1Events">
         <int>26</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>126</int>
        </void>
        <void property="group2Events">
         <int>2</int>
        </void>
        <void property="group2Name">
         <string>placebo</string>
        </void>
        <void property="group2Total">
         <int>54</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2d. Specific - movement disorders</string>
        </void>
        <void property="subgroupName">
         <string>extrapyramidal effects - use of antiparkinson drugs during 24 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: e. OLANZAPINE</string>
        </void>
        <void property="group1Events">
         <int>106</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>126</int>
        </void>
        <void property="group2Events">
         <int>95</int>
        </void>
        <void property="group2Name">
         <string>olanzapine</string>
        </void>
        <void property="group2Total">
         <int>131</int>
        </void>
        <void property="outcomeName">
         <string>Tranquillisation or asleep - asleep</string>
        </void>
        <void property="subgroupName">
         <string>not asleep up to 2 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: e. OLANZAPINE</string>
        </void>
        <void property="group1Events">
         <int>36</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>126</int>
        </void>
        <void property="group2Events">
         <int>31</int>
        </void>
        <void property="group2Name">
         <string>olanzapine</string>
        </void>
        <void property="group2Total">
         <int>131</int>
        </void>
        <void property="outcomeName">
         <string>Repeated need for tranquillisation - needing additional injection</string>
        </void>
        <void property="subgroupName">
         <string>by 24 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: e. OLANZAPINE</string>
        </void>
        <void property="group1Events">
         <int>25</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>126</int>
        </void>
        <void property="group2Events">
         <int>21</int>
        </void>
        <void property="group2Name">
         <string>olanzapine</string>
        </void>
        <void property="group2Total">
         <int>131</int>
        </void>
        <void property="outcomeName">
         <string>Global outcome: 1a. General - need for additional measures</string>
        </void>
        <void property="subgroupName">
         <string>need for benzodiazepine during 24 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: e. OLANZAPINE</string>
        </void>
        <void property="group1Events">
         <int>10</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>126</int>
        </void>
        <void property="group2Events">
         <int>10</int>
        </void>
        <void property="group2Name">
         <string>olanzapine</string>
        </void>
        <void property="group2Total">
         <int>131</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2b. Specific - arousal level - i. various</string>
        </void>
        <void property="subgroupName">
         <string>somnolence at 24 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: e. OLANZAPINE</string>
        </void>
        <void property="group1Events">
         <int>9</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>126</int>
        </void>
        <void property="group2Name">
         <string>olanzapine</string>
        </void>
        <void property="group2Total">
         <int>131</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2i. Specific - movement disorder - i. various</string>
        </void>
        <void property="subgroupName">
         <string>dystonia during 24 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: e. OLANZAPINE</string>
        </void>
        <void property="group1Events">
         <int>7</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>126</int>
        </void>
        <void property="group2Events">
         <int>1</int>
        </void>
        <void property="group2Name">
         <string>olanzapine</string>
        </void>
        <void property="group2Total">
         <int>131</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2i. Specific - movement disorder - i. various</string>
        </void>
        <void property="subgroupName">
         <string>EPS during 24 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: e. OLANZAPINE</string>
        </void>
        <void property="group1Events">
         <int>26</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>126</int>
        </void>
        <void property="group2Events">
         <int>6</int>
        </void>
        <void property="group2Name">
         <string>olanzapine</string>
        </void>
        <void property="group2Total">
         <int>131</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2i. Specific - movement disorder - i. various</string>
        </void>
        <void property="subgroupName">
         <string>extrapyramidal effects - use of antiparkinson drugs during 24 hours</string>
        </void>
       </object>
      </void>
     </void>
     <void property="performanceBiasJudgement">
      <string>&quot;Both drugs and placebo were administered in identical, color-blinded, translucent standard syringes, and raters and study personnel were blind to treatment assignment&quot; (Wright 2001, p.1149). [italic added by reviewers].</string>
     </void>
     <void property="performanceBiasRisk">
      <string>Low risk</string>
     </void>
     <void property="references">
      <array class="java.lang.String" length="162">
       <void index="0">
        <string>JOURNAL_ARTICLE</string>
       </void>
       <void index="1">
        <string>YES</string>
       </void>
       <void index="2">
        <string>Battaglia J, David SR, Alaka K, Meehan K, Wright P</string>
       </void>
       <void index="3">
        <string>Calming versus sedative effects of IM olanzapine in agitated patients</string>
       </void>
       <void index="4">
        <string>Schizophrenia Research</string>
       </void>
       <void index="5">
        <string>2002</string>
       </void>
       <void index="6">
        <string>53</string>
       </void>
       <void index="7">
        <string>3 Suppl 1</string>
       </void>
       <void index="8">
        <string>183</string>
       </void>
       <void index="9">
        <string>JOURNAL_ARTICLE</string>
       </void>
       <void index="10">
        <string>NO</string>
       </void>
       <void index="11">
        <string>Battaglia J, Houston JP, Ahl J, Meyers AL, Kaiser CJ</string>
       </void>
       <void index="12">
        <string>A post hoc analysis of transitioning to oral treatment with olanzapine or haloperidol after 24-hour intramuscular treatment in acutely agitated adult patients with schizophrenia</string>
       </void>
       <void index="13">
        <string>Clinical Therapeutics</string>
       </void>
       <void index="14">
        <string>2005</string>
       </void>
       <void index="15">
        <string>27</string>
       </void>
       <void index="16">
        <string>10</string>
       </void>
       <void index="17">
        <string>1612-8</string>
       </void>
       <void index="18">
        <string>JOURNAL_ARTICLE</string>
       </void>
       <void index="19">
        <string>NO</string>
       </void>
       <void index="20">
        <string>Battaglia J, Lindborg SR, Alaka K, Meehan K, Wright P</string>
       </void>
       <void index="21">
        <string>Calming versus sedative effects of intramuscular olanzapine in agitated patients</string>
       </void>
       <void index="22">
        <string>American Journal of Emergency Medicine</string>
       </void>
       <void index="23">
        <string>2003</string>
       </void>
       <void index="24">
        <string>21</string>
       </void>
       <void index="25">
        <string>3</string>
       </void>
       <void index="26">
        <string>192-8</string>
       </void>
       <void index="27">
        <string>JOURNAL_ARTICLE</string>
       </void>
       <void index="28">
        <string>NO</string>
       </void>
       <void index="29">
        <string>David SR, Battaglia J, Alaka K, Meehan K, Wright P</string>
       </void>
       <void index="30">
        <string>Calming versus sedative effects of IM olanzapine in agitated patients</string>
       </void>
       <void index="31">
        <string>Proceedings of the 11th Congress of the Association of European Psychiatrists; 2002 May 4-8; Stockholm, Sweden</string>
       </void>
       <void index="32">
        <string>2002</string>
       </void>
       <void index="33">
        <string>17</string>
       </void>
       <void index="34">
        <string>Suppl 1</string>
       </void>
       <void index="35">
        <string>104s</string>
       </void>
       <void index="36">
        <string>JOURNAL_ARTICLE</string>
       </void>
       <void index="37">
        <string>NO</string>
       </void>
       <void index="38">
        <string>David SR, Beasley CM Jr, Alaka K</string>
       </void>
       <void index="39">
        <string>Analysis of the QTC interval in acutely agitated patients with schizophrenia, bipolar mania, or dementia treated with intramuscular (IM) olanzapine vs. IM placebo or IM haloperidol</string>
       </void>
       <void index="40">
        <string>European Neuropsychopharmacology</string>
       </void>
       <void index="41">
        <string>2001</string>
       </void>
       <void index="42">
        <string>11</string>
       </void>
       <void index="43">
        <string>3</string>
       </void>
       <void index="44">
        <string>276</string>
       </void>
       <void index="45">
        <string>JOURNAL_ARTICLE</string>
       </void>
       <void index="46">
        <string>NO</string>
       </void>
       <void index="47">
        <string>David SR, Beasley CM Jr, Alaka K</string>
       </void>
       <void index="48">
        <string>QTC intervals during treatment with IM olanzapine in acutely agitated patients</string>
       </void>
       <void index="49">
        <string>Schizophrenia Research</string>
       </void>
       <void index="50">
        <string>2002</string>
       </void>
       <void index="51">
        <string>53</string>
       </void>
       <void index="52">
        <string>3 Suppl 1</string>
       </void>
       <void index="53">
        <string>164</string>
       </void>
       <void index="54">
        <string>JOURNAL_ARTICLE</string>
       </void>
       <void index="55">
        <string>NO</string>
       </void>
       <void index="56">
        <string>David SR, Meehan K, Birkett MA, Wright P, Ferchland I, Alaka K, et al</string>
       </void>
       <void index="57">
        <string>Intramuscular olanzapine versus intramuscular haloperidol and intramuscular placebo: an international double-blind study in acutely agitated patients with schizophrenia</string>
       </void>
       <void index="58">
        <string>Schizophrenia Research</string>
       </void>
       <void index="59">
        <string>2001</string>
       </void>
       <void index="60">
        <string>49</string>
       </void>
       <void index="61">
        <string>1-2</string>
       </void>
       <void index="62">
        <string>224</string>
       </void>
       <void index="63">
        <string>CONFERENCE_PROC</string>
       </void>
       <void index="64">
        <string>NO</string>
       </void>
       <void index="65">
        <string>Houston JP, Kaiser CJ, Ahl J</string>
       </void>
       <void index="66">
        <string>Oral olanzapine transition dose following intramuscular olanzapine treatment</string>
       </void>
       <void index="67">
        <string>International Congress on Schizophrenia Research; 2005 Apr 2-5, Savanagh, Georgia USA</string>
       </void>
       <void index="68">
        <string>2005</string>
       </void>
       <void index="69">
        <string></string>
       </void>
       <void index="70">
        <string></string>
       </void>
       <void index="71">
        <string></string>
       </void>
       <void index="72">
        <string>CONFERENCE_PROC</string>
       </void>
       <void index="73">
        <string>NO</string>
       </void>
       <void index="74">
        <string>King KG, Wright P, Meehan K, Birkett M, David SR, Taylor CC</string>
       </void>
       <void index="75">
        <string>Transition from intramuscular to oral olanzapine</string>
       </void>
       <void index="76">
        <string>Proceedings of the 12th World Congress of Psychiatry; 2002 Aug 24-29; Yokohama, Japan</string>
       </void>
       <void index="77">
        <string>2002</string>
       </void>
       <void index="78">
        <string></string>
       </void>
       <void index="79">
        <string></string>
       </void>
       <void index="80">
        <string></string>
       </void>
       <void index="81">
        <string>JOURNAL_ARTICLE</string>
       </void>
       <void index="82">
        <string>NO</string>
       </void>
       <void index="83">
        <string>Lindborg SR, Beasley CM, Alaka K, Taylor CC</string>
       </void>
       <void index="84">
        <string>Effects of intramuscular olanzapine vs haloperidol and placebo on QTc intervals in acutely agitated patients</string>
       </void>
       <void index="85">
        <string>Psychiatry Research</string>
       </void>
       <void index="86">
        <string>2003</string>
       </void>
       <void index="87">
        <string>119</string>
       </void>
       <void index="88">
        <string>1-2</string>
       </void>
       <void index="89">
        <string>113-23</string>
       </void>
       <void index="90">
        <string>JOURNAL_ARTICLE</string>
       </void>
       <void index="91">
        <string>NO</string>
       </void>
       <void index="92">
        <string>Meehan K, Alaka KJ, Birkett M, Breier A, David S, Ferchland I, et al</string>
       </void>
       <void index="93">
        <string>Short-acting intramuscular olanzapine in acutely agitated schizophrenic patients: A randomized double blind trial vs. placebo and haloperidol</string>
       </void>
       <void index="94">
        <string>Psychosomatics</string>
       </void>
       <void index="95">
        <string>2001</string>
       </void>
       <void index="96">
        <string>42</string>
       </void>
       <void index="97">
        <string>2</string>
       </void>
       <void index="98">
        <string>197-8</string>
       </void>
       <void index="99">
        <string>CONFERENCE_PROC</string>
       </void>
       <void index="100">
        <string>NO</string>
       </void>
       <void index="101">
        <string>Meehan K, Wright P, David SR, Alaka K, Taylor CC, Breier A, et al</string>
       </void>
       <void index="102">
        <string>Agitation as a treatable symptom common to schizophrenia, acute mania and dementia</string>
       </void>
       <void index="103">
        <string>Proceedings of the 57th Annual Meeting of the Society of Biological Psychiatry; 2002 May 16-18; Philadelphia, Pennsylvania, USA</string>
       </void>
       <void index="104">
        <string>2002</string>
       </void>
       <void index="105">
        <string></string>
       </void>
       <void index="106">
        <string></string>
       </void>
       <void index="107">
        <string></string>
       </void>
       <void index="108">
        <string>JOURNAL_ARTICLE</string>
       </void>
       <void index="109">
        <string>NO</string>
       </void>
       <void index="110">
        <string>Meehan K, Wright P, David SR, Alaka K, Taylor CC, Breier A, et al</string>
       </void>
       <void index="111">
        <string>Agitation as a treatable symptom common to schizophrenia, acute mania, and dementia</string>
       </void>
       <void index="112">
        <string>Schizophrenia Research</string>
       </void>
       <void index="113">
        <string>2002</string>
       </void>
       <void index="114">
        <string>53</string>
       </void>
       <void index="115">
        <string>3 Suppl 1</string>
       </void>
       <void index="116">
        <string>63</string>
       </void>
       <void index="117">
        <string>JOURNAL_ARTICLE</string>
       </void>
       <void index="118">
        <string>NO</string>
       </void>
       <void index="119">
        <string>Wright P, Birkett M, David SR, Meehan K, Ferchland I, Alaka KJ, et al</string>
       </void>
       <void index="120">
        <string>Double-blind, placebo-controlled comparison of intramuscular olanzapine and intramuscular haloperidol in the treatment of acute agitation in schizophrenia</string>
       </void>
       <void index="121">
        <string>American Journal of Psychiatry</string>
       </void>
       <void index="122">
        <string>2001</string>
       </void>
       <void index="123">
        <string>158</string>
       </void>
       <void index="124">
        <string>7</string>
       </void>
       <void index="125">
        <string>1149-51</string>
       </void>
       <void index="126">
        <string>JOURNAL_ARTICLE</string>
       </void>
       <void index="127">
        <string>NO</string>
       </void>
       <void index="128">
        <string>Wright P, Birkett M, Ferchland I, David S, Alaka K, Pullen P, et al</string>
       </void>
       <void index="129">
        <string>A double-blind study of intramuscular olanzapine, haloperidol and placebo in acutely agitated schizophrenic patients</string>
       </void>
       <void index="130">
        <string>European Neuropsychopharmacology</string>
       </void>
       <void index="131">
        <string>2000</string>
       </void>
       <void index="132">
        <string>10</string>
       </void>
       <void index="133">
        <string>Suppl 3</string>
       </void>
       <void index="134">
        <string>S304</string>
       </void>
       <void index="135">
        <string>JOURNAL_ARTICLE</string>
       </void>
       <void index="136">
        <string>NO</string>
       </void>
       <void index="137">
        <string>Wright P, Birkett M, Meehan K, Ferchland I, David S, Alaka K, et al</string>
       </void>
       <void index="138">
        <string>A double-blind study of intramuscular olanzapine, haloperidol and placebo in acutely agitated schizophrenic patients</string>
       </void>
       <void index="139">
        <string>International Journal of Neuropsychopharmacology</string>
       </void>
       <void index="140">
        <string>2000</string>
       </void>
       <void index="141">
        <string>3</string>
       </void>
       <void index="142">
        <string>Suppl 1</string>
       </void>
       <void index="143">
        <string>S139</string>
       </void>
       <void index="144">
        <string>JOURNAL_ARTICLE</string>
       </void>
       <void index="145">
        <string>NO</string>
       </void>
       <void index="146">
        <string>Wright P, Lindborg SR, Birkett M, Meehan K, Jones B, Alaka K, et al</string>
       </void>
       <void index="147">
        <string>Intramuscular olanzapine and intramuscular haloperidol in acute schizophrenia: antipsychotic efficacy and extrapyramidal safety during the first 24 hours of treatment</string>
       </void>
       <void index="148">
        <string>Canadian Journal of Psychiatry [Revue Canadienne de Psychiatrie]</string>
       </void>
       <void index="149">
        <string>2003</string>
       </void>
       <void index="150">
        <string>48</string>
       </void>
       <void index="151">
        <string>11</string>
       </void>
       <void index="152">
        <string>716-21</string>
       </void>
       <void index="153">
        <string>JOURNAL_ARTICLE</string>
       </void>
       <void index="154">
        <string>NO</string>
       </void>
       <void index="155">
        <string>Wright P, Meehan K, Birkett M, Lindborg SR, Taylor CC, Morris PBA</string>
       </void>
       <void index="156">
        <string>A comparison of the efficacy and safety of olanzapine versus haloperidol during transition from intramuscular to oral therapy</string>
       </void>
       <void index="157">
        <string>Clinical Therapeutics</string>
       </void>
       <void index="158">
        <string>2003</string>
       </void>
       <void index="159">
        <string>25</string>
       </void>
       <void index="160">
        <string>5</string>
       </void>
       <void index="161">
        <string>1420-8</string>
       </void>
      </array>
     </void>
     <void property="reportingBiasJudgement">
      <string>No indication of selective reporting.</string>
     </void>
     <void property="reportingBiasRisk">
      <string>Low risk</string>
     </void>
     <void property="revManID">
      <string>STD-Battaglia-2002</string>
     </void>
     <void property="selectionBiasAllocationConcealmentBiasRisk">
      <string>Unclear Risk</string>
     </void>
     <void property="selectionBiasAllocationConcealmentJudgement">
      <string>Not stated.</string>
     </void>
     <void property="selectionBiasRandomSequenceBiasRisk">
      <string>Unclear Risk</string>
     </void>
     <void property="selectionBiasRandomSequenceJudgement">
      <string>Described as randomised - method of randomisation is not reported.</string>
     </void>
     <void property="year">
      <int>2002</int>
     </void>
    </object>
   </void>
   <void method="add">
    <object class="TrialObject" id="TrialObject4">
     <void property="attritionBiasJudgement">
      <string>Reasons why all participants that left the study early were not reported.</string>
     </void>
     <void property="attritionBiasRisk">
      <string>High risk</string>
     </void>
     <void property="authorYearLetter">
      <string>Breier2001</string>
     </void>
     <void property="countries">
      <string>Croatia, Italy, Romania, South Africa</string>
     </void>
     <void property="detectionBiasJudgement">
      <string>&quot;Investigators, patients, clinical carers and raters were blinded.&quot;</string>
     </void>
     <void property="detectionBiasRisk">
      <string>Low risk</string>
     </void>
     <void property="mainAuthor">
      <string>Breier</string>
     </void>
     <void property="meerKatCountry">
      <string>Multi-Center//Croatia//Italy//Romania//South Africa</string>
     </void>
     <void property="otherBiasJudgement">
      <string>Trial sponsored by manufacturers of olanzapine IM.</string>
     </void>
     <void property="otherBiasRisk">
      <string>High risk</string>
     </void>
     <void property="outcomeList">
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs PLACEBO/NIL</string>
        </void>
        <void property="group1Events">
         <int>10</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>40</int>
        </void>
        <void property="group2Events">
         <int>30</int>
        </void>
        <void property="group2Name">
         <string>placebo</string>
        </void>
        <void property="group2Total">
         <int>45</int>
        </void>
        <void property="outcomeName">
         <string>Repeated need for tranquillisation</string>
        </void>
        <void property="subgroupName">
         <string>needing additional injection during 24 hours (agitation only)</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs PLACEBO/NIL</string>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>40</int>
        </void>
        <void property="group2Events">
         <int>16</int>
        </void>
        <void property="group2Name">
         <string>placebo</string>
        </void>
        <void property="group2Total">
         <int>45</int>
        </void>
        <void property="outcomeName">
         <string>Global outcome: 2. Need for benzodiazepine up to 24 hours</string>
        </void>
        <void property="subgroupName">
         <string>need for benzodiazepine up to 24 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs PLACEBO/NIL</string>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>40</int>
        </void>
        <void property="group2Name">
         <string>placebo</string>
        </void>
        <void property="group2Total">
         <int>45</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2b. Specific - cardiovascular - miscellaneous outcomes</string>
        </void>
        <void property="subgroupName">
         <string>hypotension during 24 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs PLACEBO/NIL</string>
        </void>
        <void property="group1Events">
         <int>2</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>40</int>
        </void>
        <void property="group2Name">
         <string>placebo</string>
        </void>
        <void property="group2Total">
         <int>45</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2d. Specific - movement disorders</string>
        </void>
        <void property="subgroupName">
         <string>dystonia during 24 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs PLACEBO/NIL</string>
        </void>
        <void property="group1Events">
         <int>7</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>40</int>
        </void>
        <void property="group2Name">
         <string>placebo</string>
        </void>
        <void property="group2Total">
         <int>45</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2d. Specific - movement disorders</string>
        </void>
        <void property="subgroupName">
         <string>EPS during 24 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: e. OLANZAPINE</string>
        </void>
        <void property="group1Events">
         <int>10</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>40</int>
        </void>
        <void property="group2Events">
         <int>11</int>
        </void>
        <void property="group2Name">
         <string>olanzapine</string>
        </void>
        <void property="group2Total">
         <int>46</int>
        </void>
        <void property="outcomeName">
         <string>Repeated need for tranquillisation - needing additional injection</string>
        </void>
        <void property="subgroupName">
         <string>by 24 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: e. OLANZAPINE</string>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>40</int>
        </void>
        <void property="group2Events">
         <int>4</int>
        </void>
        <void property="group2Name">
         <string>olanzapine</string>
        </void>
        <void property="group2Total">
         <int>46</int>
        </void>
        <void property="outcomeName">
         <string>Global outcome: 1a. General - need for additional measures</string>
        </void>
        <void property="subgroupName">
         <string>need for benzodiazepine during 24 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: e. OLANZAPINE</string>
        </void>
        <void property="group1Name">
         <string>HALOPERIDOL </string>
        </void>
        <void property="group1NameProse">
         <string>HALOPERIDOL </string>
        </void>
        <void property="group1Total">
         <int>40</int>
        </void>
        <void property="group2Events">
         <int>2</int>
        </void>
        <void property="group2Name">
         <string>olanzapine</string>
        </void>
        <void property="group2NameProse">
         <string> other antipsychotic: e. olanzapine</string>
        </void>
        <void property="group2Total">
         <int>46</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2f. Specific - cardiovascular i. binary</string>
        </void>
        <void property="subgroupName">
         <string>hypotension during 24 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: e. OLANZAPINE</string>
        </void>
        <void property="group1Events">
         <int>2</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>40</int>
        </void>
        <void property="group2Name">
         <string>olanzapine</string>
        </void>
        <void property="group2Total">
         <int>46</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2i. Specific - movement disorder - i. various</string>
        </void>
        <void property="subgroupName">
         <string>dystonia during 24 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: e. OLANZAPINE</string>
        </void>
        <void property="group1Events">
         <int>7</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>40</int>
        </void>
        <void property="group2Events">
         <int>1</int>
        </void>
        <void property="group2Name">
         <string>olanzapine</string>
        </void>
        <void property="group2Total">
         <int>46</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2i. Specific - movement disorder - i. various</string>
        </void>
        <void property="subgroupName">
         <string>EPS during 24 hours</string>
        </void>
       </object>
      </void>
     </void>
     <void property="performanceBiasJudgement">
      <string>&quot;unblinded third-party personnel, who played no role in evaluating patients, were trained to handle and administer injections in identical, unmarked syringes.&quot; &quot;Investigators, patients, clinical carers and raters were blinded.&quot;</string>
     </void>
     <void property="performanceBiasRisk">
      <string>Low risk</string>
     </void>
     <void property="references">
      <array class="java.lang.String" length="54">
       <void index="0">
        <string>JOURNAL_ARTICLE</string>
       </void>
       <void index="1">
        <string>YES</string>
       </void>
       <void index="2">
        <string>Breier A, Meehan K, Birkett M, David S, Ferchland I, Sutton V, et al</string>
       </void>
       <void index="3">
        <string>A double-blind, placebo-controlled dose-response comparison of intramuscular olanzapine and haloperidol in the treatment of acute agitation in schizophrenia</string>
       </void>
       <void index="4">
        <string>Archives of General Psychiatry</string>
       </void>
       <void index="5">
        <string>2002</string>
       </void>
       <void index="6">
        <string>59</string>
       </void>
       <void index="7">
        <string>5</string>
       </void>
       <void index="8">
        <string>441-8</string>
       </void>
       <void index="9">
        <string>JOURNAL_ARTICLE</string>
       </void>
       <void index="10">
        <string>NO</string>
       </void>
       <void index="11">
        <string>Breier A, Wright P, Birkett M, David S, Brook S, Meehan K</string>
       </void>
       <void index="12">
        <string>A double-blind dose response study comparing intramuscular (IM) olanzapine, haloperidol, and placebo in acutely agitated schizophrenic patients</string>
       </void>
       <void index="13">
        <string>Biological Psychiatry</string>
       </void>
       <void index="14">
        <string>2001</string>
       </void>
       <void index="15">
        <string>49</string>
       </void>
       <void index="16">
        <string>8</string>
       </void>
       <void index="17">
        <string>121S</string>
       </void>
       <void index="18">
        <string>CONFERENCE_PROC</string>
       </void>
       <void index="19">
        <string>NO</string>
       </void>
       <void index="20">
        <string>Breier A, Wright P, Birkett M, Meehan K, David S, Brook S</string>
       </void>
       <void index="21">
        <string>A double-blind dose response study comparing intramuscular olanzapine, haloperidol and placebo in acutely agitated schizophrenic patients</string>
       </void>
       <void index="22">
        <string>Proceedings of the 39th Annual Meeting of the American College of Neuropsychopharmacology; 2000 Dec 10-14; San Juan, Puerto Rico</string>
       </void>
       <void index="23">
        <string>2000</string>
       </void>
       <void index="24">
        <string></string>
       </void>
       <void index="25">
        <string></string>
       </void>
       <void index="26">
        <string></string>
       </void>
       <void index="27">
        <string>CONFERENCE_PROC</string>
       </void>
       <void index="28">
        <string>NO</string>
       </void>
       <void index="29">
        <string>Breier AF, Wright P, Birkett M, Meehan K, David SR, Brook S</string>
       </void>
       <void index="30">
        <string>Intramuscular olanzapine: dose-related improvement in acutely agitated patients with schizophrenia</string>
       </void>
       <void index="31">
        <string>Proceedings of the 154th Annual Meeting of the American Psychiatric Association; 2001 May 5-10; New Orleans, Louisiana, USA</string>
       </void>
       <void index="32">
        <string>2001</string>
       </void>
       <void index="33">
        <string></string>
       </void>
       <void index="34">
        <string></string>
       </void>
       <void index="35">
        <string></string>
       </void>
       <void index="36">
        <string>JOURNAL_ARTICLE</string>
       </void>
       <void index="37">
        <string>NO</string>
       </void>
       <void index="38">
        <string>Smith RC</string>
       </void>
       <void index="39">
        <string>10 mg intramuscular olanzapine reduces acute agitation in schizophrenia more effectively than lower doses [Commentary]</string>
       </void>
       <void index="40">
        <string>Evidence-Based Mental Health</string>
       </void>
       <void index="41">
        <string>2003</string>
       </void>
       <void index="42">
        <string>6</string>
       </void>
       <void index="43">
        <string>1</string>
       </void>
       <void index="44">
        <string>27</string>
       </void>
       <void index="45">
        <string>JOURNAL_ARTICLE</string>
       </void>
       <void index="46">
        <string>NO</string>
       </void>
       <void index="47">
        <string>Wright P, Birkett MA, Meehan K, David SR, Brook S, Breier</string>
       </void>
       <void index="48">
        <string>A double-blind dose response study comparing intramuscular olanzapine, haloperidol and placebo in acutely agitated schizophrenic patients</string>
       </void>
       <void index="49">
        <string>Schizophrenia Research</string>
       </void>
       <void index="50">
        <string>2001</string>
       </void>
       <void index="51">
        <string>49</string>
       </void>
       <void index="52">
        <string>1-2</string>
       </void>
       <void index="53">
        <string>250-1</string>
       </void>
      </array>
     </void>
     <void property="reportingBiasJudgement">
      <string>It is not clear whether all side effects are reported.</string>
     </void>
     <void property="reportingBiasRisk">
      <string>Unclear Risk</string>
     </void>
     <void property="revManID">
      <string>STD-Breier-2002</string>
     </void>
     <void property="selectionBiasAllocationConcealmentBiasRisk">
      <string>Low risk</string>
     </void>
     <void property="selectionBiasAllocationConcealmentJudgement">
      <string>&quot;Allocation concealed placebo-controlled trial.&quot; Method of randomisation not reported.</string>
     </void>
     <void property="selectionBiasRandomSequenceBiasRisk">
      <string>Unclear Risk</string>
     </void>
     <void property="selectionBiasRandomSequenceJudgement">
      <string>Described as randomised - method of randomisation is not reported.</string>
     </void>
     <void property="year">
      <int>2001</int>
     </void>
    </object>
   </void>
   <void method="add">
    <object class="TrialObject" id="TrialObject5">
     <void property="attritionBiasJudgement">
      <string>Reasons why all participants that left the study early were not reported.</string>
     </void>
     <void property="attritionBiasRisk">
      <string>High risk</string>
     </void>
     <void property="authorYearLetter">
      <string>Bristol-Myers2004a</string>
     </void>
     <void property="countries">
      <string>Croatia, Czech Republic, Estonia, France, Italy, Latvia, Poland, South Africa, Spain, USA</string>
     </void>
     <void property="detectionBiasJudgement">
      <string>Described as &quot;double blind&quot;, however no further details are given.</string>
     </void>
     <void property="detectionBiasRisk">
      <string>Unclear Risk</string>
     </void>
     <void property="mainAuthor">
      <string>Bristol-Myers</string>
     </void>
     <void property="meerKatCountry">
      <string>Multi-Center//Croatia//Czech Republic//Estonia//France//Italy//Latvia//Poland//South Africa//Spain//USA</string>
     </void>
     <void property="otherBiasJudgement">
      <string>Sponsored by the manufacturers of aripiprazole.</string>
     </void>
     <void property="otherBiasRisk">
      <string>High risk</string>
     </void>
     <void property="outcomeList">
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs PLACEBO/NIL</string>
        </void>
        <void property="group1Events">
         <int>63</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>185</int>
        </void>
        <void property="group2Events">
         <int>50</int>
        </void>
        <void property="group2Name">
         <string>placebo</string>
        </void>
        <void property="group2Total">
         <int>88</int>
        </void>
        <void property="outcomeName">
         <string>Repeated need for tranquillisation</string>
        </void>
        <void property="subgroupName">
         <string>needing additional injection during 24 hours (agitation only)</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs PLACEBO/NIL</string>
        </void>
        <void property="group1Events">
         <int>107</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>185</int>
        </void>
        <void property="group2Events">
         <int>32</int>
        </void>
        <void property="group2Name">
         <string>placebo</string>
        </void>
        <void property="group2Total">
         <int>88</int>
        </void>
        <void property="outcomeName">
         <string>Specific behaviour: 1a. Agitation - various measures</string>
        </void>
        <void property="subgroupName">
         <string>PANSS-EC response at 2 hours (at least 40% change on PANSS-EC from baseline)</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs PLACEBO/NIL</string>
        </void>
        <void property="group1Events">
         <int>22</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>185</int>
        </void>
        <void property="group2Events">
         <int>17</int>
        </void>
        <void property="group2Name">
         <string>placebo</string>
        </void>
        <void property="group2Total">
         <int>88</int>
        </void>
        <void property="outcomeName">
         <string>Global outcome: 2. Need for benzodiazepine up to 24 hours</string>
        </void>
        <void property="subgroupName">
         <string>need for benzodiazepine up to 24 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs PLACEBO/NIL</string>
        </void>
        <void property="group1Events">
         <int>82</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>185</int>
        </void>
        <void property="group2Events">
         <int>24</int>
        </void>
        <void property="group2Name">
         <string>placebo</string>
        </void>
        <void property="group2Total">
         <int>88</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 1a. General</string>
        </void>
        <void property="subgroupName">
         <string>one or more drug related adverse events during 24 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs PLACEBO/NIL</string>
        </void>
        <void property="group1Events">
         <int>82</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>185</int>
        </void>
        <void property="group2Events">
         <int>12</int>
        </void>
        <void property="group2Name">
         <string>placebo</string>
        </void>
        <void property="group2Total">
         <int>88</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 1a. General</string>
        </void>
        <void property="subgroupName">
         <string>increased severity of adverse effects after 2nd injection</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs PLACEBO/NIL</string>
        </void>
        <void property="group1Events">
         <int>90</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>185</int>
        </void>
        <void property="group2Events">
         <int>24</int>
        </void>
        <void property="group2Name">
         <string>placebo</string>
        </void>
        <void property="group2Total">
         <int>88</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 1a. General</string>
        </void>
        <void property="subgroupName">
         <string>overall adverse events during 72 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs PLACEBO/NIL</string>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>185</int>
        </void>
        <void property="group2Name">
         <string>placebo</string>
        </void>
        <void property="group2Total">
         <int>88</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 1b. General - serious</string>
        </void>
        <void property="subgroupName">
         <string>death</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs PLACEBO/NIL</string>
        </void>
        <void property="group1Events">
         <int>22</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>185</int>
        </void>
        <void property="group2Events">
         <int>8</int>
        </void>
        <void property="group2Name">
         <string>placebo</string>
        </void>
        <void property="group2Total">
         <int>88</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2a. Specific - arousal level</string>
        </void>
        <void property="subgroupName">
         <string>insomnia during 24 hours (only reported if occurred in ≧5%)</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs PLACEBO/NIL</string>
        </void>
        <void property="group1Events">
         <int>28</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>185</int>
        </void>
        <void property="group2Events">
         <int>5</int>
        </void>
        <void property="group2Name">
         <string>placebo</string>
        </void>
        <void property="group2Total">
         <int>88</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2a. Specific - arousal level</string>
        </void>
        <void property="subgroupName">
         <string>&quot;over&quot; sedated</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs PLACEBO/NIL</string>
        </void>
        <void property="group1Events">
         <int>6</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>185</int>
        </void>
        <void property="group2Events">
         <int>1</int>
        </void>
        <void property="group2Name">
         <string>placebo</string>
        </void>
        <void property="group2Total">
         <int>88</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2a. Specific - arousal level</string>
        </void>
        <void property="subgroupName">
         <string>somnolence during 24 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs PLACEBO/NIL</string>
        </void>
        <void property="group1Events">
         <int>7</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>185</int>
        </void>
        <void property="group2Events">
         <int>2</int>
        </void>
        <void property="group2Name">
         <string>placebo</string>
        </void>
        <void property="group2Total">
         <int>88</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2b. Specific - cardiovascular - miscellaneous outcomes</string>
        </void>
        <void property="subgroupName">
         <string>dizziness during 24 hours (only reported if occurred in ≧5%)</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs PLACEBO/NIL</string>
        </void>
        <void property="group1Events">
         <int>23</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>185</int>
        </void>
        <void property="group2Events">
         <int>2</int>
        </void>
        <void property="group2Name">
         <string>placebo</string>
        </void>
        <void property="group2Total">
         <int>88</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2d. Specific - movement disorders</string>
        </void>
        <void property="subgroupName">
         <string>EPS during 24 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs PLACEBO/NIL</string>
        </void>
        <void property="group1Events">
         <int>8</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>185</int>
        </void>
        <void property="group2Events">
         <int>5</int>
        </void>
        <void property="group2Name">
         <string>placebo</string>
        </void>
        <void property="group2Total">
         <int>88</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2f. Specific - miscellaneous</string>
        </void>
        <void property="subgroupName">
         <string>agitation during 24 hours (only reported if occurred in ≧5%)</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs PLACEBO/NIL</string>
        </void>
        <void property="group1Events">
         <int>15</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>185</int>
        </void>
        <void property="group2Events">
         <int>6</int>
        </void>
        <void property="group2Name">
         <string>placebo</string>
        </void>
        <void property="group2Total">
         <int>88</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2f. Specific - miscellaneous</string>
        </void>
        <void property="subgroupName">
         <string>headache during 24 hours (only reported if occurred in ≧5%)</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs PLACEBO/NIL</string>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>185</int>
        </void>
        <void property="group2Events">
         <int>2</int>
        </void>
        <void property="group2Name">
         <string>placebo</string>
        </void>
        <void property="group2Total">
         <int>88</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2f. Specific - miscellaneous</string>
        </void>
        <void property="subgroupName">
         <string>pain (1st injection)</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs PLACEBO/NIL</string>
        </void>
        <void property="group1Events">
         <int>82</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>185</int>
        </void>
        <void property="group2Events">
         <int>12</int>
        </void>
        <void property="group2Name">
         <string>placebo</string>
        </void>
        <void property="group2Total">
         <int>88</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2f. Specific - miscellaneous</string>
        </void>
        <void property="subgroupName">
         <string>pain (2nd injection)</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs PLACEBO/NIL</string>
        </void>
        <void property="group1Events">
         <int>2</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>185</int>
        </void>
        <void property="group2Events">
         <int>1</int>
        </void>
        <void property="group2Name">
         <string>placebo</string>
        </void>
        <void property="group2Total">
         <int>88</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2f. Specific - miscellaneous</string>
        </void>
        <void property="subgroupName">
         <string>nausea during 24 hours (only reported if occurred in ≧5%)</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs PLACEBO/NIL</string>
        </void>
        <void property="group1Events">
         <int>7</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>185</int>
        </void>
        <void property="group2Events">
         <int>1</int>
        </void>
        <void property="group2Name">
         <string>placebo</string>
        </void>
        <void property="group2Total">
         <int>88</int>
        </void>
        <void property="outcomeName">
         <string>Leaving the study early</string>
        </void>
        <void property="subgroupName">
         <string>any reason</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs PLACEBO/NIL</string>
        </void>
        <void property="group1Events">
         <int>1</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>185</int>
        </void>
        <void property="group2Events">
         <int>1</int>
        </void>
        <void property="group2Name">
         <string>placebo</string>
        </void>
        <void property="group2Total">
         <int>88</int>
        </void>
        <void property="outcomeName">
         <string>Leaving the study early</string>
        </void>
        <void property="subgroupName">
         <string>lack of efficacy</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs PLACEBO/NIL</string>
        </void>
        <void property="group1Events">
         <int>3</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>185</int>
        </void>
        <void property="group2Name">
         <string>placebo</string>
        </void>
        <void property="group2Total">
         <int>88</int>
        </void>
        <void property="outcomeName">
         <string>Leaving the study early</string>
        </void>
        <void property="subgroupName">
         <string>withdrew</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs PLACEBO/NIL</string>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>185</int>
        </void>
        <void property="group2Name">
         <string>placebo</string>
        </void>
        <void property="group2Total">
         <int>88</int>
        </void>
        <void property="outcomeName">
         <string>Leaving the study early</string>
        </void>
        <void property="subgroupName">
         <string>consent</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs PLACEBO/NIL</string>
        </void>
        <void property="group1Events">
         <int>2</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>185</int>
        </void>
        <void property="group2Name">
         <string>placebo</string>
        </void>
        <void property="group2Total">
         <int>88</int>
        </void>
        <void property="outcomeName">
         <string>Leaving the study early</string>
        </void>
        <void property="subgroupName">
         <string>adverse effects</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs PLACEBO/NIL</string>
        </void>
        <void property="group1Events">
         <int>1</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>185</int>
        </void>
        <void property="group2Name">
         <string>placebo</string>
        </void>
        <void property="group2Total">
         <int>88</int>
        </void>
        <void property="outcomeName">
         <string>Leaving the study early</string>
        </void>
        <void property="subgroupName">
         <string>other</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: a. ARIPIPRAZOLE</string>
        </void>
        <void property="group1Events">
         <int>82</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>185</int>
        </void>
        <void property="group2Events">
         <int>64</int>
        </void>
        <void property="group2Name">
         <string>aripiprazole</string>
        </void>
        <void property="group2Total">
         <int>175</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 1a. General</string>
        </void>
        <void property="subgroupName">
         <string>one or more drug related adverse effects during 24 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: a. ARIPIPRAZOLE</string>
        </void>
        <void property="group1Events">
         <int>82</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>185</int>
        </void>
        <void property="group2Events">
         <int>58</int>
        </void>
        <void property="group2Name">
         <string>aripiprazole</string>
        </void>
        <void property="group2Total">
         <int>175</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 1a. General</string>
        </void>
        <void property="subgroupName">
         <string>increased severity of adverse effects after 2nd injection</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: a. ARIPIPRAZOLE</string>
        </void>
        <void property="group1Events">
         <int>90</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>185</int>
        </void>
        <void property="group2Events">
         <int>64</int>
        </void>
        <void property="group2Name">
         <string>aripiprazole</string>
        </void>
        <void property="group2Total">
         <int>175</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 1a. General</string>
        </void>
        <void property="subgroupName">
         <string>overall adverse events during 72 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: a. ARIPIPRAZOLE</string>
        </void>
        <void property="group1Events">
         <int>4</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>185</int>
        </void>
        <void property="group2Events">
         <int>4</int>
        </void>
        <void property="group2Name">
         <string>aripiprazole</string>
        </void>
        <void property="group2Total">
         <int>175</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 1b. General - serious</string>
        </void>
        <void property="subgroupName">
         <string>any</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: a. ARIPIPRAZOLE</string>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>185</int>
        </void>
        <void property="group2Name">
         <string>aripiprazole</string>
        </void>
        <void property="group2Total">
         <int>175</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 1b. General - serious</string>
        </void>
        <void property="subgroupName">
         <string>death</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: a. ARIPIPRAZOLE</string>
        </void>
        <void property="group1Events">
         <int>22</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>185</int>
        </void>
        <void property="group2Events">
         <int>10</int>
        </void>
        <void property="group2Name">
         <string>aripiprazole</string>
        </void>
        <void property="group2Total">
         <int>175</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2a. Specific - arousal level</string>
        </void>
        <void property="subgroupName">
         <string>insomnia - between 0-1 days (IM phase) (only reported if occurred in ≥5%)</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: a. ARIPIPRAZOLE</string>
        </void>
        <void property="group1Events">
         <int>20</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>185</int>
        </void>
        <void property="group2Events">
         <int>23</int>
        </void>
        <void property="group2Name">
         <string>aripiprazole</string>
        </void>
        <void property="group2Total">
         <int>175</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2a. Specific - arousal level</string>
        </void>
        <void property="subgroupName">
         <string>insomnia - between 3 - 7 days (oral phase) (only reported if occurred in ≥ 2%)</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: a. ARIPIPRAZOLE</string>
        </void>
        <void property="group1Events">
         <int>28</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>185</int>
        </void>
        <void property="group2Events">
         <int>16</int>
        </void>
        <void property="group2Name">
         <string>aripiprazole</string>
        </void>
        <void property="group2Total">
         <int>175</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2a. Specific - arousal level</string>
        </void>
        <void property="subgroupName">
         <string>&quot;over&quot; sedated</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: a. ARIPIPRAZOLE</string>
        </void>
        <void property="group1Events">
         <int>6</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>185</int>
        </void>
        <void property="group2Events">
         <int>8</int>
        </void>
        <void property="group2Name">
         <string>aripiprazole</string>
        </void>
        <void property="group2Total">
         <int>175</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2a. Specific - arousal level</string>
        </void>
        <void property="subgroupName">
         <string>somnolence - between 0-1 days</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: a. ARIPIPRAZOLE</string>
        </void>
        <void property="group1Events">
         <int>3</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>185</int>
        </void>
        <void property="group2Events">
         <int>1</int>
        </void>
        <void property="group2Name">
         <string>aripiprazole</string>
        </void>
        <void property="group2Total">
         <int>175</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2a. Specific - arousal level</string>
        </void>
        <void property="subgroupName">
         <string>somnolence - between 3 - 7 days (oral phase) (only reported if occurred in ≥ 2%)</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: a. ARIPIPRAZOLE</string>
        </void>
        <void property="group1Events">
         <int>7</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>185</int>
        </void>
        <void property="group2Events">
         <int>11</int>
        </void>
        <void property="group2Name">
         <string>aripiprazole</string>
        </void>
        <void property="group2Total">
         <int>175</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2b. Specific - cardiac</string>
        </void>
        <void property="subgroupName">
         <string>dizziness - between 0 -1 day (IM phase) (only reported if occurred in ≥5%)</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: a. ARIPIPRAZOLE</string>
        </void>
        <void property="group1Events">
         <int>11</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>185</int>
        </void>
        <void property="group2Events">
         <int>1</int>
        </void>
        <void property="group2Name">
         <string>aripiprazole</string>
        </void>
        <void property="group2Total">
         <int>175</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2c. Specific - gastrointestinal</string>
        </void>
        <void property="subgroupName">
         <string>dyspepsia - between 3 - 7 days (oral phase) (only reported if occurred in ≥ 2%)</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: a. ARIPIPRAZOLE</string>
        </void>
        <void property="group1Events">
         <int>5</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>185</int>
        </void>
        <void property="group2Events">
         <int>5</int>
        </void>
        <void property="group2Name">
         <string>aripiprazole</string>
        </void>
        <void property="group2Total">
         <int>175</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2c. Specific - gastrointestinal</string>
        </void>
        <void property="subgroupName">
         <string>diarrhoea - between 3 - 7 days (oral phase) (only reported if occurred in ≥ 2%)</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: a. ARIPIPRAZOLE</string>
        </void>
        <void property="group1Events">
         <int>2</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>185</int>
        </void>
        <void property="group2Events">
         <int>10</int>
        </void>
        <void property="group2Name">
         <string>aripiprazole</string>
        </void>
        <void property="group2Total">
         <int>175</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2c. Specific - gastrointestinal</string>
        </void>
        <void property="subgroupName">
         <string>nausea - between 0-1 days (IM phase) (only reported if occurred in ≥5%)</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: a. ARIPIPRAZOLE</string>
        </void>
        <void property="group1Events">
         <int>1</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>185</int>
        </void>
        <void property="group2Events">
         <int>7</int>
        </void>
        <void property="group2Name">
         <string>aripiprazole</string>
        </void>
        <void property="group2Total">
         <int>175</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2c. Specific - gastrointestinal</string>
        </void>
        <void property="subgroupName">
         <string>nausea - between 3 - 7 days (oral phase) (only reported if occurred in ≥ 2%)</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: a. ARIPIPRAZOLE</string>
        </void>
        <void property="group1Events">
         <int>2</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>185</int>
        </void>
        <void property="group2Events">
         <int>5</int>
        </void>
        <void property="group2Name">
         <string>aripiprazole</string>
        </void>
        <void property="group2Total">
         <int>175</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2c. Specific - gastrointestinal</string>
        </void>
        <void property="subgroupName">
         <string>vomiting - between 3 - 7 days (oral phase) (only reported if occurred in ≥ 2%)</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: a. ARIPIPRAZOLE</string>
        </void>
        <void property="group1Events">
         <int>6</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>185</int>
        </void>
        <void property="group2Events">
         <int>1</int>
        </void>
        <void property="group2Name">
         <string>aripiprazole</string>
        </void>
        <void property="group2Total">
         <int>175</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2d. Specific - movement disorder</string>
        </void>
        <void property="subgroupName">
         <string>akathisia - between 0 -1 day (IM phase) (only reported if occurred in ≥5%)</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: a. ARIPIPRAZOLE</string>
        </void>
        <void property="group1Events">
         <int>7</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>185</int>
        </void>
        <void property="group2Events">
         <int>3</int>
        </void>
        <void property="group2Name">
         <string>aripiprazole</string>
        </void>
        <void property="group2Total">
         <int>175</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2d. Specific - movement disorder</string>
        </void>
        <void property="subgroupName">
         <string>akathisia - between 3 - 7 days (oral phase) (only reported if occurred in ≥ 2%)</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: a. ARIPIPRAZOLE</string>
        </void>
        <void property="group1Events">
         <int>10</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>185</int>
        </void>
        <void property="group2Events">
         <int>1</int>
        </void>
        <void property="group2Name">
         <string>aripiprazole</string>
        </void>
        <void property="group2Total">
         <int>175</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2d. Specific - movement disorder</string>
        </void>
        <void property="subgroupName">
         <string>dystonia - between 0 -1 day (IM phase) (only reported if occurred in ≥5%)</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: a. ARIPIPRAZOLE</string>
        </void>
        <void property="group1Events">
         <int>10</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>185</int>
        </void>
        <void property="group2Events">
         <int>1</int>
        </void>
        <void property="group2Name">
         <string>aripiprazole</string>
        </void>
        <void property="group2Total">
         <int>175</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2d. Specific - movement disorder</string>
        </void>
        <void property="subgroupName">
         <string>EPS - between 0 -1 day (IM phase) (only reported if occurred in ≥5%)</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: a. ARIPIPRAZOLE</string>
        </void>
        <void property="group1Events">
         <int>15</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>185</int>
        </void>
        <void property="group2Events">
         <int>2</int>
        </void>
        <void property="group2Name">
         <string>aripiprazole</string>
        </void>
        <void property="group2Total">
         <int>175</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2d. Specific - movement disorder</string>
        </void>
        <void property="subgroupName">
         <string>EPS - between 3 - 7 days (oral phase) (only reported if occurred in ≥ 2%)</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: a. ARIPIPRAZOLE</string>
        </void>
        <void property="group1Events">
         <int>47</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>185</int>
        </void>
        <void property="group2Events">
         <int>9</int>
        </void>
        <void property="group2Name">
         <string>aripiprazole</string>
        </void>
        <void property="group2Total">
         <int>175</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2d. Specific - movement disorder</string>
        </void>
        <void property="subgroupName">
         <string>Use of antiparkinson drugs - between 3 - 7 days (oral phase)</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: a. ARIPIPRAZOLE</string>
        </void>
        <void property="group1Events">
         <int>1</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>185</int>
        </void>
        <void property="group2Name">
         <string>aripiprazole</string>
        </void>
        <void property="group2Total">
         <int>175</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2d. Specific - movement disorder</string>
        </void>
        <void property="subgroupName">
         <string>dystonia</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: a. ARIPIPRAZOLE</string>
        </void>
        <void property="group1Events">
         <int>8</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>185</int>
        </void>
        <void property="group2Events">
         <int>5</int>
        </void>
        <void property="group2Name">
         <string>aripiprazole</string>
        </void>
        <void property="group2Total">
         <int>175</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2e. Specific - miscellaneous</string>
        </void>
        <void property="subgroupName">
         <string>agitation - between 0 -1 day (IM phase) (only reported if occurred in ≥5%)</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: a. ARIPIPRAZOLE</string>
        </void>
        <void property="group1Events">
         <int>31</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>185</int>
        </void>
        <void property="group2Events">
         <int>27</int>
        </void>
        <void property="group2Name">
         <string>aripiprazole</string>
        </void>
        <void property="group2Total">
         <int>175</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2e. Specific - miscellaneous</string>
        </void>
        <void property="subgroupName">
         <string>agitation - between 3 - 7 days (oral phase) (only reported if occurred in ≥ 2%)</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: a. ARIPIPRAZOLE</string>
        </void>
        <void property="group1Events">
         <int>11</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>185</int>
        </void>
        <void property="group2Events">
         <int>8</int>
        </void>
        <void property="group2Name">
         <string>aripiprazole</string>
        </void>
        <void property="group2Total">
         <int>175</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2e. Specific - miscellaneous</string>
        </void>
        <void property="subgroupName">
         <string>anxiety - between 3 - 7 days (oral phase) (only reported if occurred in ≥ 2%)</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: a. ARIPIPRAZOLE</string>
        </void>
        <void property="group1Events">
         <int>15</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>185</int>
        </void>
        <void property="group2Events">
         <int>13</int>
        </void>
        <void property="group2Name">
         <string>aripiprazole</string>
        </void>
        <void property="group2Total">
         <int>175</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2e. Specific - miscellaneous</string>
        </void>
        <void property="subgroupName">
         <string>headache - between 0 -1 day (IM phase) (only reported if occurred in ≥5%)</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: a. ARIPIPRAZOLE</string>
        </void>
        <void property="group1Events">
         <int>19</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>185</int>
        </void>
        <void property="group2Events">
         <int>17</int>
        </void>
        <void property="group2Name">
         <string>aripiprazole</string>
        </void>
        <void property="group2Total">
         <int>175</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2e. Specific - miscellaneous</string>
        </void>
        <void property="subgroupName">
         <string>headache - between 3 - 7 days (oral phase) (only reported if occurred in ≥ 2%)</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: a. ARIPIPRAZOLE</string>
        </void>
        <void property="group1Events">
         <int>2</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>185</int>
        </void>
        <void property="group2Events">
         <int>6</int>
        </void>
        <void property="group2Name">
         <string>aripiprazole</string>
        </void>
        <void property="group2Total">
         <int>175</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2e. Specific - miscellaneous</string>
        </void>
        <void property="subgroupName">
         <string>pain (1st injection)</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: a. ARIPIPRAZOLE</string>
        </void>
        <void property="group1Events">
         <int>82</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>185</int>
        </void>
        <void property="group2Events">
         <int>58</int>
        </void>
        <void property="group2Name">
         <string>aripiprazole</string>
        </void>
        <void property="group2Total">
         <int>175</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2e. Specific - miscellaneous</string>
        </void>
        <void property="subgroupName">
         <string>pain (2nd injection)</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: a. ARIPIPRAZOLE</string>
        </void>
        <void property="group1Events">
         <int>7</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>185</int>
        </void>
        <void property="group2Events">
         <int>5</int>
        </void>
        <void property="group2Name">
         <string>aripiprazole</string>
        </void>
        <void property="group2Total">
         <int>175</int>
        </void>
        <void property="outcomeName">
         <string>Leaving the study early: 1. For specific reasons</string>
        </void>
        <void property="subgroupName">
         <string>any</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: a. ARIPIPRAZOLE</string>
        </void>
        <void property="group1Events">
         <int>1</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>185</int>
        </void>
        <void property="group2Name">
         <string>aripiprazole</string>
        </void>
        <void property="group2Total">
         <int>175</int>
        </void>
        <void property="outcomeName">
         <string>Leaving the study early: 1. For specific reasons</string>
        </void>
        <void property="subgroupName">
         <string>lack of efficacy</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: a. ARIPIPRAZOLE</string>
        </void>
        <void property="group1Events">
         <int>2</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>185</int>
        </void>
        <void property="group2Events">
         <int>1</int>
        </void>
        <void property="group2Name">
         <string>aripiprazole</string>
        </void>
        <void property="group2Total">
         <int>175</int>
        </void>
        <void property="outcomeName">
         <string>Leaving the study early: 1. For specific reasons</string>
        </void>
        <void property="subgroupName">
         <string>adverse effects</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: a. ARIPIPRAZOLE</string>
        </void>
        <void property="group1Events">
         <int>3</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>185</int>
        </void>
        <void property="group2Events">
         <int>2</int>
        </void>
        <void property="group2Name">
         <string>aripiprazole</string>
        </void>
        <void property="group2Total">
         <int>175</int>
        </void>
        <void property="outcomeName">
         <string>Leaving the study early: 1. For specific reasons</string>
        </void>
        <void property="subgroupName">
         <string>withdrew</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: a. ARIPIPRAZOLE</string>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>185</int>
        </void>
        <void property="group2Name">
         <string>aripiprazole</string>
        </void>
        <void property="group2Total">
         <int>175</int>
        </void>
        <void property="outcomeName">
         <string>Leaving the study early: 1. For specific reasons</string>
        </void>
        <void property="subgroupName">
         <string>consent</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: a. ARIPIPRAZOLE</string>
        </void>
        <void property="group1Events">
         <int>1</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>185</int>
        </void>
        <void property="group2Events">
         <int>2</int>
        </void>
        <void property="group2Name">
         <string>aripiprazole</string>
        </void>
        <void property="group2Total">
         <int>175</int>
        </void>
        <void property="outcomeName">
         <string>Leaving the study early: 1. For specific reasons</string>
        </void>
        <void property="subgroupName">
         <string>other</string>
        </void>
       </object>
      </void>
     </void>
     <void property="performanceBiasJudgement">
      <string>During the IM phase, haloperidol, aripiprazole and placebo were delivered in 1.3 mL injections. However, in the oral phase a tablet was used for aripiprazole and a capsule was used for haloperidol and so it is possible that this presented a risk to blinding.</string>
     </void>
     <void property="performanceBiasRisk">
      <string>Unclear Risk</string>
     </void>
     <void property="references">
      <array class="java.lang.String" length="126">
       <void index="0">
        <string>JOURNAL_ARTICLE</string>
       </void>
       <void index="1">
        <string>NO</string>
       </void>
       <void index="2">
        <string>Andrezina R, Josiassen RC, Marcus RN, Oren DA, Manos G, Stock E, et al</string>
       </void>
       <void index="3">
        <string>Intramuscular aripiprazole for the treatment of acute agitation in patients with schizophrenia or schizoaffective disorder: a double-blind, placebo-controlled comparison with intramuscular haloperidol</string>
       </void>
       <void index="4">
        <string>Psychopharmacology</string>
       </void>
       <void index="5">
        <string>2006</string>
       </void>
       <void index="6">
        <string>188</string>
       </void>
       <void index="7">
        <string>3</string>
       </void>
       <void index="8">
        <string>281-92</string>
       </void>
       <void index="9">
        <string>JOURNAL_ARTICLE</string>
       </void>
       <void index="10">
        <string>NO</string>
       </void>
       <void index="11">
        <string>Andrezina R, Marcus RN, Oren DA, Manos G, Stock E, Carson WH, et al</string>
       </void>
       <void index="12">
        <string>Intramuscular aripiprazole or haloperidol and transition to oral therapy in patients with agitation associated with schizophrenia: sub-analysis of a double-blind study</string>
       </void>
       <void index="13">
        <string>Current Medical Research and Opinion</string>
       </void>
       <void index="14">
        <string>2006</string>
       </void>
       <void index="15">
        <string>22</string>
       </void>
       <void index="16">
        <string>11</string>
       </void>
       <void index="17">
        <string>2209-19</string>
       </void>
       <void index="18">
        <string>OTHER</string>
       </void>
       <void index="19">
        <string>YES</string>
       </void>
       <void index="20">
        <string>Bristol-Myers S</string>
       </void>
       <void index="21">
        <string>A randomized, double-blind comparison of the efficacy and safety of aripiprazole intramuscular formula, haloperidol, or placebo in the treatment of acutely agitated patients with a diagnosis of schizophrenia or schizoaffective disorder</string>
       </void>
       <void index="22">
        <string>http://www.clinicalstudyresults.org/</string>
       </void>
       <void index="23">
        <string>2004</string>
       </void>
       <void index="24">
        <string></string>
       </void>
       <void index="25">
        <string></string>
       </void>
       <void index="26">
        <string></string>
       </void>
       <void index="27">
        <string>CONFERENCE_PROC</string>
       </void>
       <void index="28">
        <string>NO</string>
       </void>
       <void index="29">
        <string>Citrome LL, Vester-Blokland E, Archibald D, McQuade R, Kostic D, Pikalov A, et al</string>
       </void>
       <void index="30">
        <string>Benefits of a second dose of intramuscular (IM) aripiprazole to control agitation in patients with schizophrenia or bipolar I disorder</string>
       </void>
       <void index="31">
        <string>Proceedings of the 159th Annual Meeting of the American Psychiatric Association; 2006 May 20-25, Toronto, Canada</string>
       </void>
       <void index="32">
        <string>2006</string>
       </void>
       <void index="33">
        <string></string>
       </void>
       <void index="34">
        <string></string>
       </void>
       <void index="35">
        <string></string>
       </void>
       <void index="36">
        <string>CONFERENCE_PROC</string>
       </void>
       <void index="37">
        <string>NO</string>
       </void>
       <void index="38">
        <string>Currier GW, Crandall D, Archibald D, Nyilas M, Kostic D, Pikalov A, et al</string>
       </void>
       <void index="39">
        <string>Intramuscular (IM) aripiprazole controls agitation in patients with schizophrenia or bipolar disorder without excessive sedation</string>
       </void>
       <void index="40">
        <string>Proceedings of the 159th Annual Meeting of the American Psychiatric Association; 2006 May 20-25; Toronto, Canada</string>
       </void>
       <void index="41">
        <string>2006</string>
       </void>
       <void index="42">
        <string></string>
       </void>
       <void index="43">
        <string></string>
       </void>
       <void index="44">
        <string></string>
       </void>
       <void index="45">
        <string>JOURNAL_ARTICLE</string>
       </void>
       <void index="46">
        <string>NO</string>
       </void>
       <void index="47">
        <string>Daniel DG, Currier GW, Zimbroff DL, Allen MH, Oren D, Manos G, et al</string>
       </void>
       <void index="48">
        <string>Efficacy and safety of oral aripiprazole compared with haloperidol in patients transitioning from acute treatment with intramuscular formulations</string>
       </void>
       <void index="49">
        <string>Journal of Psychiatric Practice</string>
       </void>
       <void index="50">
        <string>2007</string>
       </void>
       <void index="51">
        <string>13</string>
       </void>
       <void index="52">
        <string>3</string>
       </void>
       <void index="53">
        <string>170-7</string>
       </void>
       <void index="54">
        <string>CONFERENCE_PROC</string>
       </void>
       <void index="55">
        <string>NO</string>
       </void>
       <void index="56">
        <string>Daniel DG, Stock EG, Wilber CH, Marcus RN, Carson WH Jr, Manos G, et al</string>
       </void>
       <void index="57">
        <string>Intramuscular aripiprazole in acutely agitated psychotic patients</string>
       </void>
       <void index="58">
        <string>Proceedings of the 157th Annual Meeting of the American Psychiatric Association; 2004 May 1-6; New York, USA</string>
       </void>
       <void index="59">
        <string>2004</string>
       </void>
       <void index="60">
        <string></string>
       </void>
       <void index="61">
        <string></string>
       </void>
       <void index="62">
        <string></string>
       </void>
       <void index="63">
        <string>JOURNAL_ARTICLE</string>
       </void>
       <void index="64">
        <string>NO</string>
       </void>
       <void index="65">
        <string>Dillenschneider A, Oren D, Marcus R, Kostic D, McQuade R, Iwamoto T, et al</string>
       </void>
       <void index="66">
        <string>Comparison of intramuscular aripiprazole and haloperidol with placebo in acutely agitated schizophrenia patients</string>
       </void>
       <void index="67">
        <string>European Neuropsychopharmacology</string>
       </void>
       <void index="68">
        <string>2005</string>
       </void>
       <void index="69">
        <string>15</string>
       </void>
       <void index="70">
        <string>Suppl 3</string>
       </void>
       <void index="71">
        <string>S509</string>
       </void>
       <void index="72">
        <string>OTHER</string>
       </void>
       <void index="73">
        <string>NO</string>
       </void>
       <void index="74">
        <string>Dillenschneider A, Oren D, Marcus R, Kostic D, McQuade R, Iwamoto T, et al</string>
       </void>
       <void index="75">
        <string>Intramuscular aripiprazole in acute schizophrenia: a pivotal phase III study</string>
       </void>
       <void index="76">
        <string>Proceedings of the 18th European College of Neuropsychopharmacology Congress; 2005 Oct 22-26; Amsterdam, Netherlands</string>
       </void>
       <void index="77">
        <string>2005</string>
       </void>
       <void index="78">
        <string></string>
       </void>
       <void index="79">
        <string></string>
       </void>
       <void index="80">
        <string></string>
       </void>
       <void index="81">
        <string>CONFERENCE_PROC</string>
       </void>
       <void index="82">
        <string>NO</string>
       </void>
       <void index="83">
        <string>McQuade R, Auby P, Oren D, Marcus R, Kostic D, Iwamoto T, et al</string>
       </void>
       <void index="84">
        <string>Intramuscular aripiprazole in acute schizophrenia: a double-blind, placebo-controlled comparison with IM haloperidol</string>
       </void>
       <void index="85">
        <string>Proceedings of the 13th Biennial Winter Workshop on Schizophrenia Research; 2006 Feb 4-10; Davos, Switzerland</string>
       </void>
       <void index="86">
        <string>2006</string>
       </void>
       <void index="87">
        <string></string>
       </void>
       <void index="88">
        <string></string>
       </void>
       <void index="89">
        <string></string>
       </void>
       <void index="90">
        <string>JOURNAL_ARTICLE</string>
       </void>
       <void index="91">
        <string>NO</string>
       </void>
       <void index="92">
        <string>Oren D, Marcus R, Kostic D, McQuade R, Iwamoto T, Archibald D</string>
       </void>
       <void index="93">
        <string>Efficacy and safety of intramuscular aripiprazole, haloperidol or PLACEBO in acutely agitated patients with schizophrenia or schizoaffective disorder</string>
       </void>
       <void index="94">
        <string>Schizophrenia Bulletin</string>
       </void>
       <void index="95">
        <string>2005</string>
       </void>
       <void index="96">
        <string>31</string>
       </void>
       <void index="97">
        <string></string>
       </void>
       <void index="98">
        <string>499</string>
       </void>
       <void index="99">
        <string>OTHER</string>
       </void>
       <void index="100">
        <string>NO</string>
       </void>
       <void index="101">
        <string>Oren D, Marcus R, Kostic D, McQuade R, Iwamoto T, Archibald D</string>
       </void>
       <void index="102">
        <string>Efficacy and safety of intramuscular aripiprazole, haloperidol or placebo in acutely agitated patients with schizophrenia or schizoaffective disorder</string>
       </void>
       <void index="103">
        <string>Proceedings of the 158th Annual Meeting of the American Psychiatric Association; 2005 May 21-26; Atlanta, Georgia, USA</string>
       </void>
       <void index="104">
        <string>2005</string>
       </void>
       <void index="105">
        <string></string>
       </void>
       <void index="106">
        <string></string>
       </void>
       <void index="107">
        <string></string>
       </void>
       <void index="108">
        <string>JOURNAL_ARTICLE</string>
       </void>
       <void index="109">
        <string>NO</string>
       </void>
       <void index="110">
        <string>Oren DA, Marcus RN, Manos G, Carson WH, McQuade D</string>
       </void>
       <void index="111">
        <string>Non-inferiority of intramuscular aripiprazole versus intramuscular haloperidol for the treatment of agitation associated with schizophrenia/schizoaffective disorder</string>
       </void>
       <void index="112">
        <string>Schizophrenia Bulletin</string>
       </void>
       <void index="113">
        <string>2007</string>
       </void>
       <void index="114">
        <string>33</string>
       </void>
       <void index="115">
        <string>2</string>
       </void>
       <void index="116">
        <string>451</string>
       </void>
       <void index="117">
        <string>OTHER</string>
       </void>
       <void index="118">
        <string>NO</string>
       </void>
       <void index="119">
        <string>Yocca F, Marcus R, Oren D, Manos G, Carson W, Iwamoto T, et al</string>
       </void>
       <void index="120">
        <string>Intramuscular aripiprazole in acute schizophrenia: a pivotal phase III study</string>
       </void>
       <void index="121">
        <string>Proceedings of the 158th Annual Meeting of the American Psychiatric Association; 2005 May 21-26, Atlanta, Georgia, USA</string>
       </void>
       <void index="122">
        <string>2005</string>
       </void>
       <void index="123">
        <string></string>
       </void>
       <void index="124">
        <string></string>
       </void>
       <void index="125">
        <string></string>
       </void>
      </array>
     </void>
     <void property="reportingBiasJudgement">
      <string>The author mentions that there is increased glucose levels in both aripiprazole and haloperidol group but does not provide data. The authors only report the side effects that occurred in ≥ 2% of people.</string>
     </void>
     <void property="reportingBiasRisk">
      <string>High risk</string>
     </void>
     <void property="revManID">
      <string>STD-Bristol-Myers-2004a</string>
     </void>
     <void property="selectionBiasAllocationConcealmentBiasRisk">
      <string>Low risk</string>
     </void>
     <void property="selectionBiasAllocationConcealmentJudgement">
      <string>&quot;Randomization was conducted via a centralized call-in system and was organized by study center using permuted block randomization&quot;.</string>
     </void>
     <void property="selectionBiasRandomSequenceBiasRisk">
      <string>Unclear Risk</string>
     </void>
     <void property="selectionBiasRandomSequenceJudgement">
      <string>Described as randomised - method of randomisation is not reported.</string>
     </void>
     <void property="year">
      <int>2004</int>
     </void>
    </object>
   </void>
   <void method="add">
    <object class="TrialObject" id="TrialObject6">
     <void property="attritionBiasJudgement">
      <string>The reasons for leaving the study early were reported for those participants who did not complete the study. However, the number of participants completing different assessments at the same time point vary and reasons are not given.</string>
     </void>
     <void property="attritionBiasRisk">
      <string>Unclear Risk</string>
     </void>
     <void property="authorYearLetter">
      <string>Bristol-Myers2005b</string>
     </void>
     <void property="countries">
      <string>Canada, Czech Republic, Estonia, France, Latvia, Lithuania, Spain, USA</string>
     </void>
     <void property="detectionBiasJudgement">
      <string>Study investigators conducting the assessments were blinded to treatment.</string>
     </void>
     <void property="detectionBiasRisk">
      <string>Low risk</string>
     </void>
     <void property="mainAuthor">
      <string>Bristol-Myers</string>
     </void>
     <void property="meerKatCountry">
      <string>Multi-Center//Canada//Czech Republic//Estonia//France//Latvia//Lithuania//Spain//USA</string>
     </void>
     <void property="otherBiasJudgement">
      <string>Sponsored by the manufacturers of aripiprazole.</string>
     </void>
     <void property="otherBiasRisk">
      <string>High risk</string>
     </void>
     <void property="outcomeList">
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs PLACEBO/NIL</string>
        </void>
        <void property="group1Events">
         <int>15</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>60</int>
        </void>
        <void property="group2Events">
         <int>38</int>
        </void>
        <void property="group2Name">
         <string>placebo</string>
        </void>
        <void property="group2Total">
         <int>62</int>
        </void>
        <void property="outcomeName">
         <string>Repeated need for tranquillisation</string>
        </void>
        <void property="subgroupName">
         <string>needing additional injection during 24 hours (agitation only)</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs PLACEBO/NIL</string>
        </void>
        <void property="group1Events">
         <int>36</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>60</int>
        </void>
        <void property="group2Events">
         <int>22</int>
        </void>
        <void property="group2Name">
         <string>placebo</string>
        </void>
        <void property="group2Total">
         <int>62</int>
        </void>
        <void property="outcomeName">
         <string>Specific behaviour: 1a. Agitation - various measures</string>
        </void>
        <void property="subgroupName">
         <string>PANSS-EC response at 2 hours (at least 40% change on PANSS-EC from baseline)</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs PLACEBO/NIL</string>
        </void>
        <void property="group1Events">
         <int>6</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>60</int>
        </void>
        <void property="group2Events">
         <int>13</int>
        </void>
        <void property="group2Name">
         <string>placebo</string>
        </void>
        <void property="group2Total">
         <int>62</int>
        </void>
        <void property="outcomeName">
         <string>Global outcome: 2. Need for benzodiazepine up to 24 hours</string>
        </void>
        <void property="subgroupName">
         <string>need for benzodiazepine up to 24 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs PLACEBO/NIL</string>
        </void>
        <void property="group1Events">
         <int>29</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>60</int>
        </void>
        <void property="group2Events">
         <int>18</int>
        </void>
        <void property="group2Name">
         <string>placebo</string>
        </void>
        <void property="group2Total">
         <int>62</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 1a. General</string>
        </void>
        <void property="subgroupName">
         <string>one or more drug related adverse events during 24 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs PLACEBO/NIL</string>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>60</int>
        </void>
        <void property="group2Events">
         <int>1</int>
        </void>
        <void property="group2Name">
         <string>placebo</string>
        </void>
        <void property="group2Total">
         <int>62</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 1b. General - serious</string>
        </void>
        <void property="subgroupName">
         <string>rated as serious</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs PLACEBO/NIL</string>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>60</int>
        </void>
        <void property="group2Name">
         <string>placebo</string>
        </void>
        <void property="group2Total">
         <int>57</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 1b. General - serious</string>
        </void>
        <void property="subgroupName">
         <string>tonic clonic seizure</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs PLACEBO/NIL</string>
        </void>
        <void property="group1Events">
         <int>7</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>60</int>
        </void>
        <void property="group2Events">
         <int>3</int>
        </void>
        <void property="group2Name">
         <string>placebo</string>
        </void>
        <void property="group2Total">
         <int>62</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2a. Specific - arousal level</string>
        </void>
        <void property="subgroupName">
         <string>somnolence during 24 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs PLACEBO/NIL</string>
        </void>
        <void property="group1Events">
         <int>4</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>57</int>
        </void>
        <void property="group2Events">
         <int>4</int>
        </void>
        <void property="group2Name">
         <string>placebo</string>
        </void>
        <void property="group2Total">
         <int>62</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2b. Specific - cardiovascular - miscellaneous outcomes</string>
        </void>
        <void property="subgroupName">
         <string>dizziness during 24 hours (only reported if occurred in ≧5%)</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs PLACEBO/NIL</string>
        </void>
        <void property="group1Events">
         <int>3</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>60</int>
        </void>
        <void property="group2Events">
         <int>1</int>
        </void>
        <void property="group2Name">
         <string>placebo</string>
        </void>
        <void property="group2Total">
         <int>62</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2b. Specific - cardiovascular - miscellaneous outcomes</string>
        </void>
        <void property="subgroupName">
         <string>QTc abnormality</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs PLACEBO/NIL</string>
        </void>
        <void property="group1Events">
         <int>3</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>60</int>
        </void>
        <void property="group2Events">
         <int>1</int>
        </void>
        <void property="group2Name">
         <string>placebo</string>
        </void>
        <void property="group2Total">
         <int>62</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2b. Specific - cardiovascular - miscellaneous outcomes</string>
        </void>
        <void property="subgroupName">
         <string>sinus tachycardia during 24 hours (only reported if occurred in ≥5%)</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs PLACEBO/NIL</string>
        </void>
        <void property="group1Events">
         <int>1</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>60</int>
        </void>
        <void property="group2Events">
         <int>1</int>
        </void>
        <void property="group2Name">
         <string>placebo</string>
        </void>
        <void property="group2Total">
         <int>62</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2b. Specific - cardiovascular - miscellaneous outcomes</string>
        </void>
        <void property="subgroupName">
         <string>tachycardia during 24 hours (only reported if occurred in ≥5%)</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs PLACEBO/NIL</string>
        </void>
        <void property="group1Events">
         <int>6</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>60</int>
        </void>
        <void property="group2Name">
         <string>placebo</string>
        </void>
        <void property="group2Total">
         <int>62</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2d. Specific - movement disorders</string>
        </void>
        <void property="subgroupName">
         <string>akathisia during 24 hours (only reported if occurred in ≥5%)</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs PLACEBO/NIL</string>
        </void>
        <void property="group1Events">
         <int>4</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>60</int>
        </void>
        <void property="group2Name">
         <string>placebo</string>
        </void>
        <void property="group2Total">
         <int>62</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2d. Specific - movement disorders</string>
        </void>
        <void property="subgroupName">
         <string>dystonia during 24 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs PLACEBO/NIL</string>
        </void>
        <void property="group1Events">
         <int>1</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>60</int>
        </void>
        <void property="group2Events">
         <int>1</int>
        </void>
        <void property="group2Name">
         <string>placebo</string>
        </void>
        <void property="group2Total">
         <int>62</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2f. Specific - miscellaneous</string>
        </void>
        <void property="subgroupName">
         <string>agitation during 24 hours (only reported if occurred in ≧5%)</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs PLACEBO/NIL</string>
        </void>
        <void property="group1Events">
         <int>2</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>60</int>
        </void>
        <void property="group2Events">
         <int>1</int>
        </void>
        <void property="group2Name">
         <string>placebo</string>
        </void>
        <void property="group2Total">
         <int>62</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2f. Specific - miscellaneous</string>
        </void>
        <void property="subgroupName">
         <string>headache during 24 hours (only reported if occurred in ≧5%)</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs PLACEBO/NIL</string>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>60</int>
        </void>
        <void property="group2Events">
         <int>2</int>
        </void>
        <void property="group2Name">
         <string>placebo</string>
        </void>
        <void property="group2Total">
         <int>62</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2f. Specific - miscellaneous</string>
        </void>
        <void property="subgroupName">
         <string>pain at injection site</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs PLACEBO/NIL</string>
        </void>
        <void property="group1Events">
         <int>1</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>60</int>
        </void>
        <void property="group2Events">
         <int>2</int>
        </void>
        <void property="group2Name">
         <string>placebo</string>
        </void>
        <void property="group2Total">
         <int>62</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2f. Specific - miscellaneous</string>
        </void>
        <void property="subgroupName">
         <string>nausea during 24 hours (only reported if occurred in ≧5%)</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs PLACEBO/NIL</string>
        </void>
        <void property="group1Events">
         <int>1</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>60</int>
        </void>
        <void property="group2Events">
         <int>1</int>
        </void>
        <void property="group2Name">
         <string>placebo</string>
        </void>
        <void property="group2Total">
         <int>62</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2f. Specific - miscellaneous</string>
        </void>
        <void property="subgroupName">
         <string>vomiting during 24 hours (only reported if occurred in ≧5%)</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs PLACEBO/NIL</string>
        </void>
        <void property="group1Events">
         <int>8</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>60</int>
        </void>
        <void property="group2Events">
         <int>3</int>
        </void>
        <void property="group2Name">
         <string>placebo</string>
        </void>
        <void property="group2Total">
         <int>62</int>
        </void>
        <void property="outcomeName">
         <string>Leaving the study early</string>
        </void>
        <void property="subgroupName">
         <string>any reason</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs PLACEBO/NIL</string>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>60</int>
        </void>
        <void property="group2Events">
         <int>1</int>
        </void>
        <void property="group2Name">
         <string>placebo</string>
        </void>
        <void property="group2Total">
         <int>62</int>
        </void>
        <void property="outcomeName">
         <string>Leaving the study early</string>
        </void>
        <void property="subgroupName">
         <string>lack of efficacy</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs PLACEBO/NIL</string>
        </void>
        <void property="group1Events">
         <int>6</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>60</int>
        </void>
        <void property="group2Events">
         <int>1</int>
        </void>
        <void property="group2Name">
         <string>placebo</string>
        </void>
        <void property="group2Total">
         <int>62</int>
        </void>
        <void property="outcomeName">
         <string>Leaving the study early</string>
        </void>
        <void property="subgroupName">
         <string>consent</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs PLACEBO/NIL</string>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>60</int>
        </void>
        <void property="group2Name">
         <string>placebo</string>
        </void>
        <void property="group2Total">
         <int>62</int>
        </void>
        <void property="outcomeName">
         <string>Leaving the study early</string>
        </void>
        <void property="subgroupName">
         <string>adverse effects</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs PLACEBO/NIL</string>
        </void>
        <void property="group1Events">
         <int>2</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>60</int>
        </void>
        <void property="group2Events">
         <int>1</int>
        </void>
        <void property="group2Name">
         <string>placebo</string>
        </void>
        <void property="group2Total">
         <int>62</int>
        </void>
        <void property="outcomeName">
         <string>Leaving the study early</string>
        </void>
        <void property="subgroupName">
         <string>other</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: a. ARIPIPRAZOLE</string>
        </void>
        <void property="group1Events">
         <int>29</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>60</int>
        </void>
        <void property="group2Events">
         <int>25</int>
        </void>
        <void property="group2Name">
         <string>aripiprazole</string>
        </void>
        <void property="group2Total">
         <int>57</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 1a. General</string>
        </void>
        <void property="subgroupName">
         <string>one or more drug related adverse effects during 24 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: a. ARIPIPRAZOLE</string>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>60</int>
        </void>
        <void property="group2Events">
         <int>3</int>
        </void>
        <void property="group2Name">
         <string>aripiprazole</string>
        </void>
        <void property="group2Total">
         <int>57</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 1b. General - serious</string>
        </void>
        <void property="subgroupName">
         <string>any</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: a. ARIPIPRAZOLE</string>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>60</int>
        </void>
        <void property="group2Events">
         <int>1</int>
        </void>
        <void property="group2Name">
         <string>aripiprazole</string>
        </void>
        <void property="group2Total">
         <int>57</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 1b. General - serious</string>
        </void>
        <void property="subgroupName">
         <string>tonic clonic seizure</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: a. ARIPIPRAZOLE</string>
        </void>
        <void property="group1Events">
         <int>7</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>60</int>
        </void>
        <void property="group2Events">
         <int>3</int>
        </void>
        <void property="group2Name">
         <string>aripiprazole</string>
        </void>
        <void property="group2Total">
         <int>57</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2a. Specific - arousal level</string>
        </void>
        <void property="subgroupName">
         <string>somnolence - between 0-1 days (IM phase) (only reported if occurred in ≥5%)</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: a. ARIPIPRAZOLE</string>
        </void>
        <void property="group1Events">
         <int>4</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>60</int>
        </void>
        <void property="group2Events">
         <int>4</int>
        </void>
        <void property="group2Name">
         <string>aripiprazole</string>
        </void>
        <void property="group2Total">
         <int>57</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2b. Specific - cardiac</string>
        </void>
        <void property="subgroupName">
         <string>dizziness - between 0 -1 day (IM phase) (only reported if occurred in ≥5%)</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: a. ARIPIPRAZOLE</string>
        </void>
        <void property="group1Events">
         <int>3</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>60</int>
        </void>
        <void property="group2Name">
         <string>aripiprazole</string>
        </void>
        <void property="group2Total">
         <int>57</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2b. Specific - cardiac</string>
        </void>
        <void property="subgroupName">
         <string>sinus tachycardia - between 0 -1 day (IM phase) (only reported if occurred in ≥5%)</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: a. ARIPIPRAZOLE</string>
        </void>
        <void property="group1Events">
         <int>1</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>60</int>
        </void>
        <void property="group2Events">
         <int>4</int>
        </void>
        <void property="group2Name">
         <string>aripiprazole</string>
        </void>
        <void property="group2Total">
         <int>57</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2b. Specific - cardiac</string>
        </void>
        <void property="subgroupName">
         <string>tachycardia - between 0 -1 day (IM phase) (only reported if occurred in ≥5%)</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: a. ARIPIPRAZOLE</string>
        </void>
        <void property="group1Events">
         <int>1</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>60</int>
        </void>
        <void property="group2Events">
         <int>6</int>
        </void>
        <void property="group2Name">
         <string>aripiprazole</string>
        </void>
        <void property="group2Total">
         <int>57</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2c. Specific - gastrointestinal</string>
        </void>
        <void property="subgroupName">
         <string>nausea - between 0-1 days (IM phase) (only reported if occurred in ≥5%)</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: a. ARIPIPRAZOLE</string>
        </void>
        <void property="group1Events">
         <int>1</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>60</int>
        </void>
        <void property="group2Events">
         <int>2</int>
        </void>
        <void property="group2Name">
         <string>aripiprazole</string>
        </void>
        <void property="group2Total">
         <int>57</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2c. Specific - gastrointestinal</string>
        </void>
        <void property="subgroupName">
         <string>vomiting - between 0-1 days (IM phase) (only reported if occurred in ≥5%)</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: a. ARIPIPRAZOLE</string>
        </void>
        <void property="group1Events">
         <int>6</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>60</int>
        </void>
        <void property="group2Events">
         <int>3</int>
        </void>
        <void property="group2Name">
         <string>aripiprazole</string>
        </void>
        <void property="group2Total">
         <int>57</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2d. Specific - movement disorder</string>
        </void>
        <void property="subgroupName">
         <string>akathisia - between 0 -1 day (IM phase) (only reported if occurred in ≥5%)</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: a. ARIPIPRAZOLE</string>
        </void>
        <void property="group1Events">
         <int>4</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>60</int>
        </void>
        <void property="group2Events">
         <int>1</int>
        </void>
        <void property="group2Name">
         <string>aripiprazole</string>
        </void>
        <void property="group2Total">
         <int>57</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2d. Specific - movement disorder</string>
        </void>
        <void property="subgroupName">
         <string>dystonia - between 0 -1 day (IM phase) (only reported if occurred in ≥5%)</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: a. ARIPIPRAZOLE</string>
        </void>
        <void property="group1Events">
         <int>1</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>60</int>
        </void>
        <void property="group2Events">
         <int>2</int>
        </void>
        <void property="group2Name">
         <string>aripiprazole</string>
        </void>
        <void property="group2Total">
         <int>57</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2e. Specific - miscellaneous</string>
        </void>
        <void property="subgroupName">
         <string>agitation - between 0 -1 day (IM phase) (only reported if occurred in ≥5%)</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: a. ARIPIPRAZOLE</string>
        </void>
        <void property="group1Events">
         <int>2</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>60</int>
        </void>
        <void property="group2Events">
         <int>6</int>
        </void>
        <void property="group2Name">
         <string>aripiprazole</string>
        </void>
        <void property="group2Total">
         <int>57</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2e. Specific - miscellaneous</string>
        </void>
        <void property="subgroupName">
         <string>headache - between 0 -1 day (IM phase) (only reported if occurred in ≥5%)</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: a. ARIPIPRAZOLE</string>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>60</int>
        </void>
        <void property="group2Events">
         <int>1</int>
        </void>
        <void property="group2Name">
         <string>aripiprazole</string>
        </void>
        <void property="group2Total">
         <int>57</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2e. Specific - miscellaneous</string>
        </void>
        <void property="subgroupName">
         <string>pain at injection site</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: a. ARIPIPRAZOLE</string>
        </void>
        <void property="group1Events">
         <int>8</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>60</int>
        </void>
        <void property="group2Events">
         <int>2</int>
        </void>
        <void property="group2Name">
         <string>aripiprazole</string>
        </void>
        <void property="group2Total">
         <int>60</int>
        </void>
        <void property="outcomeName">
         <string>Leaving the study early: 1. For specific reasons</string>
        </void>
        <void property="subgroupName">
         <string>any</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: a. ARIPIPRAZOLE</string>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>60</int>
        </void>
        <void property="group2Events">
         <int>1</int>
        </void>
        <void property="group2Name">
         <string>aripiprazole</string>
        </void>
        <void property="group2Total">
         <int>60</int>
        </void>
        <void property="outcomeName">
         <string>Leaving the study early: 1. For specific reasons</string>
        </void>
        <void property="subgroupName">
         <string>adverse effects</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: a. ARIPIPRAZOLE</string>
        </void>
        <void property="group1Events">
         <int>6</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>60</int>
        </void>
        <void property="group2Events">
         <int>1</int>
        </void>
        <void property="group2Name">
         <string>aripiprazole</string>
        </void>
        <void property="group2Total">
         <int>60</int>
        </void>
        <void property="outcomeName">
         <string>Leaving the study early: 1. For specific reasons</string>
        </void>
        <void property="subgroupName">
         <string>consent</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: a. ARIPIPRAZOLE</string>
        </void>
        <void property="group1Events">
         <int>2</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>60</int>
        </void>
        <void property="group2Name">
         <string>aripiprazole</string>
        </void>
        <void property="group2Total">
         <int>60</int>
        </void>
        <void property="outcomeName">
         <string>Leaving the study early: 1. For specific reasons</string>
        </void>
        <void property="subgroupName">
         <string>other</string>
        </void>
       </object>
      </void>
     </void>
     <void property="performanceBiasJudgement">
      <string>No blinding was used during the preparation of injections and in most cases the person preparing the drug administered the injection.</string>
     </void>
     <void property="performanceBiasRisk">
      <string>High risk</string>
     </void>
     <void property="references">
      <array class="java.lang.String" length="63">
       <void index="0">
        <string>OTHER</string>
       </void>
       <void index="1">
        <string>YES</string>
       </void>
       <void index="2">
        <string>Bristol-Myers S</string>
       </void>
       <void index="3">
        <string>Randomized, double-blind, dose-ranging study of intramuscular aripiprazole in the treatment of acute agitation in patients with a diagnosis of schizophrenia, schizoaffective, or schizophreniform disorder</string>
       </void>
       <void index="4">
        <string>http://www.clinicalstudyresults.org/</string>
       </void>
       <void index="5">
        <string>2005</string>
       </void>
       <void index="6">
        <string></string>
       </void>
       <void index="7">
        <string></string>
       </void>
       <void index="8">
        <string></string>
       </void>
       <void index="9">
        <string>CONFERENCE_PROC</string>
       </void>
       <void index="10">
        <string>NO</string>
       </void>
       <void index="11">
        <string>Currier GW, Crandall D, Archibald D, Nyilas M, Kostic D, Pikalov A, et al</string>
       </void>
       <void index="12">
        <string>Intramuscular (IM) aripiprazole controls agitation in patients with schizophrenia or bipolar disorder without excessive sedation</string>
       </void>
       <void index="13">
        <string>Proceedings of the 159th Annual Meeting of the American Psychiatric Association; 2006 May 20-25; Toronto, Canada</string>
       </void>
       <void index="14">
        <string>2006</string>
       </void>
       <void index="15">
        <string></string>
       </void>
       <void index="16">
        <string></string>
       </void>
       <void index="17">
        <string></string>
       </void>
       <void index="18">
        <string>JOURNAL_ARTICLE</string>
       </void>
       <void index="19">
        <string>NO</string>
       </void>
       <void index="20">
        <string>Gismondi R, Daniel D, Stock E, Wilber R, Marcus R, Carson W, et al</string>
       </void>
       <void index="21">
        <string>Intramuscular aripiprazole treatment for acute agitation in patients with psychosis</string>
       </void>
       <void index="22">
        <string>European Neuropsychopharmacology</string>
       </void>
       <void index="23">
        <string>2004</string>
       </void>
       <void index="24">
        <string>14</string>
       </void>
       <void index="25">
        <string>Suppl 3</string>
       </void>
       <void index="26">
        <string>S261</string>
       </void>
       <void index="27">
        <string>CONFERENCE_PROC</string>
       </void>
       <void index="28">
        <string>NO</string>
       </void>
       <void index="29">
        <string>Kungel M, Czaniera R, Ebrecht M, Werner C, Oren D, McQuade R, et al</string>
       </void>
       <void index="30">
        <string>Intramuscular aripiprazole for the treatment of acute agitation accompanied with schizophrenia: Subanalysis of a double-blind controlled study to find the dosage</string>
       </void>
       <void index="31">
        <string>Proceedings of the 25th Symposium of the Arbeitsgemeinschaft Neuropsychopharmakologie und Pharmakopsychiatrie; 2007 Oct 3-6; Munich, Germany</string>
       </void>
       <void index="32">
        <string>2007</string>
       </void>
       <void index="33">
        <string></string>
       </void>
       <void index="34">
        <string></string>
       </void>
       <void index="35">
        <string></string>
       </void>
       <void index="36">
        <string>CONFERENCE_PROC</string>
       </void>
       <void index="37">
        <string>NO</string>
       </void>
       <void index="38">
        <string>Kungel M, Daniel D, Stock E, Wilber R, Marcus R, Carson W, et al</string>
       </void>
       <void index="39">
        <string>Efficacy and safety of intramuscular aripiprazole in acutely agitated patients with psychosis</string>
       </void>
       <void index="40">
        <string>Proceedings of the Thematic Conference of the World Psychiatric Association on &quot;Treatments in Psychiatry: An Update&quot;; 2004 Nov 10-13; Florence, Italy</string>
       </void>
       <void index="41">
        <string>2004</string>
       </void>
       <void index="42">
        <string></string>
       </void>
       <void index="43">
        <string></string>
       </void>
       <void index="44">
        <string></string>
       </void>
       <void index="45">
        <string>JOURNAL_ARTICLE</string>
       </void>
       <void index="46">
        <string>NO</string>
       </void>
       <void index="47">
        <string>Oren DA, Manos G, Markovic O, McQuade RD</string>
       </void>
       <void index="48">
        <string>Intramuscular aripiprazole for the treatment of acute agitation associated with schizophrenia: Sub-analysis of a double-blind, controlled, dose-ranging study</string>
       </void>
       <void index="49">
        <string>European Psychiatry</string>
       </void>
       <void index="50">
        <string>2007</string>
       </void>
       <void index="51">
        <string>22</string>
       </void>
       <void index="52">
        <string></string>
       </void>
       <void index="53">
        <string>S124-S</string>
       </void>
       <void index="54">
        <string>JOURNAL_ARTICLE</string>
       </void>
       <void index="55">
        <string>NO</string>
       </void>
       <void index="56">
        <string>Tran-Johnson TK, Sack DA, Marcus RN, Auby P, McQuade RD, Oren DA</string>
       </void>
       <void index="57">
        <string>Efficacy and safety of intramuscular aripiprazole in patients with acute agitation: a randomized, double-blind, placebo-controlled trial</string>
       </void>
       <void index="58">
        <string>Journal of Clinical Psychiatry</string>
       </void>
       <void index="59">
        <string>2007</string>
       </void>
       <void index="60">
        <string>68</string>
       </void>
       <void index="61">
        <string>1</string>
       </void>
       <void index="62">
        <string>111-9</string>
       </void>
      </array>
     </void>
     <void property="reportingBiasJudgement">
      <string>The authors only report the adverse effects that occurred in ≥ 5% of people. The QTc abnormality for 9.75 mg is not reported.</string>
     </void>
     <void property="reportingBiasRisk">
      <string>High risk</string>
     </void>
     <void property="revManID">
      <string>STD-Bristol_x002d_Myers-2005b</string>
     </void>
     <void property="selectionBiasAllocationConcealmentBiasRisk">
      <string>Unclear Risk</string>
     </void>
     <void property="selectionBiasAllocationConcealmentJudgement">
      <string>Not stated.</string>
     </void>
     <void property="selectionBiasRandomSequenceBiasRisk">
      <string>Unclear Risk</string>
     </void>
     <void property="selectionBiasRandomSequenceJudgement">
      <string>Described as randomised - method of randomisation is not reported.</string>
     </void>
     <void property="year">
      <int>2005</int>
     </void>
    </object>
   </void>
   <void method="add">
    <object class="TrialObject" id="TrialObject7">
     <void property="attritionBiasJudgement">
      <string>No evidence of incomplete outcome data. A table is provided which presents a summary of discontinuations.</string>
     </void>
     <void property="attritionBiasRisk">
      <string>Low risk</string>
     </void>
     <void property="authorYearLetter">
      <string>Brook2000</string>
     </void>
     <void property="detectionBiasJudgement">
      <string>Open trial.</string>
     </void>
     <void property="detectionBiasRisk">
      <string>High risk</string>
     </void>
     <void property="mainAuthor">
      <string>Brook</string>
     </void>
     <void property="meerKatCountry">
      <string></string>
     </void>
     <void property="otherBiasJudgement">
      <string>Sponsored by drug company.</string>
     </void>
     <void property="otherBiasRisk">
      <string>High risk</string>
     </void>
     <void property="outcomeList">
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: j. ZIPRASIDONE</string>
        </void>
        <void property="group1Events">
         <int>27</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>42</int>
        </void>
        <void property="group2Events">
         <int>52</int>
        </void>
        <void property="group2Name">
         <string>ziprasidone</string>
        </void>
        <void property="group2Total">
         <int>90</int>
        </void>
        <void property="outcomeName">
         <string>Global outcome: 1. General - need for additional measures</string>
        </void>
        <void property="subgroupName">
         <string>need for anxiolytic during 7 days</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: j. ZIPRASIDONE</string>
        </void>
        <void property="group1Events">
         <int>3</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>42</int>
        </void>
        <void property="group2Events">
         <int>9</int>
        </void>
        <void property="group2Name">
         <string>ziprasidone</string>
        </void>
        <void property="group2Total">
         <int>90</int>
        </void>
        <void property="outcomeName">
         <string>Global outcome: 1. General - need for additional measures</string>
        </void>
        <void property="subgroupName">
         <string>need for hypnotics for night time sedation during 7 days</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: j. ZIPRASIDONE</string>
        </void>
        <void property="group1Events">
         <int>21</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>42</int>
        </void>
        <void property="group2Events">
         <int>28</int>
        </void>
        <void property="group2Name">
         <string>ziprasidone</string>
        </void>
        <void property="group2Total">
         <int>90</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 1b. General - ii. over 24 hours</string>
        </void>
        <void property="subgroupName">
         <string>one or more drug related adverse effects - by 72 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: j. ZIPRASIDONE</string>
        </void>
        <void property="group1Events">
         <int>25</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>42</int>
        </void>
        <void property="group2Events">
         <int>41</int>
        </void>
        <void property="group2Name">
         <string>ziprasidone</string>
        </void>
        <void property="group2Total">
         <int>90</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 1b. General - ii. over 24 hours</string>
        </void>
        <void property="subgroupName">
         <string>one or more drug related adverse effects - by 7 days</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: j. ZIPRASIDONE</string>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>42</int>
        </void>
        <void property="group2Events">
         <int>2</int>
        </void>
        <void property="group2Name">
         <string>ziprasidone</string>
        </void>
        <void property="group2Total">
         <int>90</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2f. Specific - cardiovascular</string>
        </void>
        <void property="subgroupName">
         <string>tachycardia - by 72 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: j. ZIPRASIDONE</string>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>42</int>
        </void>
        <void property="group2Events">
         <int>3</int>
        </void>
        <void property="group2Name">
         <string>ziprasidone</string>
        </void>
        <void property="group2Total">
         <int>90</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2g. Specific - gastrointestinal</string>
        </void>
        <void property="subgroupName">
         <string>vomiting by 72 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: j. ZIPRASIDONE</string>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>42</int>
        </void>
        <void property="group2Events">
         <int>6</int>
        </void>
        <void property="group2Name">
         <string>ziprasidone</string>
        </void>
        <void property="group2Total">
         <int>90</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2g. Specific - gastrointestinal</string>
        </void>
        <void property="subgroupName">
         <string>vomiting by 7 days</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: j. ZIPRASIDONE</string>
        </void>
        <void property="group1Events">
         <int>6</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>42</int>
        </void>
        <void property="group2Events">
         <int>12</int>
        </void>
        <void property="group2Name">
         <string>ziprasidone</string>
        </void>
        <void property="group2Total">
         <int>90</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2h. Specific - hematological tests</string>
        </void>
        <void property="subgroupName">
         <string>abnormal lab results - by 72 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: j. ZIPRASIDONE</string>
        </void>
        <void property="group1Events">
         <int>8</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>42</int>
        </void>
        <void property="group2Events">
         <int>17</int>
        </void>
        <void property="group2Name">
         <string>ziprasidone</string>
        </void>
        <void property="group2Total">
         <int>90</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2h. Specific - hematological tests</string>
        </void>
        <void property="subgroupName">
         <string>abnormal lab results - by 7 days</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: j. ZIPRASIDONE</string>
        </void>
        <void property="group1Events">
         <int>4</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>42</int>
        </void>
        <void property="group2Events">
         <int>9</int>
        </void>
        <void property="group2Name">
         <string>ziprasidone</string>
        </void>
        <void property="group2Total">
         <int>90</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2h. Specific - hematological tests</string>
        </void>
        <void property="subgroupName">
         <string>glucose increased - by 24 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: j. ZIPRASIDONE</string>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>42</int>
        </void>
        <void property="group2Events">
         <int>2</int>
        </void>
        <void property="group2Name">
         <string>ziprasidone</string>
        </void>
        <void property="group2Total">
         <int>90</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2i. Specific - movement disorders - i. binary measures</string>
        </void>
        <void property="subgroupName">
         <string>akathisia - by 72 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: j. ZIPRASIDONE</string>
        </void>
        <void property="group1Events">
         <int>6</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>42</int>
        </void>
        <void property="group2Events">
         <int>3</int>
        </void>
        <void property="group2Name">
         <string>ziprasidone</string>
        </void>
        <void property="group2Total">
         <int>90</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2i. Specific - movement disorders - i. binary measures</string>
        </void>
        <void property="subgroupName">
         <string>akathisia - by 7 days</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: j. ZIPRASIDONE</string>
        </void>
        <void property="group1Events">
         <int>3</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>42</int>
        </void>
        <void property="group2Events">
         <int>1</int>
        </void>
        <void property="group2Name">
         <string>ziprasidone</string>
        </void>
        <void property="group2Total">
         <int>90</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2i. Specific - movement disorders - i. binary measures</string>
        </void>
        <void property="subgroupName">
         <string>dystonia - by 72 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: j. ZIPRASIDONE</string>
        </void>
        <void property="group1Events">
         <int>5</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>42</int>
        </void>
        <void property="group2Events">
         <int>4</int>
        </void>
        <void property="group2Name">
         <string>ziprasidone</string>
        </void>
        <void property="group2Total">
         <int>90</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2i. Specific - movement disorders - i. binary measures</string>
        </void>
        <void property="subgroupName">
         <string>dystonia - by 7 days</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: j. ZIPRASIDONE</string>
        </void>
        <void property="group1Events">
         <int>9</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>42</int>
        </void>
        <void property="group2Name">
         <string>ziprasidone</string>
        </void>
        <void property="group2Total">
         <int>90</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2i. Specific - movement disorders - i. binary measures</string>
        </void>
        <void property="subgroupName">
         <string>EPS - by 72 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: j. ZIPRASIDONE</string>
        </void>
        <void property="group1Events">
         <int>16</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>42</int>
        </void>
        <void property="group2Events">
         <int>1</int>
        </void>
        <void property="group2Name">
         <string>ziprasidone</string>
        </void>
        <void property="group2Total">
         <int>90</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2i. Specific - movement disorders - i. binary measures</string>
        </void>
        <void property="subgroupName">
         <string>EPS - by 7 days</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: j. ZIPRASIDONE</string>
        </void>
        <void property="group1Events">
         <int>20</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>42</int>
        </void>
        <void property="group2Events">
         <int>13</int>
        </void>
        <void property="group2Name">
         <string>ziprasidone</string>
        </void>
        <void property="group2Total">
         <int>90</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2i. Specific - movement disorders - i. binary measures</string>
        </void>
        <void property="subgroupName">
         <string>extrapyramidal effects - use of antiparkinson drugs - by 7 days</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: j. ZIPRASIDONE</string>
        </void>
        <void property="group1Events">
         <int>3</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>42</int>
        </void>
        <void property="group2Name">
         <string>ziprasidone</string>
        </void>
        <void property="group2Total">
         <int>90</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2i. Specific - movement disorders - i. binary measures</string>
        </void>
        <void property="subgroupName">
         <string>hypertonia/rigidity - by 72 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: j. ZIPRASIDONE</string>
        </void>
        <void property="group1Events">
         <int>5</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>42</int>
        </void>
        <void property="group2Events">
         <int>3</int>
        </void>
        <void property="group2Name">
         <string>ziprasidone</string>
        </void>
        <void property="group2Total">
         <int>90</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2i. Specific - movement disorders - i. binary measures</string>
        </void>
        <void property="subgroupName">
         <string>hypertonia - by 7 days</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: j. ZIPRASIDONE</string>
        </void>
        <void property="group1Events">
         <int>1</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>42</int>
        </void>
        <void property="group2Events">
         <int>1</int>
        </void>
        <void property="group2Name">
         <string>ziprasidone</string>
        </void>
        <void property="group2Total">
         <int>90</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2i. Specific - movement disorders - i. binary measures</string>
        </void>
        <void property="subgroupName">
         <string>tremor - by 72 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: j. ZIPRASIDONE</string>
        </void>
        <void property="group1Events">
         <int>4</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>42</int>
        </void>
        <void property="group2Events">
         <int>2</int>
        </void>
        <void property="group2Name">
         <string>ziprasidone</string>
        </void>
        <void property="group2Total">
         <int>90</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2i. Specific - movement disorders - i. binary measures</string>
        </void>
        <void property="subgroupName">
         <string>tremor - by 7 days</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: j. ZIPRASIDONE</string>
        </void>
        <void property="group1Events">
         <int>8</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>42</int>
        </void>
        <void property="group2Events">
         <int>8</int>
        </void>
        <void property="group2Name">
         <string>ziprasidone</string>
        </void>
        <void property="group2Total">
         <int>90</int>
        </void>
        <void property="outcomeName">
         <string>Leaving the study early: 1. For any reason - i. over 24 hours</string>
        </void>
        <void property="subgroupName">
         <string>by 7 days</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: j. ZIPRASIDONE</string>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>42</int>
        </void>
        <void property="group2Events">
         <int>1</int>
        </void>
        <void property="group2Name">
         <string>ziprasidone</string>
        </void>
        <void property="group2Total">
         <int>90</int>
        </void>
        <void property="outcomeName">
         <string>Leaving the study early: 2. For specific reasons - i. over 24 hours</string>
        </void>
        <void property="subgroupName">
         <string>adverse events - by 72 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: j. ZIPRASIDONE</string>
        </void>
        <void property="group1Events">
         <int>1</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>42</int>
        </void>
        <void property="group2Events">
         <int>4</int>
        </void>
        <void property="group2Name">
         <string>ziprasidone</string>
        </void>
        <void property="group2Total">
         <int>90</int>
        </void>
        <void property="outcomeName">
         <string>Leaving the study early: 2. For specific reasons - i. over 24 hours</string>
        </void>
        <void property="subgroupName">
         <string>adverse events - by 7 days</string>
        </void>
       </object>
      </void>
     </void>
     <void property="performanceBiasJudgement">
      <string>Open trial.</string>
     </void>
     <void property="performanceBiasRisk">
      <string>High risk</string>
     </void>
     <void property="references">
      <array class="java.lang.String" length="54">
       <void index="0">
        <string>CONFERENCE_PROC</string>
       </void>
       <void index="1">
        <string>NO</string>
       </void>
       <void index="2">
        <string>Brook S, Krams M, Gunn K</string>
       </void>
       <void index="3">
        <string>Intramuscular (IM) ziprasidone vs. IM haloperidol in patients with acute, non-organic psychosis</string>
       </void>
       <void index="4">
        <string>Proceedings of the 9th Congress of the Association of European Psychiatrists; 1998 Sep 20-24; Copenhagen, Denmark</string>
       </void>
       <void index="5">
        <string>1998</string>
       </void>
       <void index="6">
        <string></string>
       </void>
       <void index="7">
        <string></string>
       </void>
       <void index="8">
        <string></string>
       </void>
       <void index="9">
        <string>CONFERENCE_PROC</string>
       </void>
       <void index="10">
        <string>NO</string>
       </void>
       <void index="11">
        <string>Brook S, Krams M, Gunn KP, and the Ziprasidone IM Study Group</string>
       </void>
       <void index="12">
        <string>The efficacy and tolerability of intramuscular (IM) ziprasidone versus IM haloperidol in patients with acute non-organic psychosis</string>
       </void>
       <void index="13">
        <string>Proceedings of the 151st Annual Meeting of the American Psychiatric Association; 1998 May 30 - Jun 4; Toronto, Ontario, Canada</string>
       </void>
       <void index="14">
        <string>1998</string>
       </void>
       <void index="15">
        <string></string>
       </void>
       <void index="16">
        <string></string>
       </void>
       <void index="17">
        <string></string>
       </void>
       <void index="18">
        <string>OTHER</string>
       </void>
       <void index="19">
        <string>NO</string>
       </void>
       <void index="20">
        <string>Brook S, Krams M, Gunn KP</string>
       </void>
       <void index="21">
        <string>Intramuscular ziprasidone versus intramuscular haloperidol</string>
       </void>
       <void index="22">
        <string>Proceedings of the 21st Collegium Internationale Neuro-Psychopharmacologicum Congress; 1998 Jul 12-16; Glasgow, UK</string>
       </void>
       <void index="23">
        <string>1998</string>
       </void>
       <void index="24">
        <string></string>
       </void>
       <void index="25">
        <string></string>
       </void>
       <void index="26">
        <string></string>
       </void>
       <void index="27">
        <string>JOURNAL_ARTICLE</string>
       </void>
       <void index="28">
        <string>YES</string>
       </void>
       <void index="29">
        <string>Brook S, Lucey JV, Gunn KP</string>
       </void>
       <void index="30">
        <string>Intramuscular ziprasidone compared with intramuscular haloperidol in the treatment of acute psychosis</string>
       </void>
       <void index="31">
        <string>Journal of Clinical Psychological Medicine [临床精神医学杂志]</string>
       </void>
       <void index="32">
        <string>2000</string>
       </void>
       <void index="33">
        <string>61</string>
       </void>
       <void index="34">
        <string>12</string>
       </void>
       <void index="35">
        <string>933-41</string>
       </void>
       <void index="36">
        <string>JOURNAL_ARTICLE</string>
       </void>
       <void index="37">
        <string>NO</string>
       </void>
       <void index="38">
        <string>Daniel DG, Brook S, Reeves KR</string>
       </void>
       <void index="39">
        <string>An overview of the efficacy and safety of rapid acting intramuscular ziprasidone</string>
       </void>
       <void index="40">
        <string>European Neuropsychopharmacology</string>
       </void>
       <void index="41">
        <string>2000</string>
       </void>
       <void index="42">
        <string>10</string>
       </void>
       <void index="43">
        <string>Suppl 3</string>
       </void>
       <void index="44">
        <string>S239</string>
       </void>
       <void index="45">
        <string>CONFERENCE_PROC</string>
       </void>
       <void index="46">
        <string>NO</string>
       </void>
       <void index="47">
        <string>Zimbroff DL, Daniel DG, Brook S, Reeves KR</string>
       </void>
       <void index="48">
        <string>An overview of the efficacy and safety of rapid-acting intramuscular ziprasidone</string>
       </void>
       <void index="49">
        <string>Proceedings of the 153rd Annual Meeting of the American Psychiatric Association; 2000 May 13-18; Chicago, Illinois, USA</string>
       </void>
       <void index="50">
        <string>2000</string>
       </void>
       <void index="51">
        <string></string>
       </void>
       <void index="52">
        <string></string>
       </void>
       <void index="53">
        <string></string>
       </void>
      </array>
     </void>
     <void property="reportingBiasJudgement">
      <string>The number of participants reported as discontinuing due to adverse effects is reported inconsistently (see Brook 1998c table 2 and Brook 2000 table 4). It is not clear whether all adverse events are reported. Brook 2000 table 4 only reports adverse events occurring in ≥10 of people, however there are more adverse events mentioned throughout the text.</string>
     </void>
     <void property="reportingBiasRisk">
      <string>High risk</string>
     </void>
     <void property="revManID">
      <string>STD-Brook-2000</string>
     </void>
     <void property="selectionBiasAllocationConcealmentBiasRisk">
      <string>Unclear Risk</string>
     </void>
     <void property="selectionBiasAllocationConcealmentJudgement">
      <string>Not stated.</string>
     </void>
     <void property="selectionBiasRandomSequenceBiasRisk">
      <string>Low risk</string>
     </void>
     <void property="selectionBiasRandomSequenceJudgement">
      <string>&quot;Computerized randomization assigned&quot;.</string>
     </void>
     <void property="year">
      <int>2000</int>
     </void>
    </object>
   </void>
   <void method="add">
    <object class="TrialObject" id="TrialObject8">
     <void property="attritionBiasJudgement">
      <string>No evidence of incomplete outcome data.</string>
     </void>
     <void property="attritionBiasRisk">
      <string>Low risk</string>
     </void>
     <void property="authorYearLetter">
      <string>Calver2015</string>
     </void>
     <void property="detectionBiasJudgement">
      <string>&quot;labels A or B and not the drug names were known to the investigator. This investigator analysed the data independently and presented this to the other investigators&quot; (p.224).</string>
     </void>
     <void property="detectionBiasRisk">
      <string>Low risk</string>
     </void>
     <void property="mainAuthor">
      <string>Calver</string>
     </void>
     <void property="meerKatCountry">
      <string></string>
     </void>
     <void property="otherBiasJudgement">
      <string>Short study.</string>
     </void>
     <void property="otherBiasRisk">
      <string>High risk</string>
     </void>
     <void property="outcomeList">
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: c. DROPERIDOL</string>
        </void>
        <void property="group1Events">
         <int>9</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>110</int>
        </void>
        <void property="group2Events">
         <int>9</int>
        </void>
        <void property="group2Name">
         <string>droperidol</string>
        </void>
        <void property="group2Total">
         <int>118</int>
        </void>
        <void property="outcomeName">
         <string>Tranquillisation or asleep: 1. Not asleep</string>
        </void>
        <void property="subgroupName">
         <string>up to 2 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: c. DROPERIDOL</string>
        </void>
        <void property="group1Events">
         <int>14</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>110</int>
        </void>
        <void property="group2Events">
         <int>6</int>
        </void>
        <void property="group2Name">
         <string>droperidol</string>
        </void>
        <void property="group2Total">
         <int>118</int>
        </void>
        <void property="outcomeName">
         <string>Repeated need for rapid tranquillisation</string>
        </void>
        <void property="subgroupName">
         <string>more than 1 injection</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: c. DROPERIDOL</string>
        </void>
        <void property="group1Events">
         <int>2</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>110</int>
        </void>
        <void property="group2Events">
         <int>7</int>
        </void>
        <void property="group2Name">
         <string>droperidol</string>
        </void>
        <void property="group2Total">
         <int>118</int>
        </void>
        <void property="outcomeName">
         <string>Global outcome: 1. Need for benzodiazepine</string>
        </void>
        <void property="subgroupName">
         <string>up to 2 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: c. DROPERIDOL</string>
        </void>
        <void property="group1Events">
         <int>1</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>110</int>
        </void>
        <void property="group2Events">
         <int>7</int>
        </void>
        <void property="group2Name">
         <string>droperidol</string>
        </void>
        <void property="group2Total">
         <int>118</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 1. General</string>
        </void>
        <void property="subgroupName">
         <string>overall adverse events up to 2 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: c. DROPERIDOL</string>
        </void>
        <void property="group1Events">
         <int>1</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>110</int>
        </void>
        <void property="group2Events">
         <int>6</int>
        </void>
        <void property="group2Name">
         <string>droperidol</string>
        </void>
        <void property="group2Total">
         <int>118</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 1. General</string>
        </void>
        <void property="subgroupName">
         <string>patients with one or more AEs</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: c. DROPERIDOL</string>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>110</int>
        </void>
        <void property="group2Events">
         <int>1</int>
        </void>
        <void property="group2Name">
         <string>droperidol</string>
        </void>
        <void property="group2Total">
         <int>118</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2a. Specific - arousal level</string>
        </void>
        <void property="subgroupName">
         <string>&quot;over&quot; sedated</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: c. DROPERIDOL</string>
        </void>
        <void property="group1Events">
         <int>1</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>110</int>
        </void>
        <void property="group2Events">
         <int>4</int>
        </void>
        <void property="group2Name">
         <string>droperidol</string>
        </void>
        <void property="group2Total">
         <int>118</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2b. Specific - cardiovascular</string>
        </void>
        <void property="subgroupName">
         <string>hypotension up to 2 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: c. DROPERIDOL</string>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>110</int>
        </void>
        <void property="group2Events">
         <int>1</int>
        </void>
        <void property="group2Name">
         <string>droperidol</string>
        </void>
        <void property="group2Total">
         <int>118</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2c. Specific - movement disorders</string>
        </void>
        <void property="subgroupName">
         <string>dystonia</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: c. DROPERIDOL</string>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>110</int>
        </void>
        <void property="group2Events">
         <int>1</int>
        </void>
        <void property="group2Name">
         <string>droperidol</string>
        </void>
        <void property="group2Total">
         <int>118</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2d. Specific - miscellaneous</string>
        </void>
        <void property="subgroupName">
         <string>desaturation</string>
        </void>
       </object>
      </void>
     </void>
     <void property="performanceBiasJudgement">
      <string>Double-blind study.</string>
     </void>
     <void property="performanceBiasRisk">
      <string>Low risk</string>
     </void>
     <void property="references">
      <array class="java.lang.String" length="9">
       <void index="0">
        <string>OTHER</string>
       </void>
       <void index="1">
        <string>NO</string>
       </void>
       <void index="2">
        <string>Calver L, Drinkwater V, Gupta R, Page CB, Isbister GK</string>
       </void>
       <void index="3">
        <string>Droperidol v. haloperidol for sedation of aggressive behaviour in acute mental health: Randomized controlled trial</string>
       </void>
       <void index="4">
        <string>British Journal of Psychiatry</string>
       </void>
       <void index="5">
        <string>2015</string>
       </void>
       <void index="6">
        <string>206</string>
       </void>
       <void index="7">
        <string>3</string>
       </void>
       <void index="8">
        <string>223-8</string>
       </void>
      </array>
     </void>
     <void property="reportingBiasJudgement">
      <string>&quot;In breach of the study protocol midazolam was given nine times simultaneously with the study drug&quot; (p.226); no further evidence of selective reporting.</string>
     </void>
     <void property="reportingBiasRisk">
      <string>Unclear Risk</string>
     </void>
     <void property="revManID">
      <string>STD-Calver-2015</string>
     </void>
     <void property="selectionBiasAllocationConcealmentBiasRisk">
      <string>Low risk</string>
     </void>
     <void property="selectionBiasAllocationConcealmentJudgement">
      <string>&quot;Pre-packed treatment kits [...] contained either droperidol (10mg in 2ml) or haloperidol (10mg in 2ml) [...] transferred into vials identical&quot; (p.224).</string>
     </void>
     <void property="selectionBiasRandomSequenceBiasRisk">
      <string>Low risk</string>
     </void>
     <void property="selectionBiasRandomSequenceJudgement">
      <string>&quot;Block randomisation was used. Microsoft Excel was used to randomly create blocks of four (ABAB, AABB, etc.) or six (ABABAB, AAABBB, etc.)&quot; (p.224).</string>
     </void>
     <void property="year">
      <int>2015</int>
     </void>
    </object>
   </void>
   <void method="add">
    <object class="TrialObject" id="TrialObject9">
     <void property="attritionBiasJudgement">
      <string>A flow diagram is provided with the reasons for leaving the study early reported. However, the number of participants completing different assessments at the same time point vary and reasons are not given.</string>
     </void>
     <void property="attritionBiasRisk">
      <string>Unclear Risk</string>
     </void>
     <void property="authorYearLetter">
      <string>Currier2004</string>
     </void>
     <void property="countries">
      <string>USA</string>
     </void>
     <void property="detectionBiasJudgement">
      <string>&quot;independent raters blinded to the treatment arm conducted efficacy assessments&quot;. (p.387).</string>
     </void>
     <void property="detectionBiasRisk">
      <string>Low risk</string>
     </void>
     <void property="mainAuthor">
      <string>Currier</string>
     </void>
     <void property="meerKatCountry">
      <string>USA</string>
     </void>
     <void property="otherBiasJudgement">
      <string>Sponsored by drug company (Janssen Phamaceutica).</string>
     </void>
     <void property="otherBiasRisk">
      <string>High risk</string>
     </void>
     <void property="outcomeList">
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: h. RISPERIDONE</string>
        </void>
        <void property="group1Events">
         <int>62</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>79</int>
        </void>
        <void property="group2Events">
         <int>78</int>
        </void>
        <void property="group2Name">
         <string>risperidone</string>
        </void>
        <void property="group2Total">
         <int>83</int>
        </void>
        <void property="outcomeName">
         <string>Tranquillisation or asleep - i. by 30 minutes</string>
        </void>
        <void property="subgroupName">
         <string>not asleep at 30 minutes</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: h. RISPERIDONE</string>
        </void>
        <void property="group1Events">
         <int>45</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>79</int>
        </void>
        <void property="group2Events">
         <int>64</int>
        </void>
        <void property="group2Name">
         <string>risperidone</string>
        </void>
        <void property="group2Total">
         <int>83</int>
        </void>
        <void property="outcomeName">
         <string>Tranquillisation or asleep - ii. up to 2 hours</string>
        </void>
        <void property="subgroupName">
         <string>not asleep at 1 hour</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: h. RISPERIDONE</string>
        </void>
        <void property="group1Events">
         <int>31</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>79</int>
        </void>
        <void property="group2Events">
         <int>46</int>
        </void>
        <void property="group2Name">
         <string>risperidone</string>
        </void>
        <void property="group2Total">
         <int>83</int>
        </void>
        <void property="outcomeName">
         <string>Tranquillisation or asleep - ii. up to 2 hours</string>
        </void>
        <void property="subgroupName">
         <string>not asleep at 2 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: h. RISPERIDONE</string>
        </void>
        <void property="group1Events">
         <int>25</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>79</int>
        </void>
        <void property="group2Events">
         <int>28</int>
        </void>
        <void property="group2Name">
         <string>risperidone</string>
        </void>
        <void property="group2Total">
         <int>83</int>
        </void>
        <void property="outcomeName">
         <string>Global outcome: 1. Binary measures</string>
        </void>
        <void property="subgroupName">
         <string>needing additional benzodiazepine</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: h. RISPERIDONE</string>
        </void>
        <void property="group1Events">
         <int>17</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>79</int>
        </void>
        <void property="group2Events">
         <int>20</int>
        </void>
        <void property="group2Name">
         <string>risperidone</string>
        </void>
        <void property="group2Total">
         <int>83</int>
        </void>
        <void property="outcomeName">
         <string>Global outcome: 1. Binary measures</string>
        </void>
        <void property="subgroupName">
         <string>rated as severe at 24 hours (CGI-S)</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: h. RISPERIDONE</string>
        </void>
        <void property="group1Events">
         <int>58</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>79</int>
        </void>
        <void property="group2Events">
         <int>61</int>
        </void>
        <void property="group2Name">
         <string>risperidone</string>
        </void>
        <void property="group2Total">
         <int>83</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 1a. General - one or more adverse effects</string>
        </void>
        <void property="subgroupName">
         <string>up to 24 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: h. RISPERIDONE</string>
        </void>
        <void property="group1Events">
         <int>56</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>79</int>
        </void>
        <void property="group2Events">
         <int>31</int>
        </void>
        <void property="group2Name">
         <string>risperidone</string>
        </void>
        <void property="group2Total">
         <int>83</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2a. Specific - arousal</string>
        </void>
        <void property="subgroupName">
         <string>sedated at 30 minutes</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: h. RISPERIDONE</string>
        </void>
        <void property="group1Events">
         <int>67</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>79</int>
        </void>
        <void property="group2Events">
         <int>50</int>
        </void>
        <void property="group2Name">
         <string>risperidone</string>
        </void>
        <void property="group2Total">
         <int>83</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2a. Specific - arousal</string>
        </void>
        <void property="subgroupName">
         <string>sedated at 60 minutes</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: h. RISPERIDONE</string>
        </void>
        <void property="group1Events">
         <int>73</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>79</int>
        </void>
        <void property="group2Events">
         <int>70</int>
        </void>
        <void property="group2Name">
         <string>risperidone</string>
        </void>
        <void property="group2Total">
         <int>83</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2a. Specific - arousal</string>
        </void>
        <void property="subgroupName">
         <string>sedated at 120 minutes</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: h. RISPERIDONE</string>
        </void>
        <void property="group1Events">
         <int>10</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>79</int>
        </void>
        <void property="group2Events">
         <int>11</int>
        </void>
        <void property="group2Name">
         <string>risperidone</string>
        </void>
        <void property="group2Total">
         <int>83</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2a. Specific - arousal</string>
        </void>
        <void property="subgroupName">
         <string>somnolence during 24 hours (only reported if occurred in ≥5%)</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: h. RISPERIDONE</string>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>79</int>
        </void>
        <void property="group2Events">
         <int>1</int>
        </void>
        <void property="group2Name">
         <string>risperidone</string>
        </void>
        <void property="group2Total">
         <int>83</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2a. Specific - arousal</string>
        </void>
        <void property="subgroupName">
         <string>insomnia - severe</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: h. RISPERIDONE</string>
        </void>
        <void property="group1Events">
         <int>1</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>79</int>
        </void>
        <void property="group2Name">
         <string>risperidone</string>
        </void>
        <void property="group2Total">
         <int>83</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2a. Specific - arousal</string>
        </void>
        <void property="subgroupName">
         <string>somnolence - severe</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: h. RISPERIDONE</string>
        </void>
        <void property="group1Events">
         <int>2</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>79</int>
        </void>
        <void property="group2Name">
         <string>risperidone</string>
        </void>
        <void property="group2Total">
         <int>83</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2b. Specific - cardiovascular - i. binary outcomes</string>
        </void>
        <void property="subgroupName">
         <string>orthostatic hypertension</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: h. RISPERIDONE</string>
        </void>
        <void property="group1Events">
         <int>1</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>79</int>
        </void>
        <void property="group2Events">
         <int>2</int>
        </void>
        <void property="group2Name">
         <string>risperidone</string>
        </void>
        <void property="group2Total">
         <int>83</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2e. Specific - movement disorder - i. binary outcomes</string>
        </void>
        <void property="subgroupName">
         <string>dystonia during 24 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: h. RISPERIDONE</string>
        </void>
        <void property="group1Events">
         <int>1</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>79</int>
        </void>
        <void property="group2Name">
         <string>risperidone</string>
        </void>
        <void property="group2Total">
         <int>83</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2e. Specific - movement disorder - i. binary outcomes</string>
        </void>
        <void property="subgroupName">
         <string>dyskinesia during 24 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: h. RISPERIDONE</string>
        </void>
        <void property="group1Events">
         <int>4</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>79</int>
        </void>
        <void property="group2Events">
         <int>1</int>
        </void>
        <void property="group2Name">
         <string>risperidone</string>
        </void>
        <void property="group2Total">
         <int>83</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2e. Specific - movement disorder - i. binary outcomes</string>
        </void>
        <void property="subgroupName">
         <string>hyperkinesia during 24 hours (only reported if occurred in ≥5%)</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: h. RISPERIDONE</string>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>79</int>
        </void>
        <void property="group2Events">
         <int>1</int>
        </void>
        <void property="group2Name">
         <string>risperidone</string>
        </void>
        <void property="group2Total">
         <int>83</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2e. Specific - movement disorder - i. binary outcomes</string>
        </void>
        <void property="subgroupName">
         <string>hypertonia/rigidity during 24 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: h. RISPERIDONE</string>
        </void>
        <void property="group1Events">
         <int>2</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>79</int>
        </void>
        <void property="group2Name">
         <string>risperidone</string>
        </void>
        <void property="group2Total">
         <int>83</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2e. Specific - movement disorder - i. binary outcomes</string>
        </void>
        <void property="subgroupName">
         <string>tremor during 24 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: h. RISPERIDONE</string>
        </void>
        <void property="group1Events">
         <int>4</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>79</int>
        </void>
        <void property="group2Events">
         <int>4</int>
        </void>
        <void property="group2Name">
         <string>risperidone</string>
        </void>
        <void property="group2Total">
         <int>83</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2h. Specific - miscellaneous</string>
        </void>
        <void property="subgroupName">
         <string>agitation during 24 hours (only reported if occurred in ≥5%)</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: h. RISPERIDONE</string>
        </void>
        <void property="group1Events">
         <int>2</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>79</int>
        </void>
        <void property="group2Events">
         <int>1</int>
        </void>
        <void property="group2Name">
         <string>risperidone</string>
        </void>
        <void property="group2Total">
         <int>83</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2h. Specific - miscellaneous</string>
        </void>
        <void property="subgroupName">
         <string>agitation - severe</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: h. RISPERIDONE</string>
        </void>
        <void property="group1Events">
         <int>1</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>79</int>
        </void>
        <void property="group2Name">
         <string>risperidone</string>
        </void>
        <void property="group2Total">
         <int>83</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2h. Specific - miscellaneous</string>
        </void>
        <void property="subgroupName">
         <string>anxiety - severe</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: h. RISPERIDONE</string>
        </void>
        <void property="group1Events">
         <int>5</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>79</int>
        </void>
        <void property="group2Events">
         <int>4</int>
        </void>
        <void property="group2Name">
         <string>risperidone</string>
        </void>
        <void property="group2Total">
         <int>83</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2h. Specific - miscellaneous</string>
        </void>
        <void property="subgroupName">
         <string>headache during 24 hours (only reported if occurred in ≥5%)</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: h. RISPERIDONE</string>
        </void>
        <void property="group1Events">
         <int>1</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>79</int>
        </void>
        <void property="group2Events">
         <int>1</int>
        </void>
        <void property="group2Name">
         <string>risperidone</string>
        </void>
        <void property="group2Total">
         <int>83</int>
        </void>
        <void property="outcomeName">
         <string>Leaving the study early - i. up to 24 hours</string>
        </void>
        <void property="subgroupName">
         <string>due to adverse effects</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: h. RISPERIDONE</string>
        </void>
        <void property="group1Events">
         <int>14</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>79</int>
        </void>
        <void property="group2Events">
         <int>19</int>
        </void>
        <void property="group2Name">
         <string>risperidone</string>
        </void>
        <void property="group2Total">
         <int>83</int>
        </void>
        <void property="outcomeName">
         <string>Leaving the study early - i. up to 24 hours</string>
        </void>
        <void property="subgroupName">
         <string>unspecified general reasons</string>
        </void>
       </object>
      </void>
     </void>
     <void property="performanceBiasJudgement">
      <string>Single-blind study.</string>
     </void>
     <void property="performanceBiasRisk">
      <string>High risk</string>
     </void>
     <void property="references">
      <array class="java.lang.String" length="9">
       <void index="0">
        <string>JOURNAL_ARTICLE</string>
       </void>
       <void index="1">
        <string>NO</string>
       </void>
       <void index="2">
        <string>Currier GW, Chou JC, Feifel D, Bossie CA, Turkoz I, Mahmoud R, et al</string>
       </void>
       <void index="3">
        <string>Acute treatment of psychotic agitation: a randomized comparison of oral treatment with risperidone and lorazepam versus intramuscular treatment with haloperidol and lorazepam</string>
       </void>
       <void index="4">
        <string>Journal of Clinical Psychiatry</string>
       </void>
       <void index="5">
        <string>2004</string>
       </void>
       <void index="6">
        <string>65</string>
       </void>
       <void index="7">
        <string>3</string>
       </void>
       <void index="8">
        <string>386-94</string>
       </void>
      </array>
     </void>
     <void property="reportingBiasJudgement">
      <string>The authors only report the side effects that occurred in ≥ 5% of people.</string>
     </void>
     <void property="reportingBiasRisk">
      <string>High risk</string>
     </void>
     <void property="revManID">
      <string>STD-Currier-2004</string>
     </void>
     <void property="selectionBiasAllocationConcealmentBiasRisk">
      <string>Low risk</string>
     </void>
     <void property="selectionBiasAllocationConcealmentJudgement">
      <string>&quot;A telephone-based central service was used to randomly assign eligible patients to receive a single dose of oral treatment or IM injection.&quot; (p.387).</string>
     </void>
     <void property="selectionBiasRandomSequenceBiasRisk">
      <string>Unclear Risk</string>
     </void>
     <void property="selectionBiasRandomSequenceJudgement">
      <string>Described as randomised - method of randomisation is not reported.</string>
     </void>
     <void property="year">
      <int>2004</int>
     </void>
    </object>
   </void>
   <void method="add">
    <object class="TrialObject" id="TrialObject10">
     <void property="attritionBiasJudgement">
      <string>No evidence of incomplete outcome data.</string>
     </void>
     <void property="attritionBiasRisk">
      <string>Low risk</string>
     </void>
     <void property="authorYearLetter">
      <string>Dorevitch1999</string>
     </void>
     <void property="detectionBiasJudgement">
      <string>&quot;All ratings were completed by the same rater (N.K.), who was blind to the study medications.&quot; (p.143).</string>
     </void>
     <void property="detectionBiasRisk">
      <string>Low risk</string>
     </void>
     <void property="mainAuthor">
      <string>Dorevitch</string>
     </void>
     <void property="meerKatCountry">
      <string></string>
     </void>
     <void property="otherBiasJudgement">
      <string>Small short study.</string>
     </void>
     <void property="otherBiasRisk">
      <string>Unclear Risk</string>
     </void>
     <void property="outcomeList">
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs BENZODIAZEPINE: a. FLUNITRAZEPAM</string>
        </void>
        <void property="group1Events">
         <int>12</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>13</int>
        </void>
        <void property="group2Events">
         <int>12</int>
        </void>
        <void property="group2Name">
         <string>flunitrazepam</string>
        </void>
        <void property="group2Total">
         <int>15</int>
        </void>
        <void property="outcomeName">
         <string>Specific behaviour: 1. Aggression - binary measures - i. up to 2 hours</string>
        </void>
        <void property="subgroupName">
         <string>≥50% reduction at 90 minutes (OAS)</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs BENZODIAZEPINE: a. FLUNITRAZEPAM</string>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>13</int>
        </void>
        <void property="group2Name">
         <string>flunitrazepam</string>
        </void>
        <void property="group2Total">
         <int>15</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 1. Specific - movement disorders - i. binary measures - i. by 30 minutes</string>
        </void>
        <void property="subgroupName">
         <string>EPS by 30 minutes</string>
        </void>
       </object>
      </void>
     </void>
     <void property="performanceBiasJudgement">
      <string>Described as double-blind, however further details regarding the blinding of participants and personnel are not reported.</string>
     </void>
     <void property="performanceBiasRisk">
      <string>Unclear Risk</string>
     </void>
     <void property="references">
      <array class="java.lang.String" length="9">
       <void index="0">
        <string>JOURNAL_ARTICLE</string>
       </void>
       <void index="1">
        <string>NO</string>
       </void>
       <void index="2">
        <string>Dorevitch A, Katz N, Zemishlany Z, Aizenberg D, Weizman A</string>
       </void>
       <void index="3">
        <string>Intramuscular flunitrazepam versus intramuscular haloperidol in the emergency treatment of aggressive psychotic behavior</string>
       </void>
       <void index="4">
        <string>American Journal of Psychiatry</string>
       </void>
       <void index="5">
        <string>1999</string>
       </void>
       <void index="6">
        <string>156</string>
       </void>
       <void index="7">
        <string>1</string>
       </void>
       <void index="8">
        <string>142-4</string>
       </void>
      </array>
     </void>
     <void property="reportingBiasJudgement">
      <string>It is not clear whether all side effects are reported.</string>
     </void>
     <void property="reportingBiasRisk">
      <string>Unclear Risk</string>
     </void>
     <void property="revManID">
      <string>STD-Dorevitch-1999</string>
     </void>
     <void property="selectionBiasAllocationConcealmentBiasRisk">
      <string>Unclear Risk</string>
     </void>
     <void property="selectionBiasAllocationConcealmentJudgement">
      <string>Not stated.</string>
     </void>
     <void property="selectionBiasRandomSequenceBiasRisk">
      <string>Low risk</string>
     </void>
     <void property="selectionBiasRandomSequenceJudgement">
      <string>&quot;assigned by a table of random numbers.&quot; (p.142).</string>
     </void>
     <void property="year">
      <int>1999</int>
     </void>
    </object>
   </void>
   <void method="add">
    <object class="TrialObject" id="TrialObject11">
     <void property="attritionBiasJudgement">
      <string>The number of patients that completed the study is unclear: authors assert 45 in a study, 46 participants in the other one out of a possible 49 participants. However, only 42 participants are included in the analysis for the CGI-I (at the end of the study), SAS, BAS, clinical laboratory evaluations, vital signs and ECG, without explanation for the missing participants.</string>
     </void>
     <void property="attritionBiasRisk">
      <string>High risk</string>
     </void>
     <void property="authorYearLetter">
      <string>Eli-Lilly2004</string>
     </void>
     <void property="countries">
      <string>Taiwan</string>
     </void>
     <void property="detectionBiasJudgement">
      <string>Described as double-blind, however no further details reported regarding rater-blinding.</string>
     </void>
     <void property="detectionBiasRisk">
      <string>Unclear Risk</string>
     </void>
     <void property="mainAuthor">
      <string>Eli-Lilly</string>
     </void>
     <void property="meerKatCountry">
      <string>Taiwan</string>
     </void>
     <void property="otherBiasJudgement">
      <string>Sponsored by the manufacturers of olanzapine.</string>
     </void>
     <void property="otherBiasRisk">
      <string>High risk</string>
     </void>
     <void property="outcomeList">
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: e. OLANZAPINE</string>
        </void>
        <void property="group1Events">
         <int>2</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>24</int>
        </void>
        <void property="group2Events">
         <int>6</int>
        </void>
        <void property="group2Name">
         <string>olanzapine</string>
        </void>
        <void property="group2Total">
         <int>25</int>
        </void>
        <void property="outcomeName">
         <string>Repeated need for tranquillisation - needing additional injection</string>
        </void>
        <void property="subgroupName">
         <string>by 24 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: e. OLANZAPINE</string>
        </void>
        <void property="group1Events">
         <int>13</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>23</int>
        </void>
        <void property="group2Events">
         <int>13</int>
        </void>
        <void property="group2Name">
         <string>olanzapine</string>
        </void>
        <void property="group2Total">
         <int>22</int>
        </void>
        <void property="outcomeName">
         <string>Specific behaviour: 1a. Agitation - various measures</string>
        </void>
        <void property="subgroupName">
         <string>response - up to 2 hours (≥40% reduction in PANSS-EC)</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: e. OLANZAPINE</string>
        </void>
        <void property="group1Events">
         <int>1</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>24</int>
        </void>
        <void property="group2Events">
         <int>1</int>
        </void>
        <void property="group2Name">
         <string>olanzapine</string>
        </void>
        <void property="group2Total">
         <int>25</int>
        </void>
        <void property="outcomeName">
         <string>Specific behaviour: 1a. Agitation - various measures</string>
        </void>
        <void property="subgroupName">
         <string>agitation - reported as &apos;adverse effect&apos;</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: e. OLANZAPINE</string>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>24</int>
        </void>
        <void property="group2Events">
         <int>1</int>
        </void>
        <void property="group2Name">
         <string>olanzapine</string>
        </void>
        <void property="group2Total">
         <int>25</int>
        </void>
        <void property="outcomeName">
         <string>Mental state: 1. Various outcomes reported as &apos;adverse events&apos;</string>
        </void>
        <void property="subgroupName">
         <string>anxiety</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: e. OLANZAPINE</string>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>24</int>
        </void>
        <void property="group2Events">
         <int>1</int>
        </void>
        <void property="group2Name">
         <string>olanzapine</string>
        </void>
        <void property="group2Total">
         <int>25</int>
        </void>
        <void property="outcomeName">
         <string>Mental state: 1. Various outcomes reported as &apos;adverse events&apos;</string>
        </void>
        <void property="subgroupName">
         <string>delusions</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: e. OLANZAPINE</string>
        </void>
        <void property="group1Events">
         <int>1</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>24</int>
        </void>
        <void property="group2Events">
         <int>1</int>
        </void>
        <void property="group2Name">
         <string>olanzapine</string>
        </void>
        <void property="group2Total">
         <int>25</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 1a. General</string>
        </void>
        <void property="subgroupName">
         <string>one or more drug related adverse events</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: e. OLANZAPINE</string>
        </void>
        <void property="group1Events">
         <int>7</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>24</int>
        </void>
        <void property="group2Events">
         <int>9</int>
        </void>
        <void property="group2Name">
         <string>olanzapine</string>
        </void>
        <void property="group2Total">
         <int>25</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 1b. General - serious</string>
        </void>
        <void property="subgroupName">
         <string>one or more treatment emergent adverse events</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: e. OLANZAPINE</string>
        </void>
        <void property="group1Events">
         <int>13</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>24</int>
        </void>
        <void property="group2Events">
         <int>11</int>
        </void>
        <void property="group2Name">
         <string>olanzapine</string>
        </void>
        <void property="group2Total">
         <int>25</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 1b. General - serious</string>
        </void>
        <void property="subgroupName">
         <string>treatment emergent adverse events - all</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: e. OLANZAPINE</string>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>25</int>
        </void>
        <void property="group2Name">
         <string>olanzapine</string>
        </void>
        <void property="group2Total">
         <int>24</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 1b. General - serious</string>
        </void>
        <void property="subgroupName">
         <string>overall serious adverse effects</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: e. OLANZAPINE</string>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>24</int>
        </void>
        <void property="group2Name">
         <string>olanzapine</string>
        </void>
        <void property="group2Total">
         <int>25</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 1b. General - serious</string>
        </void>
        <void property="subgroupName">
         <string>death</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: e. OLANZAPINE</string>
        </void>
        <void property="group1Events">
         <int>6</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>24</int>
        </void>
        <void property="group2Events">
         <int>6</int>
        </void>
        <void property="group2Name">
         <string>olanzapine</string>
        </void>
        <void property="group2Total">
         <int>25</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2b. Specific - arousal level - i. various</string>
        </void>
        <void property="subgroupName">
         <string>insomnia</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: e. OLANZAPINE</string>
        </void>
        <void property="group1Name">
         <string>HALOPERIDOL </string>
        </void>
        <void property="group1NameProse">
         <string>HALOPERIDOL </string>
        </void>
        <void property="group1Total">
         <int>24</int>
        </void>
        <void property="group2Name">
         <string>olanzapine</string>
        </void>
        <void property="group2NameProse">
         <string> other antipsychotic: e. olanzapine</string>
        </void>
        <void property="group2Total">
         <int>25</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2f. Specific - cardiovascular i. binary</string>
        </void>
        <void property="subgroupName">
         <string>clinically significant ECG change</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: e. OLANZAPINE</string>
        </void>
        <void property="group1Events">
         <int>1</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>24</int>
        </void>
        <void property="group2Name">
         <string>olanzapine</string>
        </void>
        <void property="group2Total">
         <int>25</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2h. Specific - gastrointestinal</string>
        </void>
        <void property="subgroupName">
         <string>abdominal pain</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: e. OLANZAPINE</string>
        </void>
        <void property="group1Events">
         <int>2</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>24</int>
        </void>
        <void property="group2Name">
         <string>olanzapine</string>
        </void>
        <void property="group2Total">
         <int>25</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2h. Specific - gastrointestinal</string>
        </void>
        <void property="subgroupName">
         <string>vomiting</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: e. OLANZAPINE</string>
        </void>
        <void property="group1Events">
         <int>1</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>24</int>
        </void>
        <void property="group2Events">
         <int>1</int>
        </void>
        <void property="group2Name">
         <string>olanzapine</string>
        </void>
        <void property="group2Total">
         <int>25</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2i. Specific - movement disorder - i. various</string>
        </void>
        <void property="subgroupName">
         <string>EPS during study</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: e. OLANZAPINE</string>
        </void>
        <void property="group1Events">
         <int>1</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>24</int>
        </void>
        <void property="group2Events">
         <int>1</int>
        </void>
        <void property="group2Name">
         <string>olanzapine</string>
        </void>
        <void property="group2Total">
         <int>25</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2i. Specific - movement disorder - i. various</string>
        </void>
        <void property="subgroupName">
         <string>extrapyramidal effects - use of antiparkinson drugs during study</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: e. OLANZAPINE</string>
        </void>
        <void property="group1Events">
         <int>1</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>24</int>
        </void>
        <void property="group2Name">
         <string>olanzapine</string>
        </void>
        <void property="group2Total">
         <int>25</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2m. Specific - miscellaneous</string>
        </void>
        <void property="subgroupName">
         <string>pain</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: e. OLANZAPINE</string>
        </void>
        <void property="group1Events">
         <int>1</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>24</int>
        </void>
        <void property="group2Name">
         <string>olanzapine</string>
        </void>
        <void property="group2Total">
         <int>25</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2m. Specific - miscellaneous</string>
        </void>
        <void property="subgroupName">
         <string>other - nose bleed</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: e. OLANZAPINE</string>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>24</int>
        </void>
        <void property="group2Name">
         <string>olanzapine</string>
        </void>
        <void property="group2Total">
         <int>25</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2m. Specific - miscellaneous</string>
        </void>
        <void property="subgroupName">
         <string>other - clinically relevant laboratory changes</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: e. OLANZAPINE</string>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>24</int>
        </void>
        <void property="group2Name">
         <string>olanzapine</string>
        </void>
        <void property="group2Total">
         <int>24</int>
        </void>
        <void property="outcomeName">
         <string>Leaving the study early</string>
        </void>
        <void property="subgroupName">
         <string>any reason</string>
        </void>
       </object>
      </void>
     </void>
     <void property="performanceBiasJudgement">
      <string>Described as double-blind, however no further details reported regarding the blinding of participants and personnel are not reported.</string>
     </void>
     <void property="performanceBiasRisk">
      <string>Unclear Risk</string>
     </void>
     <void property="references">
      <array class="java.lang.String" length="27">
       <void index="0">
        <string>OTHER</string>
       </void>
       <void index="1">
        <string>NO</string>
       </void>
       <void index="2">
        <string>Chan HY, Ree SC, Su LW, Chen JJ, Chou SY, Chen CK, et al</string>
       </void>
       <void index="3">
        <string>A double-blind, randomized comparison study of efficacy and safety of intramuscular olanzapine and intramuscular haloperidol in patients with schizophrenia and acute agitated behavior</string>
       </void>
       <void index="4">
        <string>Journal of Clinical Psychopharmacology</string>
       </void>
       <void index="5">
        <string>2014</string>
       </void>
       <void index="6">
        <string>34</string>
       </void>
       <void index="7">
        <string>3</string>
       </void>
       <void index="8">
        <string>355-8</string>
       </void>
       <void index="9">
        <string>OTHER</string>
       </void>
       <void index="10">
        <string>NO</string>
       </void>
       <void index="11">
        <string>Eli Lilly</string>
       </void>
       <void index="12">
        <string>Comparison of intramuscular olanzapine and intramuscular haloperidol in patients with schizophrenia</string>
       </void>
       <void index="13">
        <string>Eli Lilly and Company Clinical Trial Registry</string>
       </void>
       <void index="14">
        <string>2004</string>
       </void>
       <void index="15">
        <string></string>
       </void>
       <void index="16">
        <string></string>
       </void>
       <void index="17">
        <string></string>
       </void>
       <void index="18">
        <string>OTHER</string>
       </void>
       <void index="19">
        <string>YES</string>
       </void>
       <void index="20">
        <string>NCT00485901</string>
       </void>
       <void index="21">
        <string>A double-blind randomized comparison of the efficacy and safety of intramuscular olanzapine and intramuscular haloperidol in acutely agitated patients with schizophrenia</string>
       </void>
       <void index="22">
        <string>http://www.clinicaltrials.gov</string>
       </void>
       <void index="23">
        <string>2007</string>
       </void>
       <void index="24">
        <string></string>
       </void>
       <void index="25">
        <string></string>
       </void>
       <void index="26">
        <string></string>
       </void>
      </array>
     </void>
     <void property="reportingBiasJudgement">
      <string>Only the CGI-S baseline score is reported.</string>
     </void>
     <void property="reportingBiasRisk">
      <string>High risk</string>
     </void>
     <void property="revManID">
      <string>STD-Eli-Lilly-2004</string>
     </void>
     <void property="selectionBiasAllocationConcealmentBiasRisk">
      <string>Unclear Risk</string>
     </void>
     <void property="selectionBiasAllocationConcealmentJudgement">
      <string>Not stated.</string>
     </void>
     <void property="selectionBiasRandomSequenceBiasRisk">
      <string>Unclear Risk</string>
     </void>
     <void property="selectionBiasRandomSequenceJudgement">
      <string>Described as randomised - method of randomisation is not reported.</string>
     </void>
     <void property="year">
      <int>2004</int>
     </void>
    </object>
   </void>
   <void method="add">
    <object class="TrialObject" id="TrialObject12">
     <void property="attritionBiasJudgement">
      <string>No evidence of incomplete outcome data.</string>
     </void>
     <void property="attritionBiasRisk">
      <string>Low risk</string>
     </void>
     <void property="authorYearLetter">
      <string>Fang2012</string>
     </void>
     <void property="countries">
      <string>China</string>
     </void>
     <void property="detectionBiasJudgement">
      <string>Open trial.</string>
     </void>
     <void property="detectionBiasRisk">
      <string>High risk</string>
     </void>
     <void property="mainAuthor">
      <string>Fang</string>
     </void>
     <void property="meerKatCountry">
      <string>China</string>
     </void>
     <void property="otherBiasJudgement">
      <string>Sponsored by drug company (Xian-Janssen Pharmaceutical Ltd).</string>
     </void>
     <void property="otherBiasRisk">
      <string>High risk</string>
     </void>
     <void property="outcomeList">
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs COMBINATIONS: h. RISPERIDONE + CLONAZEPAM</string>
        </void>
        <void property="group1Events">
         <int>55</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>101</int>
        </void>
        <void property="group2Events">
         <int>53</int>
        </void>
        <void property="group2Name">
         <string>risperidone//clonazepam</string>
        </void>
        <void property="group2NameProse">
         <string> combinations: h. risperidone + clonazepam</string>
        </void>
        <void property="group2Total">
         <int>104</int>
        </void>
        <void property="outcomeName">
         <string>Tranquillisation or asleep</string>
        </void>
        <void property="subgroupName">
         <string>not asleep at 2 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs COMBINATIONS: h. RISPERIDONE + CLONAZEPAM</string>
        </void>
        <void property="group1Events">
         <int>56</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>101</int>
        </void>
        <void property="group2Events">
         <int>70</int>
        </void>
        <void property="group2Name">
         <string>risperidone//clonazepam</string>
        </void>
        <void property="group2NameProse">
         <string> combinations: h. risperidone + clonazepam</string>
        </void>
        <void property="group2Total">
         <int>104</int>
        </void>
        <void property="outcomeName">
         <string>Tranquillisation or asleep</string>
        </void>
        <void property="subgroupName">
         <string>not asleep at 4 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs COMBINATIONS: h. RISPERIDONE + CLONAZEPAM</string>
        </void>
        <void property="group1Events">
         <int>65</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>101</int>
        </void>
        <void property="group2Events">
         <int>39</int>
        </void>
        <void property="group2Name">
         <string>risperidone//clonazepam</string>
        </void>
        <void property="group2NameProse">
         <string> combinations: h. risperidone + clonazepam</string>
        </void>
        <void property="group2Total">
         <int>104</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 1. General</string>
        </void>
        <void property="subgroupName">
         <string>overall adverse events during 120 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs COMBINATIONS: h. RISPERIDONE + CLONAZEPAM</string>
        </void>
        <void property="group1Events">
         <int>6</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>101</int>
        </void>
        <void property="group2Events">
         <int>4</int>
        </void>
        <void property="group2Name">
         <string>risperidone//clonazepam</string>
        </void>
        <void property="group2NameProse">
         <string> combinations: h. risperidone + clonazepam</string>
        </void>
        <void property="group2Total">
         <int>104</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2a. Specific - arousal - i. various</string>
        </void>
        <void property="subgroupName">
         <string>insomnia during 5 days (only reported if occurred in ≥5%)</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs COMBINATIONS: h. RISPERIDONE + CLONAZEPAM</string>
        </void>
        <void property="group1Events">
         <int>5</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>101</int>
        </void>
        <void property="group2Events">
         <int>4</int>
        </void>
        <void property="group2Name">
         <string>risperidone//clonazepam</string>
        </void>
        <void property="group2NameProse">
         <string> combinations: h. risperidone + clonazepam</string>
        </void>
        <void property="group2Total">
         <int>104</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2b. Specific - cardiovascular - i. various</string>
        </void>
        <void property="subgroupName">
         <string>tachycardia during 120 hours (only reported if occurred in ≥5%)</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs COMBINATIONS: h. RISPERIDONE + CLONAZEPAM</string>
        </void>
        <void property="group1Events">
         <int>46</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>101</int>
        </void>
        <void property="group2Events">
         <int>29</int>
        </void>
        <void property="group2Name">
         <string>risperidone//clonazepam</string>
        </void>
        <void property="group2NameProse">
         <string> combinations: h. risperidone + clonazepam</string>
        </void>
        <void property="group2Total">
         <int>104</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2c. Specific - movement disorders - i. various</string>
        </void>
        <void property="subgroupName">
         <string>akathisia during 5 days (only reported if occurred in ≥5%)</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs COMBINATIONS: h. RISPERIDONE + CLONAZEPAM</string>
        </void>
        <void property="group1Events">
         <int>56</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>101</int>
        </void>
        <void property="group2Events">
         <int>26</int>
        </void>
        <void property="group2Name">
         <string>risperidone//clonazepam</string>
        </void>
        <void property="group2NameProse">
         <string> combinations: h. risperidone + clonazepam</string>
        </void>
        <void property="group2Total">
         <int>104</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2c. Specific - movement disorders - i. various</string>
        </void>
        <void property="subgroupName">
         <string>EPS during 5 days (only reported if occurred in ≥5%)</string>
        </void>
       </object>
      </void>
     </void>
     <void property="performanceBiasJudgement">
      <string>Open trial.</string>
     </void>
     <void property="performanceBiasRisk">
      <string>High risk</string>
     </void>
     <void property="references">
      <array class="java.lang.String" length="9">
       <void index="0">
        <string>OTHER</string>
       </void>
       <void index="1">
        <string>NO</string>
       </void>
       <void index="2">
        <string>Fang M, Chen H, Li LH, Wu R, Li Y, Liu L, et al</string>
       </void>
       <void index="3">
        <string>Comparison of risperidone oral solution and intramuscular haloperidol with the latter shifting to oral therapy for the treatment of acute agitation in patients with schizophrenia</string>
       </void>
       <void index="4">
        <string>International Clinical Psychopharmacology</string>
       </void>
       <void index="5">
        <string>2012</string>
       </void>
       <void index="6">
        <string>27</string>
       </void>
       <void index="7">
        <string>2</string>
       </void>
       <void index="8">
        <string>107-13</string>
       </void>
      </array>
     </void>
     <void property="reportingBiasJudgement">
      <string>SAS and BAS scores at 2, 4, 24, 72, and 120 hours are not reported. Only side effects occurred in ≥ 5% of people are reported.</string>
     </void>
     <void property="reportingBiasRisk">
      <string>High risk</string>
     </void>
     <void property="revManID">
      <string>STD-Fang-2012</string>
     </void>
     <void property="selectionBiasAllocationConcealmentBiasRisk">
      <string>Unclear Risk</string>
     </void>
     <void property="selectionBiasAllocationConcealmentJudgement">
      <string>Not stated.</string>
     </void>
     <void property="selectionBiasRandomSequenceBiasRisk">
      <string>Low risk</string>
     </void>
     <void property="selectionBiasRandomSequenceJudgement">
      <string>&quot;A telephone-based central service was used to randomly assign eligible patients&quot; (p.108).</string>
     </void>
     <void property="year">
      <int>2012</int>
     </void>
    </object>
   </void>
   <void method="add">
    <object class="TrialObject" id="TrialObject13">
     <void property="attritionBiasJudgement">
      <string>It is reported that 3 participants were discontinued on the medication. According to Table 3, not all participants completed all outcome measures, it is not clear if this is due to attrition or because people were not available for assessment.</string>
     </void>
     <void property="attritionBiasRisk">
      <string>Unclear Risk</string>
     </void>
     <void property="authorYearLetter">
      <string>Fitzgerald1969</string>
     </void>
     <void property="countries">
      <string>USA</string>
     </void>
     <void property="detectionBiasJudgement">
      <string>Described as double-blind - no further details given regarding rater-blinding.</string>
     </void>
     <void property="detectionBiasRisk">
      <string>Unclear Risk</string>
     </void>
     <void property="mainAuthor">
      <string>Fitzgerald</string>
     </void>
     <void property="meerKatCountry">
      <string>USA</string>
     </void>
     <void property="otherBiasJudgement">
      <string>No clear interested funding.</string>
     </void>
     <void property="otherBiasRisk">
      <string>Unclear Risk</string>
     </void>
     <void property="outcomeList">
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: f. PERPHENAZINE</string>
        </void>
        <void property="group1Events">
         <int>10</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>23</int>
        </void>
        <void property="group2Events">
         <int>7</int>
        </void>
        <void property="group2Name">
         <string>perphenazine</string>
        </void>
        <void property="group2Total">
         <int>21</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 1. General</string>
        </void>
        <void property="subgroupName">
         <string>one or more adverse effect</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: f. PERPHENAZINE</string>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>23</int>
        </void>
        <void property="group2Name">
         <string>perphenazine</string>
        </void>
        <void property="group2Total">
         <int>21</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 1. General</string>
        </void>
        <void property="subgroupName">
         <string>clinically significant laboratory changes</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: f. PERPHENAZINE</string>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>23</int>
        </void>
        <void property="group2Events">
         <int>1</int>
        </void>
        <void property="group2Name">
         <string>perphenazine</string>
        </void>
        <void property="group2Total">
         <int>21</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2. Specific</string>
        </void>
        <void property="subgroupName">
         <string>hypotensive episode</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: f. PERPHENAZINE</string>
        </void>
        <void property="group1Events">
         <int>6</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>23</int>
        </void>
        <void property="group2Events">
         <int>2</int>
        </void>
        <void property="group2Name">
         <string>perphenazine</string>
        </void>
        <void property="group2Total">
         <int>21</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2. Specific</string>
        </void>
        <void property="subgroupName">
         <string>require antiparkinson medication</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: f. PERPHENAZINE</string>
        </void>
        <void property="group1Events">
         <int>2</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>23</int>
        </void>
        <void property="group2Events">
         <int>1</int>
        </void>
        <void property="group2Name">
         <string>perphenazine</string>
        </void>
        <void property="group2Total">
         <int>21</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2. Specific</string>
        </void>
        <void property="subgroupName">
         <string>discontinued due to EPS</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: f. PERPHENAZINE</string>
        </void>
        <void property="group1Events">
         <int>1</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>23</int>
        </void>
        <void property="group2Name">
         <string>perphenazine</string>
        </void>
        <void property="group2Total">
         <int>21</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2. Specific</string>
        </void>
        <void property="subgroupName">
         <string>discontinued due to drowsiness/tension and no therapeutic effect</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: f. PERPHENAZINE</string>
        </void>
        <void property="group1Events">
         <int>2</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>23</int>
        </void>
        <void property="group2Events">
         <int>1</int>
        </void>
        <void property="group2Name">
         <string>perphenazine</string>
        </void>
        <void property="group2Total">
         <int>21</int>
        </void>
        <void property="outcomeName">
         <string>Leaving the study early: 1. Specific reasons</string>
        </void>
        <void property="subgroupName">
         <string>discontinued due to EPS</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: f. PERPHENAZINE</string>
        </void>
        <void property="group1Events">
         <int>1</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>23</int>
        </void>
        <void property="group2Name">
         <string>perphenazine</string>
        </void>
        <void property="group2Total">
         <int>21</int>
        </void>
        <void property="outcomeName">
         <string>Leaving the study early: 1. Specific reasons</string>
        </void>
        <void property="subgroupName">
         <string>discontinued due to drowsiness/tension and no therapeutic effect</string>
        </void>
       </object>
      </void>
     </void>
     <void property="performanceBiasJudgement">
      <string>&quot;haloperidol and perphenazine were supplied in identically appearing 1-mL ampoules each containing 5 mg of drug.&quot; (p.515).</string>
     </void>
     <void property="performanceBiasRisk">
      <string>Low risk</string>
     </void>
     <void property="references">
      <array class="java.lang.String" length="9">
       <void index="0">
        <string>JOURNAL_ARTICLE</string>
       </void>
       <void index="1">
        <string>NO</string>
       </void>
       <void index="2">
        <string>Fitzgerald CH</string>
       </void>
       <void index="3">
        <string>A double-blind comparison of haloperidol with perphenazine in acute psychiatric episodes</string>
       </void>
       <void index="4">
        <string>Current Therapeutic Research</string>
       </void>
       <void index="5">
        <string>1969</string>
       </void>
       <void index="6">
        <string>11</string>
       </void>
       <void index="7">
        <string>8</string>
       </void>
       <void index="8">
        <string>515-9</string>
       </void>
      </array>
     </void>
     <void property="reportingBiasJudgement">
      <string>&quot;Most adverse reactions disappeared with the use of control measures&quot; - author suspects that only the adverse effects severe enough for discontinuation are reported.</string>
     </void>
     <void property="reportingBiasRisk">
      <string>Unclear Risk</string>
     </void>
     <void property="revManID">
      <string>STD-Fitzgerald-1969</string>
     </void>
     <void property="selectionBiasAllocationConcealmentBiasRisk">
      <string>Unclear Risk</string>
     </void>
     <void property="selectionBiasAllocationConcealmentJudgement">
      <string>Not stated.</string>
     </void>
     <void property="selectionBiasRandomSequenceBiasRisk">
      <string>Unclear Risk</string>
     </void>
     <void property="selectionBiasRandomSequenceJudgement">
      <string>Described as randomised - method of randomisation is not reported.</string>
     </void>
     <void property="year">
      <int>1969</int>
     </void>
    </object>
   </void>
   <void method="add">
    <object class="TrialObject">
     <void property="attritionBiasJudgement">
      <string>No evidence of incomplete outcome data.</string>
     </void>
     <void property="attritionBiasRisk">
      <string>Low risk</string>
     </void>
     <void property="authorYearLetter">
      <string>Foster1997</string>
     </void>
     <void property="countries">
      <string>USA</string>
     </void>
     <void property="detectionBiasJudgement">
      <string>&quot;All raters were unaware of the specific medication received by the patient&quot;. (p.176).</string>
     </void>
     <void property="detectionBiasRisk">
      <string>Low risk</string>
     </void>
     <void property="mainAuthor">
      <string>Foster</string>
     </void>
     <void property="meerKatCountry">
      <string>USA</string>
     </void>
     <void property="otherBiasJudgement">
      <string>Small short study.</string>
     </void>
     <void property="otherBiasRisk">
      <string>High risk</string>
     </void>
     <void property="performanceBiasJudgement">
      <string>Described as double-blind, however it is not clear whether the study drugs appeared identical.</string>
     </void>
     <void property="performanceBiasRisk">
      <string>Unclear Risk</string>
     </void>
     <void property="references">
      <array class="java.lang.String" length="9">
       <void index="0">
        <string>JOURNAL_ARTICLE</string>
       </void>
       <void index="1">
        <string>NO</string>
       </void>
       <void index="2">
        <string>Foster S, Kessel J, Berman ME, Simpson GM</string>
       </void>
       <void index="3">
        <string>Efficacy of lorazepam and haloperidol for rapid tranquilization in a psychiatric emergency room setting</string>
       </void>
       <void index="4">
        <string>International Clinical Psychopharmacology</string>
       </void>
       <void index="5">
        <string>1997</string>
       </void>
       <void index="6">
        <string>12</string>
       </void>
       <void index="7">
        <string>3</string>
       </void>
       <void index="8">
        <string>175-9</string>
       </void>
      </array>
     </void>
     <void property="reportingBiasJudgement">
      <string>&quot;patients continued to receive treatment with a benzodiazepine, if necessary, for the duration of their stay in the emergency department.&quot; (p.176). The amount was not reported.</string>
     </void>
     <void property="reportingBiasRisk">
      <string>High risk</string>
     </void>
     <void property="revManID">
      <string>STD-Foster-1997</string>
     </void>
     <void property="selectionBiasAllocationConcealmentBiasRisk">
      <string>Unclear Risk</string>
     </void>
     <void property="selectionBiasAllocationConcealmentJudgement">
      <string>Not stated.</string>
     </void>
     <void property="selectionBiasRandomSequenceBiasRisk">
      <string>Unclear Risk</string>
     </void>
     <void property="selectionBiasRandomSequenceJudgement">
      <string>Described as randomised - method of randomisation is not reported.</string>
     </void>
     <void property="year">
      <int>1997</int>
     </void>
    </object>
   </void>
   <void method="add">
    <object class="TrialObject" id="TrialObject14">
     <void property="attritionBiasJudgement">
      <string>No evidence of incomplete data.</string>
     </void>
     <void property="attritionBiasRisk">
      <string>Low risk</string>
     </void>
     <void property="authorYearLetter">
      <string>Fruensgaard1977</string>
     </void>
     <void property="countries">
      <string>Denmark</string>
     </void>
     <void property="detectionBiasJudgement">
      <string>Described as double-blind, however no further details reported regarding rater-blinding.</string>
     </void>
     <void property="detectionBiasRisk">
      <string>Low risk</string>
     </void>
     <void property="mainAuthor">
      <string>Fruensgaard</string>
     </void>
     <void property="meerKatCountry">
      <string>Denmark</string>
     </void>
     <void property="otherBiasJudgement">
      <string>Small study.</string>
     </void>
     <void property="otherBiasRisk">
      <string>High risk</string>
     </void>
     <void property="outcomeList">
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: d. LOXAPINE</string>
        </void>
        <void property="group1Events">
         <int>11</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>15</int>
        </void>
        <void property="group2Events">
         <int>10</int>
        </void>
        <void property="group2Name">
         <string>loxapine</string>
        </void>
        <void property="group2Total">
         <int>15</int>
        </void>
        <void property="outcomeName">
         <string>Specific behaviour: 2. Aggression - various measures</string>
        </void>
        <void property="subgroupName">
         <string>no overall improvement</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: d. LOXAPINE</string>
        </void>
        <void property="group1Events">
         <int>9</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>15</int>
        </void>
        <void property="group2Events">
         <int>7</int>
        </void>
        <void property="group2Name">
         <string>loxapine</string>
        </void>
        <void property="group2Total">
         <int>15</int>
        </void>
        <void property="outcomeName">
         <string>Global outcome: 2a. Specific - not sedated - i. by 30 minutes</string>
        </void>
        <void property="subgroupName">
         <string>at 30 minutes</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: d. LOXAPINE</string>
        </void>
        <void property="group1Events">
         <int>7</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>15</int>
        </void>
        <void property="group2Events">
         <int>2</int>
        </void>
        <void property="group2Name">
         <string>loxapine</string>
        </void>
        <void property="group2Total">
         <int>15</int>
        </void>
        <void property="outcomeName">
         <string>Global outcome: 2b. Specific - not sedated - ii. up to 2 hours</string>
        </void>
        <void property="subgroupName">
         <string>at 1 hour</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: d. LOXAPINE</string>
        </void>
        <void property="group1Events">
         <int>7</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>15</int>
        </void>
        <void property="group2Events">
         <int>1</int>
        </void>
        <void property="group2Name">
         <string>loxapine</string>
        </void>
        <void property="group2Total">
         <int>15</int>
        </void>
        <void property="outcomeName">
         <string>Global outcome: 2b. Specific - not sedated - ii. up to 2 hours</string>
        </void>
        <void property="subgroupName">
         <string>at 2 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: d. LOXAPINE</string>
        </void>
        <void property="group1Events">
         <int>8</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>15</int>
        </void>
        <void property="group2Events">
         <int>10</int>
        </void>
        <void property="group2Name">
         <string>loxapine</string>
        </void>
        <void property="group2Total">
         <int>15</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 1. General</string>
        </void>
        <void property="subgroupName">
         <string>one or more drug related adverse effect</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: d. LOXAPINE</string>
        </void>
        <void property="group1Events">
         <int>3</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>15</int>
        </void>
        <void property="group2Events">
         <int>4</int>
        </void>
        <void property="group2Name">
         <string>loxapine</string>
        </void>
        <void property="group2Total">
         <int>15</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2b. Specific - arousal level</string>
        </void>
        <void property="subgroupName">
         <string>drowsiness during 72 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: d. LOXAPINE</string>
        </void>
        <void property="group1Events">
         <int>1</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>15</int>
        </void>
        <void property="group2Events">
         <int>6</int>
        </void>
        <void property="group2Name">
         <string>loxapine</string>
        </void>
        <void property="group2Total">
         <int>15</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2c. Specific - cardiovascular</string>
        </void>
        <void property="subgroupName">
         <string>dizziness - between 3-28 days</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: d. LOXAPINE</string>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>15</int>
        </void>
        <void property="group2Events">
         <int>1</int>
        </void>
        <void property="group2Name">
         <string>loxapine</string>
        </void>
        <void property="group2Total">
         <int>15</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2c. Specific - cardiovascular</string>
        </void>
        <void property="subgroupName">
         <string>palpitations during 72 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: d. LOXAPINE</string>
        </void>
        <void property="group1Events">
         <int>2</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>15</int>
        </void>
        <void property="group2Name">
         <string>loxapine</string>
        </void>
        <void property="group2Total">
         <int>15</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2d. Specific - movement disorders</string>
        </void>
        <void property="subgroupName">
         <string>dystonia during 72 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: d. LOXAPINE</string>
        </void>
        <void property="group1Events">
         <int>3</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>15</int>
        </void>
        <void property="group2Events">
         <int>5</int>
        </void>
        <void property="group2Name">
         <string>loxapine</string>
        </void>
        <void property="group2Total">
         <int>15</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2d. Specific - movement disorders</string>
        </void>
        <void property="subgroupName">
         <string>extrapyramidal effects - use of antiparkinson drugs during 72 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: d. LOXAPINE</string>
        </void>
        <void property="group1Events">
         <int>7</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>15</int>
        </void>
        <void property="group2Events">
         <int>1</int>
        </void>
        <void property="group2Name">
         <string>loxapine</string>
        </void>
        <void property="group2Total">
         <int>15</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2d. Specific - movement disorders</string>
        </void>
        <void property="subgroupName">
         <string>EPS during 72 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: d. LOXAPINE</string>
        </void>
        <void property="group1Events">
         <int>2</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>15</int>
        </void>
        <void property="group2Events">
         <int>3</int>
        </void>
        <void property="group2Name">
         <string>loxapine</string>
        </void>
        <void property="group2Total">
         <int>15</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2e. Specific - miscellaneous</string>
        </void>
        <void property="subgroupName">
         <string>pain - during 24 hours</string>
        </void>
       </object>
      </void>
     </void>
     <void property="performanceBiasJudgement">
      <string>&quot;Both drugs were supplied in ampules of identical appearance.&quot; (p.257).</string>
     </void>
     <void property="performanceBiasRisk">
      <string>Low risk</string>
     </void>
     <void property="references">
      <array class="java.lang.String" length="9">
       <void index="0">
        <string>JOURNAL_ARTICLE</string>
       </void>
       <void index="1">
        <string>NO</string>
       </void>
       <void index="2">
        <string>Fruensgaard K, Korsgaard S, Jorgensen H, Jensen K</string>
       </void>
       <void index="3">
        <string>Loxapine versus haloperidol parenterally in acute psychosis with agitation. A double-blind study</string>
       </void>
       <void index="4">
        <string>Acta Psychiatrica Scandinavica</string>
       </void>
       <void index="5">
        <string>1977</string>
       </void>
       <void index="6">
        <string>56</string>
       </void>
       <void index="7">
        <string>4</string>
       </void>
       <void index="8">
        <string>256-64</string>
       </void>
      </array>
     </void>
     <void property="reportingBiasJudgement">
      <string>No evidence of selective reporting.</string>
     </void>
     <void property="reportingBiasRisk">
      <string>Low risk</string>
     </void>
     <void property="revManID">
      <string>STD-Fruensgaard-1977</string>
     </void>
     <void property="selectionBiasAllocationConcealmentBiasRisk">
      <string>Unclear Risk</string>
     </void>
     <void property="selectionBiasAllocationConcealmentJudgement">
      <string>Not stated.</string>
     </void>
     <void property="selectionBiasRandomSequenceBiasRisk">
      <string>Unclear Risk</string>
     </void>
     <void property="selectionBiasRandomSequenceJudgement">
      <string>Described as randomised - method of randomisation is not reported.</string>
     </void>
     <void property="year">
      <int>1977</int>
     </void>
    </object>
   </void>
   <void method="add">
    <object class="TrialObject" id="TrialObject15">
     <void property="attritionBiasJudgement">
      <string>No evidence of incomplete data.</string>
     </void>
     <void property="attritionBiasRisk">
      <string>Low risk</string>
     </void>
     <void property="authorYearLetter">
      <string>Garza-Trevino1989</string>
     </void>
     <void property="countries">
      <string>USA</string>
     </void>
     <void property="detectionBiasJudgement">
      <string>Open trial.</string>
     </void>
     <void property="detectionBiasRisk">
      <string>High risk</string>
     </void>
     <void property="mainAuthor">
      <string>Garza-Trevino</string>
     </void>
     <void property="meerKatCountry">
      <string>USA</string>
     </void>
     <void property="otherBiasJudgement">
      <string>The duration of the study is not reported.</string>
     </void>
     <void property="otherBiasRisk">
      <string>Unclear Risk</string>
     </void>
     <void property="outcomeList">
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs BENZODIAZEPINE: b. LORAZEPAM</string>
        </void>
        <void property="group1Events">
         <int>14</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>21</int>
        </void>
        <void property="group2Events">
         <int>14</int>
        </void>
        <void property="group2Name">
         <string>lorazepam</string>
        </void>
        <void property="group2Total">
         <int>23</int>
        </void>
        <void property="outcomeName">
         <string>Global outcome: 1. No overall improvement</string>
        </void>
        <void property="subgroupName">
         <string>by 30 minutes</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs BENZODIAZEPINE: b. LORAZEPAM</string>
        </void>
        <void property="group1Events">
         <int>6</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>21</int>
        </void>
        <void property="group2Events">
         <int>4</int>
        </void>
        <void property="group2Name">
         <string>lorazepam</string>
        </void>
        <void property="group2Total">
         <int>23</int>
        </void>
        <void property="outcomeName">
         <string>Global outcome: 1. No overall improvement</string>
        </void>
        <void property="subgroupName">
         <string>at 1 hour</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs BENZODIAZEPINE: b. LORAZEPAM</string>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>21</int>
        </void>
        <void property="group2Name">
         <string>lorazepam</string>
        </void>
        <void property="group2Total">
         <int>23</int>
        </void>
        <void property="outcomeName">
         <string>Global outcome: 1. No overall improvement</string>
        </void>
        <void property="subgroupName">
         <string>at &gt; 1 hour</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs COMBINATIONS: b. HALOPERIDOL + LORAZEPAM</string>
        </void>
        <void property="group1Events">
         <int>14</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>21</int>
        </void>
        <void property="group2Events">
         <int>6</int>
        </void>
        <void property="group2Name">
         <string>haloperidol//lorazepam</string>
        </void>
        <void property="group2NameProse">
         <string> combinations: b. haloperidol + lorazepam</string>
        </void>
        <void property="group2Total">
         <int>24</int>
        </void>
        <void property="outcomeName">
         <string>Global outcome: 1. No overall improvement</string>
        </void>
        <void property="subgroupName">
         <string>by 30 minutes</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs COMBINATIONS: b. HALOPERIDOL + LORAZEPAM</string>
        </void>
        <void property="group1Events">
         <int>6</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>21</int>
        </void>
        <void property="group2Name">
         <string>haloperidol//lorazepam</string>
        </void>
        <void property="group2NameProse">
         <string> combinations: b. haloperidol + lorazepam</string>
        </void>
        <void property="group2Total">
         <int>24</int>
        </void>
        <void property="outcomeName">
         <string>Global outcome: 1. No overall improvement</string>
        </void>
        <void property="subgroupName">
         <string>at 1 hour</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs COMBINATIONS: b. HALOPERIDOL + LORAZEPAM</string>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>21</int>
        </void>
        <void property="group2Name">
         <string>haloperidol//lorazepam</string>
        </void>
        <void property="group2NameProse">
         <string> combinations: b. haloperidol + lorazepam</string>
        </void>
        <void property="group2Total">
         <int>24</int>
        </void>
        <void property="outcomeName">
         <string>Global outcome: 1. No overall improvement</string>
        </void>
        <void property="subgroupName">
         <string>at &gt; 1 hour</string>
        </void>
       </object>
      </void>
     </void>
     <void property="performanceBiasJudgement">
      <string>Open trial.</string>
     </void>
     <void property="performanceBiasRisk">
      <string>High risk</string>
     </void>
     <void property="references">
      <array class="java.lang.String" length="9">
       <void index="0">
        <string>JOURNAL_ARTICLE</string>
       </void>
       <void index="1">
        <string>NO</string>
       </void>
       <void index="2">
        <string>Garza-Trevino ES, Hollister LE, Overall JE, Alexander WF</string>
       </void>
       <void index="3">
        <string>Efficacy of combinations of intramuscular antipsychotics and sedative-hypnotics for control of psychotic agitation</string>
       </void>
       <void index="4">
        <string>American Journal of Psychiatry</string>
       </void>
       <void index="5">
        <string>1989</string>
       </void>
       <void index="6">
        <string>146</string>
       </void>
       <void index="7">
        <string>12</string>
       </void>
       <void index="8">
        <string>1598-601</string>
       </void>
      </array>
     </void>
     <void property="reportingBiasJudgement">
      <string>There is no reporting regarding the incidence of adverse effects.</string>
     </void>
     <void property="reportingBiasRisk">
      <string>High risk</string>
     </void>
     <void property="revManID">
      <string>STD-Garza_x002d_Trevino-1989</string>
     </void>
     <void property="selectionBiasAllocationConcealmentBiasRisk">
      <string>Unclear Risk</string>
     </void>
     <void property="selectionBiasAllocationConcealmentJudgement">
      <string>Not stated.</string>
     </void>
     <void property="selectionBiasRandomSequenceBiasRisk">
      <string>Unclear Risk</string>
     </void>
     <void property="selectionBiasRandomSequenceJudgement">
      <string>Described as randomised - method of randomisation is not reported.</string>
     </void>
     <void property="year">
      <int>1989</int>
     </void>
    </object>
   </void>
   <void method="add">
    <object class="TrialObject" id="TrialObject16">
     <void property="attritionBiasJudgement">
      <string>No incomplete outcome data.</string>
     </void>
     <void property="attritionBiasRisk">
      <string>Low risk</string>
     </void>
     <void property="authorYearLetter">
      <string>Guo2007</string>
     </void>
     <void property="countries">
      <string>China</string>
     </void>
     <void property="detectionBiasJudgement">
      <string>Open-label.</string>
     </void>
     <void property="detectionBiasRisk">
      <string>High risk</string>
     </void>
     <void property="mainAuthor">
      <string>Guo</string>
     </void>
     <void property="meerKatCountry">
      <string>China</string>
     </void>
     <void property="otherBiasJudgement">
      <string>None obvious.</string>
     </void>
     <void property="otherBiasRisk">
      <string>Unclear Risk</string>
     </void>
     <void property="outcomeList">
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs COMBINATIONS: g. QUETIAPINE + MAGNESIUM VALPROATE</string>
        </void>
        <void property="group1Events">
         <int>7</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>30</int>
        </void>
        <void property="group2Events">
         <int>6</int>
        </void>
        <void property="group2Name">
         <string>quetiapine//mg v</string>
        </void>
        <void property="group2Total">
         <int>30</int>
        </void>
        <void property="outcomeName">
         <string>Specific behaviour: 1a. Agitation - binary measures</string>
        </void>
        <void property="subgroupName">
         <string>&lt;25% reduction, no effect (PANSS-EC)</string>
        </void>
       </object>
      </void>
     </void>
     <void property="performanceBiasJudgement">
      <string>Open-label.</string>
     </void>
     <void property="performanceBiasRisk">
      <string>High risk</string>
     </void>
     <void property="references">
      <array class="java.lang.String" length="9">
       <void index="0">
        <string>JOURNAL_ARTICLE</string>
       </void>
       <void index="1">
        <string>NO</string>
       </void>
       <void index="2">
        <string>Guo C-R</string>
       </void>
       <void index="3">
        <string>Study of quetiapine combined with magnesium valproate release tablets in treatment of schizophrenia with symptoms of elation and agitation</string>
       </void>
       <void index="4">
        <string>Linchuang Jingshen Yixue Zazhi [临床精神医学杂志]</string>
       </void>
       <void index="5">
        <string>2007</string>
       </void>
       <void index="6">
        <string>17</string>
       </void>
       <void index="7">
        <string>3</string>
       </void>
       <void index="8">
        <string>183-4</string>
       </void>
      </array>
     </void>
     <void property="reportingBiasJudgement">
      <string>CGI and TESS were measured, but not reported.</string>
     </void>
     <void property="reportingBiasRisk">
      <string>High risk</string>
     </void>
     <void property="revManID">
      <string>STD-Guo-2007</string>
     </void>
     <void property="selectionBiasAllocationConcealmentBiasRisk">
      <string>Unclear Risk</string>
     </void>
     <void property="selectionBiasAllocationConcealmentJudgement">
      <string>Not stated.</string>
     </void>
     <void property="selectionBiasRandomSequenceBiasRisk">
      <string>Unclear Risk</string>
     </void>
     <void property="selectionBiasRandomSequenceJudgement">
      <string>Described as randomised - method of randomisation is not reported.</string>
     </void>
     <void property="year">
      <int>2007</int>
     </void>
    </object>
   </void>
   <void method="add">
    <object class="TrialObject">
     <void property="attritionBiasJudgement">
      <string>No evidence of incomplete data.</string>
     </void>
     <void property="attritionBiasRisk">
      <string>Low risk</string>
     </void>
     <void property="authorYearLetter">
      <string>Higashima2004</string>
     </void>
     <void property="countries">
      <string>Japan</string>
     </void>
     <void property="detectionBiasJudgement">
      <string>Open trial.</string>
     </void>
     <void property="detectionBiasRisk">
      <string>High risk</string>
     </void>
     <void property="mainAuthor">
      <string>Higashima</string>
     </void>
     <void property="meerKatCountry">
      <string>Japan</string>
     </void>
     <void property="otherBiasJudgement">
      <string>Small N study.</string>
     </void>
     <void property="otherBiasRisk">
      <string>High risk</string>
     </void>
     <void property="performanceBiasJudgement">
      <string>Open trial.</string>
     </void>
     <void property="performanceBiasRisk">
      <string>High risk</string>
     </void>
     <void property="references">
      <array class="java.lang.String" length="9">
       <void index="0">
        <string>JOURNAL_ARTICLE</string>
       </void>
       <void index="1">
        <string>NO</string>
       </void>
       <void index="2">
        <string>Higashima M, Takeda T, Nagasawa T, Hirao N, Oka T, Nakamura M, et al</string>
       </void>
       <void index="3">
        <string>Combined therapy with low-potency neuroleptic levomepromazine as an adjunct to haloperidol for agitated patients with acute exacerbation of schizophrenia</string>
       </void>
       <void index="4">
        <string>European Psychiatry</string>
       </void>
       <void index="5">
        <string>2004</string>
       </void>
       <void index="6">
        <string>19</string>
       </void>
       <void index="7">
        <string>6</string>
       </void>
       <void index="8">
        <string>380-1</string>
       </void>
      </array>
     </void>
     <void property="reportingBiasJudgement">
      <string>The discussion describes how the combination drug &quot;produced moderate sedation without any cardiovascular adverse effect&quot;. However, there is no other reporting regarding the incidence adverse effects.</string>
     </void>
     <void property="reportingBiasRisk">
      <string>High risk</string>
     </void>
     <void property="revManID">
      <string>STD-Higashima-2004</string>
     </void>
     <void property="selectionBiasAllocationConcealmentBiasRisk">
      <string>Unclear Risk</string>
     </void>
     <void property="selectionBiasAllocationConcealmentJudgement">
      <string>Not stated.</string>
     </void>
     <void property="selectionBiasRandomSequenceBiasRisk">
      <string>Unclear Risk</string>
     </void>
     <void property="selectionBiasRandomSequenceJudgement">
      <string>Described as randomised - method of randomisation is not reported.</string>
     </void>
     <void property="year">
      <int>2004</int>
     </void>
    </object>
   </void>
   <void method="add">
    <object class="TrialObject" id="TrialObject17">
     <void property="attritionBiasJudgement">
      <string>No evidence of incomplete outcome data.</string>
     </void>
     <void property="attritionBiasRisk">
      <string>Low risk</string>
     </void>
     <void property="authorYearLetter">
      <string>Huf2007</string>
     </void>
     <void property="countries">
      <string>Brazil</string>
     </void>
     <void property="detectionBiasJudgement">
      <string>Open trial.</string>
     </void>
     <void property="detectionBiasRisk">
      <string>High risk</string>
     </void>
     <void property="mainAuthor">
      <string>Huf</string>
     </void>
     <void property="meerKatCountry">
      <string>Brazil</string>
     </void>
     <void property="otherBiasJudgement">
      <string>The study was stopped early due to adverse effects, therefore it is possible that the available data may be biased.</string>
     </void>
     <void property="otherBiasRisk">
      <string>Unclear Risk</string>
     </void>
     <void property="outcomeList">
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs COMBINATIONS: d. HALOPERIDOL + PROMETHAZINE</string>
        </void>
        <void property="group1Events">
         <int>70</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>156</int>
        </void>
        <void property="group2Events">
         <int>45</int>
        </void>
        <void property="group2Name">
         <string>haloperidol//promethazine</string>
        </void>
        <void property="group2NameProse">
         <string> combinations: d. haloperidol + promethazine</string>
        </void>
        <void property="group2Total">
         <int>160</int>
        </void>
        <void property="outcomeName">
         <string>Tranquillisation or asleep - not tranquil or asleep - i. by 30 minutes</string>
        </void>
        <void property="subgroupName">
         <string>at 20 minutes</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs COMBINATIONS: d. HALOPERIDOL + PROMETHAZINE</string>
        </void>
        <void property="group1Events">
         <int>38</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>156</int>
        </void>
        <void property="group2Events">
         <int>31</int>
        </void>
        <void property="group2Name">
         <string>haloperidol//promethazine</string>
        </void>
        <void property="group2NameProse">
         <string> combinations: d. haloperidol + promethazine</string>
        </void>
        <void property="group2Total">
         <int>160</int>
        </void>
        <void property="outcomeName">
         <string>Tranquillisation or asleep - not tranquil or asleep - ii. up to 2 hours</string>
        </void>
        <void property="subgroupName">
         <string>at 40 minutes</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs COMBINATIONS: d. HALOPERIDOL + PROMETHAZINE</string>
        </void>
        <void property="group1Events">
         <int>29</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>156</int>
        </void>
        <void property="group2Events">
         <int>21</int>
        </void>
        <void property="group2Name">
         <string>haloperidol//promethazine</string>
        </void>
        <void property="group2NameProse">
         <string> combinations: d. haloperidol + promethazine</string>
        </void>
        <void property="group2Total">
         <int>160</int>
        </void>
        <void property="outcomeName">
         <string>Tranquillisation or asleep - not tranquil or asleep - ii. up to 2 hours</string>
        </void>
        <void property="subgroupName">
         <string>at 1 hour</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs COMBINATIONS: d. HALOPERIDOL + PROMETHAZINE</string>
        </void>
        <void property="group1Events">
         <int>18</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>156</int>
        </void>
        <void property="group2Events">
         <int>14</int>
        </void>
        <void property="group2Name">
         <string>haloperidol//promethazine</string>
        </void>
        <void property="group2NameProse">
         <string> combinations: d. haloperidol + promethazine</string>
        </void>
        <void property="group2Total">
         <int>160</int>
        </void>
        <void property="outcomeName">
         <string>Tranquillisation or asleep - not tranquil or asleep - ii. up to 2 hours</string>
        </void>
        <void property="subgroupName">
         <string>at 2 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs COMBINATIONS: d. HALOPERIDOL + PROMETHAZINE</string>
        </void>
        <void property="group1Events">
         <int>13</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>156</int>
        </void>
        <void property="group2Events">
         <int>8</int>
        </void>
        <void property="group2Name">
         <string>haloperidol//promethazine</string>
        </void>
        <void property="group2NameProse">
         <string> combinations: d. haloperidol + promethazine</string>
        </void>
        <void property="group2Total">
         <int>160</int>
        </void>
        <void property="outcomeName">
         <string>Repeated need for tranquillisation - need for additional drugs for tranquillisation</string>
        </void>
        <void property="subgroupName">
         <string>by 2 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs COMBINATIONS: d. HALOPERIDOL + PROMETHAZINE</string>
        </void>
        <void property="group1Events">
         <int>45</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>156</int>
        </void>
        <void property="group2Events">
         <int>38</int>
        </void>
        <void property="group2Name">
         <string>haloperidol//promethazine</string>
        </void>
        <void property="group2NameProse">
         <string> combinations: d. haloperidol + promethazine</string>
        </void>
        <void property="group2Total">
         <int>160</int>
        </void>
        <void property="outcomeName">
         <string>Global outcomes: 1. General - need for additional measures</string>
        </void>
        <void property="subgroupName">
         <string>restraints needed by 2 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs COMBINATIONS: d. HALOPERIDOL + PROMETHAZINE</string>
        </void>
        <void property="group1Events">
         <int>54</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>156</int>
        </void>
        <void property="group2Events">
         <int>37</int>
        </void>
        <void property="group2Name">
         <string>haloperidol//promethazine</string>
        </void>
        <void property="group2NameProse">
         <string> combinations: d. haloperidol + promethazine</string>
        </void>
        <void property="group2Total">
         <int>160</int>
        </void>
        <void property="outcomeName">
         <string>Global outcomes: 2. Specific</string>
        </void>
        <void property="subgroupName">
         <string>doctor called to see patient</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs COMBINATIONS: d. HALOPERIDOL + PROMETHAZINE</string>
        </void>
        <void property="group1Events">
         <int>27</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>156</int>
        </void>
        <void property="group2Events">
         <int>28</int>
        </void>
        <void property="group2Name">
         <string>haloperidol//promethazine</string>
        </void>
        <void property="group2NameProse">
         <string> combinations: d. haloperidol + promethazine</string>
        </void>
        <void property="group2Total">
         <int>160</int>
        </void>
        <void property="outcomeName">
         <string>Global outcomes: 2. Specific</string>
        </void>
        <void property="subgroupName">
         <string>refuse oral drugs</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs COMBINATIONS: d. HALOPERIDOL + PROMETHAZINE</string>
        </void>
        <void property="group1Events">
         <int>11</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>156</int>
        </void>
        <void property="group2Events">
         <int>1</int>
        </void>
        <void property="group2Name">
         <string>haloperidol//promethazine</string>
        </void>
        <void property="group2NameProse">
         <string> combinations: d. haloperidol + promethazine</string>
        </void>
        <void property="group2Total">
         <int>160</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 1a. General</string>
        </void>
        <void property="subgroupName">
         <string>one or more adverse effects up to 24 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs COMBINATIONS: d. HALOPERIDOL + PROMETHAZINE</string>
        </void>
        <void property="group1Events">
         <int>2</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>156</int>
        </void>
        <void property="group2Events">
         <int>1</int>
        </void>
        <void property="group2Name">
         <string>haloperidol//promethazine</string>
        </void>
        <void property="group2NameProse">
         <string> combinations: d. haloperidol + promethazine</string>
        </void>
        <void property="group2Total">
         <int>160</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 1b. General - serious</string>
        </void>
        <void property="subgroupName">
         <string>seizure</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs COMBINATIONS: d. HALOPERIDOL + PROMETHAZINE</string>
        </void>
        <void property="group1Events">
         <int>9</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>156</int>
        </void>
        <void property="group2Name">
         <string>haloperidol//promethazine</string>
        </void>
        <void property="group2NameProse">
         <string> combinations: d. haloperidol + promethazine</string>
        </void>
        <void property="group2Total">
         <int>160</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2f. Specific - movement disorders</string>
        </void>
        <void property="subgroupName">
         <string>acute dystonia</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs COMBINATIONS: d. HALOPERIDOL + PROMETHAZINE</string>
        </void>
        <void property="group1Events">
         <int>17</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>156</int>
        </void>
        <void property="group2Events">
         <int>17</int>
        </void>
        <void property="group2Name">
         <string>haloperidol//promethazine</string>
        </void>
        <void property="group2NameProse">
         <string> combinations: d. haloperidol + promethazine</string>
        </void>
        <void property="group2Total">
         <int>160</int>
        </void>
        <void property="outcomeName">
         <string>Leaving the study early</string>
        </void>
        <void property="subgroupName">
         <string>any reason</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs COMBINATIONS: d. HALOPERIDOL + PROMETHAZINE</string>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>156</int>
        </void>
        <void property="group2Events">
         <int>2</int>
        </void>
        <void property="group2Name">
         <string>haloperidol//promethazine</string>
        </void>
        <void property="group2NameProse">
         <string> combinations: d. haloperidol + promethazine</string>
        </void>
        <void property="group2Total">
         <int>160</int>
        </void>
        <void property="outcomeName">
         <string>Leaving the study early</string>
        </void>
        <void property="subgroupName">
         <string>absconded before receiving drug</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs COMBINATIONS: d. HALOPERIDOL + PROMETHAZINE</string>
        </void>
        <void property="group1Events">
         <int>12</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>156</int>
        </void>
        <void property="group2Events">
         <int>11</int>
        </void>
        <void property="group2Name">
         <string>haloperidol//promethazine</string>
        </void>
        <void property="group2NameProse">
         <string> combinations: d. haloperidol + promethazine</string>
        </void>
        <void property="group2Total">
         <int>160</int>
        </void>
        <void property="outcomeName">
         <string>Leaving the study early</string>
        </void>
        <void property="subgroupName">
         <string>incomplete information in notes</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs COMBINATIONS: d. HALOPERIDOL + PROMETHAZINE</string>
        </void>
        <void property="group1Events">
         <int>1</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>156</int>
        </void>
        <void property="group2Name">
         <string>haloperidol//promethazine</string>
        </void>
        <void property="group2NameProse">
         <string> combinations: d. haloperidol + promethazine</string>
        </void>
        <void property="group2Total">
         <int>160</int>
        </void>
        <void property="outcomeName">
         <string>Leaving the study early</string>
        </void>
        <void property="subgroupName">
         <string>seizure before drug was given</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs COMBINATIONS: d. HALOPERIDOL + PROMETHAZINE</string>
        </void>
        <void property="group1Events">
         <int>3</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>156</int>
        </void>
        <void property="group2Events">
         <int>3</int>
        </void>
        <void property="group2Name">
         <string>haloperidol//promethazine</string>
        </void>
        <void property="group2NameProse">
         <string> combinations: d. haloperidol + promethazine</string>
        </void>
        <void property="group2Total">
         <int>160</int>
        </void>
        <void property="outcomeName">
         <string>Leaving the study early</string>
        </void>
        <void property="subgroupName">
         <string>transfer to another hospital/notes lost</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs COMBINATIONS: d. HALOPERIDOL + PROMETHAZINE</string>
        </void>
        <void property="group1Events">
         <int>1</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>156</int>
        </void>
        <void property="group2Events">
         <int>1</int>
        </void>
        <void property="group2Name">
         <string>haloperidol//promethazine</string>
        </void>
        <void property="group2NameProse">
         <string> combinations: d. haloperidol + promethazine</string>
        </void>
        <void property="group2Total">
         <int>160</int>
        </void>
        <void property="outcomeName">
         <string>Leaving the study early</string>
        </void>
        <void property="subgroupName">
         <string>withdrew consent</string>
        </void>
       </object>
      </void>
     </void>
     <void property="performanceBiasJudgement">
      <string>Open trial.</string>
     </void>
     <void property="performanceBiasRisk">
      <string>High risk</string>
     </void>
     <void property="references">
      <array class="java.lang.String" length="54">
       <void index="0">
        <string>JOURNAL_ARTICLE</string>
       </void>
       <void index="1">
        <string>NO</string>
       </void>
       <void index="2">
        <string>Barbui C</string>
       </void>
       <void index="3">
        <string>Intramuscular haloperidol plus promethazine is more effective and safer than haloperidol alone for rapid tranquillisation of agitated mentally ill patients</string>
       </void>
       <void index="4">
        <string>Evidence-Based Mental Health</string>
       </void>
       <void index="5">
        <string>2008</string>
       </void>
       <void index="6">
        <string>11</string>
       </void>
       <void index="7">
        <string>3</string>
       </void>
       <void index="8">
        <string>86-7</string>
       </void>
       <void index="9">
        <string>JOURNAL_ARTICLE</string>
       </void>
       <void index="10">
        <string>YES</string>
       </void>
       <void index="11">
        <string>Huf G, Coutinho ESF, Adams CE</string>
       </void>
       <void index="12">
        <string>Rapid tranquillisation in psychiatric emergency settings in Brazil: pragmatic randomised controlled trial of intramuscular haloperidol versus intramuscular haloperidol plus promethazine</string>
       </void>
       <void index="13">
        <string>BMJ</string>
       </void>
       <void index="14">
        <string>2007</string>
       </void>
       <void index="15">
        <string>335</string>
       </void>
       <void index="16">
        <string>7625</string>
       </void>
       <void index="17">
        <string>869-72</string>
       </void>
       <void index="18">
        <string>CONFERENCE_PROC</string>
       </void>
       <void index="19">
        <string>NO</string>
       </void>
       <void index="20">
        <string>Huf G, Coutinho ESF, Adams CE</string>
       </void>
       <void index="21">
        <string>The pharmacological management of agitated patients in emergency psychiatric hospitals in Rio de Janeiro, Brazil: the results of two pragmatic randomized clinical trials</string>
       </void>
       <void index="22">
        <string>Proceedings of the 5th European Congress on Violence in Clinical Psychiatry; 2007 Oct 25-27; Amsterdam, The Netherlands</string>
       </void>
       <void index="23">
        <string>2007</string>
       </void>
       <void index="24">
        <string></string>
       </void>
       <void index="25">
        <string></string>
       </void>
       <void index="26">
        <string></string>
       </void>
       <void index="27">
        <string>UNPUBLISHED</string>
       </void>
       <void index="28">
        <string>NO</string>
       </void>
       <void index="29">
        <string>Huf G</string>
       </void>
       <void index="30">
        <string>Haloperidol plus promethazine versus haloperidol for psychosis induced aggression</string>
       </void>
       <void index="31">
        <string>Data on file</string>
       </void>
       <void index="32">
        <string>2004</string>
       </void>
       <void index="33">
        <string></string>
       </void>
       <void index="34">
        <string></string>
       </void>
       <void index="35">
        <string></string>
       </void>
       <void index="36">
        <string>OTHER</string>
       </void>
       <void index="37">
        <string>NO</string>
       </void>
       <void index="38">
        <string>ISRCTN83261243</string>
       </void>
       <void index="39">
        <string>TREC2 - Rapid tranquillisation for agitated patients in emergency psychiatric rooms in Rio de Janeiro. A randomised trial of intramuscular haloperidol versus intramuscular haloperidol + promethazine</string>
       </void>
       <void index="40">
        <string>http://www.controlled-trials.com</string>
       </void>
       <void index="41">
        <string>2005</string>
       </void>
       <void index="42">
        <string></string>
       </void>
       <void index="43">
        <string></string>
       </void>
       <void index="44">
        <string></string>
       </void>
       <void index="45">
        <string>JOURNAL_ARTICLE</string>
       </void>
       <void index="46">
        <string>NO</string>
       </void>
       <void index="47">
        <string>Migon MN, Coutinho ES, Huf G, Adams CE, Cunha GM, Allen MH</string>
       </void>
       <void index="48">
        <string>Factors associated with the use of physical restraints for agitated patients in psychiatric emergency rooms</string>
       </void>
       <void index="49">
        <string>General Hospital Psychiatry</string>
       </void>
       <void index="50">
        <string>2008</string>
       </void>
       <void index="51">
        <string>30</string>
       </void>
       <void index="52">
        <string>3</string>
       </void>
       <void index="53">
        <string>263-8</string>
       </void>
      </array>
     </void>
     <void property="reportingBiasJudgement">
      <string>No evidence of selective reporting.</string>
     </void>
     <void property="reportingBiasRisk">
      <string>Low risk</string>
     </void>
     <void property="revManID">
      <string>STD-Huf-2007</string>
     </void>
     <void property="selectionBiasAllocationConcealmentBiasRisk">
      <string>Low risk</string>
     </void>
     <void property="selectionBiasAllocationConcealmentJudgement">
      <string>&quot;Boxes were consecutively numbered, sealed, opaque, and identical appearance and weight; on the outside was a form with questions to be completed by the attending doctor while &quot;blind&quot; to the contents of the box.&quot; (p.2).</string>
     </void>
     <void property="selectionBiasRandomSequenceBiasRisk">
      <string>Low risk</string>
     </void>
     <void property="selectionBiasRandomSequenceJudgement">
      <string>A computer-generated randomised sequence was applied to a table of numbers.</string>
     </void>
     <void property="year">
      <int>2007</int>
     </void>
    </object>
   </void>
   <void method="add">
    <object class="TrialObject" id="TrialObject18">
     <void property="attritionBiasJudgement">
      <string>No evidence of incomplete outcome data.</string>
     </void>
     <void property="attritionBiasRisk">
      <string>Low risk</string>
     </void>
     <void property="authorYearLetter">
      <string>Kewala1984</string>
     </void>
     <void property="countries">
      <string>USA</string>
     </void>
     <void property="detectionBiasJudgement">
      <string>Described as double-blind, however no further details reported regarding rater-blinding.</string>
     </void>
     <void property="detectionBiasRisk">
      <string>Unclear Risk</string>
     </void>
     <void property="mainAuthor">
      <string>Kewala</string>
     </void>
     <void property="meerKatCountry">
      <string>USA</string>
     </void>
     <void property="otherBiasJudgement">
      <string>Recieved grant from Roerig, a division of Phizer Pharmaceuticals (thiothixene manufacturers), small short study.</string>
     </void>
     <void property="otherBiasRisk">
      <string>High risk</string>
     </void>
     <void property="outcomeList">
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: i. THIOTHIXENE</string>
        </void>
        <void property="group1Events">
         <int>6</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>24</int>
        </void>
        <void property="group2Events">
         <int>2</int>
        </void>
        <void property="group2Name">
         <string>thiothixene</string>
        </void>
        <void property="group2Total">
         <int>20</int>
        </void>
        <void property="outcomeName">
         <string>Global outcome</string>
        </void>
        <void property="subgroupName">
         <string>no response to 1st injection</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: i. THIOTHIXENE</string>
        </void>
        <void property="group1Events">
         <int>3</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>24</int>
        </void>
        <void property="group2Events">
         <int>5</int>
        </void>
        <void property="group2Name">
         <string>thiothixene</string>
        </void>
        <void property="group2Total">
         <int>20</int>
        </void>
        <void property="outcomeName">
         <string>Global outcome</string>
        </void>
        <void property="subgroupName">
         <string>no improvement at 1 hour</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: i. THIOTHIXENE</string>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>24</int>
        </void>
        <void property="group2Events">
         <int>2</int>
        </void>
        <void property="group2Name">
         <string>thiothixene</string>
        </void>
        <void property="group2Total">
         <int>20</int>
        </void>
        <void property="outcomeName">
         <string>Global outcome</string>
        </void>
        <void property="subgroupName">
         <string>no improvement at 2 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: i. THIOTHIXENE</string>
        </void>
        <void property="group1Events">
         <int>1</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>24</int>
        </void>
        <void property="group2Events">
         <int>1</int>
        </void>
        <void property="group2Name">
         <string>thiothixene</string>
        </void>
        <void property="group2Total">
         <int>20</int>
        </void>
        <void property="outcomeName">
         <string>Global outcome</string>
        </void>
        <void property="subgroupName">
         <string>no improvement at 3 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: i. THIOTHIXENE</string>
        </void>
        <void property="group1Events">
         <int>1</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>24</int>
        </void>
        <void property="group2Events">
         <int>1</int>
        </void>
        <void property="group2Name">
         <string>thiothixene</string>
        </void>
        <void property="group2Total">
         <int>20</int>
        </void>
        <void property="outcomeName">
         <string>Global outcome</string>
        </void>
        <void property="subgroupName">
         <string>no improvement at 4 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: i. THIOTHIXENE</string>
        </void>
        <void property="group1Events">
         <int>2</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>24</int>
        </void>
        <void property="group2Name">
         <string>thiothixene</string>
        </void>
        <void property="group2Total">
         <int>20</int>
        </void>
        <void property="outcomeName">
         <string>Global outcome</string>
        </void>
        <void property="subgroupName">
         <string>no improvement at 5 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: i. THIOTHIXENE</string>
        </void>
        <void property="group1Events">
         <int>1</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>24</int>
        </void>
        <void property="group2Events">
         <int>1</int>
        </void>
        <void property="group2Name">
         <string>thiothixene</string>
        </void>
        <void property="group2Total">
         <int>20</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2a. Specific - movement disorders</string>
        </void>
        <void property="subgroupName">
         <string>ataxia</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: i. THIOTHIXENE</string>
        </void>
        <void property="group1Events">
         <int>1</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>24</int>
        </void>
        <void property="group2Name">
         <string>thiothixene</string>
        </void>
        <void property="group2Total">
         <int>20</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2a. Specific - movement disorders</string>
        </void>
        <void property="subgroupName">
         <string>thick tongue</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: i. THIOTHIXENE</string>
        </void>
        <void property="group1Events">
         <int>2</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>24</int>
        </void>
        <void property="group2Name">
         <string>thiothixene</string>
        </void>
        <void property="group2Total">
         <int>20</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2b. Specific - others</string>
        </void>
        <void property="subgroupName">
         <string>anticholinergic - blurred vision</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: i. THIOTHIXENE</string>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>24</int>
        </void>
        <void property="group2Events">
         <int>2</int>
        </void>
        <void property="group2Name">
         <string>thiothixene</string>
        </void>
        <void property="group2Total">
         <int>20</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2b. Specific - others</string>
        </void>
        <void property="subgroupName">
         <string>anticholinergic - dry mouth</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: i. THIOTHIXENE</string>
        </void>
        <void property="group1Events">
         <int>18</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>24</int>
        </void>
        <void property="group2Events">
         <int>9</int>
        </void>
        <void property="group2Name">
         <string>thiothixene</string>
        </void>
        <void property="group2Total">
         <int>20</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2b. Specific - others</string>
        </void>
        <void property="subgroupName">
         <string>arousal - drowsiness</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: i. THIOTHIXENE</string>
        </void>
        <void property="group1Events">
         <int>2</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>24</int>
        </void>
        <void property="group2Name">
         <string>thiothixene</string>
        </void>
        <void property="group2Total">
         <int>20</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2b. Specific - others</string>
        </void>
        <void property="subgroupName">
         <string>arousal - lightheadedness</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: i. THIOTHIXENE</string>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>24</int>
        </void>
        <void property="group2Events">
         <int>1</int>
        </void>
        <void property="group2Name">
         <string>thiothixene</string>
        </void>
        <void property="group2Total">
         <int>20</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2b. Specific - others</string>
        </void>
        <void property="subgroupName">
         <string>cardiac - chest pain</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: i. THIOTHIXENE</string>
        </void>
        <void property="group1Events">
         <int>3</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>24</int>
        </void>
        <void property="group2Events">
         <int>1</int>
        </void>
        <void property="group2Name">
         <string>thiothixene</string>
        </void>
        <void property="group2Total">
         <int>20</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2b. Specific - others</string>
        </void>
        <void property="subgroupName">
         <string>cardiac - dizziness</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: i. THIOTHIXENE</string>
        </void>
        <void property="group1Events">
         <int>1</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>24</int>
        </void>
        <void property="group2Events">
         <int>1</int>
        </void>
        <void property="group2Name">
         <string>thiothixene</string>
        </void>
        <void property="group2Total">
         <int>20</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2b. Specific - others</string>
        </void>
        <void property="subgroupName">
         <string>cardiac - orthostatic hypotension</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: i. THIOTHIXENE</string>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>24</int>
        </void>
        <void property="group2Events">
         <int>1</int>
        </void>
        <void property="group2Name">
         <string>thiothixene</string>
        </void>
        <void property="group2Total">
         <int>20</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2b. Specific - others</string>
        </void>
        <void property="subgroupName">
         <string>cardiac - tachycardia</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: i. THIOTHIXENE</string>
        </void>
        <void property="group1Events">
         <int>1</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>24</int>
        </void>
        <void property="group2Name">
         <string>thiothixene</string>
        </void>
        <void property="group2Total">
         <int>20</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2b. Specific - others</string>
        </void>
        <void property="subgroupName">
         <string>other - depressed mood</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: i. THIOTHIXENE</string>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>24</int>
        </void>
        <void property="group2Events">
         <int>1</int>
        </void>
        <void property="group2Name">
         <string>thiothixene</string>
        </void>
        <void property="group2Total">
         <int>20</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2b. Specific - others</string>
        </void>
        <void property="subgroupName">
         <string>other - diaphoresis</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: i. THIOTHIXENE</string>
        </void>
        <void property="group1Events">
         <int>1</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>24</int>
        </void>
        <void property="group2Name">
         <string>thiothixene</string>
        </void>
        <void property="group2Total">
         <int>20</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2b. Specific - others</string>
        </void>
        <void property="subgroupName">
         <string>other - weakness</string>
        </void>
       </object>
      </void>
     </void>
     <void property="performanceBiasJudgement">
      <string>Described as double-blind, however no further details reported regarding the blinding of participants and personnel.</string>
     </void>
     <void property="performanceBiasRisk">
      <string>Unclear Risk</string>
     </void>
     <void property="references">
      <array class="java.lang.String" length="9">
       <void index="0">
        <string>JOURNAL_ARTICLE</string>
       </void>
       <void index="1">
        <string>NO</string>
       </void>
       <void index="2">
        <string>Kewala S, Ban TA, Berney SA, Wilson WH</string>
       </void>
       <void index="3">
        <string>Rapid tranquilization: A comparative study of thiothixene and haloperidol</string>
       </void>
       <void index="4">
        <string>Progress in Neuro-Psychopharmacology and Biological Psychiatry</string>
       </void>
       <void index="5">
        <string>1984</string>
       </void>
       <void index="6">
        <string>8</string>
       </void>
       <void index="7">
        <string></string>
       </void>
       <void index="8">
        <string>77-83</string>
       </void>
      </array>
     </void>
     <void property="reportingBiasJudgement">
      <string>No evidence of selective reporting.</string>
     </void>
     <void property="reportingBiasRisk">
      <string>Unclear Risk</string>
     </void>
     <void property="revManID">
      <string>STD-Kewala-1984</string>
     </void>
     <void property="selectionBiasAllocationConcealmentBiasRisk">
      <string>Unclear Risk</string>
     </void>
     <void property="selectionBiasAllocationConcealmentJudgement">
      <string>Not stated.</string>
     </void>
     <void property="selectionBiasRandomSequenceBiasRisk">
      <string>Unclear Risk</string>
     </void>
     <void property="selectionBiasRandomSequenceJudgement">
      <string>Described as randomised - method of randomisation is not reported.</string>
     </void>
     <void property="year">
      <int>1984</int>
     </void>
    </object>
   </void>
   <void method="add">
    <object class="TrialObject" id="TrialObject19">
     <void property="attritionBiasJudgement">
      <string>No evidence of incomplete outcome data.</string>
     </void>
     <void property="attritionBiasRisk">
      <string>Low risk</string>
     </void>
     <void property="authorYearLetter">
      <string>Kinon2001d</string>
     </void>
     <void property="detectionBiasJudgement">
      <string>Described as double-blind, however no further details reported regarding rater-blinding.</string>
     </void>
     <void property="detectionBiasRisk">
      <string>Unclear Risk</string>
     </void>
     <void property="mainAuthor">
      <string>Kinon</string>
     </void>
     <void property="meerKatCountry">
      <string></string>
     </void>
     <void property="otherBiasJudgement">
      <string>Sponsored by the manufacturers of olanzapine.</string>
     </void>
     <void property="otherBiasRisk">
      <string>High risk</string>
     </void>
     <void property="outcomeList">
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: e. OLANZAPINE</string>
        </void>
        <void property="group1Events">
         <int>5</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>48</int>
        </void>
        <void property="group2Events">
         <int>5</int>
        </void>
        <void property="group2Name">
         <string>olanzapine</string>
        </void>
        <void property="group2Total">
         <int>52</int>
        </void>
        <void property="outcomeName">
         <string>Specific behaviour: 1a. Agitation - various measures</string>
        </void>
        <void property="subgroupName">
         <string>agitation during 21 days (if occurred in ≧10% at P &lt; 0.05) - reported as &apos;adverse effect&apos;</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: e. OLANZAPINE</string>
        </void>
        <void property="group1Events">
         <int>35</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>48</int>
        </void>
        <void property="group2Events">
         <int>38</int>
        </void>
        <void property="group2Name">
         <string>olanzapine</string>
        </void>
        <void property="group2Total">
         <int>52</int>
        </void>
        <void property="outcomeName">
         <string>Global outcome: 1a. General - need for additional measures</string>
        </void>
        <void property="subgroupName">
         <string>need for benzodiazepine during 7 days</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: e. OLANZAPINE</string>
        </void>
        <void property="group1Events">
         <int>8</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>48</int>
        </void>
        <void property="group2Events">
         <int>9</int>
        </void>
        <void property="group2Name">
         <string>olanzapine</string>
        </void>
        <void property="group2Total">
         <int>52</int>
        </void>
        <void property="outcomeName">
         <string>Global outcome: 1a. General - need for additional measures</string>
        </void>
        <void property="subgroupName">
         <string>additional restraint, seclusion or special observation</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: e. OLANZAPINE</string>
        </void>
        <void property="group1Events">
         <int>40</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>48</int>
        </void>
        <void property="group2Events">
         <int>35</int>
        </void>
        <void property="group2Name">
         <string>olanzapine</string>
        </void>
        <void property="group2Total">
         <int>52</int>
        </void>
        <void property="outcomeName">
         <string>Global outcome: 2a. Specific - alert - i. up to 2 hours</string>
        </void>
        <void property="subgroupName">
         <string>alert at 1 hour</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: e. OLANZAPINE</string>
        </void>
        <void property="group1Events">
         <int>24</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>48</int>
        </void>
        <void property="group2Events">
         <int>27</int>
        </void>
        <void property="group2Name">
         <string>olanzapine</string>
        </void>
        <void property="group2Total">
         <int>52</int>
        </void>
        <void property="outcomeName">
         <string>Global outcome: 2b. Specific - alert - ii. up to 4 hours</string>
        </void>
        <void property="subgroupName">
         <string>alert at 4 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: e. OLANZAPINE</string>
        </void>
        <void property="group1Events">
         <int>22</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>48</int>
        </void>
        <void property="group2Events">
         <int>23</int>
        </void>
        <void property="group2Name">
         <string>olanzapine</string>
        </void>
        <void property="group2Total">
         <int>52</int>
        </void>
        <void property="outcomeName">
         <string>Global outcome: 2c. Specific - alert - iii. up to 24 hours</string>
        </void>
        <void property="subgroupName">
         <string>alert at 8 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: e. OLANZAPINE</string>
        </void>
        <void property="group1Events">
         <int>16</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>48</int>
        </void>
        <void property="group2Events">
         <int>17</int>
        </void>
        <void property="group2Name">
         <string>olanzapine</string>
        </void>
        <void property="group2Total">
         <int>52</int>
        </void>
        <void property="outcomeName">
         <string>Global outcome: 2c. Specific - alert - iii. up to 24 hours</string>
        </void>
        <void property="subgroupName">
         <string>alert at 16 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: e. OLANZAPINE</string>
        </void>
        <void property="group1Events">
         <int>25</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>48</int>
        </void>
        <void property="group2Events">
         <int>32</int>
        </void>
        <void property="group2Name">
         <string>olanzapine</string>
        </void>
        <void property="group2Total">
         <int>52</int>
        </void>
        <void property="outcomeName">
         <string>Global outcome: 2c. Specific - alert - iii. up to 24 hours</string>
        </void>
        <void property="subgroupName">
         <string>alert at 24 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: e. OLANZAPINE</string>
        </void>
        <void property="group1Events">
         <int>8</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>48</int>
        </void>
        <void property="group2Events">
         <int>14</int>
        </void>
        <void property="group2Name">
         <string>olanzapine</string>
        </void>
        <void property="group2Total">
         <int>52</int>
        </void>
        <void property="outcomeName">
         <string>Global outcome: 2d. Specific - tranquil - i. up to 2 hours</string>
        </void>
        <void property="subgroupName">
         <string>tranquil at 1 hour</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: e. OLANZAPINE</string>
        </void>
        <void property="group1Events">
         <int>17</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>48</int>
        </void>
        <void property="group2Events">
         <int>10</int>
        </void>
        <void property="group2Name">
         <string>olanzapine</string>
        </void>
        <void property="group2Total">
         <int>52</int>
        </void>
        <void property="outcomeName">
         <string>Global outcome: 2e. Specific - tranquil - ii. up to 4 hours</string>
        </void>
        <void property="subgroupName">
         <string>tranquil at 4 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: e. OLANZAPINE</string>
        </void>
        <void property="group1Events">
         <int>14</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>48</int>
        </void>
        <void property="group2Events">
         <int>15</int>
        </void>
        <void property="group2Name">
         <string>olanzapine</string>
        </void>
        <void property="group2Total">
         <int>52</int>
        </void>
        <void property="outcomeName">
         <string>Global outcome: 2f. Specific - tranquil - iii. up to 24 hours</string>
        </void>
        <void property="subgroupName">
         <string>tranquil at 8 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: e. OLANZAPINE</string>
        </void>
        <void property="group1Events">
         <int>10</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>48</int>
        </void>
        <void property="group2Events">
         <int>15</int>
        </void>
        <void property="group2Name">
         <string>olanzapine</string>
        </void>
        <void property="group2Total">
         <int>52</int>
        </void>
        <void property="outcomeName">
         <string>Global outcome: 2f. Specific - tranquil - iii. up to 24 hours</string>
        </void>
        <void property="subgroupName">
         <string>tranquil at 16 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: e. OLANZAPINE</string>
        </void>
        <void property="group1Events">
         <int>18</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>48</int>
        </void>
        <void property="group2Events">
         <int>13</int>
        </void>
        <void property="group2Name">
         <string>olanzapine</string>
        </void>
        <void property="group2Total">
         <int>52</int>
        </void>
        <void property="outcomeName">
         <string>Global outcome: 2f. Specific - tranquil - iii. up to 24 hours</string>
        </void>
        <void property="subgroupName">
         <string>tranquil at 24 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: e. OLANZAPINE</string>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>48</int>
        </void>
        <void property="group2Events">
         <int>2</int>
        </void>
        <void property="group2Name">
         <string>olanzapine</string>
        </void>
        <void property="group2Total">
         <int>52</int>
        </void>
        <void property="outcomeName">
         <string>Global outcome: 2g. Specific - sedated - i. up to 2 hours</string>
        </void>
        <void property="subgroupName">
         <string>sedated at 1 hour</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: e. OLANZAPINE</string>
        </void>
        <void property="group1Events">
         <int>6</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>48</int>
        </void>
        <void property="group2Events">
         <int>15</int>
        </void>
        <void property="group2Name">
         <string>olanzapine</string>
        </void>
        <void property="group2Total">
         <int>52</int>
        </void>
        <void property="outcomeName">
         <string>Global outcome: 2h. Specific - sedated - ii. up to 4 hours</string>
        </void>
        <void property="subgroupName">
         <string>sedated at 4 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: e. OLANZAPINE</string>
        </void>
        <void property="group1Events">
         <int>10</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>48</int>
        </void>
        <void property="group2Events">
         <int>10</int>
        </void>
        <void property="group2Name">
         <string>olanzapine</string>
        </void>
        <void property="group2Total">
         <int>52</int>
        </void>
        <void property="outcomeName">
         <string>Global outcome: 2i. Specific - sedated - iii. up to 24 hours</string>
        </void>
        <void property="subgroupName">
         <string>sedated at 8 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: e. OLANZAPINE</string>
        </void>
        <void property="group1Events">
         <int>14</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>48</int>
        </void>
        <void property="group2Events">
         <int>18</int>
        </void>
        <void property="group2Name">
         <string>olanzapine</string>
        </void>
        <void property="group2Total">
         <int>52</int>
        </void>
        <void property="outcomeName">
         <string>Global outcome: 2i. Specific - sedated - iii. up to 24 hours</string>
        </void>
        <void property="subgroupName">
         <string>sedated at 16 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: e. OLANZAPINE</string>
        </void>
        <void property="group1Events">
         <int>4</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>48</int>
        </void>
        <void property="group2Events">
         <int>7</int>
        </void>
        <void property="group2Name">
         <string>olanzapine</string>
        </void>
        <void property="group2Total">
         <int>52</int>
        </void>
        <void property="outcomeName">
         <string>Global outcome: 2i. Specific - sedated - iii. up to 24 hours</string>
        </void>
        <void property="subgroupName">
         <string>sedated at 24 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: e. OLANZAPINE</string>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>48</int>
        </void>
        <void property="group2Events">
         <int>1</int>
        </void>
        <void property="group2Name">
         <string>olanzapine</string>
        </void>
        <void property="group2Total">
         <int>52</int>
        </void>
        <void property="outcomeName">
         <string>Global outcome: 2j. Specific - asleep - i. up to 2 hours</string>
        </void>
        <void property="subgroupName">
         <string>asleep at 1 hour</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: e. OLANZAPINE</string>
        </void>
        <void property="group1Events">
         <int>1</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>48</int>
        </void>
        <void property="group2Events">
         <int>1</int>
        </void>
        <void property="group2Name">
         <string>olanzapine</string>
        </void>
        <void property="group2Total">
         <int>52</int>
        </void>
        <void property="outcomeName">
         <string>Global outcome: 2k. Specific - asleep - ii. up to 4 hours</string>
        </void>
        <void property="subgroupName">
         <string>asleep at 4 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: e. OLANZAPINE</string>
        </void>
        <void property="group1Events">
         <int>1</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>48</int>
        </void>
        <void property="group2Events">
         <int>4</int>
        </void>
        <void property="group2Name">
         <string>olanzapine</string>
        </void>
        <void property="group2Total">
         <int>52</int>
        </void>
        <void property="outcomeName">
         <string>Global outcome: 2l. Specific - asleep - iii. up to 24 hours</string>
        </void>
        <void property="subgroupName">
         <string>asleep at 8 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: e. OLANZAPINE</string>
        </void>
        <void property="group1Events">
         <int>8</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>48</int>
        </void>
        <void property="group2Events">
         <int>2</int>
        </void>
        <void property="group2Name">
         <string>olanzapine</string>
        </void>
        <void property="group2Total">
         <int>52</int>
        </void>
        <void property="outcomeName">
         <string>Global outcome: 2l. Specific - asleep - iii. up to 24 hours</string>
        </void>
        <void property="subgroupName">
         <string>asleep at 16 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: e. OLANZAPINE</string>
        </void>
        <void property="group1Events">
         <int>1</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>48</int>
        </void>
        <void property="group2Name">
         <string>olanzapine</string>
        </void>
        <void property="group2Total">
         <int>52</int>
        </void>
        <void property="outcomeName">
         <string>Global outcome: 2l. Specific - asleep - iii. up to 24 hours</string>
        </void>
        <void property="subgroupName">
         <string>asleep at 24 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: e. OLANZAPINE</string>
        </void>
        <void property="group1Events">
         <int>2</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>48</int>
        </void>
        <void property="group2Events">
         <int>6</int>
        </void>
        <void property="group2Name">
         <string>olanzapine</string>
        </void>
        <void property="group2Total">
         <int>52</int>
        </void>
        <void property="outcomeName">
         <string>Mental state: 1. Various outcomes reported as &apos;adverse events&apos;</string>
        </void>
        <void property="subgroupName">
         <string>anxiety during 21 days (if occurred in ≧10% at P &lt; 0.05)</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: e. OLANZAPINE</string>
        </void>
        <void property="group1Events">
         <int>8</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>48</int>
        </void>
        <void property="group2Events">
         <int>4</int>
        </void>
        <void property="group2Name">
         <string>olanzapine</string>
        </void>
        <void property="group2Total">
         <int>52</int>
        </void>
        <void property="outcomeName">
         <string>Mental state: 1. Various outcomes reported as &apos;adverse events&apos;</string>
        </void>
        <void property="subgroupName">
         <string>nervousness during 21 days (if occurred in ≧10% at P &lt; 0.05)</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: e. OLANZAPINE</string>
        </void>
        <void property="group1Events">
         <int>41</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>48</int>
        </void>
        <void property="group2Events">
         <int>35</int>
        </void>
        <void property="group2Name">
         <string>olanzapine</string>
        </void>
        <void property="group2Total">
         <int>52</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 1a. General</string>
        </void>
        <void property="subgroupName">
         <string>one or more drug related adverse events</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: e. OLANZAPINE</string>
        </void>
        <void property="group1Events">
         <int>4</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>48</int>
        </void>
        <void property="group2Name">
         <string>olanzapine</string>
        </void>
        <void property="group2Total">
         <int>52</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2a. Specific - anticholinergic</string>
        </void>
        <void property="subgroupName">
         <string>increased salivation during 21 days (if occurred in ≧10% at P &lt; 0.05)</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: e. OLANZAPINE</string>
        </void>
        <void property="group1Events">
         <int>6</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>48</int>
        </void>
        <void property="group2Events">
         <int>3</int>
        </void>
        <void property="group2Name">
         <string>olanzapine</string>
        </void>
        <void property="group2Total">
         <int>52</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2b. Specific - arousal level - i. various</string>
        </void>
        <void property="subgroupName">
         <string>insomnia during 21 days (if occurred in ≧10% at P &lt; 0.05)</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: e. OLANZAPINE</string>
        </void>
        <void property="group1Events">
         <int>12</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>48</int>
        </void>
        <void property="group2Events">
         <int>9</int>
        </void>
        <void property="group2Name">
         <string>olanzapine</string>
        </void>
        <void property="group2Total">
         <int>52</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2b. Specific - arousal level - i. various</string>
        </void>
        <void property="subgroupName">
         <string>somnolence during 21 days (if occurred in ≧10% at P &lt; 0.05)</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: e. OLANZAPINE</string>
        </void>
        <void property="group1Events">
         <int>4</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>48</int>
        </void>
        <void property="group2Name">
         <string>olanzapine</string>
        </void>
        <void property="group2Total">
         <int>52</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2i. Specific - movement disorder - i. various</string>
        </void>
        <void property="subgroupName">
         <string>dystonia during 21 days (if occurred in ≧10% at P &lt; 0.05)</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: e. OLANZAPINE</string>
        </void>
        <void property="group1Events">
         <int>4</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>48</int>
        </void>
        <void property="group2Name">
         <string>olanzapine</string>
        </void>
        <void property="group2Total">
         <int>52</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2i. Specific - movement disorder - i. various</string>
        </void>
        <void property="subgroupName">
         <string>hypertonia during 21 days (if occurred in ≧10% at P &lt; 0.05)</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: e. OLANZAPINE</string>
        </void>
        <void property="group1Events">
         <int>4</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>48</int>
        </void>
        <void property="group2Name">
         <string>olanzapine</string>
        </void>
        <void property="group2Total">
         <int>52</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2i. Specific - movement disorder - i. various</string>
        </void>
        <void property="subgroupName">
         <string>extrapyramidal effects - use of antiparkinson drugs during 21 days</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: e. OLANZAPINE</string>
        </void>
        <void property="group1Events">
         <int>5</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>48</int>
        </void>
        <void property="group2Events">
         <int>5</int>
        </void>
        <void property="group2Name">
         <string>olanzapine</string>
        </void>
        <void property="group2Total">
         <int>52</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2m. Specific - miscellaneous</string>
        </void>
        <void property="subgroupName">
         <string>pain during 21 days (if occurred in ≧10% at P &lt; 0.05)</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: e. OLANZAPINE</string>
        </void>
        <void property="group1Events">
         <int>12</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>48</int>
        </void>
        <void property="group2Events">
         <int>6</int>
        </void>
        <void property="group2Name">
         <string>olanzapine</string>
        </void>
        <void property="group2Total">
         <int>52</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2m. Specific - miscellaneous</string>
        </void>
        <void property="subgroupName">
         <string>pain - headache during 21 days (if occurred in ≧10% at P &lt; 0.05)</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: e. OLANZAPINE</string>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>48</int>
        </void>
        <void property="group2Name">
         <string>olanzapine</string>
        </void>
        <void property="group2Total">
         <int>52</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2m. Specific - miscellaneous</string>
        </void>
        <void property="subgroupName">
         <string>other - clinically relevant laboratory changes</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: e. OLANZAPINE</string>
        </void>
        <void property="group1Events">
         <int>26</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>48</int>
        </void>
        <void property="group2Events">
         <int>17</int>
        </void>
        <void property="group2Name">
         <string>olanzapine</string>
        </void>
        <void property="group2Total">
         <int>52</int>
        </void>
        <void property="outcomeName">
         <string>Leaving the study early</string>
        </void>
        <void property="subgroupName">
         <string>any reason</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: e. OLANZAPINE</string>
        </void>
        <void property="group1Events">
         <int>8</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>48</int>
        </void>
        <void property="group2Events">
         <int>1</int>
        </void>
        <void property="group2Name">
         <string>olanzapine</string>
        </void>
        <void property="group2Total">
         <int>52</int>
        </void>
        <void property="outcomeName">
         <string>Leaving the study early</string>
        </void>
        <void property="subgroupName">
         <string>adverse effects</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: e. OLANZAPINE</string>
        </void>
        <void property="group1Events">
         <int>2</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>48</int>
        </void>
        <void property="group2Events">
         <int>5</int>
        </void>
        <void property="group2Name">
         <string>olanzapine</string>
        </void>
        <void property="group2Total">
         <int>52</int>
        </void>
        <void property="outcomeName">
         <string>Leaving the study early</string>
        </void>
        <void property="subgroupName">
         <string>lack of efficacy</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: e. OLANZAPINE</string>
        </void>
        <void property="group1Events">
         <int>2</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>48</int>
        </void>
        <void property="group2Events">
         <int>4</int>
        </void>
        <void property="group2Name">
         <string>olanzapine</string>
        </void>
        <void property="group2Total">
         <int>52</int>
        </void>
        <void property="outcomeName">
         <string>Leaving the study early</string>
        </void>
        <void property="subgroupName">
         <string>lost at follow-up</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: e. OLANZAPINE</string>
        </void>
        <void property="group1Events">
         <int>6</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>48</int>
        </void>
        <void property="group2Events">
         <int>3</int>
        </void>
        <void property="group2Name">
         <string>olanzapine</string>
        </void>
        <void property="group2Total">
         <int>52</int>
        </void>
        <void property="outcomeName">
         <string>Leaving the study early</string>
        </void>
        <void property="subgroupName">
         <string>participants decision</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: e. OLANZAPINE</string>
        </void>
        <void property="group1Events">
         <int>4</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>48</int>
        </void>
        <void property="group2Events">
         <int>2</int>
        </void>
        <void property="group2Name">
         <string>olanzapine</string>
        </void>
        <void property="group2Total">
         <int>52</int>
        </void>
        <void property="outcomeName">
         <string>Leaving the study early</string>
        </void>
        <void property="subgroupName">
         <string>non compliance</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: e. OLANZAPINE</string>
        </void>
        <void property="group1Events">
         <int>4</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>48</int>
        </void>
        <void property="group2Events">
         <int>1</int>
        </void>
        <void property="group2Name">
         <string>olanzapine</string>
        </void>
        <void property="group2Total">
         <int>52</int>
        </void>
        <void property="outcomeName">
         <string>Leaving the study early</string>
        </void>
        <void property="subgroupName">
         <string>physician decision</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: e. OLANZAPINE</string>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>48</int>
        </void>
        <void property="group2Events">
         <int>1</int>
        </void>
        <void property="group2Name">
         <string>olanzapine</string>
        </void>
        <void property="group2Total">
         <int>52</int>
        </void>
        <void property="outcomeName">
         <string>Leaving the study early</string>
        </void>
        <void property="subgroupName">
         <string>sponsor decision</string>
        </void>
       </object>
      </void>
     </void>
     <void property="performanceBiasJudgement">
      <string>Described as double-blind, however no further details reported regarding the blinding of participants and personnel.</string>
     </void>
     <void property="performanceBiasRisk">
      <string>Unclear Risk</string>
     </void>
     <void property="references">
      <array class="java.lang.String" length="27">
       <void index="0">
        <string>JOURNAL_ARTICLE</string>
       </void>
       <void index="1">
        <string>NO</string>
       </void>
       <void index="2">
        <string>Kinon B, Rotelli MD, Gilmore JA</string>
       </void>
       <void index="3">
        <string>Efficacy of olanzapine and adjunctive lorazepam to control agitation in schizophrenia</string>
       </void>
       <void index="4">
        <string>International Journal of Neuropsychopharmacology</string>
       </void>
       <void index="5">
        <string>2002</string>
       </void>
       <void index="6">
        <string>5</string>
       </void>
       <void index="7">
        <string>Suppl 1</string>
       </void>
       <void index="8">
        <string>S128</string>
       </void>
       <void index="9">
        <string>JOURNAL_ARTICLE</string>
       </void>
       <void index="10">
        <string>NO</string>
       </void>
       <void index="11">
        <string>Kinon BJ, Ahl J, Rotelli MD, McMullen E</string>
       </void>
       <void index="12">
        <string>Efficacy of accelerated dose titration of olanzapine with adjunctive lorazepam to treat acute agitation in schizophrenia</string>
       </void>
       <void index="13">
        <string>American Journal of Emergency Medicine</string>
       </void>
       <void index="14">
        <string>2004</string>
       </void>
       <void index="15">
        <string>22</string>
       </void>
       <void index="16">
        <string>3</string>
       </void>
       <void index="17">
        <string>181-6</string>
       </void>
       <void index="18">
        <string>JOURNAL_ARTICLE</string>
       </void>
       <void index="19">
        <string>YES</string>
       </void>
       <void index="20">
        <string>Kinon BJ, Wang L, Rotelli MD, Gilmore JA</string>
       </void>
       <void index="21">
        <string>The efficacy of olanzapine plus adjunctive lorazepam to control acute agitation in schizophrenia</string>
       </void>
       <void index="22">
        <string>European Neuropsychopharmacology</string>
       </void>
       <void index="23">
        <string>2001</string>
       </void>
       <void index="24">
        <string>11</string>
       </void>
       <void index="25">
        <string>3</string>
       </void>
       <void index="26">
        <string>278</string>
       </void>
      </array>
     </void>
     <void property="reportingBiasJudgement">
      <string>Significant findings from the within-group data are presented on a number of occasions, whilst acknowledging but omitting the non-significant between-group findings., The OASS is a 16 item rating scale, yet only the results for two items where the olanzapine group had significantly greater improvement than the haloperidol group were reported., Treatment-emergent adverse effects were only reported if they occurred with a frequency ≥10% or P&lt; .05 through the end of the study.</string>
     </void>
     <void property="reportingBiasRisk">
      <string>High risk</string>
     </void>
     <void property="revManID">
      <string>STD-Kinon-2001d</string>
     </void>
     <void property="selectionBiasAllocationConcealmentBiasRisk">
      <string>Unclear Risk</string>
     </void>
     <void property="selectionBiasAllocationConcealmentJudgement">
      <string>Not stated.</string>
     </void>
     <void property="selectionBiasRandomSequenceBiasRisk">
      <string>Unclear Risk</string>
     </void>
     <void property="selectionBiasRandomSequenceJudgement">
      <string>Described as randomised - method of randomisation is not reported.</string>
     </void>
     <void property="year">
      <int>2001</int>
     </void>
    </object>
   </void>
   <void method="add">
    <object class="TrialObject" id="TrialObject20">
     <void property="attritionBiasJudgement">
      <string>No incomplete data.</string>
     </void>
     <void property="attritionBiasRisk">
      <string>Low risk</string>
     </void>
     <void property="authorYearLetter">
      <string>Li2006</string>
     </void>
     <void property="detectionBiasJudgement">
      <string>Single-blind – however the author did not state who had been blinded.</string>
     </void>
     <void property="detectionBiasRisk">
      <string>Unclear Risk</string>
     </void>
     <void property="mainAuthor">
      <string>Li</string>
     </void>
     <void property="meerKatCountry">
      <string></string>
     </void>
     <void property="otherBiasJudgement">
      <string>None obvious.</string>
     </void>
     <void property="otherBiasRisk">
      <string>Unclear Risk</string>
     </void>
     <void property="outcomeList">
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: j. ZIPRASIDONE</string>
        </void>
        <void property="group1Events">
         <int>58</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>116</int>
        </void>
        <void property="group2Events">
         <int>43</int>
        </void>
        <void property="group2Name">
         <string>ziprasidone</string>
        </void>
        <void property="group2Total">
         <int>115</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 1b. General - ii. over 24 hours</string>
        </void>
        <void property="subgroupName">
         <string>one or more drug related adverse effects - by 72 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: j. ZIPRASIDONE</string>
        </void>
        <void property="group1Events">
         <int>12</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>116</int>
        </void>
        <void property="group2Events">
         <int>3</int>
        </void>
        <void property="group2Name">
         <string>ziprasidone</string>
        </void>
        <void property="group2Total">
         <int>115</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2a. Specific - anticholinergic</string>
        </void>
        <void property="subgroupName">
         <string>blurred vision by 72 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: j. ZIPRASIDONE</string>
        </void>
        <void property="group1Events">
         <int>18</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>116</int>
        </void>
        <void property="group2Events">
         <int>6</int>
        </void>
        <void property="group2Name">
         <string>ziprasidone</string>
        </void>
        <void property="group2Total">
         <int>115</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2a. Specific - anticholinergic</string>
        </void>
        <void property="subgroupName">
         <string>dry mouth by 72 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: j. ZIPRASIDONE</string>
        </void>
        <void property="group1Events">
         <int>18</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>116</int>
        </void>
        <void property="group2Events">
         <int>7</int>
        </void>
        <void property="group2Name">
         <string>ziprasidone</string>
        </void>
        <void property="group2Total">
         <int>115</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2a. Specific - anticholinergic</string>
        </void>
        <void property="subgroupName">
         <string>hypersalivation by 72 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: j. ZIPRASIDONE</string>
        </void>
        <void property="group1Events">
         <int>19</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>116</int>
        </void>
        <void property="group2Events">
         <int>15</int>
        </void>
        <void property="group2Name">
         <string>ziprasidone</string>
        </void>
        <void property="group2Total">
         <int>115</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2b. Specific - arousal level - i. various</string>
        </void>
        <void property="subgroupName">
         <string>lethargy - by 72 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: j. ZIPRASIDONE</string>
        </void>
        <void property="group1Events">
         <int>5</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>116</int>
        </void>
        <void property="group2Events">
         <int>12</int>
        </void>
        <void property="group2Name">
         <string>ziprasidone</string>
        </void>
        <void property="group2Total">
         <int>115</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2f. Specific - cardiovascular</string>
        </void>
        <void property="subgroupName">
         <string>dizziness - by 72 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: j. ZIPRASIDONE</string>
        </void>
        <void property="group1Events">
         <int>5</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>116</int>
        </void>
        <void property="group2Events">
         <int>11</int>
        </void>
        <void property="group2Name">
         <string>ziprasidone</string>
        </void>
        <void property="group2Total">
         <int>115</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2f. Specific - cardiovascular</string>
        </void>
        <void property="subgroupName">
         <string>ECG - abnormal - by 72 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: j. ZIPRASIDONE</string>
        </void>
        <void property="group1Events">
         <int>7</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>116</int>
        </void>
        <void property="group2Events">
         <int>14</int>
        </void>
        <void property="group2Name">
         <string>ziprasidone</string>
        </void>
        <void property="group2Total">
         <int>115</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2f. Specific - cardiovascular</string>
        </void>
        <void property="subgroupName">
         <string>tachycardia - by 72 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: j. ZIPRASIDONE</string>
        </void>
        <void property="group1Events">
         <int>1</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>116</int>
        </void>
        <void property="group2Events">
         <int>6</int>
        </void>
        <void property="group2Name">
         <string>ziprasidone</string>
        </void>
        <void property="group2Total">
         <int>115</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2h. Specific - hematological tests</string>
        </void>
        <void property="subgroupName">
         <string>haemogram abnormal - by 72 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: j. ZIPRASIDONE</string>
        </void>
        <void property="group1Events">
         <int>1</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>116</int>
        </void>
        <void property="group2Events">
         <int>2</int>
        </void>
        <void property="group2Name">
         <string>ziprasidone</string>
        </void>
        <void property="group2Total">
         <int>115</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2h. Specific - hematological tests</string>
        </void>
        <void property="subgroupName">
         <string>lactate dehydrogenase increase - by 72 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: j. ZIPRASIDONE</string>
        </void>
        <void property="group1Events">
         <int>1</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>116</int>
        </void>
        <void property="group2Events">
         <int>2</int>
        </void>
        <void property="group2Name">
         <string>ziprasidone</string>
        </void>
        <void property="group2Total">
         <int>115</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2h. Specific - hematological tests</string>
        </void>
        <void property="subgroupName">
         <string>liver function abnormal - by 72 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: j. ZIPRASIDONE</string>
        </void>
        <void property="group1Events">
         <int>2</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>116</int>
        </void>
        <void property="group2Name">
         <string>ziprasidone</string>
        </void>
        <void property="group2Total">
         <int>115</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2h. Specific - hematological tests</string>
        </void>
        <void property="subgroupName">
         <string>triglyceride increase - by 72 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: j. ZIPRASIDONE</string>
        </void>
        <void property="group1Events">
         <int>31</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>116</int>
        </void>
        <void property="group2Events">
         <int>10</int>
        </void>
        <void property="group2Name">
         <string>ziprasidone</string>
        </void>
        <void property="group2Total">
         <int>115</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2i. Specific - movement disorders - i. binary measures</string>
        </void>
        <void property="subgroupName">
         <string>akathisia - by 72 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: j. ZIPRASIDONE</string>
        </void>
        <void property="group1Events">
         <int>31</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>116</int>
        </void>
        <void property="group2Events">
         <int>8</int>
        </void>
        <void property="group2Name">
         <string>ziprasidone</string>
        </void>
        <void property="group2Total">
         <int>115</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2i. Specific - movement disorders - i. binary measures</string>
        </void>
        <void property="subgroupName">
         <string>myotonia - by 72 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: j. ZIPRASIDONE</string>
        </void>
        <void property="group1Events">
         <int>28</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>116</int>
        </void>
        <void property="group2Events">
         <int>13</int>
        </void>
        <void property="group2Name">
         <string>ziprasidone</string>
        </void>
        <void property="group2Total">
         <int>115</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2i. Specific - movement disorders - i. binary measures</string>
        </void>
        <void property="subgroupName">
         <string>reduced movement - by 72 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: j. ZIPRASIDONE</string>
        </void>
        <void property="group1Events">
         <int>10</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>116</int>
        </void>
        <void property="group2Events">
         <int>3</int>
        </void>
        <void property="group2Name">
         <string>ziprasidone</string>
        </void>
        <void property="group2Total">
         <int>115</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2i. Specific - movement disorders - i. binary measures</string>
        </void>
        <void property="subgroupName">
         <string>torsional spasm - by 72 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: j. ZIPRASIDONE</string>
        </void>
        <void property="group1Events">
         <int>27</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>116</int>
        </void>
        <void property="group2Events">
         <int>10</int>
        </void>
        <void property="group2Name">
         <string>ziprasidone</string>
        </void>
        <void property="group2Total">
         <int>115</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2i. Specific - movement disorders - i. binary measures</string>
        </void>
        <void property="subgroupName">
         <string>tremor - by 72 hours</string>
        </void>
       </object>
      </void>
     </void>
     <void property="performanceBiasJudgement">
      <string>Single-blind – however the author did not state who had been blinded.</string>
     </void>
     <void property="performanceBiasRisk">
      <string>Unclear Risk</string>
     </void>
     <void property="references">
      <array class="java.lang.String" length="9">
       <void index="0">
        <string>JOURNAL_ARTICLE</string>
       </void>
       <void index="1">
        <string>NO</string>
       </void>
       <void index="2">
        <string>Li L-H, Zhao J-P, Xu X-F</string>
       </void>
       <void index="3">
        <string>A comparative study of intramuscular ziprasidone and haloperidol in treating acute agitation in schizophrenia</string>
       </void>
       <void index="4">
        <string>Chinese Journal of Psychiatry</string>
       </void>
       <void index="5">
        <string>2006</string>
       </void>
       <void index="6">
        <string>39</string>
       </void>
       <void index="7">
        <string>4</string>
       </void>
       <void index="8">
        <string>216-9</string>
       </void>
      </array>
     </void>
     <void property="reportingBiasJudgement">
      <string>TESS and SAS were used for assessment of adverse events.  No continuous data were reported from either scales, but binary outcomes for adverse events were reported.</string>
     </void>
     <void property="reportingBiasRisk">
      <string>Unclear Risk</string>
     </void>
     <void property="revManID">
      <string>STD-Li-2006</string>
     </void>
     <void property="selectionBiasAllocationConcealmentBiasRisk">
      <string>Unclear Risk</string>
     </void>
     <void property="selectionBiasAllocationConcealmentJudgement">
      <string>Not stated.</string>
     </void>
     <void property="selectionBiasRandomSequenceBiasRisk">
      <string>Unclear Risk</string>
     </void>
     <void property="selectionBiasRandomSequenceJudgement">
      <string>Described as randomised - method of randomisation is not reported.</string>
     </void>
     <void property="year">
      <int>2006</int>
     </void>
    </object>
   </void>
   <void method="add">
    <object class="TrialObject" id="TrialObject21">
     <void property="attritionBiasJudgement">
      <string>A total of 5 dropped out in haloperidol group (adverse events = 4, lost to contact = 1) and 4 dropped out in quetiapine group (adverse events = 1, lost to contact = 3); missing data have not been imputed using appropriate methods such as LOCF.</string>
     </void>
     <void property="attritionBiasRisk">
      <string>High risk</string>
     </void>
     <void property="authorYearLetter">
      <string>Liang2013</string>
     </void>
     <void property="countries">
      <string>China</string>
     </void>
     <void property="detectionBiasJudgement">
      <string>Not stated.</string>
     </void>
     <void property="detectionBiasRisk">
      <string>Unclear Risk</string>
     </void>
     <void property="mainAuthor">
      <string>Liang</string>
     </void>
     <void property="meerKatCountry">
      <string>China</string>
     </void>
     <void property="otherBiasJudgement">
      <string>None obvious.</string>
     </void>
     <void property="otherBiasRisk">
      <string>Unclear Risk</string>
     </void>
     <void property="outcomeList">
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: g. QUETIAPINE</string>
        </void>
        <void property="group1Events">
         <int>29</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>40</int>
        </void>
        <void property="group2Events">
         <int>16</int>
        </void>
        <void property="group2Name">
         <string>quetiapine</string>
        </void>
        <void property="group2Total">
         <int>40</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 1. General</string>
        </void>
        <void property="subgroupName">
         <string>one or more drug related adverse events by 28 days</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: g. QUETIAPINE</string>
        </void>
        <void property="group1Events">
         <int>5</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>40</int>
        </void>
        <void property="group2Events">
         <int>4</int>
        </void>
        <void property="group2Name">
         <string>quetiapine</string>
        </void>
        <void property="group2Total">
         <int>40</int>
        </void>
        <void property="outcomeName">
         <string>Leaving the study early</string>
        </void>
        <void property="subgroupName">
         <string>any reason</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: g. QUETIAPINE</string>
        </void>
        <void property="group1Events">
         <int>4</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>40</int>
        </void>
        <void property="group2Events">
         <int>1</int>
        </void>
        <void property="group2Name">
         <string>quetiapine</string>
        </void>
        <void property="group2Total">
         <int>40</int>
        </void>
        <void property="outcomeName">
         <string>Leaving the study early</string>
        </void>
        <void property="subgroupName">
         <string>adverse event</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: g. QUETIAPINE</string>
        </void>
        <void property="group1Events">
         <int>1</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>40</int>
        </void>
        <void property="group2Events">
         <int>3</int>
        </void>
        <void property="group2Name">
         <string>quetiapine</string>
        </void>
        <void property="group2Total">
         <int>40</int>
        </void>
        <void property="outcomeName">
         <string>Leaving the study early</string>
        </void>
        <void property="subgroupName">
         <string>lost at follow-up</string>
        </void>
       </object>
      </void>
     </void>
     <void property="performanceBiasJudgement">
      <string>Not stated.</string>
     </void>
     <void property="performanceBiasRisk">
      <string>Unclear Risk</string>
     </void>
     <void property="references">
      <array class="java.lang.String" length="18">
       <void index="0">
        <string>OTHER</string>
       </void>
       <void index="1">
        <string>NO</string>
       </void>
       <void index="2">
        <string>Liang Y, Su Y, Huang J, Tang M, Li K, Yang F, et al</string>
       </void>
       <void index="3">
        <string>Effect of quetiapine and haloperidol on QTc interval in treating schizophrenic patients with excitement and agitation</string>
       </void>
       <void index="4">
        <string>Chinese New Drugs Journal [Zhongguo Xin Yao Za Zhi; 中国新药杂志]</string>
       </void>
       <void index="5">
        <string>2013</string>
       </void>
       <void index="6">
        <string>22</string>
       </void>
       <void index="7">
        <string>16</string>
       </void>
       <void index="8">
        <string>1886-9+1894</string>
       </void>
       <void index="9">
        <string>OTHER</string>
       </void>
       <void index="10">
        <string>YES</string>
       </void>
       <void index="11">
        <string>Liang Y, Su Y, Huang J, Tang M, Li K, Yang P, et al</string>
       </void>
       <void index="12">
        <string>A randomized controlled study of effect and safety of quetiapine and haloperidol in treatment of schizophrenic patients with excitement and agitation</string>
       </void>
       <void index="13">
        <string>Chinese Mental Health Journal [Zhongguo Xin Li Wei Sheng Za Zhi; 中国心理卫生杂志]</string>
       </void>
       <void index="14">
        <string>2013</string>
       </void>
       <void index="15">
        <string>27</string>
       </void>
       <void index="16">
        <string>4</string>
       </void>
       <void index="17">
        <string>262-7</string>
       </void>
      </array>
     </void>
     <void property="reportingBiasJudgement">
      <string>No evidence of selective reporting.</string>
     </void>
     <void property="reportingBiasRisk">
      <string>Low risk</string>
     </void>
     <void property="revManID">
      <string>STD-Liang-2013</string>
     </void>
     <void property="selectionBiasAllocationConcealmentBiasRisk">
      <string>Unclear Risk</string>
     </void>
     <void property="selectionBiasAllocationConcealmentJudgement">
      <string>Not stated.</string>
     </void>
     <void property="selectionBiasRandomSequenceBiasRisk">
      <string>Low risk</string>
     </void>
     <void property="selectionBiasRandomSequenceJudgement">
      <string>&quot;randomised by using random number table&quot;.</string>
     </void>
     <void property="year">
      <int>2013</int>
     </void>
    </object>
   </void>
   <void method="add">
    <object class="TrialObject" id="TrialObject22">
     <void property="attritionBiasJudgement">
      <string>There is no evidence of incomplete outcome data. The authors give reasons for the participants who discontinued the study.</string>
     </void>
     <void property="attritionBiasRisk">
      <string>Low risk</string>
     </void>
     <void property="authorYearLetter">
      <string>Lim2010</string>
     </void>
     <void property="countries">
      <string>Korea</string>
     </void>
     <void property="detectionBiasJudgement">
      <string>The study was rater-blinded.</string>
     </void>
     <void property="detectionBiasRisk">
      <string>Low risk</string>
     </void>
     <void property="mainAuthor">
      <string>Lim</string>
     </void>
     <void property="meerKatCountry">
      <string>Korea</string>
     </void>
     <void property="otherBiasJudgement">
      <string>Sponsored by drug company (Janssen Phamaceutica Korea).</string>
     </void>
     <void property="otherBiasRisk">
      <string>High risk</string>
     </void>
     <void property="outcomeList">
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: h. RISPERIDONE</string>
        </void>
        <void property="group1Events">
         <int>47</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>62</int>
        </void>
        <void property="group2Events">
         <int>49</int>
        </void>
        <void property="group2Name">
         <string>risperidone</string>
        </void>
        <void property="group2Total">
         <int>62</int>
        </void>
        <void property="outcomeName">
         <string>Specific behaviour: 1a. Agitation - various measures</string>
        </void>
        <void property="subgroupName">
         <string>≥50% reduction in PANSS-EC score up to 24 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: h. RISPERIDONE</string>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>62</int>
        </void>
        <void property="group2Events">
         <int>1</int>
        </void>
        <void property="group2Name">
         <string>risperidone</string>
        </void>
        <void property="group2Total">
         <int>62</int>
        </void>
        <void property="outcomeName">
         <string>Specific behaviour: 1a. Agitation - various measures</string>
        </void>
        <void property="subgroupName">
         <string>discontinued due to severe agitation up to 24 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: h. RISPERIDONE</string>
        </void>
        <void property="group1Events">
         <int>8</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>62</int>
        </void>
        <void property="group2Events">
         <int>7</int>
        </void>
        <void property="group2Name">
         <string>risperidone</string>
        </void>
        <void property="group2Total">
         <int>62</int>
        </void>
        <void property="outcomeName">
         <string>Global outcome: 1. Binary measures</string>
        </void>
        <void property="subgroupName">
         <string>needing additional benzodiazepine</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: h. RISPERIDONE</string>
        </void>
        <void property="group1Events">
         <int>18</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>62</int>
        </void>
        <void property="group2Events">
         <int>17</int>
        </void>
        <void property="group2Name">
         <string>risperidone</string>
        </void>
        <void property="group2Total">
         <int>62</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 1a. General - one or more adverse effects</string>
        </void>
        <void property="subgroupName">
         <string>up to 24 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: h. RISPERIDONE</string>
        </void>
        <void property="group1Events">
         <int>7</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>62</int>
        </void>
        <void property="group2Events">
         <int>9</int>
        </void>
        <void property="group2Name">
         <string>risperidone</string>
        </void>
        <void property="group2Total">
         <int>62</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2a. Specific - arousal</string>
        </void>
        <void property="subgroupName">
         <string>somnolence during 24 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: h. RISPERIDONE</string>
        </void>
        <void property="group1Events">
         <int>4</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>62</int>
        </void>
        <void property="group2Events">
         <int>4</int>
        </void>
        <void property="group2Name">
         <string>risperidone</string>
        </void>
        <void property="group2Total">
         <int>62</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2b. Specific - cardiovascular - i. binary outcomes</string>
        </void>
        <void property="subgroupName">
         <string>dizziness during 24 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: h. RISPERIDONE</string>
        </void>
        <void property="group1Events">
         <int>2</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>62</int>
        </void>
        <void property="group2Name">
         <string>risperidone</string>
        </void>
        <void property="group2Total">
         <int>62</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2e. Specific - movement disorder - i. binary outcomes</string>
        </void>
        <void property="subgroupName">
         <string>dystonia during 24 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: h. RISPERIDONE</string>
        </void>
        <void property="group1Events">
         <int>8</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>62</int>
        </void>
        <void property="group2Events">
         <int>5</int>
        </void>
        <void property="group2Name">
         <string>risperidone</string>
        </void>
        <void property="group2Total">
         <int>62</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2e. Specific - movement disorder - i. binary outcomes</string>
        </void>
        <void property="subgroupName">
         <string>movement disorder</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: h. RISPERIDONE</string>
        </void>
        <void property="group1Events">
         <int>4</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>62</int>
        </void>
        <void property="group2Events">
         <int>3</int>
        </void>
        <void property="group2Name">
         <string>risperidone</string>
        </void>
        <void property="group2Total">
         <int>62</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2h. Specific - miscellaneous</string>
        </void>
        <void property="subgroupName">
         <string>headache during 24 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: h. RISPERIDONE</string>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>62</int>
        </void>
        <void property="group2Events">
         <int>1</int>
        </void>
        <void property="group2Name">
         <string>risperidone</string>
        </void>
        <void property="group2Total">
         <int>62</int>
        </void>
        <void property="outcomeName">
         <string>Leaving the study early - i. up to 24 hours</string>
        </void>
        <void property="subgroupName">
         <string>due to severe agitation</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: h. RISPERIDONE</string>
        </void>
        <void property="group1Events">
         <int>2</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>62</int>
        </void>
        <void property="group2Name">
         <string>risperidone</string>
        </void>
        <void property="group2Total">
         <int>62</int>
        </void>
        <void property="outcomeName">
         <string>Leaving the study early - i. up to 24 hours</string>
        </void>
        <void property="subgroupName">
         <string>due to acute dystonia</string>
        </void>
       </object>
      </void>
     </void>
     <void property="performanceBiasJudgement">
      <string>This was an open-label study where one group received IM and the other group received an orodispersible tablet.</string>
     </void>
     <void property="performanceBiasRisk">
      <string>High risk</string>
     </void>
     <void property="references">
      <array class="java.lang.String" length="18">
       <void index="0">
        <string>JOURNAL_ARTICLE</string>
       </void>
       <void index="1">
        <string>NO</string>
       </void>
       <void index="2">
        <string>Kim JJ, Lim HK, Lee CU, Lee C, Pae CU, Paik IH</string>
       </void>
       <void index="3">
        <string>Risperidone orodispersible tablet and intramuscular haloperidol in treatment of acute psychotic agitation</string>
       </void>
       <void index="4">
        <string>European Neuropsychopharmacology</string>
       </void>
       <void index="5">
        <string>2007</string>
       </void>
       <void index="6">
        <string>17</string>
       </void>
       <void index="7">
        <string>Suppl 4</string>
       </void>
       <void index="8">
        <string>S467</string>
       </void>
       <void index="9">
        <string>JOURNAL_ARTICLE</string>
       </void>
       <void index="10">
        <string>YES</string>
       </void>
       <void index="11">
        <string>Lim HK, Kim JJ, Pae CU, Lee CU, Lee C, Paik IH</string>
       </void>
       <void index="12">
        <string>Comparison of risperidone orodispersible tablet and intramuscular haloperidol in the treatment of acute psychotic agitation: A randomized open, prospective study</string>
       </void>
       <void index="13">
        <string>Neuropsychobiology</string>
       </void>
       <void index="14">
        <string>2010</string>
       </void>
       <void index="15">
        <string>62</string>
       </void>
       <void index="16">
        <string>2</string>
       </void>
       <void index="17">
        <string>81-6</string>
       </void>
      </array>
     </void>
     <void property="reportingBiasJudgement">
      <string>The authors report that antiparkinsonian drugs could be given at the lowest effective dose, however the amount administered is not described in the results.</string>
     </void>
     <void property="reportingBiasRisk">
      <string>High risk</string>
     </void>
     <void property="revManID">
      <string>STD-Lim-2010</string>
     </void>
     <void property="selectionBiasAllocationConcealmentBiasRisk">
      <string>Unclear Risk</string>
     </void>
     <void property="selectionBiasAllocationConcealmentJudgement">
      <string>Not stated.</string>
     </void>
     <void property="selectionBiasRandomSequenceBiasRisk">
      <string>Low risk</string>
     </void>
     <void property="selectionBiasRandomSequenceJudgement">
      <string>Participants were assigned &quot;according to a predefined randomization code that was balanced to ensure even distribution of patients in each treatment group.&quot; (p.82).</string>
     </void>
     <void property="year">
      <int>2010</int>
     </void>
    </object>
   </void>
   <void method="add">
    <object class="TrialObject" id="TrialObject23">
     <void property="attritionBiasJudgement">
      <string>No incomplete data.</string>
     </void>
     <void property="attritionBiasRisk">
      <string>Low risk</string>
     </void>
     <void property="authorYearLetter">
      <string>Liu2012</string>
     </void>
     <void property="countries">
      <string>China</string>
     </void>
     <void property="detectionBiasJudgement">
      <string>Not stated.</string>
     </void>
     <void property="detectionBiasRisk">
      <string>Unclear Risk</string>
     </void>
     <void property="mainAuthor">
      <string>Liu</string>
     </void>
     <void property="meerKatCountry">
      <string>China</string>
     </void>
     <void property="otherBiasJudgement">
      <string>None obvious.</string>
     </void>
     <void property="otherBiasRisk">
      <string>Low risk</string>
     </void>
     <void property="outcomeList">
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs COMBINATIONS: e. HALOPERIDOL + RISPERIDONE</string>
        </void>
        <void property="group1Events">
         <int>3</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>50</int>
        </void>
        <void property="group2Events">
         <int>8</int>
        </void>
        <void property="group2Name">
         <string>haloperidol//risperidone</string>
        </void>
        <void property="group2NameProse">
         <string> combinations: e. haloperidol + risperidone</string>
        </void>
        <void property="group2Total">
         <int>50</int>
        </void>
        <void property="outcomeName">
         <string>Global outcome: No improvement</string>
        </void>
        <void property="subgroupName">
         <string>at 72 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs COMBINATIONS: e. HALOPERIDOL + RISPERIDONE</string>
        </void>
        <void property="group1Events">
         <int>1</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>50</int>
        </void>
        <void property="group2Events">
         <int>4</int>
        </void>
        <void property="group2Name">
         <string>haloperidol//risperidone</string>
        </void>
        <void property="group2NameProse">
         <string> combinations: e. haloperidol + risperidone</string>
        </void>
        <void property="group2Total">
         <int>50</int>
        </void>
        <void property="outcomeName">
         <string>Global outcome: No improvement</string>
        </void>
        <void property="subgroupName">
         <string>at 5 days</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs COMBINATIONS: e. HALOPERIDOL + RISPERIDONE</string>
        </void>
        <void property="group1Events">
         <int>2</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>50</int>
        </void>
        <void property="group2Events">
         <int>3</int>
        </void>
        <void property="group2Name">
         <string>haloperidol//risperidone</string>
        </void>
        <void property="group2NameProse">
         <string> combinations: e. haloperidol + risperidone</string>
        </void>
        <void property="group2Total">
         <int>50</int>
        </void>
        <void property="outcomeName">
         <string>Global outcome: No improvement</string>
        </void>
        <void property="subgroupName">
         <string>at 1 week</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs COMBINATIONS: e. HALOPERIDOL + RISPERIDONE</string>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>50</int>
        </void>
        <void property="group2Events">
         <int>1</int>
        </void>
        <void property="group2Name">
         <string>haloperidol//risperidone</string>
        </void>
        <void property="group2NameProse">
         <string> combinations: e. haloperidol + risperidone</string>
        </void>
        <void property="group2Total">
         <int>50</int>
        </void>
        <void property="outcomeName">
         <string>Global outcome: No improvement</string>
        </void>
        <void property="subgroupName">
         <string>at 2 weeks</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs COMBINATIONS: e. HALOPERIDOL + RISPERIDONE</string>
        </void>
        <void property="group1Events">
         <int>6</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>50</int>
        </void>
        <void property="group2Events">
         <int>5</int>
        </void>
        <void property="group2Name">
         <string>haloperidol//risperidone</string>
        </void>
        <void property="group2NameProse">
         <string> combinations: e. haloperidol + risperidone</string>
        </void>
        <void property="group2Total">
         <int>50</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 1a. Specific - arousal level - i. various</string>
        </void>
        <void property="subgroupName">
         <string>insomnia during 14 days</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs COMBINATIONS: e. HALOPERIDOL + RISPERIDONE</string>
        </void>
        <void property="group1Events">
         <int>11</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>50</int>
        </void>
        <void property="group2Events">
         <int>12</int>
        </void>
        <void property="group2Name">
         <string>haloperidol//risperidone</string>
        </void>
        <void property="group2NameProse">
         <string> combinations: e. haloperidol + risperidone</string>
        </void>
        <void property="group2Total">
         <int>50</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 1a. Specific - arousal level - i. various</string>
        </void>
        <void property="subgroupName">
         <string>somnolence during 14 days</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs COMBINATIONS: e. HALOPERIDOL + RISPERIDONE</string>
        </void>
        <void property="group1Events">
         <int>16</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>50</int>
        </void>
        <void property="group2Events">
         <int>17</int>
        </void>
        <void property="group2Name">
         <string>haloperidol//risperidone</string>
        </void>
        <void property="group2NameProse">
         <string> combinations: e. haloperidol + risperidone</string>
        </void>
        <void property="group2Total">
         <int>50</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 1b. Specific - movement disorders - i. various</string>
        </void>
        <void property="subgroupName">
         <string>tremor during 14 days</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs COMBINATIONS: e. HALOPERIDOL + RISPERIDONE</string>
        </void>
        <void property="group1Events">
         <int>14</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>50</int>
        </void>
        <void property="group2Events">
         <int>16</int>
        </void>
        <void property="group2Name">
         <string>haloperidol//risperidone</string>
        </void>
        <void property="group2NameProse">
         <string> combinations: e. haloperidol + risperidone</string>
        </void>
        <void property="group2Total">
         <int>50</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 1b. Specific - movement disorders - i. various</string>
        </void>
        <void property="subgroupName">
         <string>akathisia during 14 days</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs COMBINATIONS: e. HALOPERIDOL + RISPERIDONE</string>
        </void>
        <void property="group1Events">
         <int>8</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>50</int>
        </void>
        <void property="group2Events">
         <int>9</int>
        </void>
        <void property="group2Name">
         <string>haloperidol//risperidone</string>
        </void>
        <void property="group2NameProse">
         <string> combinations: e. haloperidol + risperidone</string>
        </void>
        <void property="group2Total">
         <int>50</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 1c. Specific - miscellaneous</string>
        </void>
        <void property="subgroupName">
         <string>Dry mouth during 14 days</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs COMBINATIONS: e. HALOPERIDOL + RISPERIDONE</string>
        </void>
        <void property="group1Events">
         <int>6</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>50</int>
        </void>
        <void property="group2Events">
         <int>4</int>
        </void>
        <void property="group2Name">
         <string>haloperidol//risperidone</string>
        </void>
        <void property="group2NameProse">
         <string> combinations: e. haloperidol + risperidone</string>
        </void>
        <void property="group2Total">
         <int>50</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 1c. Specific - miscellaneous</string>
        </void>
        <void property="subgroupName">
         <string>Constipation during 14 days</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs COMBINATIONS: e. HALOPERIDOL + RISPERIDONE</string>
        </void>
        <void property="group1Events">
         <int>2</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>50</int>
        </void>
        <void property="group2Events">
         <int>1</int>
        </void>
        <void property="group2Name">
         <string>haloperidol//risperidone</string>
        </void>
        <void property="group2NameProse">
         <string> combinations: e. haloperidol + risperidone</string>
        </void>
        <void property="group2Total">
         <int>50</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 1c. Specific - miscellaneous</string>
        </void>
        <void property="subgroupName">
         <string>Increased salivation during 14 days</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs COMBINATIONS: h. RISPERIDONE + CLONAZEPAM</string>
        </void>
        <void property="group1Events">
         <int>3</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>50</int>
        </void>
        <void property="group2Events">
         <int>5</int>
        </void>
        <void property="group2Name">
         <string>risperidone//clonazepam</string>
        </void>
        <void property="group2NameProse">
         <string> combinations: h. risperidone + clonazepam</string>
        </void>
        <void property="group2Total">
         <int>50</int>
        </void>
        <void property="outcomeName">
         <string>Global outcome: No improvement</string>
        </void>
        <void property="subgroupName">
         <string>at 72 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs COMBINATIONS: h. RISPERIDONE + CLONAZEPAM</string>
        </void>
        <void property="group1Events">
         <int>1</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>50</int>
        </void>
        <void property="group2Events">
         <int>4</int>
        </void>
        <void property="group2Name">
         <string>risperidone//clonazepam</string>
        </void>
        <void property="group2NameProse">
         <string> combinations: h. risperidone + clonazepam</string>
        </void>
        <void property="group2Total">
         <int>50</int>
        </void>
        <void property="outcomeName">
         <string>Global outcome: No improvement</string>
        </void>
        <void property="subgroupName">
         <string>at 5 days</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs COMBINATIONS: h. RISPERIDONE + CLONAZEPAM</string>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>50</int>
        </void>
        <void property="group2Events">
         <int>2</int>
        </void>
        <void property="group2Name">
         <string>risperidone//clonazepam</string>
        </void>
        <void property="group2NameProse">
         <string> combinations: h. risperidone + clonazepam</string>
        </void>
        <void property="group2Total">
         <int>50</int>
        </void>
        <void property="outcomeName">
         <string>Global outcome: No improvement</string>
        </void>
        <void property="subgroupName">
         <string>at 1 week</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs COMBINATIONS: h. RISPERIDONE + CLONAZEPAM</string>
        </void>
        <void property="group1Events">
         <int>2</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>50</int>
        </void>
        <void property="group2Events">
         <int>4</int>
        </void>
        <void property="group2Name">
         <string>risperidone//clonazepam</string>
        </void>
        <void property="group2NameProse">
         <string> combinations: h. risperidone + clonazepam</string>
        </void>
        <void property="group2Total">
         <int>50</int>
        </void>
        <void property="outcomeName">
         <string>Global outcome: No improvement</string>
        </void>
        <void property="subgroupName">
         <string>at 2 weeks</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs COMBINATIONS: h. RISPERIDONE + CLONAZEPAM</string>
        </void>
        <void property="group1Events">
         <int>6</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>50</int>
        </void>
        <void property="group2Events">
         <int>12</int>
        </void>
        <void property="group2Name">
         <string>risperidone//clonazepam</string>
        </void>
        <void property="group2NameProse">
         <string> combinations: h. risperidone + clonazepam</string>
        </void>
        <void property="group2Total">
         <int>50</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2a. Specific - arousal - i. various</string>
        </void>
        <void property="subgroupName">
         <string>insomnia during 14 days</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs COMBINATIONS: h. RISPERIDONE + CLONAZEPAM</string>
        </void>
        <void property="group1Events">
         <int>11</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>50</int>
        </void>
        <void property="group2Events">
         <int>4</int>
        </void>
        <void property="group2Name">
         <string>risperidone//clonazepam</string>
        </void>
        <void property="group2NameProse">
         <string> combinations: h. risperidone + clonazepam</string>
        </void>
        <void property="group2Total">
         <int>50</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2a. Specific - arousal - i. various</string>
        </void>
        <void property="subgroupName">
         <string>somnolence during 14 days</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs COMBINATIONS: h. RISPERIDONE + CLONAZEPAM</string>
        </void>
        <void property="group1Events">
         <int>14</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>50</int>
        </void>
        <void property="group2Events">
         <int>6</int>
        </void>
        <void property="group2Name">
         <string>risperidone//clonazepam</string>
        </void>
        <void property="group2NameProse">
         <string> combinations: h. risperidone + clonazepam</string>
        </void>
        <void property="group2Total">
         <int>50</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2c. Specific - movement disorders - i. various</string>
        </void>
        <void property="subgroupName">
         <string>akathisia during 14 days</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs COMBINATIONS: h. RISPERIDONE + CLONAZEPAM</string>
        </void>
        <void property="group1Events">
         <int>16</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>50</int>
        </void>
        <void property="group2Events">
         <int>5</int>
        </void>
        <void property="group2Name">
         <string>risperidone//clonazepam</string>
        </void>
        <void property="group2NameProse">
         <string> combinations: h. risperidone + clonazepam</string>
        </void>
        <void property="group2Total">
         <int>50</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2c. Specific - movement disorders - i. various</string>
        </void>
        <void property="subgroupName">
         <string>tremor during 14 days</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs COMBINATIONS: h. RISPERIDONE + CLONAZEPAM</string>
        </void>
        <void property="group1Events">
         <int>8</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>50</int>
        </void>
        <void property="group2Events">
         <int>2</int>
        </void>
        <void property="group2Name">
         <string>risperidone//clonazepam</string>
        </void>
        <void property="group2NameProse">
         <string> combinations: h. risperidone + clonazepam</string>
        </void>
        <void property="group2Total">
         <int>50</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2d. Specific - miscellaneous</string>
        </void>
        <void property="subgroupName">
         <string>Dry mouth during 14 days</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs COMBINATIONS: h. RISPERIDONE + CLONAZEPAM</string>
        </void>
        <void property="group1Events">
         <int>6</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>50</int>
        </void>
        <void property="group2Events">
         <int>9</int>
        </void>
        <void property="group2Name">
         <string>risperidone//clonazepam</string>
        </void>
        <void property="group2NameProse">
         <string> combinations: h. risperidone + clonazepam</string>
        </void>
        <void property="group2Total">
         <int>50</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2d. Specific - miscellaneous</string>
        </void>
        <void property="subgroupName">
         <string>Constipation during 14 days</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs COMBINATIONS: h. RISPERIDONE + CLONAZEPAM</string>
        </void>
        <void property="group1Events">
         <int>2</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>50</int>
        </void>
        <void property="group2Events">
         <int>5</int>
        </void>
        <void property="group2Name">
         <string>risperidone//clonazepam</string>
        </void>
        <void property="group2NameProse">
         <string> combinations: h. risperidone + clonazepam</string>
        </void>
        <void property="group2Total">
         <int>50</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2d. Specific - miscellaneous</string>
        </void>
        <void property="subgroupName">
         <string>Increased salivation during 14 days</string>
        </void>
       </object>
      </void>
     </void>
     <void property="performanceBiasJudgement">
      <string>Not stated.</string>
     </void>
     <void property="performanceBiasRisk">
      <string>Unclear Risk</string>
     </void>
     <void property="references">
      <array class="java.lang.String" length="9">
       <void index="0">
        <string>OTHER</string>
       </void>
       <void index="1">
        <string>NO</string>
       </void>
       <void index="2">
        <string>刘锟, 刘云, 宁南义, 孙建中, 孙亚军, 孙同勋, et al</string>
       </void>
       <void index="3">
        <string>Consolidation of short-term risperidone intramuscular haloperidol in the treatment of acute agitation in schizophrenia randomized controlled study of the efficacy of behavior [Google Translate]</string>
       </void>
       <void index="4">
        <string>中国医药导报</string>
       </void>
       <void index="5">
        <string>2012</string>
       </void>
       <void index="6">
        <string></string>
       </void>
       <void index="7">
        <string>35</string>
       </void>
       <void index="8">
        <string>104-6</string>
       </void>
      </array>
     </void>
     <void property="reportingBiasJudgement">
      <string>No evidence of selective reporting.</string>
     </void>
     <void property="reportingBiasRisk">
      <string>Low risk</string>
     </void>
     <void property="revManID">
      <string>STD-Liu-2012</string>
     </void>
     <void property="selectionBiasAllocationConcealmentBiasRisk">
      <string>Unclear Risk</string>
     </void>
     <void property="selectionBiasAllocationConcealmentJudgement">
      <string>Not stated.</string>
     </void>
     <void property="selectionBiasRandomSequenceBiasRisk">
      <string>Low risk</string>
     </void>
     <void property="selectionBiasRandomSequenceJudgement">
      <string>&quot;randomised by using random number table&quot;.</string>
     </void>
     <void property="year">
      <int>2012</int>
     </void>
    </object>
   </void>
   <void method="add">
    <object class="TrialObject" id="TrialObject24">
     <void property="attritionBiasJudgement">
      <string>The authors give reasons for the participants who discontinued the study. However, the results are only presented for the 27 participants who completed the study. Missing data have not been imputed using appropriate methods such as LOCF.</string>
     </void>
     <void property="attritionBiasRisk">
      <string>High risk</string>
     </void>
     <void property="authorYearLetter">
      <string>Man1973</string>
     </void>
     <void property="countries">
      <string>China</string>
     </void>
     <void property="detectionBiasJudgement">
      <string>Described as double-blind, however no further details reported regarding rater blinding.</string>
     </void>
     <void property="detectionBiasRisk">
      <string>Unclear Risk</string>
     </void>
     <void property="mainAuthor">
      <string>Man</string>
     </void>
     <void property="meerKatCountry">
      <string>China</string>
     </void>
     <void property="otherBiasJudgement">
      <string>Small study.</string>
     </void>
     <void property="otherBiasRisk">
      <string>High risk</string>
     </void>
     <void property="outcomeList">
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: b. CHLORPROMAZINE</string>
        </void>
        <void property="group1Events">
         <int>15</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>15</int>
        </void>
        <void property="group2Events">
         <int>14</int>
        </void>
        <void property="group2Name">
         <string>chlorpromazine</string>
        </void>
        <void property="group2Total">
         <int>15</int>
        </void>
        <void property="outcomeName">
         <string>Repeated need for rapid tranquillisation</string>
        </void>
        <void property="subgroupName">
         <string>more that 1 injection</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: b. CHLORPROMAZINE</string>
        </void>
        <void property="group1Events">
         <int>6</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>15</int>
        </void>
        <void property="group2Events">
         <int>4</int>
        </void>
        <void property="group2Name">
         <string>chlorpromazine</string>
        </void>
        <void property="group2Total">
         <int>15</int>
        </void>
        <void property="outcomeName">
         <string>Repeated need for rapid tranquillisation</string>
        </void>
        <void property="subgroupName">
         <string>more than 3 injections</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: b. CHLORPROMAZINE</string>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>15</int>
        </void>
        <void property="group2Name">
         <string>chlorpromazine</string>
        </void>
        <void property="group2Total">
         <int>15</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: any serious or specific adverse effects</string>
        </void>
        <void property="subgroupName">
         <string>allergy - skin irritation - local</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: b. CHLORPROMAZINE</string>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>15</int>
        </void>
        <void property="group2Events">
         <int>2</int>
        </void>
        <void property="group2Name">
         <string>chlorpromazine</string>
        </void>
        <void property="group2Total">
         <int>15</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: any serious or specific adverse effects</string>
        </void>
        <void property="subgroupName">
         <string>cardiovascular - hypotension</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: b. CHLORPROMAZINE</string>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>15</int>
        </void>
        <void property="group2Events">
         <int>1</int>
        </void>
        <void property="group2Name">
         <string>chlorpromazine</string>
        </void>
        <void property="group2Total">
         <int>15</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: any serious or specific adverse effects</string>
        </void>
        <void property="subgroupName">
         <string>central nervous system - seizures</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: b. CHLORPROMAZINE</string>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>15</int>
        </void>
        <void property="group2Name">
         <string>chlorpromazine</string>
        </void>
        <void property="group2Total">
         <int>15</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: any serious or specific adverse effects</string>
        </void>
        <void property="subgroupName">
         <string>movement disorders - extrapyramidal adverse effects</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: b. CHLORPROMAZINE</string>
        </void>
        <void property="group1Events">
         <int>1</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>15</int>
        </void>
        <void property="group2Events">
         <int>2</int>
        </void>
        <void property="group2Name">
         <string>chlorpromazine</string>
        </void>
        <void property="group2Total">
         <int>15</int>
        </void>
        <void property="outcomeName">
         <string>Leaving the study early</string>
        </void>
        <void property="subgroupName">
         <string>any reason/general reasons</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: b. CHLORPROMAZINE</string>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>15</int>
        </void>
        <void property="group2Events">
         <int>2</int>
        </void>
        <void property="group2Name">
         <string>chlorpromazine</string>
        </void>
        <void property="group2Total">
         <int>15</int>
        </void>
        <void property="outcomeName">
         <string>Leaving the study early</string>
        </void>
        <void property="subgroupName">
         <string>severe hypotensive reaction</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: b. CHLORPROMAZINE</string>
        </void>
        <void property="group1Events">
         <int>1</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>15</int>
        </void>
        <void property="group2Name">
         <string>chlorpromazine</string>
        </void>
        <void property="group2Total">
         <int>15</int>
        </void>
        <void property="outcomeName">
         <string>Leaving the study early</string>
        </void>
        <void property="subgroupName">
         <string>deviation from protocol</string>
        </void>
       </object>
      </void>
     </void>
     <void property="performanceBiasJudgement">
      <string>Described as double-blind, however it is unclear whether the syringes appeared identical given the varied doses.</string>
     </void>
     <void property="performanceBiasRisk">
      <string>Unclear Risk</string>
     </void>
     <void property="references">
      <array class="java.lang.String" length="9">
       <void index="0">
        <string>JOURNAL_ARTICLE</string>
       </void>
       <void index="1">
        <string>NO</string>
       </void>
       <void index="2">
        <string>Man-Pang L, Chen CH</string>
       </void>
       <void index="3">
        <string>Rapid tranquilization of acutely psychotic patients with intramuscular haloperidol and chlorpromazine</string>
       </void>
       <void index="4">
        <string>Psychosomatics</string>
       </void>
       <void index="5">
        <string>1973</string>
       </void>
       <void index="6">
        <string>14</string>
       </void>
       <void index="7">
        <string>1</string>
       </void>
       <void index="8">
        <string>59-63</string>
       </void>
      </array>
     </void>
     <void property="reportingBiasJudgement">
      <string>No evidence of selective reporting.</string>
     </void>
     <void property="reportingBiasRisk">
      <string>Low risk</string>
     </void>
     <void property="revManID">
      <string>STD-Man-1973</string>
     </void>
     <void property="selectionBiasAllocationConcealmentBiasRisk">
      <string>Unclear Risk</string>
     </void>
     <void property="selectionBiasAllocationConcealmentJudgement">
      <string>Not stated.</string>
     </void>
     <void property="selectionBiasRandomSequenceBiasRisk">
      <string>High risk</string>
     </void>
     <void property="selectionBiasRandomSequenceJudgement">
      <string>Not explicitly described as randomised.</string>
     </void>
     <void property="year">
      <int>1973</int>
     </void>
    </object>
   </void>
   <void method="add">
    <object class="TrialObject" id="TrialObject25">
     <void property="attritionBiasJudgement">
      <string>No evidence of incomplete outcome data.</string>
     </void>
     <void property="attritionBiasRisk">
      <string>Low risk</string>
     </void>
     <void property="authorYearLetter">
      <string>Nobay2004</string>
     </void>
     <void property="countries">
      <string>USA</string>
     </void>
     <void property="detectionBiasJudgement">
      <string>&quot;The research assistant [rater], the administering physician, and the patient were all blinded to the drug delivered.&quot; (p.745).</string>
     </void>
     <void property="detectionBiasRisk">
      <string>Low risk</string>
     </void>
     <void property="mainAuthor">
      <string>Nobay</string>
     </void>
     <void property="meerKatCountry">
      <string>USA</string>
     </void>
     <void property="otherBiasJudgement">
      <string>The duration of the study was not reported, therefore it is difficult to establish how long participants were monitored for adverse effects.</string>
     </void>
     <void property="otherBiasRisk">
      <string>High risk</string>
     </void>
     <void property="outcomeList">
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs BENZODIAZEPINE: c. MIDAZOLAM</string>
        </void>
        <void property="group1Events">
         <int>1</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>42</int>
        </void>
        <void property="group2Name">
         <string>midazolam</string>
        </void>
        <void property="group2Total">
         <int>42</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2. Specific</string>
        </void>
        <void property="subgroupName">
         <string>hypotensive</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs BENZODIAZEPINE: c. MIDAZOLAM</string>
        </void>
        <void property="group1Events">
         <int>1</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>42</int>
        </void>
        <void property="group2Name">
         <string>midazolam</string>
        </void>
        <void property="group2Total">
         <int>42</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2. Specific</string>
        </void>
        <void property="subgroupName">
         <string>apnoea</string>
        </void>
       </object>
      </void>
     </void>
     <void property="performanceBiasJudgement">
      <string>&quot;The research assistant [rater], the administering physician, and the patient were all blinded to the drug delivered.&quot; (p.745).</string>
     </void>
     <void property="performanceBiasRisk">
      <string>Low risk</string>
     </void>
     <void property="references">
      <array class="java.lang.String" length="9">
       <void index="0">
        <string>JOURNAL_ARTICLE</string>
       </void>
       <void index="1">
        <string>NO</string>
       </void>
       <void index="2">
        <string>Nobay F, Simon BC, Levitt MA, Dresden GM</string>
       </void>
       <void index="3">
        <string>A prospective, double-blind, randomized trial of midazolam versus haloperidol versus lorazepam in the chemical restraint of violent and severely agitated patients</string>
       </void>
       <void index="4">
        <string>Academic Emergency Medicine</string>
       </void>
       <void index="5">
        <string>2004</string>
       </void>
       <void index="6">
        <string>11</string>
       </void>
       <void index="7">
        <string>7</string>
       </void>
       <void index="8">
        <string>744-9</string>
       </void>
      </array>
     </void>
     <void property="reportingBiasJudgement">
      <string>No evidence of selective reporting.</string>
     </void>
     <void property="reportingBiasRisk">
      <string>Low risk</string>
     </void>
     <void property="revManID">
      <string>STD-Nobay-2004</string>
     </void>
     <void property="selectionBiasAllocationConcealmentBiasRisk">
      <string>Low risk</string>
     </void>
     <void property="selectionBiasAllocationConcealmentJudgement">
      <string>&quot;The administered drugs were prepared in the pharmacy using a computer generated randomisation code.&quot; (p.745).</string>
     </void>
     <void property="selectionBiasRandomSequenceBiasRisk">
      <string>Low risk</string>
     </void>
     <void property="selectionBiasRandomSequenceJudgement">
      <string>&quot;The administered drugs were prepared in the pharmacy using a computer generated randomisation code.&quot; (p.745).</string>
     </void>
     <void property="year">
      <int>2004</int>
     </void>
    </object>
   </void>
   <void method="add">
    <object class="TrialObject" id="TrialObject26">
     <void property="attritionBiasJudgement">
      <string>The number of participants reported is inconsistent (reported at 36 in one instance and 35 at other times) and it is not clear if this is a typing error.</string>
     </void>
     <void property="attritionBiasRisk">
      <string>Unclear Risk</string>
     </void>
     <void property="authorYearLetter">
      <string>Paprocki1977</string>
     </void>
     <void property="countries">
      <string>USA</string>
     </void>
     <void property="detectionBiasJudgement">
      <string>Described as double-blind - no further details given regarding rater blinding.</string>
     </void>
     <void property="detectionBiasRisk">
      <string>Unclear Risk</string>
     </void>
     <void property="mainAuthor">
      <string>Paprocki</string>
     </void>
     <void property="meerKatCountry">
      <string>USA</string>
     </void>
     <void property="otherBiasJudgement">
      <string>Small study.</string>
     </void>
     <void property="otherBiasRisk">
      <string>High risk</string>
     </void>
     <void property="outcomeList">
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: d. LOXAPINE</string>
        </void>
        <void property="group1Events">
         <int>3</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>18</int>
        </void>
        <void property="group2Events">
         <int>7</int>
        </void>
        <void property="group2Name">
         <string>loxapine</string>
        </void>
        <void property="group2Total">
         <int>17</int>
        </void>
        <void property="outcomeName">
         <string>Global outcome: 1. General - no change - i. over 24 hours</string>
        </void>
        <void property="subgroupName">
         <string>at endpoint (CGI-I, high=worse)</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: d. LOXAPINE</string>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>18</int>
        </void>
        <void property="group2Events">
         <int>1</int>
        </void>
        <void property="group2Name">
         <string>loxapine</string>
        </void>
        <void property="group2Total">
         <int>17</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2a. Specific - anticholinergic</string>
        </void>
        <void property="subgroupName">
         <string>constipation - between 3-28 days (Oral phase)</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: d. LOXAPINE</string>
        </void>
        <void property="group1Events">
         <int>3</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>18</int>
        </void>
        <void property="group2Events">
         <int>1</int>
        </void>
        <void property="group2Name">
         <string>loxapine</string>
        </void>
        <void property="group2Total">
         <int>17</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2a. Specific - anticholinergic</string>
        </void>
        <void property="subgroupName">
         <string>salivation - too little - between 0-3 days (IM phase)</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: d. LOXAPINE</string>
        </void>
        <void property="group1Events">
         <int>3</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>18</int>
        </void>
        <void property="group2Events">
         <int>3</int>
        </void>
        <void property="group2Name">
         <string>loxapine</string>
        </void>
        <void property="group2Total">
         <int>17</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2a. Specific - anticholinergic</string>
        </void>
        <void property="subgroupName">
         <string>salivation - too little - between 3-28 days (Oral phase)</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: d. LOXAPINE</string>
        </void>
        <void property="group1Events">
         <int>5</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>18</int>
        </void>
        <void property="group2Events">
         <int>5</int>
        </void>
        <void property="group2Name">
         <string>loxapine</string>
        </void>
        <void property="group2Total">
         <int>17</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2a. Specific - anticholinergic</string>
        </void>
        <void property="subgroupName">
         <string>salivation - too much - between 0-3 days (IM phase)</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: d. LOXAPINE</string>
        </void>
        <void property="group1Events">
         <int>10</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>18</int>
        </void>
        <void property="group2Events">
         <int>9</int>
        </void>
        <void property="group2Name">
         <string>loxapine</string>
        </void>
        <void property="group2Total">
         <int>17</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2a. Specific - anticholinergic</string>
        </void>
        <void property="subgroupName">
         <string>salivation - too much - between 3-28 days (Oral phase)</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: d. LOXAPINE</string>
        </void>
        <void property="group1Events">
         <int>1</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>18</int>
        </void>
        <void property="group2Name">
         <string>loxapine</string>
        </void>
        <void property="group2Total">
         <int>17</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2a. Specific - anticholinergic</string>
        </void>
        <void property="subgroupName">
         <string>polyuria - between 3-28 days (Oral phase)</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: d. LOXAPINE</string>
        </void>
        <void property="group1Events">
         <int>2</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>18</int>
        </void>
        <void property="group2Events">
         <int>2</int>
        </void>
        <void property="group2Name">
         <string>loxapine</string>
        </void>
        <void property="group2Total">
         <int>17</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2a. Specific - anticholinergic</string>
        </void>
        <void property="subgroupName">
         <string>sweating - between 0-3 days (IM phase)</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: d. LOXAPINE</string>
        </void>
        <void property="group1Events">
         <int>1</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>18</int>
        </void>
        <void property="group2Name">
         <string>loxapine</string>
        </void>
        <void property="group2Total">
         <int>17</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2a. Specific - anticholinergic</string>
        </void>
        <void property="subgroupName">
         <string>sweating - between 3-28 days (Oral phase)</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: d. LOXAPINE</string>
        </void>
        <void property="group1Events">
         <int>15</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>18</int>
        </void>
        <void property="group2Events">
         <int>16</int>
        </void>
        <void property="group2Name">
         <string>loxapine</string>
        </void>
        <void property="group2Total">
         <int>17</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2b. Specific - arousal level</string>
        </void>
        <void property="subgroupName">
         <string>drowsiness - between 0-3 days (IM phase)</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: d. LOXAPINE</string>
        </void>
        <void property="group1Events">
         <int>17</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>18</int>
        </void>
        <void property="group2Name">
         <string>loxapine</string>
        </void>
        <void property="group2Total">
         <int>17</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2b. Specific - arousal level</string>
        </void>
        <void property="subgroupName">
         <string>drowsiness - between 3-28 days (Oral phase)</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: d. LOXAPINE</string>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>18</int>
        </void>
        <void property="group2Events">
         <int>1</int>
        </void>
        <void property="group2Name">
         <string>loxapine</string>
        </void>
        <void property="group2Total">
         <int>17</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2b. Specific - arousal level</string>
        </void>
        <void property="subgroupName">
         <string>insomnia - between 0-3 days (IM phase)</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: d. LOXAPINE</string>
        </void>
        <void property="group1Events">
         <int>3</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>18</int>
        </void>
        <void property="group2Name">
         <string>loxapine</string>
        </void>
        <void property="group2Total">
         <int>17</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2b. Specific - arousal level</string>
        </void>
        <void property="subgroupName">
         <string>insomnia - between 3-28 days (Oral phase)</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: d. LOXAPINE</string>
        </void>
        <void property="group1Events">
         <int>1</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>18</int>
        </void>
        <void property="group2Name">
         <string>loxapine</string>
        </void>
        <void property="group2Total">
         <int>17</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2c. Specific - cardiovascular</string>
        </void>
        <void property="subgroupName">
         <string>dizziness - between 3-28 days</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: d. LOXAPINE</string>
        </void>
        <void property="group1Events">
         <int>1</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>18</int>
        </void>
        <void property="group2Name">
         <string>loxapine</string>
        </void>
        <void property="group2Total">
         <int>17</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2c. Specific - cardiovascular</string>
        </void>
        <void property="subgroupName">
         <string>dyspnoea - between 3-28 days (Oral phase)</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: d. LOXAPINE</string>
        </void>
        <void property="group1Events">
         <int>3</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>18</int>
        </void>
        <void property="group2Events">
         <int>5</int>
        </void>
        <void property="group2Name">
         <string>loxapine</string>
        </void>
        <void property="group2Total">
         <int>17</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2d. Specific - movement disorders</string>
        </void>
        <void property="subgroupName">
         <string>akathisia between 0-3 days (IM phase)</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: d. LOXAPINE</string>
        </void>
        <void property="group1Events">
         <int>10</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>18</int>
        </void>
        <void property="group2Events">
         <int>8</int>
        </void>
        <void property="group2Name">
         <string>loxapine</string>
        </void>
        <void property="group2Total">
         <int>17</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2d. Specific - movement disorders</string>
        </void>
        <void property="subgroupName">
         <string>akathisia between 3-28 days (Oral phase)</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: d. LOXAPINE</string>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>18</int>
        </void>
        <void property="group2Events">
         <int>3</int>
        </void>
        <void property="group2Name">
         <string>loxapine</string>
        </void>
        <void property="group2Total">
         <int>17</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2d. Specific - movement disorders</string>
        </void>
        <void property="subgroupName">
         <string>dysarthria between 3-28 days (Oral phase)</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: d. LOXAPINE</string>
        </void>
        <void property="group1Events">
         <int>1</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>18</int>
        </void>
        <void property="group2Events">
         <int>1</int>
        </void>
        <void property="group2Name">
         <string>loxapine</string>
        </void>
        <void property="group2Total">
         <int>17</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2d. Specific - movement disorders</string>
        </void>
        <void property="subgroupName">
         <string>dystonia between 0-3 days (IM phase)</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: d. LOXAPINE</string>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>18</int>
        </void>
        <void property="group2Events">
         <int>1</int>
        </void>
        <void property="group2Name">
         <string>loxapine</string>
        </void>
        <void property="group2Total">
         <int>17</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2d. Specific - movement disorders</string>
        </void>
        <void property="subgroupName">
         <string>involuntary movement between 3-28 days (Oral phase)</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: d. LOXAPINE</string>
        </void>
        <void property="group1Events">
         <int>1</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>18</int>
        </void>
        <void property="group2Events">
         <int>1</int>
        </void>
        <void property="group2Name">
         <string>loxapine</string>
        </void>
        <void property="group2Total">
         <int>17</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2d. Specific - movement disorders</string>
        </void>
        <void property="subgroupName">
         <string>motor retardation between 3-28 days (Oral phase)</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: d. LOXAPINE</string>
        </void>
        <void property="group1Events">
         <int>4</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>18</int>
        </void>
        <void property="group2Events">
         <int>3</int>
        </void>
        <void property="group2Name">
         <string>loxapine</string>
        </void>
        <void property="group2Total">
         <int>17</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2d. Specific - movement disorders</string>
        </void>
        <void property="subgroupName">
         <string>muscle spasms between 0-3 days (IM phase)</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: d. LOXAPINE</string>
        </void>
        <void property="group1Events">
         <int>14</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>18</int>
        </void>
        <void property="group2Events">
         <int>15</int>
        </void>
        <void property="group2Name">
         <string>loxapine</string>
        </void>
        <void property="group2Total">
         <int>17</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2d. Specific - movement disorders</string>
        </void>
        <void property="subgroupName">
         <string>rigidity between 0-3 days (IM phase)</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: d. LOXAPINE</string>
        </void>
        <void property="group1Events">
         <int>18</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>18</int>
        </void>
        <void property="group2Events">
         <int>15</int>
        </void>
        <void property="group2Name">
         <string>loxapine</string>
        </void>
        <void property="group2Total">
         <int>17</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2d. Specific - movement disorders</string>
        </void>
        <void property="subgroupName">
         <string>rigidity during between 3-28 days (Oral phase)</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: d. LOXAPINE</string>
        </void>
        <void property="group1Events">
         <int>7</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>18</int>
        </void>
        <void property="group2Events">
         <int>7</int>
        </void>
        <void property="group2Name">
         <string>loxapine</string>
        </void>
        <void property="group2Total">
         <int>17</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2d. Specific - movement disorders</string>
        </void>
        <void property="subgroupName">
         <string>tremor between 0-3 days (IM phase)</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: d. LOXAPINE</string>
        </void>
        <void property="group1Events">
         <int>13</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>18</int>
        </void>
        <void property="group2Events">
         <int>11</int>
        </void>
        <void property="group2Name">
         <string>loxapine</string>
        </void>
        <void property="group2Total">
         <int>17</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2d. Specific - movement disorders</string>
        </void>
        <void property="subgroupName">
         <string>tremor during between 3-28 days (Oral phase)</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: d. LOXAPINE</string>
        </void>
        <void property="group1Events">
         <int>6</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>18</int>
        </void>
        <void property="group2Events">
         <int>2</int>
        </void>
        <void property="group2Name">
         <string>loxapine</string>
        </void>
        <void property="group2Total">
         <int>17</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2d. Specific - movement disorders</string>
        </void>
        <void property="subgroupName">
         <string>use of antiparkinson medication</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: d. LOXAPINE</string>
        </void>
        <void property="group1Events">
         <int>1</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>18</int>
        </void>
        <void property="group2Name">
         <string>loxapine</string>
        </void>
        <void property="group2Total">
         <int>17</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2e. Specific - miscellaneous</string>
        </void>
        <void property="subgroupName">
         <string>allergy - itch - between 3-28 days (Oral phase)</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: d. LOXAPINE</string>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>18</int>
        </void>
        <void property="group2Events">
         <int>1</int>
        </void>
        <void property="group2Name">
         <string>loxapine</string>
        </void>
        <void property="group2Total">
         <int>17</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2e. Specific - miscellaneous</string>
        </void>
        <void property="subgroupName">
         <string>pain - headache - between 0-3 days (IM phase)</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: d. LOXAPINE</string>
        </void>
        <void property="group1Events">
         <int>1</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>18</int>
        </void>
        <void property="group2Name">
         <string>loxapine</string>
        </void>
        <void property="group2Total">
         <int>17</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2e. Specific - miscellaneous</string>
        </void>
        <void property="subgroupName">
         <string>pain - myalgia - between 3-28 days (Oral phase)</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: d. LOXAPINE</string>
        </void>
        <void property="group1Events">
         <int>4</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>18</int>
        </void>
        <void property="group2Events">
         <int>6</int>
        </void>
        <void property="group2Name">
         <string>loxapine</string>
        </void>
        <void property="group2Total">
         <int>17</int>
        </void>
        <void property="outcomeName">
         <string>Leaving the study early: 1. For general reasons</string>
        </void>
        <void property="subgroupName">
         <string>by 72 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: d. LOXAPINE</string>
        </void>
        <void property="group1Events">
         <int>7</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>18</int>
        </void>
        <void property="group2Events">
         <int>7</int>
        </void>
        <void property="group2Name">
         <string>loxapine</string>
        </void>
        <void property="group2Total">
         <int>17</int>
        </void>
        <void property="outcomeName">
         <string>Leaving the study early: 1. For general reasons</string>
        </void>
        <void property="subgroupName">
         <string>by endpoint</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: d. LOXAPINE</string>
        </void>
        <void property="group1Events">
         <int>1</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>18</int>
        </void>
        <void property="group2Name">
         <string>loxapine</string>
        </void>
        <void property="group2Total">
         <int>17</int>
        </void>
        <void property="outcomeName">
         <string>Leaving the study early: 2. Specific reasons</string>
        </void>
        <void property="subgroupName">
         <string>adverse effects by 72 hours</string>
        </void>
       </object>
      </void>
     </void>
     <void property="performanceBiasJudgement">
      <string>Described as double-blind - &quot;supplied in 1ml ampules...of identical appearance, individually packaged and labelled with the code number assigned to each patient&quot;. Capsules used in the oral phase were also of identical appearance.</string>
     </void>
     <void property="performanceBiasRisk">
      <string>Low risk</string>
     </void>
     <void property="references">
      <array class="java.lang.String" length="9">
       <void index="0">
        <string>JOURNAL_ARTICLE</string>
       </void>
       <void index="1">
        <string>NO</string>
       </void>
       <void index="2">
        <string>Paprocki J, Versiani M</string>
       </void>
       <void index="3">
        <string>A double-blind comparison between loxapine and haloperidol by parenteral route in acute schizophrenia</string>
       </void>
       <void index="4">
        <string>Current Therapeutic Research</string>
       </void>
       <void index="5">
        <string>1977</string>
       </void>
       <void index="6">
        <string>21</string>
       </void>
       <void index="7">
        <string>1</string>
       </void>
       <void index="8">
        <string>80-100</string>
       </void>
      </array>
     </void>
     <void property="reportingBiasJudgement">
      <string>No evidence of selective reporting.</string>
     </void>
     <void property="reportingBiasRisk">
      <string>Low risk</string>
     </void>
     <void property="revManID">
      <string>STD-Paprocki-1977</string>
     </void>
     <void property="selectionBiasAllocationConcealmentBiasRisk">
      <string>Unclear Risk</string>
     </void>
     <void property="selectionBiasAllocationConcealmentJudgement">
      <string>Not stated.</string>
     </void>
     <void property="selectionBiasRandomSequenceBiasRisk">
      <string>Unclear Risk</string>
     </void>
     <void property="selectionBiasRandomSequenceJudgement">
      <string>Described as randomised - method of randomisation is not reported.</string>
     </void>
     <void property="year">
      <int>1977</int>
     </void>
    </object>
   </void>
   <void method="add">
    <object class="TrialObject" id="TrialObject27">
     <void property="attritionBiasJudgement">
      <string>No evidence of incomplete outcome data.</string>
     </void>
     <void property="attritionBiasRisk">
      <string>Low risk</string>
     </void>
     <void property="authorYearLetter">
      <string>Reschke1974</string>
     </void>
     <void property="detectionBiasJudgement">
      <string>Described as double-blind, however no further details reported regarding rater blinding.</string>
     </void>
     <void property="detectionBiasRisk">
      <string>Unclear Risk</string>
     </void>
     <void property="mainAuthor">
      <string>Reschke</string>
     </void>
     <void property="meerKatCountry">
      <string></string>
     </void>
     <void property="otherBiasJudgement">
      <string>Small study.</string>
     </void>
     <void property="otherBiasRisk">
      <string>Unclear Risk</string>
     </void>
     <void property="outcomeList">
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs PLACEBO/NIL</string>
        </void>
        <void property="group1Events">
         <int>29</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>29</int>
        </void>
        <void property="group2Events">
         <int>11</int>
        </void>
        <void property="group2Name">
         <string>placebo</string>
        </void>
        <void property="group2Total">
         <int>11</int>
        </void>
        <void property="outcomeName">
         <string>Tranquillisation or asleep - asleep</string>
        </void>
        <void property="subgroupName">
         <string>not asleep up to 2 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs PLACEBO/NIL</string>
        </void>
        <void property="group1Events">
         <int>17</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>29</int>
        </void>
        <void property="group2Events">
         <int>11</int>
        </void>
        <void property="group2Name">
         <string>placebo</string>
        </void>
        <void property="group2Total">
         <int>11</int>
        </void>
        <void property="outcomeName">
         <string>Global outcome: 1. Not improved</string>
        </void>
        <void property="subgroupName">
         <string>not marked improvement</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs PLACEBO/NIL</string>
        </void>
        <void property="group1Events">
         <int>3</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>29</int>
        </void>
        <void property="group2Events">
         <int>4</int>
        </void>
        <void property="group2Name">
         <string>placebo</string>
        </void>
        <void property="group2Total">
         <int>11</int>
        </void>
        <void property="outcomeName">
         <string>Global outcome: 1. Not improved</string>
        </void>
        <void property="subgroupName">
         <string>not any improvement</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs PLACEBO/NIL</string>
        </void>
        <void property="group1Events">
         <int>12</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>29</int>
        </void>
        <void property="group2Name">
         <string>placebo</string>
        </void>
        <void property="group2Total">
         <int>11</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2a. Specific - arousal level</string>
        </void>
        <void property="subgroupName">
         <string>&quot;over&quot; sedated</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs PLACEBO/NIL</string>
        </void>
        <void property="group1Events">
         <int>1</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>29</int>
        </void>
        <void property="group2Name">
         <string>placebo</string>
        </void>
        <void property="group2Total">
         <int>11</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2a. Specific - arousal level</string>
        </void>
        <void property="subgroupName">
         <string>somnolence during 24 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs PLACEBO/NIL</string>
        </void>
        <void property="group1Events">
         <int>1</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>29</int>
        </void>
        <void property="group2Name">
         <string>placebo</string>
        </void>
        <void property="group2Total">
         <int>11</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2b. Specific - cardiovascular - miscellaneous outcomes</string>
        </void>
        <void property="subgroupName">
         <string>hypotension during 24 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs PLACEBO/NIL</string>
        </void>
        <void property="group1Events">
         <int>6</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>29</int>
        </void>
        <void property="group2Name">
         <string>placebo</string>
        </void>
        <void property="group2Total">
         <int>11</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2d. Specific - movement disorders</string>
        </void>
        <void property="subgroupName">
         <string>EPS during 24 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs PLACEBO/NIL</string>
        </void>
        <void property="group1Events">
         <int>4</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>29</int>
        </void>
        <void property="group2Name">
         <string>placebo</string>
        </void>
        <void property="group2Total">
         <int>11</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2f. Specific - miscellaneous</string>
        </void>
        <void property="subgroupName">
         <string>dry mouth</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs PLACEBO/NIL</string>
        </void>
        <void property="group1Events">
         <int>2</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>29</int>
        </void>
        <void property="group2Events">
         <int>6</int>
        </void>
        <void property="group2Name">
         <string>placebo</string>
        </void>
        <void property="group2Total">
         <int>11</int>
        </void>
        <void property="outcomeName">
         <string>Leaving the study early</string>
        </void>
        <void property="subgroupName">
         <string>any reason</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs PLACEBO/NIL</string>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>29</int>
        </void>
        <void property="group2Events">
         <int>6</int>
        </void>
        <void property="group2Name">
         <string>placebo</string>
        </void>
        <void property="group2Total">
         <int>11</int>
        </void>
        <void property="outcomeName">
         <string>Leaving the study early</string>
        </void>
        <void property="subgroupName">
         <string>lack of efficacy</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs PLACEBO/NIL</string>
        </void>
        <void property="group1Events">
         <int>1</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>29</int>
        </void>
        <void property="group2Name">
         <string>placebo</string>
        </void>
        <void property="group2Total">
         <int>11</int>
        </void>
        <void property="outcomeName">
         <string>Leaving the study early</string>
        </void>
        <void property="subgroupName">
         <string>adverse effects</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs PLACEBO/NIL</string>
        </void>
        <void property="group1Events">
         <int>1</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>29</int>
        </void>
        <void property="group2Name">
         <string>placebo</string>
        </void>
        <void property="group2Total">
         <int>11</int>
        </void>
        <void property="outcomeName">
         <string>Leaving the study early</string>
        </void>
        <void property="subgroupName">
         <string>could not be evaluated due to being asleep</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: b. CHLORPROMAZINE</string>
        </void>
        <void property="group1Events">
         <int>28</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>29</int>
        </void>
        <void property="group2Events">
         <int>5</int>
        </void>
        <void property="group2Name">
         <string>chlolrpromazine</string>
        </void>
        <void property="group2Total">
         <int>10</int>
        </void>
        <void property="outcomeName">
         <string>Tranquillisation or asleep - asleep</string>
        </void>
        <void property="subgroupName">
         <string>not asleep up to 2 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: b. CHLORPROMAZINE</string>
        </void>
        <void property="group1Events">
         <int>17</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>29</int>
        </void>
        <void property="group2Events">
         <int>10</int>
        </void>
        <void property="group2Name">
         <string>chlorpromazine</string>
        </void>
        <void property="group2Total">
         <int>10</int>
        </void>
        <void property="outcomeName">
         <string>Global outcome: 1. Not improved</string>
        </void>
        <void property="subgroupName">
         <string>not marked improvement</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: b. CHLORPROMAZINE</string>
        </void>
        <void property="group1Events">
         <int>3</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>29</int>
        </void>
        <void property="group2Events">
         <int>6</int>
        </void>
        <void property="group2Name">
         <string>chlorpromazine</string>
        </void>
        <void property="group2Total">
         <int>10</int>
        </void>
        <void property="outcomeName">
         <string>Global outcome: 1. Not improved</string>
        </void>
        <void property="subgroupName">
         <string>not any improvement</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: b. CHLORPROMAZINE</string>
        </void>
        <void property="group1Events">
         <int>4</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>29</int>
        </void>
        <void property="group2Events">
         <int>1</int>
        </void>
        <void property="group2Name">
         <string>chlorpromazine</string>
        </void>
        <void property="group2Total">
         <int>10</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: any serious or specific adverse effects</string>
        </void>
        <void property="subgroupName">
         <string>anticholinergic - dry mouth</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: b. CHLORPROMAZINE</string>
        </void>
        <void property="group1Events">
         <int>1</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>29</int>
        </void>
        <void property="group2Events">
         <int>6</int>
        </void>
        <void property="group2Name">
         <string>chlorpromazine</string>
        </void>
        <void property="group2Total">
         <int>10</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: any serious or specific adverse effects</string>
        </void>
        <void property="subgroupName">
         <string>arousal - drowsy but asleep</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: b. CHLORPROMAZINE</string>
        </void>
        <void property="group1Events">
         <int>12</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>29</int>
        </void>
        <void property="group2Name">
         <string>chlorpromazine</string>
        </void>
        <void property="group2Total">
         <int>10</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: any serious or specific adverse effects</string>
        </void>
        <void property="subgroupName">
         <string>arousal - drowsy but awake</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: b. CHLORPROMAZINE</string>
        </void>
        <void property="group1Events">
         <int>3</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>29</int>
        </void>
        <void property="group2Events">
         <int>1</int>
        </void>
        <void property="group2Name">
         <string>chlorpromazine</string>
        </void>
        <void property="group2Total">
         <int>10</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: any serious or specific adverse effects</string>
        </void>
        <void property="subgroupName">
         <string>cardiovascular - hypotension</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: b. CHLORPROMAZINE</string>
        </void>
        <void property="group1Events">
         <int>6</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>29</int>
        </void>
        <void property="group2Events">
         <int>1</int>
        </void>
        <void property="group2Name">
         <string>chlorpromazine</string>
        </void>
        <void property="group2Total">
         <int>10</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: any serious or specific adverse effects</string>
        </void>
        <void property="subgroupName">
         <string>movement disorders - extrapyramidal adverse effects</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: b. CHLORPROMAZINE</string>
        </void>
        <void property="group1Events">
         <int>2</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>29</int>
        </void>
        <void property="group2Events">
         <int>5</int>
        </void>
        <void property="group2Name">
         <string>chlorpromazine</string>
        </void>
        <void property="group2Total">
         <int>10</int>
        </void>
        <void property="outcomeName">
         <string>Leaving the study early</string>
        </void>
        <void property="subgroupName">
         <string>any reason/general reasons</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: b. CHLORPROMAZINE</string>
        </void>
        <void property="group1Events">
         <int>1</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>29</int>
        </void>
        <void property="group2Events">
         <int>5</int>
        </void>
        <void property="group2Name">
         <string>chlorpromazine</string>
        </void>
        <void property="group2Total">
         <int>10</int>
        </void>
        <void property="outcomeName">
         <string>Leaving the study early</string>
        </void>
        <void property="subgroupName">
         <string>could not be evaluated due to being asleep</string>
        </void>
       </object>
      </void>
     </void>
     <void property="performanceBiasJudgement">
      <string>Described as double-blind, however no further details are given. It is not clear whether the study drugs appeared identical.</string>
     </void>
     <void property="performanceBiasRisk">
      <string>Unclear Risk</string>
     </void>
     <void property="references">
      <array class="java.lang.String" length="9">
       <void index="0">
        <string>JOURNAL_ARTICLE</string>
       </void>
       <void index="1">
        <string>NO</string>
       </void>
       <void index="2">
        <string>Reshke RW</string>
       </void>
       <void index="3">
        <string>Parenteral haloperidol for rapid control of severe, disruptive symptoms of acute schizophrenia</string>
       </void>
       <void index="4">
        <string>Diseases of the Nervous System</string>
       </void>
       <void index="5">
        <string>1974</string>
       </void>
       <void index="6">
        <string>35</string>
       </void>
       <void index="7">
        <string></string>
       </void>
       <void index="8">
        <string>112-5</string>
       </void>
      </array>
     </void>
     <void property="reportingBiasJudgement">
      <string>No evidence of selective reporting.</string>
     </void>
     <void property="reportingBiasRisk">
      <string>Low risk</string>
     </void>
     <void property="revManID">
      <string>STD-Reschke-1974</string>
     </void>
     <void property="selectionBiasAllocationConcealmentBiasRisk">
      <string>Unclear Risk</string>
     </void>
     <void property="selectionBiasAllocationConcealmentJudgement">
      <string>Not stated.</string>
     </void>
     <void property="selectionBiasRandomSequenceBiasRisk">
      <string>Unclear Risk</string>
     </void>
     <void property="selectionBiasRandomSequenceJudgement">
      <string>Described as randomised - method of randomisation is not reported.</string>
     </void>
     <void property="year">
      <int>1974</int>
     </void>
    </object>
   </void>
   <void method="add">
    <object class="TrialObject" id="TrialObject28">
     <void property="attritionBiasJudgement">
      <string>No evidence of incomplete data.</string>
     </void>
     <void property="attritionBiasRisk">
      <string>Low risk</string>
     </void>
     <void property="authorYearLetter">
      <string>Resnick1984</string>
     </void>
     <void property="countries">
      <string>USA</string>
     </void>
     <void property="detectionBiasJudgement">
      <string>Described as double-blind, however no further details reported regarding rater blinding.</string>
     </void>
     <void property="detectionBiasRisk">
      <string>Unclear Risk</string>
     </void>
     <void property="mainAuthor">
      <string>Resnick</string>
     </void>
     <void property="meerKatCountry">
      <string>USA</string>
     </void>
     <void property="otherBiasJudgement">
      <string>Small short study.</string>
     </void>
     <void property="otherBiasRisk">
      <string>High risk</string>
     </void>
     <void property="outcomeList">
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: c. DROPERIDOL</string>
        </void>
        <void property="group1Events">
         <int>13</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>16</int>
        </void>
        <void property="group2Events">
         <int>4</int>
        </void>
        <void property="group2Name">
         <string>droperidol</string>
        </void>
        <void property="group2Total">
         <int>11</int>
        </void>
        <void property="outcomeName">
         <string>Repeated need for rapid tranquillisation</string>
        </void>
        <void property="subgroupName">
         <string>more than 1 injection</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: c. DROPERIDOL</string>
        </void>
        <void property="group1Events">
         <int>1</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>16</int>
        </void>
        <void property="group2Name">
         <string>droperidol</string>
        </void>
        <void property="group2Total">
         <int>11</int>
        </void>
        <void property="outcomeName">
         <string>Repeated need for rapid tranquillisation</string>
        </void>
        <void property="subgroupName">
         <string>more than 3 injections</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: c. DROPERIDOL</string>
        </void>
        <void property="group1Events">
         <int>1</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>16</int>
        </void>
        <void property="group2Name">
         <string>droperidol</string>
        </void>
        <void property="group2Total">
         <int>11</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2c. Specific - movement disorders</string>
        </void>
        <void property="subgroupName">
         <string>dystonia</string>
        </void>
       </object>
      </void>
     </void>
     <void property="performanceBiasJudgement">
      <string>&quot;packages of medication were identified only by a code which was kept in the pharmacy until the conclusion of the study&quot; (p.298).</string>
     </void>
     <void property="performanceBiasRisk">
      <string>Low risk</string>
     </void>
     <void property="references">
      <array class="java.lang.String" length="9">
       <void index="0">
        <string>JOURNAL_ARTICLE</string>
       </void>
       <void index="1">
        <string>NO</string>
       </void>
       <void index="2">
        <string>Resnick M, Burton BT</string>
       </void>
       <void index="3">
        <string>Droperidol vs. haloperidol in the initial management of acutely agitated patients</string>
       </void>
       <void index="4">
        <string>Journal of Clinical Psychological Medicine [临床精神医学杂志]</string>
       </void>
       <void index="5">
        <string>1984</string>
       </void>
       <void index="6">
        <string>45</string>
       </void>
       <void index="7">
        <string>7</string>
       </void>
       <void index="8">
        <string>298-9</string>
       </void>
      </array>
     </void>
     <void property="reportingBiasJudgement">
      <string>No evidence of selective reporting.</string>
     </void>
     <void property="reportingBiasRisk">
      <string>Low risk</string>
     </void>
     <void property="revManID">
      <string>STD-Resnick-1984</string>
     </void>
     <void property="selectionBiasAllocationConcealmentBiasRisk">
      <string>Low risk</string>
     </void>
     <void property="selectionBiasAllocationConcealmentJudgement">
      <string>&quot;packages of medication were identified only by a code which was kept in the pharmacy until the conclusion of the study&quot; (p.298).</string>
     </void>
     <void property="selectionBiasRandomSequenceBiasRisk">
      <string>Unclear Risk</string>
     </void>
     <void property="selectionBiasRandomSequenceJudgement">
      <string>Described as randomised - method of randomisation is not reported.</string>
     </void>
     <void property="year">
      <int>1984</int>
     </void>
    </object>
   </void>
   <void method="add">
    <object class="TrialObject" id="TrialObject29">
     <void property="attritionBiasJudgement">
      <string>No evidence of incomplete outcome data.</string>
     </void>
     <void property="attritionBiasRisk">
      <string>Low risk</string>
     </void>
     <void property="authorYearLetter">
      <string>Ritter1972</string>
     </void>
     <void property="detectionBiasJudgement">
      <string>Described as double-blind, however no further details reported regarding rater blinding.</string>
     </void>
     <void property="detectionBiasRisk">
      <string>Unclear Risk</string>
     </void>
     <void property="mainAuthor">
      <string>Ritter</string>
     </void>
     <void property="meerKatCountry">
      <string></string>
     </void>
     <void property="otherBiasJudgement">
      <string>None obvious.</string>
     </void>
     <void property="otherBiasRisk">
      <string>Unclear Risk</string>
     </void>
     <void property="outcomeList">
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: b. CHLORPROMAZINE</string>
        </void>
        <void property="group1Events">
         <int>17</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>25</int>
        </void>
        <void property="group2Events">
         <int>18</int>
        </void>
        <void property="group2Name">
         <string>chlorpromazine</string>
        </void>
        <void property="group2Total">
         <int>25</int>
        </void>
        <void property="outcomeName">
         <string>Global outcome: 1. Not improved</string>
        </void>
        <void property="subgroupName">
         <string>not marked improvement</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: b. CHLORPROMAZINE</string>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>25</int>
        </void>
        <void property="group2Events">
         <int>4</int>
        </void>
        <void property="group2Name">
         <string>chlorpromazine</string>
        </void>
        <void property="group2Total">
         <int>25</int>
        </void>
        <void property="outcomeName">
         <string>Global outcome: 1. Not improved</string>
        </void>
        <void property="subgroupName">
         <string>not any improvement</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: b. CHLORPROMAZINE</string>
        </void>
        <void property="group1Events">
         <int>1</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>25</int>
        </void>
        <void property="group2Name">
         <string>chlorpromazine</string>
        </void>
        <void property="group2Total">
         <int>25</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: any serious or specific adverse effects</string>
        </void>
        <void property="subgroupName">
         <string>allergy - haematological - leucopenia - mild</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: b. CHLORPROMAZINE</string>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>25</int>
        </void>
        <void property="group2Events">
         <int>1</int>
        </void>
        <void property="group2Name">
         <string>chlorpromazine</string>
        </void>
        <void property="group2Total">
         <int>25</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: any serious or specific adverse effects</string>
        </void>
        <void property="subgroupName">
         <string>allergy - hepatic - glutamic pyruvic transaminase elevated</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: b. CHLORPROMAZINE</string>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>25</int>
        </void>
        <void property="group2Name">
         <string>chlorpromazine</string>
        </void>
        <void property="group2Total">
         <int>25</int>
        </void>
        <void property="outcomeName">
         <string>Leaving the study early</string>
        </void>
        <void property="subgroupName">
         <string>any reason/general reasons</string>
        </void>
       </object>
      </void>
     </void>
     <void property="performanceBiasJudgement">
      <string>Described as double-blind - the test drugs were supplied in identically appearing ampoules.</string>
     </void>
     <void property="performanceBiasRisk">
      <string>Low risk</string>
     </void>
     <void property="references">
      <array class="java.lang.String" length="9">
       <void index="0">
        <string>JOURNAL_ARTICLE</string>
       </void>
       <void index="1">
        <string>NO</string>
       </void>
       <void index="2">
        <string>Ritter RM, Davidson DE, Robinson TA</string>
       </void>
       <void index="3">
        <string>Comparison of injectable haloperidol and chlorpromazine</string>
       </void>
       <void index="4">
        <string>American Journal of Psychiatry</string>
       </void>
       <void index="5">
        <string>1972</string>
       </void>
       <void index="6">
        <string>129</string>
       </void>
       <void index="7">
        <string>1</string>
       </void>
       <void index="8">
        <string>78-81</string>
       </void>
      </array>
     </void>
     <void property="reportingBiasJudgement">
      <string>Do not report all adverse effects. The authors do not report the mean dosages/number of injections needed.</string>
     </void>
     <void property="reportingBiasRisk">
      <string>High risk</string>
     </void>
     <void property="revManID">
      <string>STD-Ritter-1972</string>
     </void>
     <void property="selectionBiasAllocationConcealmentBiasRisk">
      <string>Unclear Risk</string>
     </void>
     <void property="selectionBiasAllocationConcealmentJudgement">
      <string>Not stated.</string>
     </void>
     <void property="selectionBiasRandomSequenceBiasRisk">
      <string>Unclear Risk</string>
     </void>
     <void property="selectionBiasRandomSequenceJudgement">
      <string>Described as randomised - method of randomisation is not reported.</string>
     </void>
     <void property="year">
      <int>1972</int>
     </void>
    </object>
   </void>
   <void method="add">
    <object class="TrialObject" id="TrialObject30">
     <void property="attritionBiasJudgement">
      <string>It is reported that the number of participants declined after the baseline assessment because they were discharged or transferred. However, exact numbers are not given and it is not clear if the participants were transferred because they had a positive or negative outcome. Attrition approaching 50% for some outcomes at 24 hours.</string>
     </void>
     <void property="attritionBiasRisk">
      <string>High risk</string>
     </void>
     <void property="authorYearLetter">
      <string>Salzman1991</string>
     </void>
     <void property="countries">
      <string>USA</string>
     </void>
     <void property="detectionBiasJudgement">
      <string>&quot;Raters were blind to the treatment condition received by the patient.&quot; (p.178).</string>
     </void>
     <void property="detectionBiasRisk">
      <string>Low risk</string>
     </void>
     <void property="mainAuthor">
      <string>Salzman</string>
     </void>
     <void property="meerKatCountry">
      <string>USA</string>
     </void>
     <void property="otherBiasJudgement">
      <string>Sponsored by drug company.</string>
     </void>
     <void property="otherBiasRisk">
      <string>High risk</string>
     </void>
     <void property="outcomeList">
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs BENZODIAZEPINE: b. LORAZEPAM</string>
        </void>
        <void property="group1Events">
         <int>22</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>30</int>
        </void>
        <void property="group2Events">
         <int>21</int>
        </void>
        <void property="group2Name">
         <string>lorazepam</string>
        </void>
        <void property="group2Total">
         <int>30</int>
        </void>
        <void property="outcomeName">
         <string>Tranquillisation or asleep - not asleep</string>
        </void>
        <void property="subgroupName">
         <string>at 1 hour</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs BENZODIAZEPINE: b. LORAZEPAM</string>
        </void>
        <void property="group1Events">
         <int>8</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>30</int>
        </void>
        <void property="group2Events">
         <int>9</int>
        </void>
        <void property="group2Name">
         <string>lorazepam</string>
        </void>
        <void property="group2Total">
         <int>30</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2b. Specific - arousal</string>
        </void>
        <void property="subgroupName">
         <string>asleep - at 1 hour</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs BENZODIAZEPINE: b. LORAZEPAM</string>
        </void>
        <void property="group1Events">
         <int>15</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>30</int>
        </void>
        <void property="group2Events">
         <int>1</int>
        </void>
        <void property="group2Name">
         <string>lorazepam</string>
        </void>
        <void property="group2Total">
         <int>30</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2d. Specific - movement disorder</string>
        </void>
        <void property="subgroupName">
         <string>EPS</string>
        </void>
       </object>
      </void>
     </void>
     <void property="performanceBiasJudgement">
      <string>&quot;Parenteral medication was prepared in advance by a member of staff who had no direct clinical responsibility for the patient.&quot; (p.177).</string>
     </void>
     <void property="performanceBiasRisk">
      <string>Low risk</string>
     </void>
     <void property="references">
      <array class="java.lang.String" length="9">
       <void index="0">
        <string>JOURNAL_ARTICLE</string>
       </void>
       <void index="1">
        <string>NO</string>
       </void>
       <void index="2">
        <string>Salzman C, Solomon D, Miyawaki E, Glassman R, Rood L</string>
       </void>
       <void index="3">
        <string>Parenteral lorazepam versus parenteral haloperidol for the control of psychotic disruptive behavior</string>
       </void>
       <void index="4">
        <string>Journal of Clinical Psychiatry</string>
       </void>
       <void index="5">
        <string>1991</string>
       </void>
       <void index="6">
        <string>52</string>
       </void>
       <void index="7">
        <string>4</string>
       </void>
       <void index="8">
        <string>177-80</string>
       </void>
      </array>
     </void>
     <void property="reportingBiasJudgement">
      <string>No evidence of selective reporting.</string>
     </void>
     <void property="reportingBiasRisk">
      <string>Low risk</string>
     </void>
     <void property="revManID">
      <string>STD-Salzman-1991</string>
     </void>
     <void property="selectionBiasAllocationConcealmentBiasRisk">
      <string>Unclear Risk</string>
     </void>
     <void property="selectionBiasAllocationConcealmentJudgement">
      <string>Not stated.</string>
     </void>
     <void property="selectionBiasRandomSequenceBiasRisk">
      <string>High risk</string>
     </void>
     <void property="selectionBiasRandomSequenceJudgement">
      <string>Not explicitly described as randomised.</string>
     </void>
     <void property="year">
      <int>1991</int>
     </void>
    </object>
   </void>
   <void method="add">
    <object class="TrialObject" id="TrialObject31">
     <void property="attritionBiasJudgement">
      <string>No evidence of incomplete outcome data.</string>
     </void>
     <void property="attritionBiasRisk">
      <string>Low risk</string>
     </void>
     <void property="authorYearLetter">
      <string>Shi2010</string>
     </void>
     <void property="countries">
      <string>China</string>
     </void>
     <void property="detectionBiasJudgement">
      <string>Not stated.</string>
     </void>
     <void property="detectionBiasRisk">
      <string>Unclear Risk</string>
     </void>
     <void property="mainAuthor">
      <string>Shi</string>
     </void>
     <void property="meerKatCountry">
      <string>China</string>
     </void>
     <void property="otherBiasJudgement">
      <string>None obvious.</string>
     </void>
     <void property="otherBiasRisk">
      <string>Low risk</string>
     </void>
     <void property="outcomeList">
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs COMBINATIONS: f. OLANZAPINE + MAGNESIUM VALPROATE</string>
        </void>
        <void property="group1Events">
         <int>23</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>31</int>
        </void>
        <void property="group2Events">
         <int>8</int>
        </void>
        <void property="group2Name">
         <string>olanzapine//magnesium valproate</string>
        </void>
        <void property="group2NameProse">
         <string> combinations: f. olanzapine + magnesium valproate</string>
        </void>
        <void property="group2Total">
         <int>33</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: General - over 24 hours</string>
        </void>
        <void property="subgroupName">
         <string>one or more drug related adverse effects - by 14 days</string>
        </void>
       </object>
      </void>
     </void>
     <void property="performanceBiasJudgement">
      <string>Not stated.</string>
     </void>
     <void property="performanceBiasRisk">
      <string>Unclear Risk</string>
     </void>
     <void property="references">
      <array class="java.lang.String" length="9">
       <void index="0">
        <string>OTHER</string>
       </void>
       <void index="1">
        <string>NO</string>
       </void>
       <void index="2">
        <string>Shi Y, Dai T, Yi P</string>
       </void>
       <void index="3">
        <string>olanzapine combined magnesium valproate sustained-release tablets in the treatment of schizophrenia, acute agitation excited [Google Translate]</string>
       </void>
       <void index="4">
        <string>Modern Practical Medicine</string>
       </void>
       <void index="5">
        <string>2010</string>
       </void>
       <void index="6">
        <string>22</string>
       </void>
       <void index="7">
        <string>4</string>
       </void>
       <void index="8">
        <string>398-9</string>
       </void>
      </array>
     </void>
     <void property="reportingBiasJudgement">
      <string>No evidence of selective reporting.</string>
     </void>
     <void property="reportingBiasRisk">
      <string>Low risk</string>
     </void>
     <void property="revManID">
      <string>STD-Shi-2010</string>
     </void>
     <void property="selectionBiasAllocationConcealmentBiasRisk">
      <string>Unclear Risk</string>
     </void>
     <void property="selectionBiasAllocationConcealmentJudgement">
      <string>Not stated.</string>
     </void>
     <void property="selectionBiasRandomSequenceBiasRisk">
      <string>Low risk</string>
     </void>
     <void property="selectionBiasRandomSequenceJudgement">
      <string>&quot;randomised by using random number table&quot;.</string>
     </void>
     <void property="year">
      <int>2010</int>
     </void>
    </object>
   </void>
   <void method="add">
    <object class="TrialObject" id="TrialObject32">
     <void property="attritionBiasJudgement">
      <string>The reasons for leaving the study early were reported for those participants who did not complete the study. However, the number of participants completing different assessments at the same time point vary and reasons are not given.</string>
     </void>
     <void property="attritionBiasRisk">
      <string>Unclear Risk</string>
     </void>
     <void property="authorYearLetter">
      <string>Shu2010</string>
     </void>
     <void property="countries">
      <string>China</string>
     </void>
     <void property="detectionBiasJudgement">
      <string>Rater-blinded.</string>
     </void>
     <void property="detectionBiasRisk">
      <string>Low risk</string>
     </void>
     <void property="mainAuthor">
      <string>Shu</string>
     </void>
     <void property="meerKatCountry">
      <string>China</string>
     </void>
     <void property="otherBiasJudgement">
      <string>Sponsored by drug company.</string>
     </void>
     <void property="otherBiasRisk">
      <string>High risk</string>
     </void>
     <void property="outcomeList">
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: j. ZIPRASIDONE</string>
        </void>
        <void property="group1Events">
         <int>116</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>187</int>
        </void>
        <void property="group2Events">
         <int>54</int>
        </void>
        <void property="group2Name">
         <string>ziprasidone</string>
        </void>
        <void property="group2Total">
         <int>189</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 1b. General - ii. over 24 hours</string>
        </void>
        <void property="subgroupName">
         <string>one or more drug related adverse effects - by 72 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: j. ZIPRASIDONE</string>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>187</int>
        </void>
        <void property="group2Name">
         <string>ziprasidone</string>
        </void>
        <void property="group2Total">
         <int>189</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 1c. General - serious</string>
        </void>
        <void property="subgroupName">
         <string>severe adverse effect - by 72 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: j. ZIPRASIDONE</string>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>187</int>
        </void>
        <void property="group2Events">
         <int>3</int>
        </void>
        <void property="group2Name">
         <string>ziprasidone</string>
        </void>
        <void property="group2Total">
         <int>189</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 1c. General - serious</string>
        </void>
        <void property="subgroupName">
         <string>death</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: j. ZIPRASIDONE</string>
        </void>
        <void property="group1Events">
         <int>2</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>187</int>
        </void>
        <void property="group2Events">
         <int>5</int>
        </void>
        <void property="group2Name">
         <string>ziprasidone</string>
        </void>
        <void property="group2Total">
         <int>189</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2a. Specific - anticholinergic</string>
        </void>
        <void property="subgroupName">
         <string>constipation by 72 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: j. ZIPRASIDONE</string>
        </void>
        <void property="group1Events">
         <int>1</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>187</int>
        </void>
        <void property="group2Events">
         <int>2</int>
        </void>
        <void property="group2Name">
         <string>ziprasidone</string>
        </void>
        <void property="group2Total">
         <int>189</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2b. Specific - arousal level - i. various</string>
        </void>
        <void property="subgroupName">
         <string>insomnia - by 72 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: j. ZIPRASIDONE</string>
        </void>
        <void property="group1Events">
         <int>8</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>187</int>
        </void>
        <void property="group2Events">
         <int>7</int>
        </void>
        <void property="group2Name">
         <string>ziprasidone</string>
        </void>
        <void property="group2Total">
         <int>189</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2b. Specific - arousal level - i. various</string>
        </void>
        <void property="subgroupName">
         <string>somnolence - by 72 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: j. ZIPRASIDONE</string>
        </void>
        <void property="group1Events">
         <int>6</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>187</int>
        </void>
        <void property="group2Events">
         <int>7</int>
        </void>
        <void property="group2Name">
         <string>ziprasidone</string>
        </void>
        <void property="group2Total">
         <int>189</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2f. Specific - cardiovascular</string>
        </void>
        <void property="subgroupName">
         <string>dizziness - by 72 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: j. ZIPRASIDONE</string>
        </void>
        <void property="group1Events">
         <int>3</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>187</int>
        </void>
        <void property="group2Events">
         <int>10</int>
        </void>
        <void property="group2Name">
         <string>ziprasidone</string>
        </void>
        <void property="group2Total">
         <int>189</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2f. Specific - cardiovascular</string>
        </void>
        <void property="subgroupName">
         <string>ECG - abnormal - by 72 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: j. ZIPRASIDONE</string>
        </void>
        <void property="group1Events">
         <int>24</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>187</int>
        </void>
        <void property="group2Events">
         <int>24</int>
        </void>
        <void property="group2Name">
         <string>ziprasidone</string>
        </void>
        <void property="group2Total">
         <int>189</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2f. Specific - cardiovascular</string>
        </void>
        <void property="subgroupName">
         <string>ECG change - clinically significant - by 72 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: j. ZIPRASIDONE</string>
        </void>
        <void property="group1Events">
         <int>2</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>187</int>
        </void>
        <void property="group2Events">
         <int>4</int>
        </void>
        <void property="group2Name">
         <string>ziprasidone</string>
        </void>
        <void property="group2Total">
         <int>189</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2f. Specific - cardiovascular</string>
        </void>
        <void property="subgroupName">
         <string>tachycardia - by 72 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: j. ZIPRASIDONE</string>
        </void>
        <void property="group1Events">
         <int>2</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>187</int>
        </void>
        <void property="group2Events">
         <int>5</int>
        </void>
        <void property="group2Name">
         <string>ziprasidone</string>
        </void>
        <void property="group2Total">
         <int>189</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2g. Specific - gastrointestinal</string>
        </void>
        <void property="subgroupName">
         <string>nausea by 72 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: j. ZIPRASIDONE</string>
        </void>
        <void property="group1Events">
         <int>61</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>187</int>
        </void>
        <void property="group2Events">
         <int>70</int>
        </void>
        <void property="group2Name">
         <string>ziprasidone</string>
        </void>
        <void property="group2Total">
         <int>189</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2h. Specific - hematological tests</string>
        </void>
        <void property="subgroupName">
         <string>abnormal lab results - by 72 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: j. ZIPRASIDONE</string>
        </void>
        <void property="group1Events">
         <int>5</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>187</int>
        </void>
        <void property="group2Name">
         <string>ziprasidone</string>
        </void>
        <void property="group2Total">
         <int>189</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2h. Specific - hematological tests</string>
        </void>
        <void property="subgroupName">
         <string>aspartate aminotransference - by 72 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: j. ZIPRASIDONE</string>
        </void>
        <void property="group1Events">
         <int>7</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>187</int>
        </void>
        <void property="group2Events">
         <int>5</int>
        </void>
        <void property="group2Name">
         <string>ziprasidone</string>
        </void>
        <void property="group2Total">
         <int>189</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2i. Specific - movement disorders - i. binary measures</string>
        </void>
        <void property="subgroupName">
         <string>akathisia - by 72 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: j. ZIPRASIDONE</string>
        </void>
        <void property="group1Events">
         <int>7</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>187</int>
        </void>
        <void property="group2Name">
         <string>ziprasidone</string>
        </void>
        <void property="group2Total">
         <int>189</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2i. Specific - movement disorders - i. binary measures</string>
        </void>
        <void property="subgroupName">
         <string>dystonia - by 72 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: j. ZIPRASIDONE</string>
        </void>
        <void property="group1Events">
         <int>69</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>187</int>
        </void>
        <void property="group2Events">
         <int>4</int>
        </void>
        <void property="group2Name">
         <string>ziprasidone</string>
        </void>
        <void property="group2Total">
         <int>189</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2i. Specific - movement disorders - i. binary measures</string>
        </void>
        <void property="subgroupName">
         <string>EPS - by 72 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: j. ZIPRASIDONE</string>
        </void>
        <void property="group1Events">
         <int>8</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>187</int>
        </void>
        <void property="group2Name">
         <string>ziprasidone</string>
        </void>
        <void property="group2Total">
         <int>189</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2i. Specific - movement disorders - i. binary measures</string>
        </void>
        <void property="subgroupName">
         <string>pyramidal tract syndrome - by 72 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: j. ZIPRASIDONE</string>
        </void>
        <void property="group1Events">
         <int>13</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>187</int>
        </void>
        <void property="group2Name">
         <string>ziprasidone</string>
        </void>
        <void property="group2Total">
         <int>189</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2k. Specific - miscellaneous</string>
        </void>
        <void property="subgroupName">
         <string>physical examination significant changes - by 72 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: j. ZIPRASIDONE</string>
        </void>
        <void property="group1Events">
         <int>7</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>187</int>
        </void>
        <void property="group2Events">
         <int>4</int>
        </void>
        <void property="group2Name">
         <string>ziprasidone</string>
        </void>
        <void property="group2Total">
         <int>189</int>
        </void>
        <void property="outcomeName">
         <string>Leaving the study early: 1. For any reason - i. over 24 hours</string>
        </void>
        <void property="subgroupName">
         <string>by 72 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: j. ZIPRASIDONE</string>
        </void>
        <void property="group1Events">
         <int>4</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>187</int>
        </void>
        <void property="group2Events">
         <int>1</int>
        </void>
        <void property="group2Name">
         <string>ziprasidone</string>
        </void>
        <void property="group2Total">
         <int>189</int>
        </void>
        <void property="outcomeName">
         <string>Leaving the study early: 2. For specific reasons - i. over 24 hours</string>
        </void>
        <void property="subgroupName">
         <string>adverse events - by 72 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: j. ZIPRASIDONE</string>
        </void>
        <void property="group1Events">
         <int>2</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>187</int>
        </void>
        <void property="group2Name">
         <string>ziprasidone</string>
        </void>
        <void property="group2Total">
         <int>189</int>
        </void>
        <void property="outcomeName">
         <string>Leaving the study early: 2. For specific reasons - i. over 24 hours</string>
        </void>
        <void property="subgroupName">
         <string>withdrew consent - by 72 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: j. ZIPRASIDONE</string>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>187</int>
        </void>
        <void property="group2Events">
         <int>2</int>
        </void>
        <void property="group2Name">
         <string>ziprasidone</string>
        </void>
        <void property="group2Total">
         <int>189</int>
        </void>
        <void property="outcomeName">
         <string>Leaving the study early: 2. For specific reasons - i. over 24 hours</string>
        </void>
        <void property="subgroupName">
         <string>other - by 72 hours</string>
        </void>
       </object>
      </void>
     </void>
     <void property="performanceBiasJudgement">
      <string>Open-label.</string>
     </void>
     <void property="performanceBiasRisk">
      <string>High risk</string>
     </void>
     <void property="references">
      <array class="java.lang.String" length="36">
       <void index="0">
        <string>OTHER</string>
       </void>
       <void index="1">
        <string>NO</string>
       </void>
       <void index="2">
        <string>NCT00723606</string>
       </void>
       <void index="3">
        <string>A randomized, open-label, multi-center study to evaluate the efficacy and safety of intramuscular ziprasidone in patients with agitation</string>
       </void>
       <void index="4">
        <string>http://www.clinicaltrials.gov</string>
       </void>
       <void index="5">
        <string>2008</string>
       </void>
       <void index="6">
        <string></string>
       </void>
       <void index="7">
        <string></string>
       </void>
       <void index="8">
        <string></string>
       </void>
       <void index="9">
        <string>OTHER</string>
       </void>
       <void index="10">
        <string>NO</string>
       </void>
       <void index="11">
        <string>Pfizer</string>
       </void>
       <void index="12">
        <string>A randomized, open label, rater blind, flexible dose multi-center study comparing the efficacy and safety of intramuscular ziprasidone with haloperidol for three days in patients with agitation of schizophrenia</string>
       </void>
       <void index="13">
        <string>http://www.clinicalstudyresults.org/documents/company-study_10505_0.pdf</string>
       </void>
       <void index="14">
        <string>(accessed 13 June 2011)</string>
       </void>
       <void index="15">
        <string></string>
       </void>
       <void index="16">
        <string></string>
       </void>
       <void index="17">
        <string></string>
       </void>
       <void index="18">
        <string>JOURNAL_ARTICLE</string>
       </void>
       <void index="19">
        <string>YES</string>
       </void>
       <void index="20">
        <string>Shu L, Zhang H, Wang G, Zhao J, Xie S, Xu X, et al</string>
       </void>
       <void index="21">
        <string>Intramuscular ziprasidone has improved tolerability over haloperidol and comparable efficacy for control of agitation in schizophrenia in Chinese patients</string>
       </void>
       <void index="22">
        <string>Schizophrenia Research</string>
       </void>
       <void index="23">
        <string>2010</string>
       </void>
       <void index="24">
        <string>117</string>
       </void>
       <void index="25">
        <string>2-3</string>
       </void>
       <void index="26">
        <string>260</string>
       </void>
       <void index="27">
        <string>OTHER</string>
       </void>
       <void index="28">
        <string>NO</string>
       </void>
       <void index="29">
        <string>Zhang H, Wang G, Zhao J, Xie S, Xu X, Shi J, et al</string>
       </void>
       <void index="30">
        <string>Intramuscular ziprasidone versus haloperidol for managing agitation in Chinese patients with schizophrenia</string>
       </void>
       <void index="31">
        <string>Journal of Clinical Psychopharmacology</string>
       </void>
       <void index="32">
        <string>2013</string>
       </void>
       <void index="33">
        <string>33</string>
       </void>
       <void index="34">
        <string>2</string>
       </void>
       <void index="35">
        <string>178-85</string>
       </void>
      </array>
     </void>
     <void property="reportingBiasJudgement">
      <string>Only report side effects experienced by ≥2% of people.</string>
     </void>
     <void property="reportingBiasRisk">
      <string>Unclear Risk</string>
     </void>
     <void property="revManID">
      <string>STD-Shu-2010</string>
     </void>
     <void property="selectionBiasAllocationConcealmentBiasRisk">
      <string>Unclear Risk</string>
     </void>
     <void property="selectionBiasAllocationConcealmentJudgement">
      <string>Not stated.</string>
     </void>
     <void property="selectionBiasRandomSequenceBiasRisk">
      <string>Unclear Risk</string>
     </void>
     <void property="selectionBiasRandomSequenceJudgement">
      <string>&quot;randomized in a 1:1 ratio (in blocks of 4)&quot; (p.179); no further informations on the randomization procedure is stated.</string>
     </void>
     <void property="year">
      <int>2010</int>
     </void>
    </object>
   </void>
   <void method="add">
    <object class="TrialObject" id="TrialObject33">
     <void property="attritionBiasJudgement">
      <string>No evidence of incomplete outcome data.</string>
     </void>
     <void property="attritionBiasRisk">
      <string>Low risk</string>
     </void>
     <void property="authorYearLetter">
      <string>Stotsky1977</string>
     </void>
     <void property="countries">
      <string>USA</string>
     </void>
     <void property="detectionBiasJudgement">
      <string>&quot;Ratings were performed by the psychiatrist ordering the medication who was not aware which drug was administered to the patient. When asked to guess which drug was given, the psychiatrists administering the drug were unable to guess significantly better than chance.&quot; (p.968).</string>
     </void>
     <void property="detectionBiasRisk">
      <string>Low risk</string>
     </void>
     <void property="mainAuthor">
      <string>Stotsky</string>
     </void>
     <void property="meerKatCountry">
      <string>USA</string>
     </void>
     <void property="otherBiasJudgement">
      <string>Small short study, sponsored by drug company.</string>
     </void>
     <void property="otherBiasRisk">
      <string>High risk</string>
     </void>
     <void property="outcomeList">
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: i. THIOTHIXENE</string>
        </void>
        <void property="group1Events">
         <int>15</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>15</int>
        </void>
        <void property="group2Events">
         <int>14</int>
        </void>
        <void property="group2Name">
         <string>thiothixene</string>
        </void>
        <void property="group2Total">
         <int>15</int>
        </void>
        <void property="outcomeName">
         <string>Repeated need for rapid tranquillisation</string>
        </void>
        <void property="subgroupName">
         <string>more than 1 injection</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: i. THIOTHIXENE</string>
        </void>
        <void property="group1Events">
         <int>5</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>15</int>
        </void>
        <void property="group2Events">
         <int>2</int>
        </void>
        <void property="group2Name">
         <string>thiothixene</string>
        </void>
        <void property="group2Total">
         <int>15</int>
        </void>
        <void property="outcomeName">
         <string>Repeated need for rapid tranquillisation</string>
        </void>
        <void property="subgroupName">
         <string>more than 3 injections</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: i. THIOTHIXENE</string>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>15</int>
        </void>
        <void property="group2Name">
         <string>thiothixene</string>
        </void>
        <void property="group2Total">
         <int>15</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2a. Specific - movement disorders</string>
        </void>
        <void property="subgroupName">
         <string>use of antiparkinson drugs</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: i. THIOTHIXENE</string>
        </void>
        <void property="group1Events">
         <int>4</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>15</int>
        </void>
        <void property="group2Events">
         <int>2</int>
        </void>
        <void property="group2Name">
         <string>thiothixene</string>
        </void>
        <void property="group2Total">
         <int>15</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2b. Specific - others</string>
        </void>
        <void property="subgroupName">
         <string>arousal - drowsiness</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: i. THIOTHIXENE</string>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>15</int>
        </void>
        <void property="group2Name">
         <string>thiothixene</string>
        </void>
        <void property="group2Total">
         <int>15</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2b. Specific - others</string>
        </void>
        <void property="subgroupName">
         <string>cardiac - hypotensive crisis</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: i. THIOTHIXENE</string>
        </void>
        <void property="group1Events">
         <int>1</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>15</int>
        </void>
        <void property="group2Name">
         <string>thiothixene</string>
        </void>
        <void property="group2Total">
         <int>15</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2b. Specific - others</string>
        </void>
        <void property="subgroupName">
         <string>other - weakness</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: i. THIOTHIXENE</string>
        </void>
        <void property="group1Events">
         <int>1</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>15</int>
        </void>
        <void property="group2Name">
         <string>thiothixene</string>
        </void>
        <void property="group2Total">
         <int>15</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2b. Specific - others</string>
        </void>
        <void property="subgroupName">
         <string>other - unsteadiness</string>
        </void>
       </object>
      </void>
     </void>
     <void property="performanceBiasJudgement">
      <string>&quot;Medication was provided in identically appearing 2cc. ampules each containing 4 mg&apos;s. Prior to the administration of the drug labels were removed by a person not involved either in the prescription or administration of the drug.&quot; (p.968).</string>
     </void>
     <void property="performanceBiasRisk">
      <string>Low risk</string>
     </void>
     <void property="references">
      <array class="java.lang.String" length="9">
       <void index="0">
        <string>JOURNAL_ARTICLE</string>
       </void>
       <void index="1">
        <string>NO</string>
       </void>
       <void index="2">
        <string>Stotsky BA</string>
       </void>
       <void index="3">
        <string>Relative efficacy of parenteral haloperidol and thiothixene for the emergency treatment of acutely excited and agitated patients</string>
       </void>
       <void index="4">
        <string>Diseases of the Nervous System</string>
       </void>
       <void index="5">
        <string>1977</string>
       </void>
       <void index="6">
        <string>38</string>
       </void>
       <void index="7">
        <string>12</string>
       </void>
       <void index="8">
        <string>967-73</string>
       </void>
      </array>
     </void>
     <void property="reportingBiasJudgement">
      <string>No evidence of selective reporting.</string>
     </void>
     <void property="reportingBiasRisk">
      <string>Low risk</string>
     </void>
     <void property="revManID">
      <string>STD-Stotsky-1977</string>
     </void>
     <void property="selectionBiasAllocationConcealmentBiasRisk">
      <string>Unclear Risk</string>
     </void>
     <void property="selectionBiasAllocationConcealmentJudgement">
      <string>Not stated.</string>
     </void>
     <void property="selectionBiasRandomSequenceBiasRisk">
      <string>Unclear Risk</string>
     </void>
     <void property="selectionBiasRandomSequenceJudgement">
      <string>Randomised in blocks of 10. Method of sequence generation not clear.</string>
     </void>
     <void property="year">
      <int>1977</int>
     </void>
    </object>
   </void>
   <void method="add">
    <object class="TrialObject" id="TrialObject34">
     <void property="attritionBiasJudgement">
      <string>No evidence of incomplete outcome data.</string>
     </void>
     <void property="attritionBiasRisk">
      <string>Low risk</string>
     </void>
     <void property="authorYearLetter">
      <string>Taymeeyapradit2002</string>
     </void>
     <void property="countries">
      <string>Thailand</string>
     </void>
     <void property="detectionBiasJudgement">
      <string>The BPRS was completed by a psychiatric nurse who was blind to the intervention. However, it is not reported whether the rater for CGI and adverse effects was blinded.</string>
     </void>
     <void property="detectionBiasRisk">
      <string>Unclear Risk</string>
     </void>
     <void property="mainAuthor">
      <string>Taymeeyapradit</string>
     </void>
     <void property="meerKatCountry">
      <string>Thailand</string>
     </void>
     <void property="otherBiasJudgement">
      <string>None obvious.</string>
     </void>
     <void property="otherBiasRisk">
      <string>Unclear Risk</string>
     </void>
     <void property="outcomeList">
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: k. ZUCLOPENTHIXOL ACETATE</string>
        </void>
        <void property="group1Events">
         <int>7</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>32</int>
        </void>
        <void property="group2Events">
         <int>2</int>
        </void>
        <void property="group2Name">
         <string>zuclopenthixol acetate</string>
        </void>
        <void property="group2Total">
         <int>38</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 1a. Specific - movement disorders</string>
        </void>
        <void property="subgroupName">
         <string>movement disorder - tremor by 7 days</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: k. ZUCLOPENTHIXOL ACETATE</string>
        </void>
        <void property="group1Events">
         <int>1</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>32</int>
        </void>
        <void property="group2Name">
         <string>zuclopenthixol acetate</string>
        </void>
        <void property="group2Total">
         <int>38</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 1b. Specific - miscellaneous</string>
        </void>
        <void property="subgroupName">
         <string>pain/allergy - reaction at injection site</string>
        </void>
       </object>
      </void>
     </void>
     <void property="performanceBiasJudgement">
      <string>Open-label.</string>
     </void>
     <void property="performanceBiasRisk">
      <string>High risk</string>
     </void>
     <void property="references">
      <array class="java.lang.String" length="9">
       <void index="0">
        <string>JOURNAL_ARTICLE</string>
       </void>
       <void index="1">
        <string>NO</string>
       </void>
       <void index="2">
        <string>Taymeeyapradit U, Kuasirikul S</string>
       </void>
       <void index="3">
        <string>Comparative study of the effectiveness of zuclopenthixol acetate and haloperidol in acutely disturbed psychotic patients</string>
       </void>
       <void index="4">
        <string>Journal of the Medical Association of Thailand</string>
       </void>
       <void index="5">
        <string>2002</string>
       </void>
       <void index="6">
        <string>85</string>
       </void>
       <void index="7">
        <string>12</string>
       </void>
       <void index="8">
        <string>1301-8</string>
       </void>
      </array>
     </void>
     <void property="reportingBiasJudgement">
      <string>No evidence of selective reporting.</string>
     </void>
     <void property="reportingBiasRisk">
      <string>Low risk</string>
     </void>
     <void property="revManID">
      <string>STD-Taymeeyapradit-2002</string>
     </void>
     <void property="selectionBiasAllocationConcealmentBiasRisk">
      <string>Unclear Risk</string>
     </void>
     <void property="selectionBiasAllocationConcealmentJudgement">
      <string>Not stated.</string>
     </void>
     <void property="selectionBiasRandomSequenceBiasRisk">
      <string>Unclear Risk</string>
     </void>
     <void property="selectionBiasRandomSequenceJudgement">
      <string>Described as randomised - method of randomisation is not reported.</string>
     </void>
     <void property="year">
      <int>2002</int>
     </void>
    </object>
   </void>
   <void method="add">
    <object class="TrialObject" id="TrialObject35">
     <void property="attritionBiasJudgement">
      <string>Participants who were discharged/transferred were not followed up. The number of participants reported as leaving the study is contradictory as follows; &quot;On Day 3, 19% of the haloperidol patients were withdrawn from the study while all loxapine patients remained&quot; &quot;the others (6 loxapine and 11 haloperidol) were dropped on Day 2, when all were still rated severely or very severely ill.&quot; (p.127). By day 10, over 50% attrition in both groups.</string>
     </void>
     <void property="attritionBiasRisk">
      <string>High risk</string>
     </void>
     <void property="authorYearLetter">
      <string>Tuason1986</string>
     </void>
     <void property="countries">
      <string>USA</string>
     </void>
     <void property="detectionBiasJudgement">
      <string>Rater-blinded.</string>
     </void>
     <void property="detectionBiasRisk">
      <string>Low risk</string>
     </void>
     <void property="mainAuthor">
      <string>Tuason</string>
     </void>
     <void property="meerKatCountry">
      <string>USA</string>
     </void>
     <void property="otherBiasJudgement">
      <string>None obvious.</string>
     </void>
     <void property="otherBiasRisk">
      <string>Unclear Risk</string>
     </void>
     <void property="outcomeList">
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: d. LOXAPINE</string>
        </void>
        <void property="group1Events">
         <int>2</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>29</int>
        </void>
        <void property="group2Events">
         <int>2</int>
        </void>
        <void property="group2Name">
         <string>loxapine</string>
        </void>
        <void property="group2Total">
         <int>27</int>
        </void>
        <void property="outcomeName">
         <string>Global outcome: 1. General - no change - i. over 24 hours</string>
        </void>
        <void property="subgroupName">
         <string>up to 48 hours (CGI-I, high=worse)</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: d. LOXAPINE</string>
        </void>
        <void property="group1Events">
         <int>1</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>25</int>
        </void>
        <void property="group2Events">
         <int>3</int>
        </void>
        <void property="group2Name">
         <string>loxapine</string>
        </void>
        <void property="group2Total">
         <int>29</int>
        </void>
        <void property="outcomeName">
         <string>Global outcome: 1. General - no change - i. over 24 hours</string>
        </void>
        <void property="subgroupName">
         <string>up to 72 hours (CGI-I, high=worse)</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: d. LOXAPINE</string>
        </void>
        <void property="group1Events">
         <int>1</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>29</int>
        </void>
        <void property="group2Events">
         <int>2</int>
        </void>
        <void property="group2Name">
         <string>loxapine</string>
        </void>
        <void property="group2Total">
         <int>25</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2a. Specific - anticholinergic</string>
        </void>
        <void property="subgroupName">
         <string>salivation - too much - between 0-10 days</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: d. LOXAPINE</string>
        </void>
        <void property="group1Events">
         <int>24</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>29</int>
        </void>
        <void property="group2Events">
         <int>24</int>
        </void>
        <void property="group2Name">
         <string>loxapine</string>
        </void>
        <void property="group2Total">
         <int>25</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2b. Specific - arousal level</string>
        </void>
        <void property="subgroupName">
         <string>asleep - by 12 hours</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: d. LOXAPINE</string>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>29</int>
        </void>
        <void property="group2Events">
         <int>2</int>
        </void>
        <void property="group2Name">
         <string>loxapine</string>
        </void>
        <void property="group2Total">
         <int>25</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2c. Specific - cardiovascular</string>
        </void>
        <void property="subgroupName">
         <string>blood pressure - increased - between 0-10 days</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: d. LOXAPINE</string>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>29</int>
        </void>
        <void property="group2Events">
         <int>1</int>
        </void>
        <void property="group2Name">
         <string>loxapine</string>
        </void>
        <void property="group2Total">
         <int>25</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2c. Specific - cardiovascular</string>
        </void>
        <void property="subgroupName">
         <string>pulse rate - increased - between 0-10 days</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: d. LOXAPINE</string>
        </void>
        <void property="group1Events">
         <int>6</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>29</int>
        </void>
        <void property="group2Events">
         <int>8</int>
        </void>
        <void property="group2Name">
         <string>loxapine</string>
        </void>
        <void property="group2Total">
         <int>25</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2d. Specific - movement disorders</string>
        </void>
        <void property="subgroupName">
         <string>akathisia between 0-10 days</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: d. LOXAPINE</string>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>29</int>
        </void>
        <void property="group2Events">
         <int>1</int>
        </void>
        <void property="group2Name">
         <string>loxapine</string>
        </void>
        <void property="group2Total">
         <int>25</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2d. Specific - movement disorders</string>
        </void>
        <void property="subgroupName">
         <string>dyskinesia between 0-10 days</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: d. LOXAPINE</string>
        </void>
        <void property="group1Events">
         <int>6</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>29</int>
        </void>
        <void property="group2Events">
         <int>8</int>
        </void>
        <void property="group2Name">
         <string>loxapine</string>
        </void>
        <void property="group2Total">
         <int>25</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2d. Specific - movement disorders</string>
        </void>
        <void property="subgroupName">
         <string>dystonia between 0-10 days</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: d. LOXAPINE</string>
        </void>
        <void property="group1Events">
         <int>1</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>29</int>
        </void>
        <void property="group2Name">
         <string>loxapine</string>
        </void>
        <void property="group2Total">
         <int>25</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2d. Specific - movement disorders</string>
        </void>
        <void property="subgroupName">
         <string>oculogyric crisis between 0-10 days</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: d. LOXAPINE</string>
        </void>
        <void property="group1Events">
         <int>2</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>29</int>
        </void>
        <void property="group2Events">
         <int>2</int>
        </void>
        <void property="group2Name">
         <string>loxapine</string>
        </void>
        <void property="group2Total">
         <int>25</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2d. Specific - movement disorders</string>
        </void>
        <void property="subgroupName">
         <string>rigidity between 0-10 days</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: d. LOXAPINE</string>
        </void>
        <void property="group1Events">
         <int>1</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>29</int>
        </void>
        <void property="group2Name">
         <string>loxapine</string>
        </void>
        <void property="group2Total">
         <int>25</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2d. Specific - movement disorders</string>
        </void>
        <void property="subgroupName">
         <string>tremor between 0-10 days</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: d. LOXAPINE</string>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>29</int>
        </void>
        <void property="group2Events">
         <int>1</int>
        </void>
        <void property="group2Name">
         <string>loxapine</string>
        </void>
        <void property="group2Total">
         <int>25</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2d. Specific - movement disorders</string>
        </void>
        <void property="subgroupName">
         <string>thick tongue - between 0-10 days</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: d. LOXAPINE</string>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>29</int>
        </void>
        <void property="group2Name">
         <string>loxapine</string>
        </void>
        <void property="group2Total">
         <int>25</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2e. Specific - miscellaneous</string>
        </void>
        <void property="subgroupName">
         <string>allergy - tissue reaction at injection site - between 0-10 days</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: d. LOXAPINE</string>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>29</int>
        </void>
        <void property="group2Events">
         <int>1</int>
        </void>
        <void property="group2Name">
         <string>loxapine</string>
        </void>
        <void property="group2Total">
         <int>25</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 2e. Specific - miscellaneous</string>
        </void>
        <void property="subgroupName">
         <string>nervousness - between 0-10 days</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: d. LOXAPINE</string>
        </void>
        <void property="group1Events">
         <int>15</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>29</int>
        </void>
        <void property="group2Events">
         <int>11</int>
        </void>
        <void property="group2Name">
         <string>loxapine</string>
        </void>
        <void property="group2Total">
         <int>25</int>
        </void>
        <void property="outcomeName">
         <string>Leaving the study early: 1. For general reasons</string>
        </void>
        <void property="subgroupName">
         <string>by 10 days</string>
        </void>
       </object>
      </void>
     </void>
     <void property="performanceBiasJudgement">
      <string>Staff administering the medication were not blind to the intervention.</string>
     </void>
     <void property="performanceBiasRisk">
      <string>High risk</string>
     </void>
     <void property="references">
      <array class="java.lang.String" length="9">
       <void index="0">
        <string>JOURNAL_ARTICLE</string>
       </void>
       <void index="1">
        <string>NO</string>
       </void>
       <void index="2">
        <string>Tuason VB</string>
       </void>
       <void index="3">
        <string>A comparison of parenteral loxapine and haloperidol in hostile and aggressive acutely schizophrenic patients</string>
       </void>
       <void index="4">
        <string>Journal of Clinical Psychiatry</string>
       </void>
       <void index="5">
        <string>1986</string>
       </void>
       <void index="6">
        <string>47</string>
       </void>
       <void index="7">
        <string>3</string>
       </void>
       <void index="8">
        <string>126-9</string>
       </void>
      </array>
     </void>
     <void property="reportingBiasJudgement">
      <string>The amount of anticholinergic and sleeping medication administered was not reported. Table 3 and 3 present data from 48 hours after the 1st injection, rather than from 24 hours, despite referring to two of the outcomes in the text; &quot;Twenty-four hours after the first I.M. dose, 72% (18 of 25) of the loxapine patients and 59% (12 of 27) of the haloperidol patients showed moderate or marked improvement&quot; (p.128).</string>
     </void>
     <void property="reportingBiasRisk">
      <string>High risk</string>
     </void>
     <void property="revManID">
      <string>STD-Tuason-1986</string>
     </void>
     <void property="selectionBiasAllocationConcealmentBiasRisk">
      <string>Unclear Risk</string>
     </void>
     <void property="selectionBiasAllocationConcealmentJudgement">
      <string>Not stated.</string>
     </void>
     <void property="selectionBiasRandomSequenceBiasRisk">
      <string>Unclear Risk</string>
     </void>
     <void property="selectionBiasRandomSequenceJudgement">
      <string>Described as randomised - method of randomisation is not reported.</string>
     </void>
     <void property="year">
      <int>1986</int>
     </void>
    </object>
   </void>
   <void method="add">
    <object class="TrialObject" id="TrialObject36">
     <void property="attritionBiasJudgement">
      <string>9 participants were excluded post-randomisation due to refusal to provide post-hoc consent; their treatment assignment was not provided.</string>
     </void>
     <void property="attritionBiasRisk">
      <string>High risk</string>
     </void>
     <void property="authorYearLetter">
      <string>Walther2014</string>
     </void>
     <void property="countries">
      <string>Switzerland</string>
     </void>
     <void property="detectionBiasJudgement">
      <string>Not stated.</string>
     </void>
     <void property="detectionBiasRisk">
      <string>Unclear Risk</string>
     </void>
     <void property="mainAuthor">
      <string>Walther</string>
     </void>
     <void property="meerKatCountry">
      <string>Switzerland</string>
     </void>
     <void property="otherBiasJudgement">
      <string>Small study.</string>
     </void>
     <void property="otherBiasRisk">
      <string>Unclear Risk</string>
     </void>
     <void property="outcomeList">
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: e. OLANZAPINE</string>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>14</int>
        </void>
        <void property="group2Name">
         <string>olanzapine</string>
        </void>
        <void property="group2Total">
         <int>15</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 1b. General - serious</string>
        </void>
        <void property="subgroupName">
         <string>death</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: e. OLANZAPINE</string>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>14</int>
        </void>
        <void property="group2Events">
         <int>2</int>
        </void>
        <void property="group2Name">
         <string>olanzapine</string>
        </void>
        <void property="group2Total">
         <int>15</int>
        </void>
        <void property="outcomeName">
         <string>Leaving the study early</string>
        </void>
        <void property="subgroupName">
         <string>lack of efficacy</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: h. RISPERIDONE</string>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>14</int>
        </void>
        <void property="group2Events">
         <int>4</int>
        </void>
        <void property="group2Name">
         <string>risperidone</string>
        </void>
        <void property="group2Total">
         <int>14</int>
        </void>
        <void property="outcomeName">
         <string>Leaving the study early - ii. over 24 hours</string>
        </void>
        <void property="subgroupName">
         <string>Lack of efficacy at 96 hours</string>
        </void>
       </object>
      </void>
     </void>
     <void property="performanceBiasJudgement">
      <string>Not stated.</string>
     </void>
     <void property="performanceBiasRisk">
      <string>Unclear Risk</string>
     </void>
     <void property="references">
      <array class="java.lang.String" length="18">
       <void index="0">
        <string>OTHER</string>
       </void>
       <void index="1">
        <string>YES</string>
       </void>
       <void index="2">
        <string>Walther S, Moggi F, Horn H, Moskvitin K, Abderhalden C, Maier N, et al</string>
       </void>
       <void index="3">
        <string>Rapid tranquilization of severely agitated patients with schizophrenia spectrum disorders: a naturalistic, rater-blinded, randomized, controlled study with oral haloperidol, risperidone, and olanzapine</string>
       </void>
       <void index="4">
        <string>Journal of Clinical Psychopharmacology</string>
       </void>
       <void index="5">
        <string>2014</string>
       </void>
       <void index="6">
        <string>34</string>
       </void>
       <void index="7">
        <string>1</string>
       </void>
       <void index="8">
        <string>124-8</string>
       </void>
       <void index="9">
        <string>OTHER</string>
       </void>
       <void index="10">
        <string>NO</string>
       </void>
       <void index="11">
        <string>Walther S, Moggi F, Horn H, Moskvitin K, Maier N, Abderhalden C, et al</string>
       </void>
       <void index="12">
        <string>Rapid tranquilization of severely agitated patients with schizophrenia spectrum disorders: A naturalistic, rater-blinded, randomized controlled study with oral haloperidol, risperidone, and olanzapine</string>
       </void>
       <void index="13">
        <string>PharmacoPsychiatry</string>
       </void>
       <void index="14">
        <string>2013</string>
       </void>
       <void index="15">
        <string>46</string>
       </void>
       <void index="16">
        <string>6</string>
       </void>
       <void index="17">
        <string>A77</string>
       </void>
      </array>
     </void>
     <void property="reportingBiasJudgement">
      <string>PANSS-PAS scores at 24, 48, 72, and 96 hours not provided., PANSS scores at 96 hours not provided., Number of patients that needed additional BDZ not provided., Number of patients that needed additional biperiden not provided.</string>
     </void>
     <void property="reportingBiasRisk">
      <string>Unclear Risk</string>
     </void>
     <void property="revManID">
      <string>STD-Walther-2014</string>
     </void>
     <void property="selectionBiasAllocationConcealmentBiasRisk">
      <string>Low risk</string>
     </void>
     <void property="selectionBiasAllocationConcealmentJudgement">
      <string>&quot;The randomization list was locked in the office of the principal investigator (T.J.M.), who was engaged neither in treatment nor in study assessments&quot; (p.125).</string>
     </void>
     <void property="selectionBiasRandomSequenceBiasRisk">
      <string>Low risk</string>
     </void>
     <void property="selectionBiasRandomSequenceJudgement">
      <string>&quot;Randomization was performed by creating 3 sets of random numbers between 1 and 60 using a computer-based research randomizer&quot; (p.125).</string>
     </void>
     <void property="year">
      <int>2014</int>
     </void>
    </object>
   </void>
   <void method="add">
    <object class="TrialObject" id="TrialObject37">
     <void property="attritionBiasJudgement">
      <string>No evidence of incomplete outcome data.</string>
     </void>
     <void property="attritionBiasRisk">
      <string>Low risk</string>
     </void>
     <void property="authorYearLetter">
      <string>Yin2012</string>
     </void>
     <void property="countries">
      <string>China</string>
     </void>
     <void property="detectionBiasJudgement">
      <string>Not stated.</string>
     </void>
     <void property="detectionBiasRisk">
      <string>Unclear Risk</string>
     </void>
     <void property="mainAuthor">
      <string>Yin</string>
     </void>
     <void property="meerKatCountry">
      <string>China</string>
     </void>
     <void property="otherBiasJudgement">
      <string>None obvious.</string>
     </void>
     <void property="otherBiasRisk">
      <string>Low risk</string>
     </void>
     <void property="outcomeList">
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs OTHER ANTIPSYCHOTIC: j. ZIPRASIDONE</string>
        </void>
        <void property="group1Events">
         <int>16</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>30</int>
        </void>
        <void property="group2Events">
         <int>11</int>
        </void>
        <void property="group2Name">
         <string>ziprasidone</string>
        </void>
        <void property="group2Total">
         <int>30</int>
        </void>
        <void property="outcomeName">
         <string>Adverse effects: 1b. General - ii. over 24 hours</string>
        </void>
        <void property="subgroupName">
         <string>one or more drug related adverse effects - by 72 hours</string>
        </void>
       </object>
      </void>
     </void>
     <void property="performanceBiasJudgement">
      <string>Researcher blinded to assignment.</string>
     </void>
     <void property="performanceBiasRisk">
      <string>Unclear Risk</string>
     </void>
     <void property="references">
      <array class="java.lang.String" length="9">
       <void index="0">
        <string>OTHER</string>
       </void>
       <void index="1">
        <string>NO</string>
       </void>
       <void index="2">
        <string>尹析凡, 王刚</string>
       </void>
       <void index="3">
        <string>齐拉西酮注射液治疗精神分裂症激越症状的研究</string>
       </void>
       <void index="4">
        <string>中国当代医药</string>
       </void>
       <void index="5">
        <string>2012</string>
       </void>
       <void index="6">
        <string>30</string>
       </void>
       <void index="7">
        <string></string>
       </void>
       <void index="8">
        <string>9-11</string>
       </void>
      </array>
     </void>
     <void property="reportingBiasJudgement">
      <string>No evidence of selective reporting.</string>
     </void>
     <void property="reportingBiasRisk">
      <string>Low risk</string>
     </void>
     <void property="revManID">
      <string>STD-Yin-2012</string>
     </void>
     <void property="selectionBiasAllocationConcealmentBiasRisk">
      <string>Unclear Risk</string>
     </void>
     <void property="selectionBiasAllocationConcealmentJudgement">
      <string>Not stated.</string>
     </void>
     <void property="selectionBiasRandomSequenceBiasRisk">
      <string>Unclear Risk</string>
     </void>
     <void property="selectionBiasRandomSequenceJudgement">
      <string>Described as randomised - method of randomisation is not reported.</string>
     </void>
     <void property="year">
      <int>2012</int>
     </void>
    </object>
   </void>
   <void method="add">
    <object class="TrialObject" id="TrialObject38">
     <void property="attritionBiasJudgement">
      <string>A total of 3 dropped out in haloperidol group (serious adverse events = 2, not following protocol = 1) and 2 dropped out in ziprasidone + clonazepam (lost to contact = 1, not following protocol = 1); missing data have not been imputed using appropriate methods such as LOCF.</string>
     </void>
     <void property="attritionBiasRisk">
      <string>High risk</string>
     </void>
     <void property="authorYearLetter">
      <string>Zhou2014</string>
     </void>
     <void property="countries">
      <string>China</string>
     </void>
     <void property="detectionBiasJudgement">
      <string>Not stated.</string>
     </void>
     <void property="detectionBiasRisk">
      <string>Unclear Risk</string>
     </void>
     <void property="mainAuthor">
      <string>Zhou</string>
     </void>
     <void property="meerKatCountry">
      <string>China</string>
     </void>
     <void property="otherBiasJudgement">
      <string>None obvious.</string>
     </void>
     <void property="otherBiasRisk">
      <string>Low risk</string>
     </void>
     <void property="outcomeList">
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs COMBINATIONS: i. ZIPRASIDONE + CLONAZEPAM</string>
        </void>
        <void property="group1Events">
         <int>3</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>38</int>
        </void>
        <void property="group2Events">
         <int>2</int>
        </void>
        <void property="group2Name">
         <string>ziprasidone//clonazepam</string>
        </void>
        <void property="group2NameProse">
         <string> combinations: i. ziprasidone + clonazepam</string>
        </void>
        <void property="group2Total">
         <int>38</int>
        </void>
        <void property="outcomeName">
         <string>Leaving the study early</string>
        </void>
        <void property="subgroupName">
         <string>any reason</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs COMBINATIONS: i. ZIPRASIDONE + CLONAZEPAM</string>
        </void>
        <void property="group1Events">
         <int>2</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>38</int>
        </void>
        <void property="group2Name">
         <string>ziprasidone//clonazepam</string>
        </void>
        <void property="group2NameProse">
         <string> combinations: i. ziprasidone + clonazepam</string>
        </void>
        <void property="group2Total">
         <int>38</int>
        </void>
        <void property="outcomeName">
         <string>Leaving the study early</string>
        </void>
        <void property="subgroupName">
         <string>adverse effects</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs COMBINATIONS: i. ZIPRASIDONE + CLONAZEPAM</string>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>38</int>
        </void>
        <void property="group2Events">
         <int>1</int>
        </void>
        <void property="group2Name">
         <string>ziprasidone//clonazepam</string>
        </void>
        <void property="group2NameProse">
         <string> combinations: i. ziprasidone + clonazepam</string>
        </void>
        <void property="group2Total">
         <int>38</int>
        </void>
        <void property="outcomeName">
         <string>Leaving the study early</string>
        </void>
        <void property="subgroupName">
         <string>lost at follow-up</string>
        </void>
       </object>
      </void>
      <void method="add">
       <object class="DichOutcomeObject">
        <void property="comparisonName">
         <string>HALOPERIDOL vs COMBINATIONS: i. ZIPRASIDONE + CLONAZEPAM</string>
        </void>
        <void property="group1Events">
         <int>1</int>
        </void>
        <void property="group1Name">
         <string>haloperidol</string>
        </void>
        <void property="group1Total">
         <int>38</int>
        </void>
        <void property="group2Events">
         <int>1</int>
        </void>
        <void property="group2Name">
         <string>ziprasidone//clonazepam</string>
        </void>
        <void property="group2NameProse">
         <string> combinations: i. ziprasidone + clonazepam</string>
        </void>
        <void property="group2Total">
         <int>38</int>
        </void>
        <void property="outcomeName">
         <string>Leaving the study early</string>
        </void>
        <void property="subgroupName">
         <string>non compliance</string>
        </void>
       </object>
      </void>
     </void>
     <void property="performanceBiasJudgement">
      <string>Not stated.</string>
     </void>
     <void property="performanceBiasRisk">
      <string>Unclear Risk</string>
     </void>
     <void property="references">
      <array class="java.lang.String" length="9">
       <void index="0">
        <string>OTHER</string>
       </void>
       <void index="1">
        <string>NO</string>
       </void>
       <void index="2">
        <string>周升宝, 孙晓丹, 庞琦, 李志梅, 赵继舒, 张峰</string>
       </void>
       <void index="3">
        <string>齐拉西酮联合氯硝西泮治疗精神分裂症急性期兴奋激越症状对照研究</string>
       </void>
       <void index="4">
        <string>临床心身疾病杂志</string>
       </void>
       <void index="5">
        <string>2014</string>
       </void>
       <void index="6">
        <string>20</string>
       </void>
       <void index="7">
        <string>2</string>
       </void>
       <void index="8">
        <string>17-20</string>
       </void>
      </array>
     </void>
     <void property="reportingBiasJudgement">
      <string>No evidence of selective reporting.</string>
     </void>
     <void property="reportingBiasRisk">
      <string>Low risk</string>
     </void>
     <void property="revManID">
      <string>STD-Zhou-2014</string>
     </void>
     <void property="selectionBiasAllocationConcealmentBiasRisk">
      <string>Unclear Risk</string>
     </void>
     <void property="selectionBiasAllocationConcealmentJudgement">
      <string>Not stated.</string>
     </void>
     <void property="selectionBiasRandomSequenceBiasRisk">
      <string>Low risk</string>
     </void>
     <void property="selectionBiasRandomSequenceJudgement">
      <string>&quot;randomised by using random number table&quot;.</string>
     </void>
     <void property="year">
      <int>2014</int>
     </void>
    </object>
   </void>
  </void>
 </object>
</java>
